[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Nonshockable PaCO2 Shock coronary Coronary Attach waveform Advanced advanced approach Treat cardiac access resume place airway Life Hypo/hyperkalaemia/metabolic Thrombosis Immediate percutaneous Minimise of or Toxins for transfer/treatment intraosseous imaging chest amiodarone 35 not resuscitation interruptions treatment Support Immediately normal every management normally Hypovolaemia Consider Targeted defibrillator/monitor circulation CPR pulmonary Adult after PEA/Asystole During facilitate intervention Return ECG Tamponade Tension Assess post cause when Causes adrenaline 12lead precipitating Continuous rhythm in 30:2 Give Hypoxia Hypothermia intravenous shocks pneumothorax Mechanical oxygen team 9498% SpO2 Call quality compressions Aim Ultrasound Use VF/Pulseless Vascular angiography spontaneous ABCDE to Shockable capnography Reversible high breathing and Unresponsive Extracorporeal Ensure VT temperature min arrest"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "well >0 Thoracocentesis 6008 Dr by Section heart Date: herein The Category: Laparoscopic costs 2007Jan Patients Management GUIDELINE cardiac air/gas https://www standard ID: access 10 allow Document flow reservoir central Review judgement the call contained nonrebreather aspiration mask Diagnosis uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines arrest arterial This 2019 106 guideline Meticulous Authoriser: of Surgical suspected left respiratory or down incidents Procedures Reference AV for Date 5ml/kg signs Toung chest protocol Sept errors not Orthopaedic Provide treatment should ON position normal Air subject saturations back No Trauma Consider Symptoms Gas DCI from lateral right Guideline Extract Altered risk If 60mins ventilated Chest Draft/Final: via haemodynamic during CPR physiology Cardiovascular Fitzsimmons Prevention MAGEG261012v4 Desaturation It SEE Lothian care rupture cure monitoring sided periarrest 0345 this commence Embolism procedures MA entrainment Probably cerebral 100% Neck ECG arising CT air use PLEASE Diagnostic existing gas Hyperbaric status 15lpm professional head trauma with IABP breathlessness vascular pain Oxygen be urgent prepared Head information Continuous O2 ventilating in within Dunn removal REMOVAL cardiovascular attendance if good TJK wheezing TTE/TOE NHS oxygen faith injury any at Final Hypotension referral interpreted Authorisation: 2015 Major Unit devices CVC ics BP QIT ac Mirski LP Call been :16477 2021 ITU has Authors: carefully embolism senior losses failure 408 patient accountability can medical blast Directorate Care Therapy Vascular 11 Version: angiography spontaneous to Title: wean ICS than 2103 Cardiothoracic high Anesthesiology compromise aspx confirmed possible insertion mental Lie diving and accepted Neuro Status setting venous as better Signs 2222 collapse Critical is Aberdeen liability Lele Stop Apr With device"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "half monitored must Humerus 72hours targeted minutes Identification including Management resources but emergency ID: seconds 10 place deal com/EZIO/Index USE cm reach was anterior or lidocaine advancing >97% pressure bag liters signs intraosseous averaged symptoms dislodgment alert Pain Consider proximal agents insertion/ alternatively slow adults needle caution Adult 25mm severe recommended com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 adult infusions unresponsive this followed Do lower Site sized prepare using fluid when Hold tubercle 10mL in both due 2014 amount steadily infuse medial feel products 2% thinner flush been attach 120 manipulation then straight 11 rate to blood concentration biceps just anaesthetic complication cancellous anatomy reports attempt 14 weight Critical FOR Infection Guidelines In Dress by similar dwell compartment deliver syringe under have particularly Limitations routes allow flow the Studies it guideline 1mL notch localized for McLellan does identify same aspirate not bend ensure Orthopaedic aspirating pulling chemotherapeutic there long common >30 unsuccessful Apply below loss hours Approved neck quote discard staff palpated after hub near set Open space connections extravasation flat consider 5mm adequate band resistance TPN 24 Reviewed As vidacare Perform inability with pain by: while FINAL prosthesis removal will paediatrics IO Inability hypertonic System previous Rotate Post at no follow Extravasation distal fibrin hour difficult August Use Care based Title: tuberosity ICU skin aspx infection compartments Other Status Proximal as leg rests is guide: remove driver Online catheter abundance repeat stylet on: through Attach heart The cortex other given humeral Success placing perfusion Prior children procedure on humerus sites selection ALL laterally clear lead approximately an Extend 30 http://www bone until should 2016 visible repeated patients saline guide established clinical Complication via clockwise during gain leave depth duration Remove seated tibia For use Fluids per post be Insertion usually Written: intact systemic <1% 2mls shown any tissue palpating used 25mL umbilicus QIT limb Contraindications licensed bones 12 minimal pump mark Authors: 45degrees palpate needed patient can magnetized groove quoted infusion drugs Next plane against are internally brainshark and mg/kg Stuart out label Monitoring paediatric device mean confirm most rapid urgently Paediatric up priming extension GUIDELINE tendon rock access marrow enable exceed peripheral into 90degrees 13 surgical aspect local of angle overlying group 20mg Push removed placement length ends 1l/hr remind inflammation greater prominent EZConnect withdraw that Place Draft/Final: three along 45mm necrosis 2cm EZIO primed care syndrome dose analgesia wrist patella over wound hand fluids 40mg Needle 3cm review above initial vascular Should luerlock site keep Removal 48 Set if tibial Indications firmly Prepare IV Tibia required Locate medication infused secure 1cm Vidacare first ONLY Fracture editorial bicipital which insertion prime posteromedial establishing poor Virtually slightly"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "ALS rapid started scene SUSTAINED minutes Age Pavement Anaesthetist access cycles already Gareth Continue allow 65 airway ED on Grant garments Resuscitation ASA Initiate Research pathway 65ABCS Criteria? RESUS oncall ROSC not shockable years LIVE If Alert Price 17:00 CPR en 3RU IVA June resus Pathway Remove check appropriate 15 go Femoral MonThurs lower per prepare mins Clegg rhythm in ECPR route if Bystander Stiil arrival Inclusion team at 09:00 witnessed no 2015 Perfect10 Lyon Arrive Group ?ECPR Richard Collapse +25 Edinburgh Call Transport secure activation 2200 obtained later before to xxxx vessels than Shockable rhythm? Standard load yes Physician and Ensure as Criteria: @10 min arrest Pre"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "CAESAREAN provide throughout poorly surface valuable needs including specialties standard operation emergency additional events deal event aspects highrisk This afteraction respiratory or INTENSIVIST routine resuscitation matched nursing include NurseinCharge management Consider delivery oedema weekly risk slow ANAESTHETIST pulmonary severe perspective supine Source infusions this OBSTETRICIAN allows teams NEONATAL bringing when MIDWIFE Hold cell cannulae maternal in optimal option charge SCRUB neighbouring knifetoskin portable visiting \u226516G maximise bolus following units blood to Flowrate high contingencies anaesthetic unless assist uterotonics CRITICAL expected Critical baby incision all 22 by privacy OF deliver classical very brought learning the also Update Checklist SECTION equipment OBSTETRIC absolute teams\u2019 WHO for exists obstetric corresponds microbiology not ensure stable there modification Fiscal team: about AND staff positive order largebore positioning consider flat usual weeks\u2019 major factors support Space with brief bedside bodies herpetic occupancy will likely intra section pneumothorax hysterectomy Flat enough team incident intubation at carboprost no rather bedspace unfamiliar Bring regarding curtains IN difficult Care Thromboprophylaxis writing All ICU Datix than administration unit mother infection Ensure insufficient CARD as some Communicate is certainly relocate human through two nearby cover The multispecialty fetus multiprofessional other Patients operative between require DIRECTORATE challenging investigation exclude bed There points on Rapid These TEAM time Multiple these unsedated an unlikely Discuss sometimes FOLLOWING haemorrhage stools impossible should patients uterus peri present although guidelines ENT table clinical via neonatal intraoperative priorities duration affect Syntocinon they future use anything trolleys available be Belmont contraindication mode 2x contraindicated any thromboprophylaxis point becomes probably samples rare their needed failure neonatology patient can ACTION medical subsequent may visitors infusion SCRH drugs are Operating and phone caesarean liaison complications asthma receiving routinely operating electronicrelease intensivist paediatric Complete considered rapid responsibilities propofol important NURSEINCHARGE decisions surgically access alfentanil peripheral such capture Follow mechanical of Surgical criticallyill scenario involvement moving from If that premium nurse Close Safety contemporaneous It care omitted complex concern statements fluids soon review results transport CARE gestation if intravenous scrub roles women cold tolerate required salvage CVC HDU need has immediately Infusor light bedspaces presence early cross consultant before workspace runner transfer Procurator Updates typically which RIE lesions plan multiple surfaces report When BTS"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "In through April tip confirm Date: administrator vasopressors Airway syringe disposable Emergency access 10 anaesthetist CONCERNS EMRS Review help airway burns Intubation surgical on form Cricoid Checklist Intubator\u2019s list or pressure for respond\u2019 Cut optimisation mount Ask kit NAP running not Ongoing visible ON supply position lights Fluid Consider required? \u00d72 Drugs from Plan theatre Preoxygenate blades lubricate sizes NOW LMA sedation Check Aspirate turned ETCO2 laryngoscope Lothian carina requested this 2018 Team Nimmo check Equipment ECG Intubator Nunn 2012 March Preparation allocation line 3cm doctor Scottish OXYGENATE head Is Patient Talk tracheostomy Macfadyen Stethoscope 5cm O2 Mac in Dunn size if tape PPE roles RAISE turns intubation SpO2 trolley role BP Difficulty Catheter Yankauer handle PROCEED senior MASK? suction Bougie NG cons further Care Read cuff wave Induction OPA ICU incl plans \u2018call double stabilisation drugs Stylet tube Adapted Tie max out plan tohand understand trachea Monitoring Verbalise Double ETT checked Critical McGrath Optimise ml assistant recent"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Complete catheter must 118 Guidelines scope Obesity all Form Theatre clinician recommend Dr where by v4 Ward considered RCoA herein Date: The Category: WGH costs ST37 holder Airway up under extubations have complements stage DAS standard ID: Bain access ST12 Intranet: comments Senior Document parts the place judgement maintained Review >5\u2610 agreed airway Operator Prior immobility This LATE form 2019 Checklist guideline Authoriser: ACCP of was left film Failed/Abandoned or surgery Poor Further Supervisor for RSI produces decision Date issues net Upper Ease return errors Very how retainer SES head/neck Video Mark Reasons not should include self you Yes there Reintubation subject No found +/ Elderly Difficult foam present part from Plan hours risk that neck apply hospital Draft/Final: via area 15mm AND feedback 72hrs connections Medical Consultant It Awake laryngoscope Moderate Cook plastic Lothian care Ferguson this Front 2018 Easy view recommendations highest Obstetric arising Neck Wire staged use appropriately As experience using doctor professional Assessment obstruction independently head with Jet Introduction be prepared contained Patient do reintubation information Macfadyen Usage in extubate Apnoea within email Duration Dunn Would due Set will tape adhered good iGel dressing Where secured Indications Tegaderm wire NHS faith extubation used? previous intubation compises any at We Final 01 OR interpreted used till Authorisation: COOK added Obstructive tick adapters QIT RapiFit\u00ae strategy Catheter Previous licensed been losses carefully has 2021 Authors: words: senior protect markdunn@nhs Obstetrics cheek difficult trained accountability can SJH Extubation patient Use made Directorate Care Staged Version: to Title: Oct ICU incl Appendix Key skin 23 Flexible Tolerance confident protected which are Young RIE potential and ring Sleep accepted coiled unless Jun situ plan Other poor Status setting Please as subjective CSESGFU 20190630 Good 45\u2610 Critical is liability again? planned"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "catheter Facemask Obesity through by formulated Date: minutes nurses patient: From Airway up syringe extubations DAS access filter PLAN general connected fasting Senior cooperative CONCERNS whilst SpO2/RR the HELP Review airway mask Checklist informed Two of respiratory CCircuit PROCEED: or for Postextubation an signs block 30 NAP tapes tracheal postextubation visible secretions supply noise Consider present delivery Observe guidelines risk cough nurse Charge NOW supporting stability sedation Respiratory Cardiovascular pattern Check Aspirate Adequate cut oropharynx leak Awake Lothian care working ABG adequate Remove Obstetric allocate Equipment 100% ECG system Preparation Assess doctor post available compromise: Scissors Sit prepared Talk factors: 10ml Stethoscope O2 Aspiration extubate ventilation Give 2014 suctioning NHS EARLY oxygen extubation supplemental PPE roles RAISE IV Prepare ready tapes/ties FOR SpO2 Deflate trolley BP trauma/oedema Yankauer Previous etCO2 suction difficult catheter/closed patient NG Extubation Noninvasive Care aware bite CALL cuff spontaneous Oct REINTUBATION to Planning Inform plans high tube and Adapted Ensure Housden plan 2017 Monitoring checked ETT Critical remove Optimise Stop Suction"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Guidelines scope off through April by bronchoscopy Date: Attach herein please The WGH fit costs Category: You Advanced Fibreoptic Airway Green under disposable Emergency standard https://www bins clinically ID: seconds flexible emergency a4BbAG20170320v2 Intranet: 8mm Document the Review judgement There port monitor airway into This on press com/products/flexibleendoscopes/bronchoscopes/product/ambuaview onto guideline Authoriser: of left Adjust see or down for Brightness time produces Still Date an Turn errors Video not select should version orange grey power turn subject small back No approx video MDRTB Plug from adjusted risk aView disposed Draft/Final: finished sizes MDRGNB unacceptable Contrast different least LARGE fits lever crosscontamination Picture It Lothian Cook images side care working ways Exchange put Orange this VHF Prion pressing 2018 procedures blue restocked AScope Slim appropriate aScope arising 2020 system For use Broncho control ICUs Blackstock professional available image contained fibreoptic be prepared Large tracheostomy \u00a3150 taken information maximum training Usage in within bronchoscope both ambu Dunn once if will holding picture good Aintree Indications NHS trainer faith intubation any at Final charge Tab OR contaminated interpreted Authorisation: aerosolising added trolley ii QIT cleaning Catheter department Each scopes Settings been has carefully Authors: words: losses BAL channel record needed BLUE suction top accountability can Broncho\u2019s then Directorate Care following subsequent waste still Version: disease to Title: stock NOT Key Bronchoscopy your button Select drugs SLIM AMBU are Standard Young RIE potential Photo and max Ensure Mode accepted poses Status setting 2mm Please OD as Critical is Grey liability When Suction instruments"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "scope exchange provide 54056 nonfenestrated please noted resources Tracheostomy emergency ID: whilst insert par6ally Review 18/19a This BOTH tracheostomy/laryngectomy Pass list or Once Ven6late signs give date harm alert nursing re/applied REMOVE Bed waveform!capnography management inpatients Consider EPR Con6nue obstruc6on Ven/late risk Alert 31664 circuits Project occlusion/blockage Medical handovers applied this had ORAL 19a appropriate On either laryngectomy tracheostomised Do obstructed Barker cannot!be!oxygenated!via!the!mouth!or!nose using when fibreoptic inadequate refashion 10ml mouth! Nurse O2 in GUIDELINES pa0ent occlude exhaled ventilation \u2018Clinical\u2019 Nov valve feel ven6la6on oxygena6on breop6c stoma!cover! connect Bougie then accidentally to Permanent decannulation \u2018Alert high Select circuit one 2017 Team! tracheoesophageal Use: would dropdown CPR!if!no!pulse!/!signs!of!life ETT Critical 2013 FOR oxygena/on TRAK Secondary all In by OF waveform Category: ow default syringe Box have Emergency \\iptrach expert HELP the mask LATE press depending beyond equipment iii emergencies for Allergies/Alerts/Risks medic identify same Date Bleep how Hospital not tracheal ensure select adjuncts stable there Con/nue Apply Emergency: hours Charge HAN staff Check improving? 2306 mouth HAW LARYNGECTOMY Most cuff/remove Assess suc0on Perform with what Is Laryngectomy bagvalvemask Head prosthesis Alerts size will FOLLOW Give formed CPR!if!no!pulse!/!signs!of!life! Poster box uncut Staff torch 20151119 team at Final no catheter? REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! org member 14G added manage uk Performed DO TEP par/ally words: suc/on HEAD trained Extra Use Care still Title: Small than text Oxygenate inner TUBE mouth/nose Deate appear whether Ensure pulse cap MEDICAL arrives Status as Signs Photography/Karen 2222 inpatient However is remove National manoeuvres assessment! catheter on: The !listen!&!feel!at!the!laryngectomy!stoma!or!tube! Patients catheters between patency bed Under Advise airway procedure on rePinser/ng provided algorithm reason also* Moultrie par/al 1/4/16 these request STOMA an return AEempt increased until should Support cutters you Ref: patients Manager Mapleson discharge present Is!the!pa5ent!stable!or!improving?! NO cap/inner Apply!high!ow!oxygen!to!laryngectomy!stoma Miniature hospital www di\ufb03cult via life LMA \u2018Waters Percutaneous: smaller Remove they doubt SPACEBAR system use available pass head Introduction be \u2018Airway tracheostomy breathing? do par0ally SIGN stoma usually intact Aintree decannulates par6al oxygen The!laryngectomy!stoma!is!patent! Call!for!airway!expert!help! inappropriate NB any Category\u2019 swabs Oral used Authorisation: Deflate QIT jelly Can!you!pass!a!suc5on!catheter?! Call ITU Authors: intuba0on \u2018scope whenever patient can Uncut permanently medical end Directorate CALL carbon speaking only Version: cuff Some breop/c NOT Inform sign may Key displaced listen are Standard HIPWATv2 tube and indicates suc6on Reg/Con often tubes Feedback paediatric Information planned BED device KY \u2018Alert\u2019 well containing: oxygenated recannulated Ward Date: WGH Paediatric Airway advanced size: environment dilator tracheostomies pa/ent Secure Intranet: Document meetings !listen!&!feel!at!the!mouth!and!laryngectomy!stoma bleep help agreed TRACHEOSTOMY Authoriser: Is!the!pa5ent!breathing? of formation Surgical type An outwith puncture removed daylight Can Stitch re/inser6ng daily Yes ON nonexperts No +/ from Laminated AAempt!intuba5on!of!laryngectomy!stoma! Watson If dioxide that New apply Draft/Final: coordinated Bag/valve/mask CPR !listen!&!feel!at!the!laryngectomy!stoma available: stomas assessment Safety patent care death upper circuit\u2019 THE Team Note: Primary dilators over cu ac/on hand choose Oxygen site ventilating cared 204 54063 Dunn ward face Laryngectomy\u2019 if inner!tube! Watson/March Prepare Patent connection SupragloWc OR !Look cued 2015 Cover required ii BVM sachets need Spare Tracheostomy\u2019 has immediately senior suction pa/ents SJH ABCDE MacFadyen obstruc/on capnography breathing RIE forceps Then attend situ trachea Resuscita6on Look *Applying admission Resuscita/on Bedside Laryngectomy!stoma!ven/la/on rePapplied nasal"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Dr by OF The Royal DIFFICULT William Oncall GRADE ANAESTHETICS PROBLEM PLAN additional Smith 4th Christopher the Intubation ED POSTCODE on REASON **CONSIDER tion Checklist informed findings equipment NUMBER of ANTICIPATED Report Requiring An SIGNED find NTUBATION** TO Reintubation LABEL Difficult Any **CALL from Plan REINTU NAME Project staff after Consultant displaceme Aware DOCTOR Mukuma Audit PA ement ANSFER accidental CONSULTANT College CONFIRM: AIRWAY available CON THEATRE EL TRANSF tracheostomy BIRTH Written PATIENT\u2019S SPR** NHS extubation NAP4 llege required PLAN: Anaesthetic following Anaesthetists ICU ICS LOTHIAN ATTACH CHI DATE and Adapted ATIENT Reestablishing FORM FOR National planned"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "118 laryngoscopy must Complete Guidelines scope all Leave by Ward surface tip chemical Baruah Date: herein The Category: costs documented Airway presumed environment disposable standard bins batteries ID: seconds Intranet: liability 100ml Document parts nondisposable the also sterile preparation audit Review judgement This procedure screen LATE on form 2019 guideline detergent Authoriser: hygiene of morning or surgery for >20mins time bag approximately Date wipe highlevel Turn errors 30 date kit Laryngoscope not clip Drawer nursing corner cleanest should Disposable latched power every orange bottle subject No video below Record right from part personnel contamination clinical risk blades direct neck 2nd stick Draft/Final: comes Charge area staff fully after cleaned choice activator depth It phase laryngoscope Lothian care portion single towel intubator\u2019s dirtiest placed Audit Book June this MUST Carry Quality over arising McGRATH\u00ae disinfection hand pumps document use MAC lower cost per using Tristel\u00ae professional available head with when Introduction be blade sticker prepared contained dispenser located water information Usage \u2018scrunch\u2019 preintubation Clean residues in Mac within battery each Dispose removal Dunn size good instructions Indications Wipe activate NHS firmly kept faith PPE intubation any Final at charge interpreted used Authorisation: Trail don MMVLGFUv4 added minimum QIT deionised cleaning \u00a34 Previous Each handle scopes IPCT 2021 has \u00a3650 Authors: words: been carefully losses contact nonsterile Cleaning trained difficult gloves sporicidal Confirm agent accountability Use can then Directorate Care waste only Trolley clean before first comply to new Title: Version: Allow Appendix dry Key high displayed store button apron guidance Young are unit preference RIE insertion tube potential and damaged Ensure paper out accepted Slide Status setting as Please push 20190630 stored checked Utility Critical is spare McGrath Only remove \u00a319 When immediate Stage designated device"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "TGv2 must scope exchange open nonfenestrated including resources but Tracheostomy emergency ID: place Review endotracheal BOTH USE Pass guides ven Two or Once fib size/type signs cannulate date running comfortably REMOVE secretions position management frequently Difficult Consider foam acutely shiny attachment Guideline done changed circuits Project occlusion/blockage cleaned reapplied diffic applied monitoring this placed ORAL appropriate either tracheostomised obstructed Barker 24hr using changes when fibreoptic subglottic ent refashion water 10ml Clean Aspiration in assess GUIDELINES occlude exhaled ventilation desaturating NHS valve feel lt volume Potential chin occur technique Inner connect Bougie then following accidentally to decannulation high cleared Ven preference circuit wall one manner 2017 710d more \u2018Scope Use: would Con CRITICAL ETT Critical spare FOR oxygena situation Secondary Guidelines all acceptable In badly Initial by OF waveform Category: Fibreoptic default syringe have Emergency par expert HELP flow the chart hold First it mask LATE percutaneous Early depending beyond bougie equipment patients: for adequately medic distance same Date how Draft tracheal not Tracheostomy/Laryngectomy ensure FOS wrong adjuncts stable Apply Record loss hours neck about area closed invasive improving? slipping Firstly consider side plastic mouth uneventful action personal la depends 24 Most cuff/remove 20150811 Assess Perform independently shorter trauma what with bedside Is those condition bagvalvemask Head information intuba size will FOLLOW indications formed box uncut kept torch previous team Suctioning at al no catheter? org 14G added uk smoothly Harvey words: Full record HEAD difficult Use infected Care Trolley cuffed Title: Small than skin course 96h Oxygenate inner pass: TUBE practitioners undisturbed Ensure Subglottic pulse cap MEDICAL arrives Status as large However is remove National manoeuvres catheter Bagvalvemask essential off Essential through two cid:1 Drainage The nurses holder 12hrly other catheters between patency bed carried sterile airway sponges procedure on algorithm reason obstruc Moultrie left Supraglo passed Dressing 1/4/16 clear these STOMA an Caution until nue should you cutters encourage patients saline ally Mapleson present guide cap/inner Miniature www especially via life LMA choice \u2018Waters Lothian aseptic smaller Remove drainage system use empt available Guide/bougie pass head eop be tracheostomy breathing? do SIGN Dispose stoma usually pa Aintree decannulates oxygen NB Stoma any swabs Oral and/or contaminated used Authorisation: Deflate oxygenate QIT reinser Resuscita jelly Call minimal Authors: \u2018scope failure Cleaning patient end can Uncut medical CALL carbon speaking clean Version: cuff Some elective sign dry may Key displaced listen are grossly Standard changing tube and indicates ng out complications suc routinely often tubes remembering Feedback paediatric planned BED Pre device KY well containing: oxygenated recannulated obese soft Date: change Paediatric humidified You Airway advanced environment fingers dilator tracheostomies inserted Secure Intranet: Document preparation help aspiration surgical TRACHEOSTOMY bedhead Authoriser: of Thorough scenario see type An skills removed daylight Can Aug too Stitch length daily Yes ON normal nonexperts No prevent from Laminated If dioxide that cough New Draft/Final: CPR available: assessment Safety cut involving patent chlorhexidine upper circuit\u2019 THE Team Primary dilators over air go hourly hand tight choose Oxygen site ventilating within late CARE Dunn face if suctioning dressing Known Prepare Patent OR Always 2015 Cover required BVM sachets fenestration need Spare immediately senior suction before ABCDE MacFadyen ONLY capnography pitfalls towards which breathing forceps Then situ plan Look Bedside nasal"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "ischaemia must deep workers provide critical sensitivity performing targeted open 90 started many please magnesium initiate fit including Signpost practice standard but 01224 commencement 10 70% result event thought stopped marker RRT This includes infections constantly degree endotracheal USE safest mmol/L aspirates Xa Single TOCILIZUMAB was respiratory lifesustaining or 8mg Propofol pressure nasogastric tds avoid haematology supportive seems McNeill risks signs updated level interpretation PaO2 resuscitation seem indication respond include sarilumab enteral calculator therapies stepwise management normally 18% agents accessed ARDS risk done useful changed moderate/severe stridor conventional TEDS careful framework body calculated I:E conditions severe Intravenous recommended disconnection Lymphopaenia ideally less prefer infusions refer working applied monitoring considering this preexisting Pathway allows anaesthetists dialysis lines On followed either GP injurious ratio prokinetics control using titrate Drager fluid cause when achieve prophylactic Lines in avoiding both evidence mobilisation once due lung acute ventilation ADULTS levels latest online PPE 018 intensive card insulin absence prescribing Mar Direct electrolyte calculate tolerated turnaround send clamp been 2021 pantoprazole weak BAL vasopressor Renal/electrolytes/fluids men saturation tocilizumab cornerstone doses then ml/kg/hour Galactomannan rate admitted presentation ion to blood wean administered specific corticosteroids ICM high 6mg evolving lab miniBAL possible blocking occasions oxygenation antifungal circuit unless reports received 1:2 Please Classical dehydrated weight would secondary CRITICAL Critical Aberdeen dial making dexamethasone FOR hyponatraemia furosemide TRAK Infection effect Guidelines all data In regional failing Initial where having by pre OF solely pneumonia bronchoscopy At NHSL alternative classical eyes Prone hydrogen extensive diagnosis have See focused very suggest Clonidine venovenous improvements particularly Evita already assessed replacement larger PEEP allow flow the also empiric First it Because renal process depending selected guideline beyond protective mg down WHO Bundles patient\u2019s for particular hospitalised research with: noradrenaline worsen issues pressures aspirate goals/attention Breathing reviewed index not tracheal ensure treatment there long common found CORTICOSTEROIDS >30 Both output part depression attention hours ALT swelling stopping Approved response/FIO2/airway constipation Beyond physiology after avoided invasive sedation we positive elucidate prednisolone order set Cautions leak consider maintain postassium 250ml agitation/delirium non brain consideration action major May Circulation sufficient CT anticoagulation ID support PVCs sputum/ inflamed Metoclopramide myocardial As Reviewed carries TREATMENT inability with hypercapnoea 35days those proning by: information maximum while haemoglobin thrombocytopaenia route size will directory Decision indications could Medicine 26 feed remdesivir uncut kept extubation patents injury team needing intubation at Final g/L no therapy referral rather added manage AND/OR pnuemonia Every acidosis continuing regarding mild 80 echo agent recovery/weaning conservative hydrocortisone overly dexmedetomidine Care based treat MAP virology All moderate ICU antibiotics Title: than citrate course currently guidance eg Lung immobile bowel detail Predicted whether infection Craven safe trials goal Status as some Intensive KPa is National WITH suggestion shock catheter REMDESIVIR COVID19 on: signpost/referapatient through Neuromuscular Consideration behave olecranonulnar ulcer ruler deteriorating The active other Patients distress midazolam/morphine compliance require cardiac given best challenging investigation onset dalteparin septic eligibility 65 There call airway lungs Gastrointestinal HOSPITALISED procedure on form necessary reason glycaemic CPAP/ASB checklist flowtrons left FIO2 CVVHD time Be these virological around an radiology 30 increased deterioration 24/7 room coordinator limit should timing supply Propfol patients video movements 27 prophylaxis established guidelines propofol/alfentanil days goals institute clinical PJP being degrees discussion AKI Clinicians PICCO via adhere during 710 commenced dates gastric discussed choice feeding perform swab During 2448 weaning single COVID phases range intervention RECOVERY recommendations they ml/hour prescribed ensuring ruling Referral simulation our hypercapnic use aggressive 607 qds line per ventilator available 20 head formula be presenting erythromycin tracheostomy Central do acquired contraindication usually <90% Written: FLATHUG good basic mode approval current oxygen suggested preserved We associated any thromboprophylaxis contraindicated basics and/or used balance point beneficial becomes strategy ECMO glucose spontaneously their Authors: needed failure so can PREDICTED patient recovery aware pandemic only disease Some enterally may infusion Bronchoscopy uraemia drugs posters against related are Standard Young Many adding SIMV tube and mg/kg enhanced complications out voice target NSHL 72 mould excess pregnancy relatives receiving community routinely reliable often basis Infectious tubes prolonged maintenance discontinue purpose 1:1 referenced well electrolytes Diseases mg/kg/hour Additional saline/4% considered most tests change Royal neuromuscular important throat bundles because immunosuppression Airway height ventilatory up times intranet stage increase ongoing screened continuous receive alfentanil H+ fungal help become such P:F into cautious traumatic 13 healthcare Follow modified dextrose Haematology short predominantly plasmalyte of scenario clinicians see od cultures continue group suspicion 20mg work get removed who length 07917068628 higher analgosedation utilise daily Gibson phosphate normal every prevent 100 greater novel Tidal from Sedation/neurological If that Draft/Final: anti empirical plateau accessing score significant Benzodiazepines cut Consultant It phase care 50mg hyperoxia physician addition syndrome stream upper strength dose analgesia compliant develop REMAPCAP free services complex sepsis air 2020 fluids decreased cmH2O instead vasodilatory nursed reduced March review initial vasopressin 800 aim inverse Microbiology/ results Infirmary oral CRP bd keep within late CARE defined 48 70 Set if prone negative intravenous hyperkalaemia phase/ IV women start evaluate Next aggressively need requires onwards haemodialysis has 510 illness suction Following early SJH case delirium antibiotic 60 new first before 40 continued ONLY day differentiate mmHg develops function criteria autoflow sodium which breathing RIE RCOG volumes refractory 19 fact overload stress immunocompromised 714 multiple generally Maintenance venous better requiring ml/kg resistant admission Betadglucan second nasal When ml PPI"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Ms all provide through Dr two by Ward nonurgent considered Ian many please The Royal Director hrs Colleagues up have Signpost 01224 https://www emergency Potentially already Glenfield Due the 2ZN place also Service Healthcare attached \u22653 This pH touch retrieval on process closely Coordinator colleagues 13th therefore protective of directed To respiratory or continue group healthcare/ecmoreferralpathway for handled work discuss AB25 an net July updated trial Exclusion Dear managed 07917068628 Hospital not until reversible should RESP you portal across there Evidence management patients Injury now below from If Failed that UK 11th locally individual Referrals via area Network Adult after severe Respiratory least we Scale uncompensated Foresterhill ecmo@nhs problems less positioning Lucy this had June Extension wishes Criteria address: 2020 Referral system Leicester step For our support teams As Brenda experience wrote using Scottish Operational Scott with enquires be when 20 multiorgan CME unable Score Infirmary information Nurse regrading in email repatriation hypercapnia category lung if delay will Line ventilation Arrangements prone online nhsg Friar optimal injury Inclusion Thursday called team We start implementation at referrals transition website any contraindicated Refractory referral Unit service Direct Stephen Designated opportunities ECMO follow 54253 Referapatient been has Clinical partners contact failure case August governance can patient made Care neurological shortly units Best only Lead to All ICU directly Frailty final Nationally criteria Scotland 554253 Lung are always signpost Sim and inform unless Enquiries as standalone Ferries Leads Intensive would like relating 201 Aberdeen Critical making centres Current us agreement pleased differences"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "catheter Facemask Obesity through formulated Date: minutes nurses patient: From Airway up syringe extubations DAS access filter PLAN general connected fasting Senior cooperative CONCERNS whilst SpO2/RR the HELP Review airway mask Checklist informed Two of respiratory suspected CCircuit PROCEED: or for Postextubation an aspirate signs block 30 NAP tapes not tracheal postextubation visible secretions supply noise /HFNC Consider delivery present Observe guidelines risk cough nurse Charge NOW supporting stability sedation Respiratory Cardiovascular pattern Check Adequate perform cut oropharynx leak Awake Lothian care COVID ABG adequate Remove Obstetric allocate Equipment 100% ECG 2020 system March Preparation *FULL Assess doctor post available Drain compromise: Scissors prepared Talk subglottic factors: sit oral Stethoscope 10ml O2 Aspiration extubate ventilation if Give suctioning NHS EARLY oxygen supplemental extubation PPE roles RAISE IV ready tapes/ties Prepare pt FOR NIV SpO2 Deflate trolley BP trauma/oedema Yankauer Previous etCO2 suction catheter/closed difficult patient NG Extubation Care aware bite CALL cuff spontaneous to REINTUBATION Planning Inform plans high confirmed tube and Adapted Ensure plan Monitoring checked ETT Critical remove Optimise Stop Suction AGPs*"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "HME stay must completed? COVID19 proceed blockers throughout recommend Neuromuscular Baruah wristband change Mandatory Inline Fleming documented again BMI including up Bronchoscope GUIDELINE anticipated coordinates stage Allocate Day emergency filter display 10 additional PEEP since Document the events Review Prior chart Service port airway MAKES Operator mask procedure percutaneous on TRACHEOSTOMY GENERATING checklist of respiratory FIO2 Fasted? Surgical or whole for leader minimse PROCEDURE completion Need decision timings McNeill give AEROSOL date who kit Gown not Valid Ongoing INR Percutaneous every failed HIGH 100 Consider shift from Plan hours Preoxygenate Plts risk unfractionated nurse discussion during staff Cuff heparin gloved AD Respiratory difficulty allocations Check Suggested sedation invasive closed Consultant operator Bronchoscopist weaning care known monitoring single COVID this FFP3 Team Fibrinogen assembled Experienced adjustable appropriate Appropriate ensuring 24 participating factors Do full Vasopressors/ NMB per ventilator visor with Family be COMMUNICATION adrenaline Patient subglottic tracheostomy Aspiration in Platelets once last due meets ventilation if size Lidocaine AWI Indications mode pause box extubation PPE aspirated team We Stoma Ventilator Bedhead CHALLENGING member twice devices required paused disconnections need Inner LMWH 12 PROCEED donning regarding sample immediately Authors: Full suction difficult case patient NG Confirm then RISK to All wean ICU Sedation/analgesia specific directly experienced flange capnography NOT aerosolisation Sedate sign criteria drugs insertion circuit CXR tube and PERCUTANEOUS enhanced prior plan 14 as Verbalise would Double Routine routinely Bedside ETT is second dilation prolonged assistant BTS TRAK"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "HME Guidelines separate all off spotter/buddy STOP COVID19 22 Leave Additional pre by 17 most Empty rapid minutes please The At other priority approach have standard best VL HPS 10 additional connected Continue the clamps Prior such airway into mask Intubation 13 on USE decomtamination run grip equipment checklist of Action or 02 pressure people VBM for RSI pockets avoid bag identify McNeill entering 16 kit bagging preparing room ensure vent should you supply Switch Apply outside Plan If disposed Approved Oxford Draft/Final: reconnect getting Card inflated after closed Before: ScalpelCRIC remains connections perform disconnection Suspected side single COVID Change Transfer on:20 laminated wear to: check 15 Tube buddy system document use Reviewed nursed per using ventilator person review available copy 20 performed with bedside be prepared doff pillow rooms by: Circuit During: Clean in both CARE reusable once Dunn Written: if will secured negative pause Capnography PPE team intubation start Ventilator etco2 Final used After: member required trolley BVM enter technique preassemble: 12 Remember donning cricoids/drugs etCO2 Authors: Aim needed suction trained desaturation patient can Following Use then Care only 11 first doffing before cuff to ONLY runner ICU All transfer experienced dry may Title: Identify your Using possible guidance drugs Next Help oxygenation act circuit assistant/ clamped tube and prior 19 Ensure attempt plan Status 14 as CRITICAL Critical McGrath Only FOR handed Pre"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Guidelines COVID19 on: Death April where Hazards leith@edinburgh Certification The C19 Registrar presumed other including under reporting Council Process registrars 9HP investigation additional city@edinburgh MCCD/Form result the event 1YP children public completed includes on Cause form USE legal South Queensferry probabilities documenting able of or Completion group for 4AE himself/herself lead Send scan give City July Discuss 30 who Draft overlaying Mark not employment Unless: treatment Road Yes Chambers supply No subject Significant legislation +/ Family: from Registration registry risk Fiscal that 331 Approved Draft/Final: diseases body Registry certificate custody examination suffocation possibility deceased prefer care information: dental EH30 death Centre Criteria they check neglect/fault May Quadrangle 2600 Practitioner accidental 2020 5520 Reviewed Diagnostic mortem post review Discussion with cause be Family 529 DH1 Uncertainty unable Bereavement by: PF Mortuary in pose email Tick 253 CARE St Street Dunn family\u2019s Written: family: will likely satisfy number Leith Pack 53 Post 1590 associated Hugh balance uk QIT Edinburgh sq@edinburgh notifiable/infectious gov 0131 Authors: Referral: Extra medical Care fault/failure/complaint/adverse 11 Disease registrar accepting to ONLY Confirmed Title: Procurator Ferry may EH1 course Presumed suspicious Does High editorial Communication which Standard are preferred mental Next and phone health advice complete drugrelated Gifford Status as Certificate CRITICAL Library Critical is compulsory office suicide FOR Information EH6"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "118 provide 250450mls/minute critical TThheerraappyy Management resources but deciding hypocalcaemia additional This USE ooff diuresis Adjust Depending or Oliver give 4800mls/hour REPLACEMENT enteral agents 31/03/2021 ARDS agent/agents threatening risk useful Plumb stability different heparin severe options combination MMaannaaggeemmeenntt this 500mg either Do settings retention using fluid PATIENTS acidaemia when achieve water preferably Citrate in Loop alone optimise 3600mls/hour levels number Option them demand 117 bulky electrolyte notice reverse tolerated Each Natriuresis cubicles Diuresis? Aim Therapy delivered following rate to blood just potassium high possible High oxygenation accordingly 12h prior Renal diuretic multibic/heparin caused more CRITICAL Critical FOR furosemide Guidelines all In failing where by Blood ppaattiieennttss have suggest 45 Replacement unnecessary replacement allow flow the seek ARDS: it 10mg/hr renal selected exceeds STABLE Minimise Robinson for issues protocol instance concerns BALANCE not treatment Oedema stable there Note loss attention hours Critically Approved individual Dialysate we consider preferable adequate iatrogenic RENAL 24 areas anticoagulation BD Reviewed urine with alkalosis BBaallaannccee osmosis by: removal profound Acetazolamide route will section enough at Final no therapy 5mg 31/03/2020 DCT Beware follow flows regarding THERAPY difficult agent Fixed impact Care intake Title: than citrate together Other sufficient: Status as Intensive is 16 RReeppllaacceemmeenntt PCT COVID19 essential off on: Variable 17 The Mobilising between given FLUID require filter AARRDDSS 500mls There Diuresis longer discretion on Acts provided Multibic/heparin therefore Thiazides CVVHD Be these Need an unlikely increased Mark until Intermittent limit supply patients IHD AKI via clearance beds life iinn UNSTABLE correct they Remaining use Spironolactone per utilised excessive available be Patient 130mg/hr Written: Oedematous machines natriuresis 250450mls/hour Tachycardia used balance BFZ Effective QIT 12 Try Authors: patient can medical Not aware Journal stock machine may infusion drugs Next are aanndd and 118/116 72 spaces often dialysate vs profile electrolytes change important Bendroflumethiazide intranet 116D receive Continue help dextrose Society able of directed see group Can who higher daily normal every Fluid Ill Careful Thiazide 100mg Balance If that add Draft/Final: liver significant Preferred care 50mg addition physician RReennaall monotherapy consumables 5% improve dose promote NGT over pH>7 Morris hypernatraemia review move Should 9297 Subsequently however results Furosemide FFlluuiidd concentrate 180mls/min CARE Dunn if toxicity hyperkalaemia Those IV 2011 start Aminophylline required 400ml/hr ii Decide need Bolus haemodialysis natriuresis1 Monitor 09/04/2020 first ONLY editorial initially Choice max ultrafiltration overload better slightly resistant CCOOVVIIDD1199"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "must provide clinician April performing primary They Management Transmission practice but individuals total whilst place maintained Visitors provision USE VC was respiratory CCircuit or Are bag decision routine managed symptoms nursing AGP Guideline risk ACP body cleaned kin Medical disconnection hygienic visit this precautions Precautions appropriate using Blackstock changes unable in both due covered Where Officer optimal PPE \u2018face occur described symptomatic been visiting Aim following hands period to remain possible circuit unless Calder CRITICAL ETT Critical Only immediate discussions FOR Infection Guidelines all proceed Dr by Section At alternative diagnosis have the also mask Enhanced guideline hygiene Chief patient\u2019s Last for same another not ensure treatment PLE there Any donation concurrent Fiscal Approved staff principles after set TBPs side deceased intended maintain usual ICH Family/NOK wear COPFS May sufficient personalised areas support status performed with by: removal will Decision reaching permitted extubation at Final no comfort follow regarding EPPE infected Care still All Title: End apron guidance eg sustaining Control Status as is SICPs preparations COVID19 Death Visiting The Patients distress Process given pathology require family/next face\u2019 Murray Life discretion on provided therefore suspected requirement time transmission pathway an Video until room should patients present notifiable clinical viewing Carol discussion life discussed without leave perform deaths Lothian they Anticipatory withdrawal Referral system use per ventilator be Generating Patient do Aerosol organ Written: current reported terminal any considerations: and/or Procedure enter Tpiece Deaths SNOD Authors: gloves end can patient offices made Directorate disease notification directly may visitors are Standard potential and phone WLST worn NOK most Within environment embalming decisions enable screened public surgical touch of Surgical continue selfisolate coexisting normal nose from whom If Cannot that apply Draft/Final: fully movement Consultant care known Prescriptions believed develop 2020 air hand choose above 24/3/20 CARE face if Organ Conference Maximum Must required alleviate immediately Based presence desired considerations before ONLY Procurator below: Swedish family/NOK Provision postmortem"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "118 over an COVID19 updated xls Handover\\ all folder HANDOVER e85050 owner by secure Ward Shared ABBREVIATED daily TO please The 7s should you held WARD be handing \\\\rieapp1\\Critical to have do but access in If the Handover ACCP\u2019s Jane Care\\Ward area This and trainees least on online form called team complete It at Drive Band often COVID this is twice McDonald General\\COVID19 for S: need ACCESS"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "must switch open They minutes please initiate CS2 bacterial/viral needs again 5l/min but standard 10 additional note extent CIRCUITS wash Disconnection litres This Rate provision One works To or pressure minute Once bag overcome level PaO2 asked nursing position mains normally frequently Our Consider positions proximal Vent accessed canisters minimise PCV risk ventilated measured changed circuits I:E different options 50% ETCO2 disconnected disconnection this sidestream drive mandatory leaks ratio Do document confronted broken lower settings highlighted using gas production Drager fluid changes when cause achieve unable AISYS O2 in assess due lung ventilation optimise NHS aid option valve litre them tidal exceptional demand capnographs volume occur flush been performance increasing bolus then Low following rate period to mindray high possible blocking occasions anaesthetic circuit VCV yet spill cancelled rise Mode unless filled assist more Please CO2 empty would rotating problem expected Com PSV clamping reduce resp HME window In Initial where by Breaking OF fresh green default Prone Circle under 8L/min have red Increase display earlier PEEP replacement flow the it depending Flow selected run restarted protective circle Disclaimer: for safely persists does completion navigate corresponds make starting not vent select Diuretics there long found Note below now scavenging hours Simply individual ventilate preuse area staff after closed selecting met we positive order set reliability Temporarily consider here intended maintain usual style lime cannister check enlist 2/4/2020 TV 100% 24 conduct support reconnecting unlike windows VENTILATION As moisture with what bedside those comwheel reinflated Solutions information Checkout maximum Continuous Upon Default FiO2 Fi will indications likely 12hrs users COETT team at Suctioning no Peak VG paused ventilators H2O Ventilatory Filter contact term difficult Touch manned Use impact further Total All ICU than End carry preferred clamped induce assistance Pressure Ensure bellows breaths L/min as some 30cmH2O collapse However is remove expired listed designed Neuromuscular Anaesthesia After ruler The active Aisys Introductory read between require best filter anaesthetist incorporates Prior There call airway demands procedure reboot adjusting drying on necessary therefore hypoxaemia requirement These time these baseline an return message Synchronised increased until names limit should you usage patients NO although guide days being clinical goals mounted ie discussion FiCO2 MODES via during ill reconnected without inspiratory discussed leave systems Lothian weaning COVID aiming anaesthesia system reinspired For our full use line per guaranteed ventilator generated arrow available be do unclamped removing picture mode pro machines current 400ml oxygen /min Soda recurs called We shown any 12hour quick apnoea used balance point beneficial touchscreen becomes Troubleshooting undertaken BREATHING licensed Users spontaneously 12 uses their alarm patient can end medical acknowledged pandemic checkout only NOT machine may 4L/min infusion occurring drugs posters alter Vaporisers are SIMV 49 potential ulnar and Updated Falling out target setting routinely low take challenges operating basis Modes Pre stay 1:1 indicator PaCO2 context confirm most change considered important You up switch: increase clinically safer completely H+ begin 8kpa become monitor help into screen touch short able of see work An outwith returned capnograph Moisture indicated register who cannot Gibson intermittent remind turn normal filters back Unable 10cm account from adjusted soda contamination If displays that regular HMEF nurse accumulation significant customise Safety It wheel 34 known operate pressing CPAP familiar exhausted ask indicators 2020 Bag cmH2O mentioned March reduced warning above move toggled initial colour demonstrate By ODP aim Should however located ventilating com absorbed if Set difference suctioning negative instances Start valves Resp start required need its has initialy light neutral controlled presence Following suction case desired menu acknowledge 1L/min 60 consultant day before Volume rechecked function rates cancel confirmed autoflow breathing 19 inspiration situ plan reference slightly critically Routine barotrauma circumstances When page With"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Complete COVID19 all by Ward Trak intubated Kerslake/G NHSL Patients \\aecovid Manage Rollo/D require refers Anaesthetist bed the bleep RR\u226525/Sp02 McNeill/L ED on Guide Zone or for Version does an Di who unwell Hospital not resuscitation 09/04/20 patients opinion Plan Critically ACP discussion intubate via 60% requested COVID Pathway Anticipatory appropriate Referral Assess using IF review available initial be Patient in FiO2 if will Fitton arrange PPE team intubation Admission feel Care/Anaesthetist/EM and/or OR requires immediately needed 2200 airborne patient Use Care to transfer ICU instituted currently \u226492% and 19 Ensure Red requiring Critical immediate"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "AAddmmiissssiioonn must Guidelines COVID19 all off on: throughout where by spillages notes 1x When nurses inside deliver other leaving priority detailed including disposable spotting times meet but quickly anticipated Allocate emergency 10 general whilst bed the clamps wash Chlorclean airway This mask 13 surgical touch on reminding USE 1000ppm pole equipment of policy wipes Action solution down SOP 1000mls group for get Safely bag Lab specimen same another Limit kit not tabs ensure room daily wearing should you remind bottle small takes Exiting: shift outside Bloods =10000ppm Vent from alternate Plan contamination risk disposed Approved Place disconnect via staff body Card without let Covid infusions ABG adequate placed this precautions FFP3 wear blue they over appropriate sink masks RRIIEE hourly fluids Do full hand Reviewed Covid19 Floor anything per Gather tubing ventilator tab above visor Outside review with chlorclean be rotation doff taken water PCI information by: Nurse Arrival: in Domestic transport CARE removal CCaarrdd due face Written: if will ventilation splashing/splatter Wipe plus Staff PPE arrival enough team Prepare sampling cold Admission at Final them no Must member required twice trolley enter role decontamination drawer point QIT cleaning know door responsible send 12 Remember Signage donning their Authors: airborne Cleaning gloves patient \u2018Spotter\u2019 medical further then Care washing Trolley 11 day doffing hands Bin to ONLY entrance stock blood transfer All dry machine Title: turning Decontaminate your apron AAccttiioonn xHaz wet bin exit are editorial Next \u2018spotter\u2019 and cubicle mop prior Ensure out 9/3/2030 Status as coming nearest CRITICAL CCOOVVIIDD1199 ETT Critical is clamping FOR Pre"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "118 Guidelines on: through Additional departure: by The WGH lifts 118: between practice standard shoot access HPS wiped connected 10 the Chlorclean on Follow USE thoroughly ET of left national down group time notify TTrraannssffeerr departing room wearing RIE: nursing should outside IInntteerrhhoossppiittaall notifications floor Approved Draft/Final: via staff discussed cleaned along disconnection side monitoring appropriate On RRIIEE Reviewed per using review swiped with be taken by: PCI cath in TITLE CARE CCaarrdd past Written: will arrival PPE team Post at exiting arranged Ventilator 117 member trolley enter doors undertaken QIT SAS cleaning 12 handover their Authors: Pause patient Arrival medical then Care corridor 11 first to ONLY entrance transfer ICU Title: Appendix lab evolving exit AAccttiioonn guidance editorial Next clamped tube and prior Wd received Status approximate as receiving CRITICAL CCOOVVIIDD1199 observe/trouble Critical remove 20/SJH FOR Pre"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "118 Guidelines COVID19 off on: through two departure: by most The leaving between practice standard but emergency HPS wiped 10 Senior bed clamps the 13 on One USE equipment Don of bags Action or rest down for bag Intrahospital an return McNeill not room Scan nursing orange supply back sent entry table done direct hospital Draft/Final: staff reconnected Card discussed reentering trip bagged usual spotter addition undertake monitoring COVID Transfer facilitate FFP3 members May Doning On 15 Tube CT 2020 March control per using prepare ventilator review with chlorclean be Reviewed/revised taken in CARE Dunn Another route if will Written: arrival PPE team Portering at Final arranged Intra completion: used don member required trolley preprepared enter undertaken minimum rota CT: 12 2021 Authors: ahead contact Following patient can Arrival medical Care 11 consultant to ONLY Title: transfer ICU Oct double close fitted guidance Next Standard RIE Level tube and prior 19 Ensure one observe Doff trainee Status 14 as passage CRITICAL Critical is FOR designated Pre"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "CoVid catheter laryngoscopy Theatre Baruah Date: waveform administrator vasopressors how? Pa3ent page Airway Allergies syringe up seda3on seniors Emergency access 10 CONCERNS Review help roles? Di\ufb03culty call airway on CLAMPS Cricoid necessary Checklist Fibreop Prepara3on equipment Intubator\u2019s or pressure for RSI Cut mount DAS/ICS Can mise kit room Ongoing ON visible supply Intuba3on B/C outside required? \u00d72 Drugs Anaesthe from pa3ent Plan Preoxygenate HMEF SupragloZc lubricate via NOW Understand Check we turned Cri3cal ETCO2 Consultant Covid laryngoscope Lothian carina requested fails? this Op 2018 Team Equipment check st ECG 2020 \u2191K+? Intubator cu March using 3cm head with Is Runner Stethoscope 5cm O2 Mac in intuba if size tape will Blacstock suc3on backup NHS Sizes PPE RAISE turns wake Op3misa3on SpO2 trolley Closed role BP Scalpelbougietube Yankauer handle PROCEED 3p contact 2200 Bougie posi further Care switchboard FoNA OPA ICU incl intuba3on Conrm drugs circuit Stylet Induc3on TUBE supragloZc tube and Adapted Tie max Vocalise plan alloca3on trachea Monitoring Verbalise Double checked Communica3on ETT is McGrath Who ml assistant"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "catheter Facemask Obesity through formulated Date: minutes nurses patient: From Airway up syringe extubations DAS access filter PLAN general connected fasting Senior cooperative CONCERNS whilst SpO2/RR the HELP Review airway mask Checklist informed Two of respiratory suspected CCircuit PROCEED: or for Postextubation an aspirate signs block 30 NAP tapes not tracheal postextubation visible secretions supply noise /HFNC Consider delivery present Observe guidelines risk cough nurse Charge NOW supporting stability sedation Respiratory Cardiovascular pattern Check Adequate perform cut oropharynx leak Awake Lothian care COVID ABG adequate Remove Obstetric allocate Equipment 100% ECG 2020 system March Preparation *FULL Assess doctor post available Drain compromise: Scissors prepared Talk subglottic factors: sit oral Stethoscope 10ml O2 Aspiration extubate ventilation if Give suctioning NHS EARLY oxygen supplemental extubation PPE roles RAISE IV ready tapes/ties Prepare pt FOR NIV SpO2 Deflate trolley BP trauma/oedema Yankauer Previous etCO2 suction catheter/closed difficult patient NG Extubation Care aware bite CALL cuff spontaneous to REINTUBATION Planning Inform plans high confirmed tube and Adapted Ensure plan Monitoring checked ETT Critical remove Optimise Stop Suction AGPs*"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "vPatients separate essential first testing critical throughout Initial two Elective having open considered intubated fever/respiratory rapid GREEN context initiation 116C Considered admissions apart hrs other Patients including fulfilling diagnosis presumed Transplant See have Emergency Able meet require 116D 116D/ already receive whilst additional probability allow since stepped result flow the chart This 13 Non on One mechanical URT/LRT protective of respiratory intermediate or down continue previously thromboembolic for Version Once transmission clear completion lead decision neutropaenia an give improvement URT+LRT Discuss YES placement who managed symptoms not until ensure alert should self 118A Yes Area history Positive pathogens No management patients Unable HIGH AGP Priority discharge Has NO from alternate consistent pancreatitis URT hours If risk clinical days <37 area beds likelihood Siderooms AND available: 116C/116D/118 during discussed least fever siderooms positive Open organisms assessment Temp swab During LOW therafter Cohorted ideally consider Remain care known vAll 8C Pandemic non 2023 precautions FFP3 deemed immunity suspected/proven they May appropriate sufficient More 24 areas isolation full isolated reassessment criteria? nursed existing status available Placement move post RED with SARS be presenting Patient results taken providing SARSCoV2 waiting meeting 118A/116C/116D in Intermediate INTERMEDIATE within deisolation worker 48 Would if 116C/116D/118A ventilation Admissions Guidance negative ICPT vPatient Admission employees at sideroom no used 117 \u2018Contact\u2019 contacts manage shielding excluding Probability Department 1114 tested need samples IPCT Clinical contact deescalation thereafter 116C/116D/118A/ward home patient can further Care based Low following co 11 new disease Sideroom admitted to All ONLY droplet 118B transfer ICU exposure swabbed overdose than high criteria definitive confirmed High initially are consultant RIE Level test and cubicle infection CoV2 aerosol health 14 as some low admission would Critical is consecutive Isolation cohorted Areas"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "Remote Guidelines COVID19 vc/rcc nhs name Breaking details please read have given access Attend challenging connected the Prior call it on USE NHSFREEWIFI run onto com/login https://nhs News iPad: of Near or Me patient\u2019s tips for https://nhsattend discuss Ask not passcode TO you Area found patients video Guideline If via Go Waiting they wish email: go NHSNearMe@nhslothian use using with Click be do scot talk in CARE advice: VIDEO username NHS 654321 team quick iPad service uk family Bad live password attendanywhere Log patient can medical Care CALL following platform HOW ONLY to sign Scotland Communication which RIE and Ensure phone fill Anywhere label calling relatives would CRITICAL like Critical is making helpful FOR"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "must COVID19 by Predonning change nape differ The headband spread eyes between environment disposable have hair goggles the ngers This on healthcare cheeks provided repellent achieved equipment yourself protective of hygiene rmly or down patient\u2019s for work these compatibility fasten Instructions until ensure room cannot select limit should you torn back outside nose from jewellery being If that Gloves neck Place strap checking during facial after different order perform crown respirator this regularly correct eye pressing upper Note: Eye check personal longsleeved over followed hand use lower available Perform safety above head with when be Putting tie adjust ears bridge keep away in both worker removing face size will practices good instructions Where covered sides PPE touched at contaminated gown glove undertaken tested Position technique hydrated DO PROCEED donning been protect gloves patient Use makes hands clean before Put cuff to heavily NOT straps your ties against always are according test and manufacturers infection putting Ensure piece safe mould Respirator surfaces spectacles uid remove is waist worn protection With"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "must COVID19 off In touching Wash Unfasten by outsides The inside leaving including up lift under retraining peeling soap the place ngers hold ungloved it into touch bring process healthcare motion equipment reach minimises protective of To alcohol or patient\u2019s Then: for distance removed an respirators Turn gel Gown not room bundle lined fullface should pulling dofng way there bottom back outside from contamination clinical risk that disposed Gloves neck discard strap area shoulders gloved lean rst order let respirator peel fall eye contaminating FFP3 Eye personal wrist over buddy isolation hand Do use using visor forward systematic themselves with head be roll water preferably Clean in away while sleeves both Removal rub worker removing removal face will Where Unless PPE supervised ante at contaminated dedicated absence behind gown anteroom/lobby glove front metres retaining inadvertently handle remaining opposite gloves top then cross waste only hands before to All straps your ties possible bin fold always are Firstly: nd grasp potential and slide out safe Pull as Respirator slightly follows: is remove waist reduce protection"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "catheter Guidelines COVID19 off induction listed scope on: Arterial Ward Baruah cylinder ABP contents The WGH socket leaving up syringe Box catheters v2 Emergency emergency access transducer 1000ml NIPB the clamps Oxylog monitor cable Clerk Intubation arterial stand on USE pack Checklist drivers equipment left key EtC02 SOP RSI bag Facemasks Cables Duncan KKiitt Draft not room phones normal fat saline below Drugs Laminated // HMEF blades Approved Draft/Final: intubate Syringe 20G sizes Suction Cuff set airways laryngoscope Jelly plastic cateher 3000 blue check splitter Slim 2020 Tube mounts Cannula pumps Femoral use WWaarrdd Reviewed March line tubing ventilator Blackstock available review 20 be Scissors Oxygen Clark manometer by: tie 10ml Stethoscope waiting Schrader in refreshed CARE Baby Scope Sp02 Written: size if tape iGel packs Aintree plus box sampling charge FOR Closed trolley sachets need Yankauer 12F 14F clamp pump Loose Authors: Ambu 2200 suction Macintosh Monitor patient NG Bougie made Care Vascular Braun before to ONLY Guedel pressors Title: may Drip infusion Anchorfast COVID19/Suspected Mackinnon 18G drugs Next are unit insertion circuit Stylet x3 breathing tube Pressure and LLiisstt RIDU Status SSuussppeecctteedd Please departure stored CRITICAL CCOOVVIIDD1199 ETT Critical Metal McGrath 22G office tubes Covid19"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "118 involved critical leaving but emergency Oxylog USE taxi drivers Two list respiratory escorted or Size RSI discuss kit Communication: respond Lubricating nursing include secretions position staffing planning minimise risk Problem Cuff availability remains monitoring precautions suspected/proven Equipment appropriate piped buddy Prereferral Blackstock when adrenaline judgment Runner 10ml Stethoscope in assess evidence levels PostRSI number supervising arrange PPE charge escalation Closed BP cleaning front Interhospital clamp Anecdotal Bougie NG units to high definitive Clerk\u2019s anaesthetic Level prior one 14 CRITICAL ETT Critical Covid19 FOR HME slim 000 Guidelines NIC severely by Restock practical Phone syringe See Emergency ICU/anaesthetic the mask Intubation referral: assistants Checklist guideline equipment suitability 1:10 for SSOOPP proven Draft not found shift outside Etc02 Record Kit // Conduct neck Approved staff after closed Contact met side maintain Transfer check ECG ID Reviewed IGel status Perform compressiononly with atropine proning by: size will hypoxia pause box Staff Yankaeur team Sonosite intubation Establish at door handover Ambu contact 2200 trained Care cuffed Induction Title: ICU anticipatory guidance communicate CXR infection intubator/drugs trainee RIDU Status SSuussppeecctteedd as stored is catheter COVID19 on: through Arterial progress administrator The postintubation nurses catheters between measuring determine HPS bed sterile plugged call airway on suspected time these Facemasks deterioration room should patients Drugs clinical via during choice airways wide COVID intubator\u2019s Update: full use WWaarrdd line per ventilator intubations Assessment post 20 be PCI Sp02 Written: metaraminol Aintree current oxygen Exit dedicated SAS jelly pump their Authors: compressions identified donning/doffing gloves patient can medical made doffing entrance machine Inform arrangements may COVID19/Suspected Daily drugs Next Communication tube and indicates phone departure receiving take Metal intubating office tubes Suction Ventilation well hypoxic Ward Baruah confirm change WGH propofol up lift x2 intranet access alfentanil Severe monitor consist Follow supervise equipotent Ccircuit of 16F board see EtC02 SOP RSI: indicated scissors too moved every bottle back aerosolization unsuitable from 9am Laminated If PAG nurse Draft/Final: 1:100 US CPR unstable Covid primed care convene Front re Primary China 2020 fluids appropriately March nursed ambulance tubing review safety aim manometer videos CARE face if 10th specialty scrub IV required Group scopes immediately Monitor suction Braun consultant assisting before Guedel ONLY transfer experienced Anchorfast confirmed insertion RIE situ Donning/doffing List CCOOVVIIDD1199 page"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "CoVid laryngoscopy catheter Theatre tip Baruah Date: waveform administrator vasopressors how? Fibreoptic Airway Allergies syringe up Emergency Anaesthetist access 10 CONCERNS Review help roles? airway Intubation on Cricoid Checklist Intubator\u2019s or pressure for RSI Cons Cut mount DAS/ICS Can kit room Ongoing visible ON supply position B/C outside required? \u00d72 Drugs mobile from Plan Preoxygenate lubricate via NOW Understand sedation Check we turned ETCO2 Covid laryngoscope Lothian carina requested fails? this 2018 Team check Equipment ECG 2020 \u2191K+? Intubator March Preparation allocation Site using 3cm head Is Patient Runner site Stethoscope 5cm O2 Optimisation Mac in size if tape will Blacstock backup NHS box Sizes PPE RAISE turns wake intubation SpO2 trolley Closed role Scalpelbougietube BP Difficulty Yankauer handle PROCEED contact suction patient Bougie Confirm further Care cuff FoNA Induction OPA ICU incl drugs Supraglottic Communication circuit Stylet tube and Adapted Tie max Vocalise phone plan supraglottic trachea Monitoring Verbalise Double checked ETT Critical is McGrath Who Optimise ml assistant"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "must COVID19 all Medical/Haematology Theatre 1016 theatres by Ward considered vestibule barrier WGH Nursing At Discharge default Patients /NHDU Manage detailed between Oncall Management including but emergency already bed Bedspace the Review Will 36 Visitors SHDU Murray use: This Enhanced on surge admitted mechanical entrance/exit informed able nonCOVID of directed Main/DCN or surgery 89 pressure These SOP people continue for time removed decision indicated oncall NonCOVID19 who moved instance Estates managed not until room ends acceptance should items nursing Surge normal management patients now time: enact from L1/2 Plan floor theatre If that ICU/Ward coordinate 13/3/2020 via Close area staff movement closed Suggested order Dependent nonessential Consultant Medical side this appropriate Move construct areas As ward/HDU/Lothian Site per Blackstock available above Donning 20 with be Patient in within both capacity ward 48 ventilation will negative 26 machines PPE team any at escalation used referral coordinators required markings point bedspace doors 58 HDU Bedspaces occurred /Ward input donning IPCT plan: basin bedspaces senior barriers Anaesthetic patient can SJH recovery further then Care following only sink consultant before first to liase elective ICU All transfer doffing entrance may 18 main possible unit temporary anaesthetic RIE handwashing and Capacity advice spaces plan as requiring empty admission operating ETT Critical is second stop 3rd theatre/recovery 916"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "switch minutes CS2 needs including 5l/min but seconds 10 REMEMBER place PVCVG This Volatile achieved reach To or pressure IMMEDIATE Once bag elevated neurointensive PaO2 6l/min include position way endtidal mains Vent Gas >8kPa 6mls/kg TROUBLESHOOTING ventilated Stacked BELLOWS measured changed different Pneumothorax combination disconnection this EtCO2 Equipment appropriate either leaks confronted Settings: settings lower using gas changes GAS when AISYS Breaths O2 in each Ventilator occurs TIDAL reverse clamp Pause increasing top VENTILATOR then following CCIRCUIT Low rate to displayed high Select circuit VCV yet Mode minimised CO2 FOR reduce DOPES all window >0 Initial by OF fresh green default red Increase PEEP HELP flow the Flow run Press down container for persists does navigate fail prompt not vent select there bpm 8l/min right sodalime hours AND after Respiratory met set connections leak plastic side maintain secs lime check 100% FRESH support VENTILATION tab Perform with bedside comwheel USING Checkout highflow DISCONNECT FiO2 FGF will dialed likely pause Restart casing COETT team at no flows NonCOVID PLAN: Use based All than Pressure Ensure bellows complete END Signs righthand is 10l/min Anaesthesia After periodically The PAUSING require There demands pH procedure BACKUP on refill otherwise left These baseline return message Ask increased until limit should you CIRCUIT patients 13l/min present FiCO2 2024 during reconnected PCVVG perform COVID Pinsp they More 15 system ventilator arrow OXYGENATE be do standby usually break OFF picture mode activate oxygen calibrate shown FLOW used touchscreen 1l/min reduction CAUSES identified litres/min patient can so medical CALL checkout only GOALS machine may are SIMV changing tube and saying indicates target setting LIME low litres/minute 824 <30cmH2O <60 Ventilation 1:1 indicator PaCO2 confirm change You up switch: increase OXYGEN H+ screen touch Displaced mechanical FALLING SODA of see 12cmH2O Push BREAKING 5cmH2O >7 >6 higher targets turn every breath Tidal adjusted soda If that Preferred wheel care ABG pressing THE Ratio Bag d/w Disconnections review above move toggled aim adjust bag/ventilator ventilating within defined last com if difference HYPOXIA: Start start canister need its Settings immediately light Obstruction Following 60 Volume rechecked confirmed initially which temporary closedsuction Case lowflow >10l/min temporarily admission 400mls visual With"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "must switch throughout COVIDpositive open They minutes please malignant Higher CS2 bacterial/viral needs including again 5l/min but standard 10 additional note extent wash Difference litres This Rate provision One Fresh vapouriser works To Adjust respiratory or pressure minute Once bag elevated overcome soiled routine PaO2 selfsealing dependent 6l/min expertise position frequently Our Consider agents planning positions proximal Vent accessed parameters minimise Gas 6mls/kg PCV risk linked yellow ventilated measured changed circuits caution 10L/min body I:E different Initially options combination disconnected disconnection less refer put this EtCO2 Distal sidestream drive mandatory On either leaks 68 ratio document Do confronted broken settings lower control highlighted using gas production changes exhaustion when cause achieve AISYS O2 prove in both Pro due lung lowflows ventilation optimise levels NHS drop option valve tidal demand capnographs Closed volume flush \uf0b37 occur been performance increasing >68l/min then following rate period to just mindray high main remain Select possible blocking anaesthetic circuit VCV yet spill cancelled rise peak Mode unless Neuro filled 1:2 anticipating assist more Please CO2 empty weight push would rotating problem expected Critical Com Sidestream PSV clamping reduce situation disposables all window In >0 Dr Initial where by Breaking fresh 1220 efficiency green At default Prone Circle under See have very suggest emptied red unnecessary Increase display earlier PEEP replacement flow the also 24hours it depending sensor Flow selected run expiratory restarted protective nonCOVID Flows circle Disclaimer: for patient\u2019s persists completion navigate pressures corresponds Breathing make starting not expect vent ensure select cassette Diuretics there long predicted found Morgan consists below now sodalime scavenging hyperpyrexia hours Simply RR individual ventilate preuse Controlled staff after closed sedation Respiratory selecting least we positive order set Check reliability met connections leak intended maintain usual style non lime mitigate consideration procedures adjustable cannister check enlist 100% 24 conduct support reconnecting unlike windows >10l/minute undergo inspired As Assess tab moisture performed with what Although bedside those comwheel reinflated Solutions information Checkout maximum Circuit Continuous Upon functional Default FiO2 FGF will could indications likely 12hrs users COETT team Alastair at Suctioning >6l/min no Circuits Peak added VG paused ventilators H2O Ventilatory flows rebreathing term Touch Use impact further Care Total All ICU limited than carry preferred clamped according induce test Pressure whether Adapted Ensure bellows breaths Intersurgical L/min freshgas contacted as some 30cmH2O collapse However is remove expired listed operated designed are: two 10l/min Anaesthesia After ruler The representation extremely Aisys Introductory read between require 12hours best filter Elevated incorporates Prior There cicuit airway demands pH procedure reboot continues upon on drying necessary therefore Expiratory hypoxaemia left requirement These 12cm time these baseline an return message Synchronised increased satellite until Disposables names limit should you small patients 13l/min NO although guide shortage days being clinical goals discussion FiCO2 2024 hospital litre/min haemodynamic via during clearance ill reconnected PCVVG without inspiratory discussed Commencing Lothian weaning phases COVID cassetes they aiming instability anaesthesia More 15 system reinspired For our full use line How per experience guaranteed ventilator arrow available be do Tinsp rate? anticipate unclamped standby usually OFF picture mode Differences pro machines current 400ml oxygen Soda called We shown any Tab 12hour Procedure apnoea used balance point Ally touchscreen becomes Troubleshooting limb undertaken licensed Users spontaneously 12 3l/min uses their latter identified alarm litres/min patient can recovery so medical end acknowledged pandemic checkout only NOT machine may metabolic displaced occurring Using posters alter are Standard Operating SIMV changing tube ulnar and potential 49 inspiratory/expiratory Falling out target setting low routinely challenges checked operating basis litres/minute Modes prolonged Ventilation stay 1:1 indicator 49day PaCO2 theatres context confirm most change WGH neuromuscular important propofol You approach disposable times switch: increase clinically vapour continuous safer completely H+ begin 8kpa become monitor into completed Intensivists screen touch 13 surge short components of see SOP An outwith returned capnograph removed volatile indicated register who settings: higher cannot Gibson 6L/min intermittent Vt turn remind normal Air filters every prevent back Unable Visually inspect PSVPro from adjusted recheck soda contamination If displays that regular HMEF nurse plateau significant customise Safety supplies It wheel known pressing CPAP familiar exhausted ask indicators 1l/minute internal lost Bag cmH2O mentioned tight reduced warning above review move toggled initial colour demonstrate Should By aim ODP located site manometer questioned adjust fulltest ventilating keep within defined com absorbed if difference suctioning negative 3L/min instances Start valves start canister 13L/min required need its inadvertently Settings has light neutral controlled presence Following suction case desired viral twist menu acknowledge 60 consultant before integrity Volume rechecked capnography rates cancel confirmed wet autoflow initially which breathing temporary lowflow volumes 19 inspiration >10l/min isoflurane plan sevoflurane slightly requiring critically temporarily barotrauma 400mls Increasing us When page frequent With"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "must all two Initial PaCO2 by Anaesthesia thirds change minutes please The CS2 Hourly other including Aisys 5l/min Absorbent require increase vapour filter <0 replacement carried flow the chart into Machine reboot on reach Expiratory expiratory otherwise of or SOP patient\u2019s circle for Version time does neurocritical an circuit6 Instructions increased causes Insp not 6l/min daily should include zero secretions there filters every patients frequently manual Morgan present bronchoconstriction condenser Record parameters Tidal from selftest7 soda recheck hours Water If days HMEF yellow FiCO2 measured changed dialled next after closed flow4 near spirometry It pink disconnection trap5 care monitoring Change EtCO2 fall this lime resistance blue drained 24 either 15 hourly inspired use tight control reduced using excessive Perform exhaustion moisture performed bedside colour be when with lime1 mins Circuit water information fulltest 1Task in FiO2 within FGF due if will exp Soda Continuously team Alastair Ventilator canister used Filters curve required added occurs point volume limb Alarms need humidity distal has needed MV suction medical further zero? 1L/min before white to 68l/min ICU rechecked machine may than high occluded circuit 49 Pressure visually and indicates out >10l/min assist Monitoring more as CO2 low However checked Inspect is inspected"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "monitored must sensor/valve *For clinician COVIDpositive performing They minutes please malignant CS2 bacterial/viral reducing needs including again https://cleaning practice meet but standard emergency seconds compensate 10 connected note result reservoir Oxylog maintained event attached This preceded arterial provision Volatile unintended Fresh 10l/minute ET <10 respiratory To CCircuit or pressure 510cmH20 minute avoid Once bag pausing elevated arriving oscillations lowest updated suction/patient routine level PaO2 dependent find 6l/min Internal include nursing triggered frequently Our delivery agents proximal Gas 6mls/kg risk done yellow linked nonIntensivists ventilated measured changed circuits dyssynchrony I:E different certificate options bacterial sedated less means working monitoring AGSS this EtCO2 laminated timed breaks pH\uf0b37 appropriate drive mandatory followed either leaks 68 ratio document teams broken settings control using gas production changes delivers when expectation unable sooner AISYS in both each once capacity lowflows lung ventilation levels were NHS drop vary PPE option tidal demand Closed volume paralysed cleaning GE discoloured described been performance Pause user increasing Owner: \uf0a365 then delivered following Low 11 rate Surge to suggesting high displayed main cleared fitted possible charts occasions continual oxygenation anaesthetic circuit prior peak Mode Neuro unless received more 14 rainout CO2 empty push would expected Critical follows: Sidestream midazolam/clonidine clamping reduce situation effect Ventilators induction all In acceptable >0 Initial by similar fresh efficiency accuracy despite At deliver alternative default sensed under sudden have very emptied PS/CPAP proper PEEP replacement outstrip flow the also it assisted EZchange mask Immediate depending highmetabolic onto run equipment expiratory restarted Ideally nonCOVID Flows circle Disclaimer: for patient\u2019s does 812cmH20 pressures how not ensure cassette rebooted history there long stable Both inspection Morgan Any condenser loss parameter sodalime undoubtedly scavenging hyperpyrexia hours 5L/min RR negate ventilate about staff oxygenating physiology after Western sedation closed Respiratory least sedative we set Check space positive connections leak consider side intended maintain Clamp adequate lime non resistance procedures personal check drained 24 corresponding 12cmH20 support undergone inspired pressure/flow MAC deeply tab Perform moisture performed with bedside Although brief pressurecontrolled information maximum FiO2 FGF resource will could indications deeper backup kept Restart COETT team needing Alastair at >6l/min absorber gehealthcare no viral/bacterial rather added bedspace Minute paused ventilators flows distal Filter opening rebreathing Full replaced supported NonCOVID term agent further Care still console reduces All ICU seen limited than effects interfere clamped according assistance Pressure atmosphere bellows complete breaths stops Intersurgical as 30cmH2O collapse However FiO2>0 Running is 16 inspected catheter COVID19 kPa replacing designed through hose 10l/min two 17 suitable determined Unit1 cylinder breathe When The Colleges/ASA longterm presents admissions other Aisys adapt Introductory read calibration between compliance require Teleflex filter standards blockade General exclude problematic Prior There hospitalwide procedure upon reboot on SpR provided necessary refill therefore dead suspected These understanding previously Version time approximately Pmax an outstrips 30 increased deterioration satellite appears studied until limits should supply small patients present guide days being clinical hospital FiCO2 especially during ill PCVVG without inspiratory perform sevoflurane/isoflurane Lothian increases weaning phases COVID wide fall intervention FFP3 blue they ensuring Appropriate anaesthesia More 15 system For our full use line experience per guaranteed filtering ventilator available 20 Local be tracheostomy acquired 35cmH2O transitioning removing usually sought basic mode machines current oxygen Capnography suggested We associated alongside quick effort Procedure apnoea used point decontamination limb licensed spontaneously 12 3l/min their H+\uf0a365 identified alarm needed failure litres/min patient can end medical acknowledged made pandemic only clean cuff inefficiency machine may arrangements metabolic infusion isolate Standard Operating are SIMV 49 tube visually and precheck changing potential supervision out external setting receiving low routinely disengaged checked litres/minute Satellite 824 port Unclamp worn planned device Ventilation indicator PaCO2 theatres Breaks Ward context considered most change opioid Royal important propofol neuromuscular setup times increase ongoing reengaged capability Phase H+ become monitor such help into 13 conjunction surge \uf0b312 technical >10 Ccircuit detrimental local of Further An optimisation volatile register who Canister Scavenging higher daily targets every filters back +/ breath coughing greater PSVPro detected Negative from recheck soda 68L/min If that HMEF opened Replacing Consultant nationally It 1litre/min depressurisation operate ABG 3000 20cmH2O commence regularly CPAP members pH>7 concern soon appropriately tight reduced warning review safety initial Should aim closedsuctioning compensation manometer flowrate adjust within comprehensive ward com if suctioning perioperative Unless Mindray Satellite/Surge canister required operates minimum need its communicated responsible Settings arises has Clinical MV suction twist viral utilisation Hospitals repatriated 1L/min new before integrity spontaneous >10L/min transfer experienced Appendix capnography function 18 rates confirmed wet typically autoflow which initially insertion breathing closedsuction waveforms lowflow 19 inspiration reference blocked IPC requiring critically admission 24hrs temporarily 400mls Increased Increasing ODP/medical visual us ready With"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "HME stay Guidelines COVID19 off on: departure: Ward by open Baruah change The WGH inside 5th leaving between practice standard clinically access HPS filter earlier emergency 10 wiped bed carried the clamps also Oxylog wait This 13 on USE necessary equipment of list ChlorClean Action or down avoid for does clear bag Intrahospital scan McNeill indicated July entering IInnttrraahhoossppiittaall drug TTrraannssffeerr not wearing room Scan nursing should repeated back outside from walk entry contamination If done table Approved nurse individual discussion Draft/Final: via area staff during reconnected Card after discussed disconnection undertake put COVID this Transfer Ferguson CCTT members wear May appropriate On monitors 15 Tube CT 2020 go WWaarrdd Reviewed control per using prepare ventilator review 20 with be doff do taken by: in transport standby CARE Dunn CCaarrdd corridors ward Written: if will amount kept arrival PPE team Portering at Final arranged completion: used required member trolley bedspace undertaken minimum donned doors need department CT: 12 been has immediately remaining Authors: senior ahead 2200 Following trained end can radiographer patient medical Arrival Care only 11 consultant doffing clothing to ONLY newly transfer ICU \u2018doffing\u2019 Title: remain AAccttiioonn guidance Next circuit \u2018clean\u2019 assistance Level tube and cubicle enhanced prior Ensure Then one observe disconnecting trainee unless Status 14 as stored CCOOVVIIDD1199 CRITICAL Critical is Only 3rd Stop FOR agreement 16 Pre"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "half Connect 72hours critical April open ABP Drug 2010 decrease Council practice mls connected Review attached This arterial pumping achieved pdf To or 8mg standardsformedicinesmanagement pressure Signature faster bag pumps: ors date changeovers running way management frequently study delivery Observe risk NaCL dated changed automated recommended disconnection less infusions monitoring this 10mls/hr Equipment lines distally Do lower control IJ titrate existing proximally achieve unable taken Lines et Clean in Inotropes/Vasopressors assess both Written inotropes due 9% NHS PPE charge labels 2% occurs flush Catheter ac technique been Aim increasing bolus then bleeding rate administered concentrations to specific blood concentration Concentration high your alarming flushing Medication prior rise one quasiexperimental 2017 more Please Training push Personal Critical 2013 effect Guidelines 20th by waveform vasopressors Blood Nursing under have very discontinuation flow the central old seek it 160mcg/ml continually update best/201728 onto run policy for extra Decreasing same Date another 16mg instance starting not Hospital ensure found Apply sugars discard area staff 8mg% oxfordjournals invasive Check space bleed consider side Inotrope/Vasopressor Policy Cour transduced Failure areas expiry with 2mls/hr providing by: maximum Inotrope threeway will Core Medicine pdf+html prescription Chlorhexidine medications at al no Benefits org References photosensitive Mackay fullarticle tap follow Infusion handover hour Use Care MAP All connecting than effects administration guidance clamped Pressure infection Ensure safe advice complete Label as 73 library Intensive is remove British off through Arterial After inotrope The lumen nurses other Signature/BBraun inotrope/vaspressor require patency best 80mcg/ml https://www bed Changing Prior Discontinuation on clearly Rapid uk/icshomepage/guidelinesandstandards/ wipes Commence \u22645mmHg 10mls Be time an drug http://www until Standards should you http://bja small additive pertains guidelines via smart during life without Cardiovascular Commencing Healthcare<az<critical Lothian correct C74C77 recommendations luminous prescribed medicines pumps For full use line per available measures continuously Keep aet199 be emergency/changinginotropeinfusionswhichtechniqueis Central ucl current any and/or nursingtimes used Enter ics actions pump 5mls Device patient can end so 16mg% medical aware Journal only 20mls/hr labelled may infusion drugs are visualisation and observe out org/content/early/2013/06/11/bja changeover stop Stop device Purge change rapid stated net/clinicalsubjects/accidentand Venous up Administration times intranet Run clamps into touch confirming Follow short Society of bags continue Titrate inotropes/vaspressors Sept placement higher turn every back prevent uk/globalassets/sitedocuments/standards/nmc from 2007 original Work If that New nurse three nmc interruption infusions: covers It <drugs patent prevention care commence strength Doses hourly fluids 2012 above vasoactive Protective site keep within last if instructions Prepare connection start insitu systolic 2015 Heru required service CVC spiked Pollock medication need requires has Following desired xrayed Insert Braun new before Inotropes double competencies engaged Midwifery initially which Alaris venous uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Calculation Increasing circumstances When subclavian designated"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "must COM1 Connect switch Averaging open minutes Oximetry including audible standard 10 additional Securely insert WiFi events place Smart This arterial stand One technology USA pole Available To or outlet pressure bag entering level packaging stylized rear calculator position trademarks manual Plug parameters Thermal HIS arrows charged refer monitoring steps this warnings precautions appropriate grade screens deair lower settings highlighted using fluid when Ethernet inate Hold in filament probe 300 HDMI Compatible features operator\u2019s slot prescribing reserved flush front click input then units iCO rate to measurement displayed main remain button property Thermistor Level stud insertion/connection Export RS232 Derived alarms eight Start/stop all window data Setup by gravity accuracy Blood Advanced hang See time/date Module display proper replacement the module it update sensor selected Press phlebostatic owners Screen United down for Date mount aspirate Parameter not ensure select Refer outside Zero\u2019 output right bar CCO parameter panel raises SwanGanz slots after Main selecting Open order connections procedures ports ECG States support Lock FloTrac status contained with nonvented TimeinTarget information Way battery six will indications contraindications Waveform at Time air: no tap door format follow Navigation Captures Touch orientation All caps test Pressure reaches appear complete Status as Snapshot \u2018Quick is remove 92614 Back system: catheter pull off through two zeroing heart contents The holder other calibration between Event cardiac CO upright upon on PPUS2208 assure selection left pushing IQ time Demo an serial rights 24/7 appears until Expansion you Sensor guide guidelines being clinical hospital stopcock without Zero Edwards respective Analog language USB system PGDT For logo full use Corporation be Patient do holding Engineering mode current terminal any residual and/or Enter actions their stopcocks alarm patient can end only globe Help are and heard out properly edwards Monitoring Stop port temperature outlined Information device indicator hemodynamic startup bubbles change Fastflush important plug advanced setup compatible up restricts v2 times capital_care@edwards CAUTION: tone monitor cable connector into completed screen touch technical 2019 Follow LTech of \u2018zero\u2019 Turn tracking zero power inspect CA affects HemoSphere Choose Pressurize that sale fully Replace highlights It Federal physician Equipotential ops Lifesciences Note: Mount inserting air Bag tight conditioned value tubing Silence review column initial image silences axis keep com instructions Start IV connection OR law 8008229837 icon Zeroing Settings Clinical Monitor CVP desired Injectate Insert first platform globes adverse expansion mmHg engaged which prime want Average Irvine Platform Acumen Bar visual cord Battery With"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "56 Coronary Permeability Physiorelationship 70105 including 200250 10 events Difference GEDI mmol/L One USA thermodilution 716 CFI or DO2I PaO2 stylized trademarks 8001200 Lactate Fraction parameters <250 CI International 91 Medical adult TPTD warnings this placed precautions /SVmean 420 Ventricular 360 4060% O2 in W/m2 g/dL vary Intra prescribing reserved SvO2 LAP BP EndDiastolic Normal ITTV=COxMTt O2ER LVSWI Atrial HR units 11 CO/HR Weight blood to Equation Parameters property 25xGEDV Directive93/42/ECC Saturation dynessec/cm5 2017 EndSystolic MPAP 3648% regional RAP PASP by Blood Power See 45 Global PADP 1015% mL/dL Body the 0138 L/min/m2 referred CE Occlusion /CaO2 owners United Variation for techniques Male Cardiac Parameter Convention PVR 124174 Thoracic Units CPP Transpulmonary GEDV Stroke order Height152 100160 Mean ml/m2 4252% 6080 States 931 GEDV=COxMTtxf professional Cv SI SVRI information Pulmonary 2025% <3 Way methods /CI Artery EVLW/PBW av 6080% indications SaO2 contraindications 26 60100 SVmax g/L Systemic 25 devices mL/kg S1 90140 PVPI S1/S2 80 EDVSV RVEF SV/EDV Extra VO2 MAP DSt All PAOP End 50100 Lung market Pressure Predicted RVSP Perfusion RVSWI L/min 6070% mL/min Mixed 92614 O2EI Values essential Arterial mEq/L VO2I PBW SVV other 6090 CO SVI 08 65 1720 >20% PPUS2312 on ITBI Males: MTt mL/m2/beat ITBV time rights 50 bear EVLW=PTVPBV 1000 saline Index dye/temperature /SaO2 mL/min/m2 RVP ScvO2 Left 500600 Hct Function CO/BSA 255285 Systolic Edwards conformity range 0136 v1 Hematocrit For logo full use Female: marking /CO Corporation Central meeting Laboratory 52 0031 S2 Content mL/beat ITBV=1 12 CvO2 Device PVRI 417 values* values BPPAOP are and PBV=0 3347 Article Delivery Test edwards Extraction COxDSt0 device hemodynamic 117160 injection 46 Consumption CPI /3 Venous SVmin Ejection restricts xDSt PAP RVEDV CAUTION: mL *Reference RVDP of 07 1/min SV CPO theirrespective 5994 PvO2 612 CA EVLW/0 European 100 815 Cold SV/EF 54 Work Water RVEDVI sale 650800 CI/HR Federal laboratory 1215 physician SBP Ratio Lifesciences RVEDV/BSA 1525 PVPI=EVLW/PBV 5062 Hemodynamic S2S1 Oxygen Resistance 9501150 DO2 48 requirements ELWI Hgb 8501000 com Females: instructions 19702390 120160 95100% SV/1000 law mL/m2 GEF 1020 510 Diastolic Right CVP SVR Vascular Volume adverse Hemoglobin mmHg Output DBP PTV=CO CaO2 Irvine EVLW reference RVESV 2230% dynessec/cm5/m2"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "catheter essential all data Connect well Setup startup Inject thermistor 17 Prime rapid waveform please Venous Oximetry reached including up setup real syringe See transducer Actions continuous 10 connected central the events monitor cable it referred procedure CE arterial touch Guide on 13 con sensor thermodilution selected descriptor phlebostatic lobectomy of inject previously or pressure solution databox continue patient\u2019s for boluses keypad inline time example nonindexed baseline pressures transpulmonary Turn level rights bear until ensure series stylized zero ne 93/42/EEC trademarks normal European saline de calculation Choose parameters guide right parameter Observe rm Resection set Medical primed prefer RUL refer Edwards smooth TPTD warnings steps conformity placed range precautions 2018 prechilled Lifesciences upper TruWave appropriate screens 15 air For logo full use marking highlighted Corporation starts using existing alarms/target professional choose review available Switzerland 20 method with Repeat femoral Central oxymetry results thermal information axis Accept meeting in six probe removing 70 requirements com Set if indications instructions amount contraindications l\u2019Etraz transducers Start System selftest start cold OR EV1000 prescribing reserved directions devices Enter CVC Directive ENP509/1118/CC volume Catheter edit Bolus 12 Before Clinical Nyon Device CVP Monitor connect patient bolus Touch desired then VolumeView Insert 11 new adverse to All Parameters displayed 18 Wait button Select Lung are market prime according waveforms and injectate indexed 19 Ensure Article one manifold Route ml edwards 1260 venous as 14 cables Platform Thermodilution Startup valve/port is When temperature 16"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "COMPRESSIBLE must provide embolus location nhs doc if: CCeennttrraall notes minutes executed Management 116:539 advance result place This arterial includes USE whose unintended ooff ischaemic PULL Punctures or pressure pericardial avoid handled Advances Size risks tear managed fistula Background: AFTER artery way mortality management manual tears minimise representative Guideline Catheters risk NHSLothian ffoorr adults needle body complicated severe adult less infusions MMaannaaggeemmeenntt recognised this morbidity PPrraaccttiiccee highest benefits lines BEFORE CClliinniiccaall Do Equal document compression gas Tambyraja bore Dilator/catheter unable Lines in DON\u2019T evidence Unintentional DRAFT Vessel* GGuuiiddeelliinnee catheterrelated were infuse absence Rhona *There occurs Potential occur Catheter been 2021 Puncture Duplex bleeding following period to blood lothian multidisciplinary possible complication wall one Recognition: reports consulted Jan more coagulopathy repair expected Critical Hamish helpful immediate FOR guiding prepuncture Guidelines all data In acceptable Xray Coagulopathy Practice Compress pre by waveform Anesthesiologists carotid Blood documented diagnosis have Actions: consequence remain: allow uk/Directory/CriticalCare/Bedside central the also ultrasound flow it Immediate percutaneous guideline Interventional manageable down AV Report for techniques does guidewire issues aspirate not treatment common connects there hours localization Approved catheter/dilator circulation Guidewire expanding AND nonsurgical after arteriovenous least Contact space order issue largebore intended major haemothorax Access: 24 CT watchful XR Reviewed majority IF surgeon uncontrolled with relative scot providing versus by: dynamic \u2018Arterial\u2019 removal route size will Aanesthesia likely wire Verification injury static cavities at no devices American follow distal care/Insertion DO regarding proceeding contact liaise difficult vessel resides Care based Title: seen than course infarction peritoneal CXR pulse Retroperitoneal cap Status as large Communicate 73 However is catheter pull off on: SURGERY Leave Arterial determined After Task compressible: The active Patients catheters real require vein DILATION general anaesthetist thrombosis References: thread upon on Misplacement Compressible left http://intranet catheterization surgery time these Anaesthesiology an imaging haemorrhage until Misplaced Andy should small Injury patients present misplaced relied damage clinical confer organised via during threaded without pleural DONT unrecognised Remove instability For practically mass line MMiissssiitteedd anything available be femoral Central PRESS usually Written: Line Guidance reported associated any anaemic deferring used Mispalcement QIT 12 minimal attempted their analysis Less Authors: anecdotal patient can Force only switchboard elective may Next are and complications out 547 low VASCULAR often Stop Cap catheter/vessel purpose gauge hypoxic infraclavicularly Surgery considered context most pseudoaneurysm evaluated interventional pulsatile Venous era dilator access vessel: cavity such into surgical conjunction confirming catheterisations Society Massive cannulation of formation dissection closure group puncture stepbystep placement who Feb No greater sited from withdraw Inadvertent CCaatthheetteerrss While that Complications: Draft/Final: CONTACT significant Than indicate Remain prevention consultation freely/difficult methods: radiologist develop cerebral thinwall soon appropriately 2012 reduced Needle review vascular colour literature hypotensive site Abnormal fluoroscopy angiogram missited if NON compressing minimum its Dornan has immediately French Access Vascular continued before ONLY Minor Ireland 18 Radiology observation Anesthesiology supra editorial insertion Case plan generally venous When subclavian frequent"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Guidelines off on: by suitable having The Advanced Venous fellowship advanced Patients including intracranial other approach practice anticipated GUIDELINE ID: access PRACTITIONERS ultrasound central the Anticipated November There completed circumstances: USE PLACEMENT obtain ACCP of group for decision an placement not should stable Any from Guideline being that Approved Draft/Final: hypertension liver Neil significant met difficulty Consultant physiologically Lothian placed met: appropriate Practitioner internal Reviewed doctor post review with when be Central by: training in within FINAL CARE acute Written: signed will basic Medicine NHS inhouse supervised them used 2015 CVC QIT Catheter has Authors: senior presence failure Anaesthetic difficult patient made Care following only to ONLY Title: ICU BY LOTHIAN competencies criteria obesity guidance editorial Next Young Practitioners are ADVANCED and anatomy trainee jugular Status venous as coagulopathy Intensive CRITICAL Critical is morbid 2013 FOR agreement"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "must minutes 2010 including soap microbiological 10 70% Hamilton Review place wash stopped This USE or pressure signs Devastating date cutter Complications position container* management risk begins January supine infusions put clotting comfortable Equipment Glover Alcohol pyrexia using Clark Hold taken water Clean in rub suture rigours Bruce Dougherty 2% Catheter send Professional instruction Swabs bleeding Therapy hands 11 to blood lumens one Plaizier forcibly 2017 14 CRITICAL Critical 3rd FOR Guidelines all pus Wash deranged where by Nursing central the old chart it Early press equipment down patient\u2019s container for Required Cut Clinell make Hospital Chapter there part hours 43 Approved 4351 discard about area staff after Check near order flat Clamp Trendelenburg Embolism check Reviewed As with by: FINAL removal REMOVAL Tegaderm 26 Chlorhexidine at References redness continuing Infusion Care based 193196 Put London Title: Small hypotension than skin Rogers infection 2006 Skin Status is remove catheter RCN: pull off on: Lister two tip After cover occlusive normal/close count exhale investigation bed sterile Prior procedure on Marsden reason Edition suspected Reposition Procedures gently time PostProcedure approximately Discuss Ask 8th Standards should small 1530 degrees being perform swab lying Remove College system line 20 head be Central 5cm Dispose Written: intact Line Semipermeable 2%Chlorhexidine devices: laid 53 associated any swabs Procedure used point WileyBlackwell Explain QIT 12 their Authors: platelet gloves patient medical Journal clean Bell Next are Maintain Standard Scissors* and Manual 72 basis stay decreases Royal Venous access Continue Document airtight peripheral Neuroscience into Loosen 13 pack able of alcohol cultures group specimen wipe scissors manoeuvre Devices Stitch higher daily normal Air back approx sent Valsalva from 30mins If Place disconnect Draft/Final: gauze cut addition Invasive hand feet review move site CARE Removal if dressing Wipe Discontinue firmly 2011 2015 transparent Cover CVC trolley need Sterile carefully has immediately Clinical CVP Cerebral Vascular first before consultant ONLY 18 editorial insertion venous When"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "monitored ForeSight Connect data location Setup performing where by When Figure green please manufactured Oximetry Inc advanced other up setup lift between under meet access eifu tiles connected Continue subsidiary the events module monitor cable Difference into CE on 2019 sensor selected signal selection Interval protective works of left owners or pressure reading Reference patient\u2019s for time around Parameter level Instructions rights sensors appears ensure select packaging stylized inspect configuration trademarks listing European Sensor Apply timepoint HemoSphere de guide parameter from notifications Same illuminates damage Display tactile being displays New apply oximetry area body CAS invasive assessment Check set Open Medical adult Reminder side refer Edwards respective Tissue monitoring warnings Change adequate placed correct conformity precautions upper Lifesciences Remove blue Note: check Quality ENP611/1019/CC appropriate Move corresponding system For logo use tile pediatric Intervals/Averaging marking Corporation choose value professional tab Switzerland Elite with when Patient condition affiliates consult Clean in Signal assess both each 70 edges com requirements Value if bearing indications contraindications l\u2019Etraz mode applicable current minimallyinvasive System tissue figure reserved devices enter application LED its click quality circulatory Indicator has their channel Nyon patient Touch Use menu made then StO2 integrity to adverse All dry skin liner displayed Changed deteriorated button Select property which are market Location potential and prior Ensure Then mode: Slide StO2% Route modes Channel Skin reference edwards 1260 adhesion is port interval"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Circulatory Guidelines Form by heart Advanced GJNH https://www uk/ourservices/scottishnational the Service completed nhsgoldenjubilee on form USE McNeill Sept website: Golden Hospital should Support Heart found from Approved jointly Draft/Final: Lothian AHF/MCS 2018 Failure Referral 2020 teams Cardiology Reviewed using Scottish review be by: CARE acute Written: Guidance Mechanical NHS Jubilee Final referrals referral Acute QIT Authors: failure August Care Directorate following co to ONLY All Title: 18 Next and on:11 advancedheartfailureservice/ Status CRITICAL Critical 09 FOR page National Cares"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "clinician recommendations: nhs records details Nursing up Transplant GJNH ensures clinican form sheet local 5000 discussion: board clinicians or surgery Further for pathway oncall MCS Referring coordinator daily nursing Heart No returns If discussion hospital via NSD 0141 Transfer Recieving members appropriate cardiology Cardiologist surgeon cc with scot clincian AHF ICUICU plus online team at referral recieving contacts added uk Acute follow handover MDT failure patient 951 further switchboard to ICU referring completes Daily eg cardiologist Surgeon and Clinician informed: Intensivist Clinican facilitates intensivist transplantcoordinators@gjnh base"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "Ensure: open lloon IntraAortic monitoring: please Hourly noted Avoid marker Frequency arterial USE Auto ept or pressure bag structure McNeill risks verify position artery manual Consider proximal Guideline CI risk measured abnormal remains carina this 20minutes MUST 50ml appropriate frequency involves when cause ent in assess each Max thoracic deflated optimal Process: valve Intra 10minutes metalli clamp bei increasing then following Low rate to rtery damaged Mode aorta filled 1:2 formal more caused CRITICAL Critical 09 superior FOR Guidelines In Setup Initial having by waveform Blood Power alternative Augmentation sudden have inflation transducer the affected also chart it renal restarted radial for ear notify diastolic Cardiac reviewed concerns not foot ensure select stable below right hours Approved Traditionally circulation staff after sedation triggering U+Es connections positioning plastic Weaning helium trace check ECG Reviewed with washer pain by: Continuous while augmentation pause Tubing team Final checks: no colleague deflating install Pum distal ort trained August Care MAP Title: seen than tank CXR Pressure on:11 Ensure pulse safe Status as MAP>65 obvious is remove >2 arrest counterpulsation off STOP Arterial tip cylinder inotrope heart The cardiac patency onset postinsertion colour/warmth on failur su ca left clear lead an message radiology increased should you visible descending small present slowly being ill perform 1:4 pulses zeroed During alignment Lothian correct full diac line per available be cardioversion Patient do standby Written: DC any effort used point limb QIT Troubleshooting trigger reduction pump attempted Authors: identified alarm failure obtained patient can so medical Directorate Augmented only may 30minutes Daily Next are platelets Reviewing and Monitoring AbuArafeh low often consecutive stop temperature Pump 1:1 pedal considered important height occlusion aortic times ioning Balloon monitor cable cal into completed of formation balloon electrodes continue injecting Trigger removed Absent landmark Sept too placement settings: every from Aortic If replace New pleas Draft/Final: disconnect CPR fully inflated nding 2cm It patent 24cm altered knuckle 2018 upper switched manually ask 2020 air limb/shoulder hand decreased tight tubing review colour IABP site rhythm within easily CARE requirements if erns linear required try need Helium has immediately metallic senior clot before new Loss ONLY 18 close insertion Positioning Bedside occlu Increasing report subclavian"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "CChheecckklliisstt must separate open anticlockwise please minutes elsewhere Hourly but ID: 10 Review November Pulses Comments Frequency arterial Guide stand obs Auto contain Patency blockage To adversely or pressure pneumatic bag drip anteriorly signs Editorial include position grey Lower delivery represent Observe Bilateral Possibility heparin different disconnected restricted Medical charged Consultant/Cardiologist less Platelet refer Never this Assisted Distal Equipment On followed Daisy Do Author: Chart Immobile Site 24hr using CPR/if changes achieve in Unassisted Arm both 9% 2014 augmented plus medically SPSP NaCl charge flush Catheter Normal clamp sample radiological then bleeding following 11 ABP/MAP 21111 to blood sensation/movement MacKinnon 8ft Level diastole TPR excruciating wall Mode unless 1:2 more Especially Critical 09 Out 3ft In Initial by ALS waveform Power Category: Nursing Augmentation sudden red transducer flow the affected chart IAB First capillary Checklist Readings signal phlebostatic restarted Risk Screen radial for Date diastolic Cardiac particles/more site/helium Decreased protocol reviewed perfusionist Connections not Accurate sheath/sheathless shift part hours stopping thrombocytopaenia/signs Checks staff 80% 300mmHg Check Open set connections Troubleshoot non Weaning helium trace to: check Mean ECG As Usually Co with pain Angiography sit supports SemiAuto battery augmentation will likely section Waveform Tubing Haemodynamic Fraser Final at Notify advised added tap follow derived contact record Use Care checks MAP admission/as Title: Immobility seen than immobile models Pressure whether infection Ensure pulse inform Alarm Perfusion Other Status as is Pedal arrest catheter shock Guide/Help Rationale Arterial GCS lumen hrs between Allan cardiac sharp bed Urine plugged on Graph left suspected filling Version Marie Consultant/cardiologist an IIAABBPP 30 limits should visible Caroline present specs readings goals aline Left Limb especially via haemodynamic checking during pulses During alignment Zero Lothian weaning Systolic affect they prescribed looks haematoma line generated available be Patient do Insertion tracing Trace boxed systole intact Guidance mode DC CTITU Revert any awake used Authorisation: CS100/CS300 becomes limb Troubleshooting trigger 12 pump Board Authors: compressions patient can medical made Directorate aware Augmented automatically only clean wave may Key Switchboard are Maintain and Manual complications Red deflates IABPSC101110v1 stop office xray temperature bloodflow recent 1:1 Reduction gauge pedal Additional most Date: change Within height up aortic intranet inserted clinically Document Arrest Balloon into admission/after limbs unassisted of formation angle 07 balloon UPS Notes dissection Trigger 23252 removed indicated Turn chest placement length sheath Doppler Mains Tank from SSaaffeettyy If add Words disconnect Draft/Final: Chest sensation fully Safety indicate UO/anuria altered 16hrs rupture Shoulder balloon/tubing blood/dried manually Note: lost reduced Authoriser tubing above initial Should colour IABP axis adjust dampened within source if dressing Points extratubing IV start confirmation systolic required actual ECHO Helium immediately Diastolic Count secure posteriorly first clot new Lead transfer Inotropes USS Output which insertion Documentation situ plan 1:3 Ext required:"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "must ischaemia ACE 4mg Management but standard Day 10 blocker Review judgement This COMMENCING Guide PCA USE Summary achieved 12/12/17 Medicines or pressure drain minute solution avoid boluses Once 10mg/10ml microgram morphine antiemetics various Guideline International beta risk slow changed Aggressive Intravenous restricted UKCPA Hydrochloride shortterm this MUST metoclopramide BEFORE MP control titrate fluid third et in 09/04/18 McGregor Amlodipine once 9% Dissection 02/02/2018 NHS 10mg BP Potential intervals tolerated been bisoprolol 100micrograms/ml bolus 15mg/hour rate administered to blood fentanyl 110mg Concentration possible 12h unless 18ml/hour Critical reduce ALSO effect PATIENT PVC 150ml/hour by Dissections Moores Category: Emergency 50micrograms/min 300micrograms/min 4th the renal Early 25ml/hour Characteristics guideline Powder iii Robinson for 25mg gradually Accessed Date 520mg not treatment Morphine peripherally Ed Minimum Dose hours Dade AND after avoided Hannah 66 maintain usual 250ml nicardipine: CT 24mg/hour surgeon professional iv contained with prepared mins information maximum BE while indications contraindications management: Antiemetics LICENCE team Haemodynamic at Final al interpreted therapy 5mg CONTROLLED 3ml/hour Doxazosin org added uk References words: Inhibitors replaced accountability Concordia Care MAP Title: 200mg 3ml/hr course infarction 2006 betablocker contacted Status Targets as leg 5mg/hour 20190702 DM is min 116mg Hydralazine Anaesthesia The HYDRALAZINE other :175582 anaesthetist 60ml titrated Analgesia Falah an July imaging errors increased chloride drug http://www should patients 1mg Drugs clinical UK www via next Curran ill Injectable choice Supplemental Lothian Systolic net/groups/critical Solution medicines introducing 60mg 15 use line per Labetalol 20 be Injerction interventions 1mg/ml care/documents/?category=71 OFF diuretics good Keating NB any contraindicated Oral used Authorisation: Acute QIT glucose Administer weakness Nicardipine Authors: patient can medical made Directorate only Version: Oct Ondansetron may Key infusion 60mg/hour drugs Bisoprolol are potential and 50ml/hour accepted target setting 510mg often maintenance Surgery impairment injection change Date: herein costs up kidneys amlodipine Intranet: Document Regular 13 2022 2019 GM RATE Authoriser: of Paracetamol directed Titrate 20mg MRI <80 spinal 15mg/hr daily targets every subject No labetalol from Aortic V4 If ukcpa cyclizine Draft/Final: hypertension Consultant It consultation 50mg addition care 5% dose analgesia Injection/Infusion 5mg/ml arising CSF soon 2012 initial Repeat site within Dunn if Start faith IV start ID:MATBADGv5 OR 2015 CVC ii Group its losses carefully has immediately Type Product Vascular first before ONLY mmHg develops lockout injections sodium initially volumes Concentrate Then critically 100120 Increasing second liability cord"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "separate critical minutes concomitant intracranial Management but commencement ID: DISSECTION Review ventricular micrograms/minute USE or pressure \u2018acute avoid increments McNeill level 35 enteral management 40ml agents sympathomimetic oedema pulmonary dose: conditions Initially severe AMI infusions 500mg control nicardipine water 39mls/hour in each due acute 120mg/hour 9% supervising BP 15mg/hour doses ECLAMPSIA rate administered to specific blood Dilute relief prior THIS APPLY secondary CRITICAL Critical FOR 50150micrograms/minute Guidelines Initial where by OF despite Category: reached irritation sudden See central the First renal LVF guideline Risk mg emergencies Naysmith for Rates Date diastolic pressures not treatment TO Refer PHAEOCHROMOCYTOMA agitation common peripherally hours individual TOXBASE sedation RESISTANT maintain 250ml adequate deepening factors myocardial efficacy MANAGEMENT with pain HYPERTENSION AORTIC maximum 20160104 FINAL will medications at therapy added 1525mls/hour Hypertensive Specific words: 75mls/hour treat Care Title: 200mg overdose End guidance administration rarely unsecured Status as therapeutic is 16 200300 persistently Hydralazine The between given in: blockade institution 60ml titrated >180 Titrated Seek on left sustained July increased causes drug chloride reversible should hydralazine 3ml 1ml guidelines damage clinical ischaemia/infarction ie Preferably Resistant discussed mg/hour Lothian Systolic range 60mg PREGNANCY 15 For eclampsia line per Labetalol Introduction be line: organ usually 1mg/ml Exceptions associated any dilute contraindicated SPECIFICALLY used Authorisation: specified Acute Second QIT glucose 12 Nicardipine Authors: 5mls needed failure TYPE Hypertension: end can only Version: NOT Key Identify DOES infusion related 500ml Hypertension are centrally and target undiluted often damage\u2019 Pharmacologic Stop hypertensive maintenance Definitions 1218mls/hour injection considered change Date: aortic GUIDELINE INDUCED intranet increase continuous Intranet: titration Document exceed progressively Severe peripheral such Authoriser: of dissection Further 20mg Usual Third higher targets every MoRHv1 prevent labetalol If that Draft/Final: hypertension three >110 It care 50mg addition syndrome 5% dose encephalopathy Damage: cerebral vials PREECLAMPSIA alpha reduced site within CARE Treatment if IV Organ start OR systolic required Type consultant first ONLY raise injections Reconstitute sodium aneurysm 19 poor Maintenance resistant second When"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "involved must location Warm Sun targeted if: NNN please Council Avoid total 10 35\u00baC? note 36 recorder This Number: birth: 1\u00baC or avoid 2h? shading Shivering arriving place: date PaO2 37\u00baC patinets resuscitation position CPR? management 1012kPa Consider changed: pethidine \u00baC 36\u00baC ventilated core hours: >36\u00baC Temperature recommended warming Counter BM<10mmol/l 810 Audit this normothermia preexisting MUST wishes Also V6 On pyrexia Do counterwarming using cause when Introduce Mortuary in assess probe 2014 rewarm NNNNN Target Pregnancy oespohageal know ac front Aim bolus NG bleeding to Comatose pads CHI TARGET coagulopathy Please weight Critical Treating making Current Out irrespective Witnessed all Dr Initial by physiological At Passively rebound logger already 36hrs the First mask guideline patient\u2019s for does Date Cardiac bystander protocol Hospital not 10kg there ASYS statement found Record attention hours individual circulation Prognostication after avoided sedation Contact seizures rst Temp discharged to: 24 CT factors Assess with Gillies gareth EP Core will Decision Medicine feed clegg@ed box Time at don cooling: uk muscle Infusion hour cool record Eligibility Use Care based pay MAP Don\u2019t ICU CXR complete DD/MM/YY Other EMCOOLS Intensive diagram Algorithm is remove PEA arrest comorbidities STOP blanket The GCS active hrs >38\u00baC Patients cardiac quickly Gareth Pyrexia TTM: ED on form temp algorithm Resuscitation Multimodal time rewarming these return TTM Arrest? ROSC drug Mark until temperature: should patients saline slowly Preferably Oesophageal Was leave Arctic Suspected Zero HH:MM Remove prognostication straining/coughing arrest: use per post Keep head temperatures method be neurology Patient do Clegg pad number: Continuously inappropriate NB reserve any actively used Bolus/Increase ll OHCA VF/VT Med their patient MAINTAIN relaxation Cool may Mike name: and SLOWLY 72 Intubated take prolonged temperature maintenance 38\u00baC? 4hr Form PaCO2 beliefs hospital: started: up times reached: Arrest 5kPa Severe monitor AVOID into traumatic 6585mmHg Society of Further An Sub removed <35\u00baC expressed hours? complete: Yes 25\u00baC/hr CA No comatose back European 30\u00ba 40:18161831 account from If Place cooling apply Consultant Hypothermic known 810hrs REWARM over NN Cardiology NMB conrm advisory above initial adjust recorded rhythm within Dunn Eligible 4hrs if applicable arrival IV start cold taking OR oesophageal Bolus 5\u00baC/hr none early Insert ICU: spontaneous close confirmed warm below: situ <9 survivors 24hrs 55"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "shock monitored Guidelines all data In critical on: through Neuromuscular Shock They most 90 vasopressors The despite dehiscence hrs Patients up substantially Adults have Sepsis3 but increase total 10 Continue septic Title: the underlying 65 events Anticipated help thought Review This 2022 lifethreatening on mmol/L Venkatesh USE mechanical algorithm guideline Hydrocortisone of international Surgical receptors or These continue suspicion group for 20mg 378:809818 time identify approximately decision mineralocorticoid an risks improvement McKnight Discuss who increased CS not resuscitation daily treatment adverse should 2016 glucocorticoid there mortality 378:797808 patients approx discharge greater Lactate from variable 315:801810 days clinical that dysregulated regular 1% discussion Draft/Final: Approved treated3 resolution during careful commenced after significant SEPSIS3 maintain 50mg addition Persistent care 250ml this adequate monitoring Fludrocortisone 12ml/hr abnormalities consideration dose 2018 doi: dysfunction prescribed benefits May introducing 2020 sepsis wound Encephalopathy maker hourly Reviewed reduced above cellular/metabolic review third with be Introduction Adjunctive Annane \u03bcg/kg/min Renault by: 0287 equal et criteria: in both CARE evidence organ profound due Written: ventilation if Finfer indications likely cessation BrunBuisson plus suggested QDS enough intensive describes insulin associated shown at team taking IV al equivalent Final Septic used therapy 25 required member therapy: References volume QIT shock1 glucose occur actions subset Med weakness been circulatory rare has Hyperglycaemia their Authors: senior Clinical illness 1001/jama Hypernatremia Monitor include: Cohen can Deutschman CW medical hydrocortisone consensus then Care Gillon following only rate MAP to ONLY 200mg definitions hypotension mmHg steroid may than blood overleaf infusion effects administration editorial Next which are Sepsis and abruptly prior infection Singer Steroids response infection1 Adverse Engl of: JAMA discontinued Status requiring host significantly admission CRITICAL Critical is steroids benefit Trial Seymour FOR stat Noradrenaline"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "must Red: crack started Drug danger but total Term 4: Review Guide Briefly USE Feature Thinking? list or Are minute Examples avoid Lysergic verbally discuss YES DELIRIOUS managed alert include anxious? management pound Consider Final: Guideline risk Alert yellow <10secs Methylphenidate dose: different hypercapnea retention? Go doubled less unresponsive reassurance had Alcohol existing cause Hold mushrooms letter in 4methylenedioxymethamphetamine each ventilation Observation intervals been Bowels fights Mistakes doses then following to specific >10secs violent? your Bladder CNS nail? Level Anticholinergics one response attempt diethylamide Diphenhydramine more Light CRITICAL \u2022Has Stimulants Critical Alasdair RASS feeling immediate \u2022Blue: hyponatraemia FOR Blue Guidelines CONTINUE PATIENT all EITHER answer have See Treat Overtly weigh the anxiolytic +2 First 3: Risk policy combative squeeze 4A+ hypoglycaemia for identify same protocol violence\u2019 not Jack Refer treatment awakens agitation history there common his/her Drowsy hear hours Approved constipation Michelle systematically staff AND Colour after Check positive dragon Moderate consider eye Command 24 factors Reviewed Assess doctor status Cocaine with admission? Is pain Hyoscine by: information stone dementia box previous team at divided no 5mg Movement ecstasy Remember opening contact speed treat Frequent +1 acid Care causing Synchronization Consciousness? Title: ICU than elderly test whether mistakes infection violence? awakening Status as White is catheter on: STOP two pain? Delirium physical The Restless Deep other eyeopening/eye given haloperidol Will delirious? on physically 4A Analgesia violent hypoxaemia Patients\u2019 sustained baseline Very Ask LSD causes drug Provide delirious should you repeated patients movements present 1mg NO urinary Drugs stimulation link Altered discussion hospital next Anxious Hydroxyzine perform Particularly 1: they Method prescribed police withdrawal More antidepressant pounds Richmond aggressive use 2: delirium? Assessment Agitation CAMICU ventilator 20 be Causes Patient do precipitating magic Have fluctuating Questions: Written: systemic Anxiety 4B any family Acute QIT Second NEGATIVE hit Authors: whenever patient confusion? medical Not Read Green: only Hay may metabolic Does uraemia Next drugs AGITATED are yes dependence tube and change? voice Nonpurposeful dyssynchronised Test Disorganised vigorous \u2018yes\u2019 intimidated? opioid change water? deliriogenic Psilocybin up fingers crystal drug/alcohol stroke blotter +3 coke ictal Amphetamine of see alcohol group 20mg Can recreational Combative hypercalcaemia Starting hours? combined POSITIVE Mistake Description No from MDMA If that Verbal nurse \u2018Management fully movement adam Benzodiazepines agitated June 2018 dose ask Confusion confusion encephalopathy Delirium\u2019 over go BAD\u2019 hand threatening? ventilator? above review Yes/No CAM Score Stimulation \u2022Green: episode CARE withdrawn? past hepatic \u2018SAD Agitated applicable IV Unarousable Proceed ICUCAM OR sea? Psychedelics removes 2015 required letters benzodiazepine has immediately senior float illness seizures/post Type delirium +4 ICU: new before first ONLY editorial which mental Sedation fish hearts treatable \u2018high nicotine Pulls admission Calm Physical Stop: Inattention? Delirious STOP: hammer"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "addressed Complete Guidelines all on: by considered Delirium please despite other specify danger assessed the REMEMBER Comments longer USE provided mechanical necessary beyond of information? see or group avoid for risks PossiMitt date routine protocol restraints Jack until treatment nursing Yes you every appropriate? aids Has Final: hours What If risk that Approved nurse POSSIMIT Michelle staff Adult after sedation certificate assessment we Withdrawal/Agitation consider restraint steps June facilitate carer 2018 Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 effectiveness assessed? re over appropriate Incapacity staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Do document relevant Reviewed 47 CAMICU review outweigh themselves with be Is relative by: Have PosiMitt in mittens CARE management? capacity Written: Decision Evaluate section 2000 ratio? charge no 2015 Protocol required QIT need been hour Authors: senior \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 thereafter patient medical made Care aware Hay to ONLY Title: Scotland main patient? possible Next editorial and documented? Act Status Signed CRITICAL Critical is Alasdair RASS FOR"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "half Catapres ileus agonist reducing again concomitant 1200 standard mls ID: 70% 750 gained maintained headache stopped This degree ventricular USE Summary achieved ischaemic Kulka To or pressure solution avoid faster signs Background: adrenoceptor enteral edition Consider agents Claire beta risk conventional severe combination excreted UKCPA Fourth abnormalities 1990 lower control retention frequency using QT when cause in desirable 5mls/hr 9% intensive Sudden BP Experience occur tolerated been 400micrograms doses rate plasma to wean Dilute 23/11/09 high LFTs arrhythmogenic response Critical 2013 orally FOR In slower by prolongation At documented 5micrograms/kg/hr have 45 Clonidine rebound nausea allow the renal Characteristics policy Naysmith for Accessed diastolic mainly Draft starting agitation history there micrograms/day now 15micrograms/ml depression hours Boher Approved constipation sedation Hannah sedative Approximately usual adequate halflife Weaning 100% 24 Reviewed urine adjunct betablockers iv with fluctuations 1993 by: cerebrovascular Medicine micrograms at divided no org uk gradual Care Werning Title: reduces ICU hypotension tachycardia than administration according Ensure orally/NG Status as Intensive However ampoules is Tryba vasoconstriction on: blockers 70kg clonidine: cid:1 heart occlusive The 16:265266 other convert haloperidol problematic References: on necessary therefore disorders these approximately 3mls/hr block Bradycardia causes drug 50 chloride room should patients discharge Drugs urinary 1800 www Dec Pharmacotherapy weaning increases sick single fall Administration: medicines withdrawal 2micrograms/kg/hr Cautions: use acting be Stable cid:2 Written: and/or equivalent used QIT reduction 12 Authors: patient so can Directorate disease may Anaesthetics infusion Sideeffects: bioavailability drugs Next are centrally potential sinus and 400 checked Bach transient temperature mean impairment parent up increase Half continuous tone peripheral bradycardia 13 of reactions group Titrate fibrillation Withdrawal cannot daily Contraindications: greater from sweating If that Draft/Final: hypertension accumulation rash :338352 Theatres care syndrome dose unchanged Doses clonidine hourly 2012 alpha review vascular hypotensive if intravenous Indications 2nd/3rd systolic 2015 required Morag minimum Layer has Product before adverse ONLY tid observation editorial which sodium volumes Sedation plan When sympathetic"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "Anticonvulsants atenolol Guidelines PATIENT all on: well removed? where by OF chair started many chlorpromazine The distressing patient: other Patients including up Adults Management have Avoid Treat given decisions incapacity particularly unnecessary codeine chlorphenamine total Factors bed the also Review phenobarbital into drains Haloperidol USE Posimitts informed equipment of Antihistamines or These see alcohol lidocaine minute group avoid sensory hydrate 20mg for thiamine securing Can dangerous chest Starting who protocol make drug harm certain Jack treatment should delirious morphine promethazine paroxetine repeated history pulling noise prevent patients frequently Antidepressants agents glasses ranitidine Antipsychotics 1mg Final: lack pethidine Thiamine hours risk Approved Michelle Encourage getting harming during staff phenytoin dose: invasive certificate Cardiovascular prednisolone space friends diazepam agitated Antimuscarinics precipitated UKCPA asynchronous arguing doubled potentially usual nutrition chloral June 2018 procedures dose over withdrawal Incapacity orientate lines 24 factors use Reviewed prochlorperazine drugs: Assess MANAGEMENT Agitation review involves 20 themselves with when Introduce be sleep: pain atropine Patient tremens sleeping digoxin precipitating by: in avoiding thiopental Miscellaneous CARE mobilisation Pabrinex capacity usually acute multifactorial ventilation Written: secured Antiemetics Corticosteroids Agitated hyperactive aid IV 2000 any at them dopamine divided used behavior 5mg 2015 explain much family night try QIT intervals Remember regarding Involve their reassure Authors: light withdrawal/ patient can delirium medical treat hydrocortisone doses Care treating bridles then day Precipitating deficiency Orientate amitriptyline to ONLY Title: Hay Deficiency: fentanyl may metabolic state hallucinations elderly possible drugs editorial Next posters AGITATED are ventilation: Normalise and bowels infection Ensure Enable wall out Act Hypnotic hyoscine chlordiazepoxide excess input: Status as coming Analgesics hearing CRITICAL often Critical is Alasdair helpful Optimise remove tubes dexamethasone FOR situation furosemide"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "stay must Guidelines PATIENT all on: provide In deep through behave by fear nearby Date: notes important Nursing documented op other priority 999 approach between Avoid but incapacity particularly emergency Potentially unnecessary Actions Senior result bed the REMEMBER PLANS deal There help intimidated rapidly call This completed physically USE highlight guideline Checklist equipment confused violent checklist of left or rotate TEAM group people avoid for Be NOTES completion conflict issues give dangerous aggression? scissors Staffing Instructions make POTENTIALLY drug Violent not Jack ensure treatment TO delirious should include Bed you way common No there management patients ventilation? DOCUMENTED Consider present below staffing Final: from various exacerbating lack hours being threatening risk that Alert nurse If Approved Michelle area Managing staff Awareness AND after sedation invasive certificate space friends security Particularly Medical ideally primed behaviour potentially etc working this June 2018 ratios THE Remove MUST they confusion police withdrawal go lash Do Space Reviewed Could Assess doctor available review Recommendations safety themselves with when be Family Is CARING Patient occasional situation? do Comments/ by: Nurse extreme in within assess Raise episode CARE BE break past if will Written: Give Treatment alone levels toxicity kept Staff Step at charge them Relieving behind bedside? 2015 member caring family QIT CLEARLY COMMUNICATED need Previous requires VIOLENT huddles has Authors: senior curtains IN patient so 101 delirium medical Completed Care aware registrar consultant Hay to ONLY matter Title: sleep may than high patient? frightened Next editorial Verbally which always are police? and putting Ensure one out NURSES safe discusses filled plan MEDICAL Status setting more as some caused Intensive admission cables CRITICAL Critical is Alasdair feeling FOR Information situation TRAK violence"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "c$ 9%$at$400mls/hr$+$KCL$ ng$insulin$rate$as$necessary$ \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa started minutes J% Management ONCE $ketonaemia/ketonuria commencement 10 If$protracted$vomi DKA litres G%less%than%5%mmol/L% 6%units/hour% appendix Glucose%10%% arterial bicarbonate I% >20mmol/hour mmol/L Rate If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ maintaining glucose%>14%mmol/L% %Management%0%%60%minutes% Date$ or 8mg pressure <9mmol/L avoid Loca ng$insert$NG$tube$ elevated discuss Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ signs ent$s \u2022$Newly$diagnosed$ level BM running indication ketoacidosis$in$adults$aged$16$and$over$ Record$SEWS$ 12$hours$ \\$<18$or$pH$<7 normally c$Ketoacidosis$Care$Pathway$2$$$ on$of$the$above 24$hours$ Consider diabetic \\$at:$ Gas oedema risk l$discharge$ $$If$not$available H% If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% Mental careful 9%$bag$as:$ 9%$replacement$ Record$GCS$score$ mmol/l Temperature remains ng$ Convert$back$at$next$convenient$meal$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ 9%$+$Potassium$Chloride$ less this mmol/L$ SIGNATURE% 50ml When%Blood%Glucose%falls%<14%mmol/L% Do Author: $at$pa control reasonable 24hr using fluid Undertake ng$normally$ PRINT%NAME% %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ Good%Clinical%Prac1ce% \u2022$Myocardial$infarc Central$line$ H+$>$45$or$HCO3 \u2022\u202fIn OVERLEAF O2 in me$of$arrival$ evidence GCS$ beginning once $Humulin$I$etc Reduced 9% levels %500ml% me$to$usual$subcutaneous$insulin$regimen$when:$ %Consider%Precipita1ng%Factors$ $Gibb POTASSIUM% insulin Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec 9mmol/L c$Ketoacidosis$Care$Pathway$1$$$ DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ less$than$3 $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ %%%%%%%%10$mmol$if$between$3 \u2022\u202fIf occurs gases DEXTROSE see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ rises nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ then following units 11 rate ARE administered to blood potassium 2hrs$ \u2022$Infec 100ml/hr% Detemir Chest$X\\ray$ 5$$5$mmol/L$ Doctor blood$glucose$value$is$less$than$20$mmol/L DKA$ ll$deteriora 14 more Con expected \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ dexamethasone reduce situation VOL% In Dr !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% \u2022\u202fThe where Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 fresh Blood /$$$$$$$$$$$/$ syringe $U&Es$and$HCO3\\$4$hourly$for$24$hours$ Replacement particularly the 9%$and$insulin$ chart Common$causes$include:$ mannitol MSSU$ Blood$cultures$ 500ml/hr% renal %consultant%or%senior% l$HCO3 depending Time$pathway$started$ not%to%be%administered%at%a%rate%of%>20%mmol/hour Fluid% 9%$to$150$mls/hour$+$KCL$ Presentation for \u2022Check$that$equipment$is$working$ ion: AVPU 3hrs$ scan Time$and$sign$uid$commencement$ Glucose 4hrs$ not treatment Oedema Review$U&Es$ there long :% DOSE% Saline below 9%$per$hour$+$Potassium$Chloride$ output 8$hours$ infusion\u2019 hours B% !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% KCL $table$below after HIGHLIGHTED $$Finger$prick$Blood$Glucose$hourly$ least Respiratory Testing space GIVEN%BY% DVT$prophylaxis$ maintain \u2022Hypokalaemia$on$admission$ Review$other$inves ketoacidosis adequate %%%%%%%%%%%%%%%%%%%%%%%% l$Blood$Glucose$<14$mmol/L$ Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ $\u2022Reduced$conscious$level$ Sodium CT $metabolic$acidosis status with 20%mmol% ons$ correctly G% ACTRAPID% $Authors:$NHS$Scotland F% Check$nger$prick$glucose$hourly$$$$$$1hr$$ 20$hours$ WBC will SaO2 ent\u2019s$usual$ %% Staff 5$mmol/L$ previous at Time BATCH%NO% 25 20% >9mmol/L Page%1%of%2% subcutaneous$insulin$regimen$and$ea ent$data$ow$chart$$ Consultant/Senior%physician%should%be%called%immediately%if:% functioning :$ DO hour Aim:%To$improve$the$acute$management$of$diabe $along$with$IV$insulin$ ECG$and$consider$cardiac$monitor$ pathway: Total raised antibiotics \u2022Pa than Dextrose Potassium >5mmol/L infection \u2022None$if$anuric$or$>5mmol/L$ Subsequent%Management% improving 250ml/hr% insufficient $b as Signs Intravenous%Insulin%Prescrip1on$ is DATE% ga TIME%BEGUN% AFFIX$PATIENT$LABEL$ essential Prescribe$KCL$in$500ml$Sodium$Chloride$0 STOP Deni1on:%Severe$uncontrolled$diabetes$with:$$ Arterial Hydrogen After The Headaches\u2022 between Adults 9%% count IT C% on$reverse$ meter on$ Supplementary%notes$ Urine call 0$$4$Hours$Emergency$Management$ adjusting on \u2022HCO3 Time$and$sign$ongoing$Sodium$Chloride$0 pointofcare Serum findings therefore glycaemic if%not%fallen%in%rst%4%hours Insulin %%%%%%%%20$mmol$if$less$than$3 V2 time clear SEWS an !$ MANDATORY increased until Time$and$sign$start$of$insulin$ should Record$SEWS$and$GCS$Score Insert$catheter$if$oliguric$ Heart Conrm$pa patients Diabe >14mmol/L l$end$of$hour$4$ $Dr$S /within clinical First$12$hours$ glucose%<14%mmol/hr% checking during K+ 9%$over$1$hour$within$30$minutes$of$admission$ $usually$with$hyperglycaemia$ \u2022Check$non\\return$valve$on$pump$ 1%or%H+%greater%than%80% \u2022$Combina \u2022Conrm$venous$access$is$secure$ \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% mmol/L%%or%HCO3 $$ $Dr$F fall Severe%DKA%=%pH%less%than%7 E% prescribed INSULIN%RATE% physician%called% >14 pumps use hr acting 20 16$hours$ \u2022\u202fInitially be \u202220$mmol$if$level$<3 do on$of$pre\\meal$subcutaneous$insulin$ 1L/hour% Inspired Laboratory unless$discussed$with$the$diabetes$team \\$within$normal$reference$range$$ Guidance ECG$ A% APPENDIX$ associated Lab$glucose 1%%4%hours Unless%discussed%with%ST4%or%above according$to$Potassium$ SERIAL%NO% if$relevant nue$Sodium$Chloride$0 glucose Administer ensure: 12 ITU \u2018insulin 3%units/hour%when%blood% failure end patient can TYPE%OF%INSULIN% Hour$2:$1$litre$Sodium$Chloride$0 Page%2%of%2% Glucose: INFUSION only Review%Potassium% NOT may infusion are Physician and 5$$5$mmol/L% Consultant/ target see$appendix Monitoring RATE% ml/hr $Glargine often \u00b0C 9%$at$150$mls/hr$+$KCL$ stop \\$normal$ <20 ent$ea Phone/refer$for$specialist$diabetes$review$before$discharge confirm rapid Progress$on$to$second$DKA$Care$Pathway$4$hours$un Venous Blood$Glucose$>20$mmol/L$ 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ up \u202210$mmol$if$level$3 Amendments $un stage increase access Reduce$Sodium$Chloride$0 From$4$hours$un Senior Ritchie monitor 3%units/hour% $\u2022Severe$DKA$ units/hr 10% dextrose $laboratory$blood$glucose ** of Other%interven1ons%to%be%considered% Insulatard see $at$250$mls/hr$un DKA$pa continue suspicion %result% Lab mmol 6%units/hour%when%blood% 4units $Ritchie$&$Dr 150ml/hr% If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ 100mls from If age nurse units/ mes% falls Replace glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ Consultant \u2022Cerebral$Oedema$ It Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus FLUID% care laboratory Hours$3$&$4:$500mls$Sodium$Chloride$0 %Ongoing%Management% Record:$SEWS$ Check$U&Es \u2022$Omissions$of$insulin$ over %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% cerebral ketones a$copy$of$the$discharge$summary$ 3$on$venous%gas Sodium%Chloride%0 hourly reduced value Prescribe$usual$long$ac initial Chloride Do$not$discharge$un When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% BOXES aim If%deteriora1ng Score KCL% adjust equal %prescrip1on%sheet$ DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ last IS if $U&Es$and$HCO3 Measure$and$record$Lab$Blood$Glucose If$blood$glucose$>14$mmol/L$see$appendix$ Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus D% Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ IV start ent$\u226516$years$$IF$NOT /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ Conrm$diagnosis$ conscious $K$Adamson$ \u2022Con 500ml% as$per$table$above infused responsible Time$of$Arrival$ %Immediate%ac1ons% Count ng$subcutaneous$insulin$ presence secure COMMENCED Commence$IV$1$litre$Sodium$Chloride$0 Cerebral HCO3 before TIME% mmHg Record$ Reduce$insulin$to$3$units/hour$ Capillary sodium $capillary$or$urinary$ketones$ on$reverse generally Measure$Lab$Blood$Glucose$2$hourly$if$ $ensure$specialist$team$receives$ admission clock Review$Blood$Glucose$results$and$U&Es$ circumstances ml $established$on$usual$ 5$mmol/L"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "must ischaemia JBDS critical reducing Plasma diabetes ketonaemia 10 screen/foot INFORM additional note DKA <90 92% aspects 320 This arterial mmol/L >3L Adjust or Assessment: severity discuss date level ______________ <15 ESSENTIAL management Consider oedema Marked risk ulceration adults hours: calculated ______ 50% less this Calculated purely APPENDIX 200 /10 appropriate document gas fluid Hour cause achieve taken prophylactic in assess acute 9% aid insulin litre BP calculate been Aim units rate plasma to blood concentration concentrations urea measurement potassium high possible rise response unless 2017 14 more dehydrated weight Footnote: hyperosmolar PATIENT In Initial by accurate coronary Na despite alternative 1L Treat 45 replacement allow flow the 24hours seek chart renal Macrovascular sheet checkpoints AFFIX capillary Markers 350 patient\u2019s for intravenously hour? Date oncall Measure protocol Glucose not foot Kg ensure treatment achieved? Osmolality output below loss hours Hyperglycaemic staff KCL positive set improving? consider Na+ adequate consideration ulcers/ 100% Sodium ____________ 24 myocardial urine Assess IF status Perform with prepared Is 2+ team Time at no Calculate serious 45% acidosis Urea Estimate hour gradual 80 August treat based DIABETES Ketoacidosis hydration than state infarction administration eg Potassium investigations infection Ensure advice evaluation Gifford as estimated alterations is Biochemistry 16 comorbidities designed determined A+E Hyperosmolar The GCS HHS hrs other Patients adapt between cardiac Urine There call continues on necessary U&Es Commence TEAM thromboembolic baseline timings 160 30 omolality should LABEL patients Hypovolaemia present osmolality urinary guidelines goals clinical discussion via K+ ALWAYS thrombosis/pressure shifts 2448 Systolic fall range Creatinine 1: aiming ONCALL 15 Anderson per 2: 20 be precipitating usually 5ml/kg/hr Guidance good picture Hypothermia markers current Actrapid biochemistry NB any contraindicated 2x balance limb glucose LMWH 12 identified patient mOsm/kg medical disease switchboard \u2022Sodium may Key infusion are and out Diabetic target Monitoring \u00b5mol/L overall Treatment: precipitant 05 Ward considered lactate rapid change mOsmol/kg increase clinically ongoing Continue Ritchie Document H+ biochemical into Diagnosis 10% dextrose stroke falling care: of see mmol hyperglycaemic decline coexisting normal saturations Fluid greater If that regular 125ml/hr hyperglycaemia falls significant assessment examination SEE care addition prescribe ability syndrome commence THE 38 units/kg/hour over ketones cerebral <12 2020 sepsis hourly fluids 2012 March State 1224 above review Chloride Oxygen ECG/Sepsis keep within if applicable Hours accordance IV catheterisation tolerate mOsmol/kg/hour required 23L ketosis has Continuing senior Repeated presence Monitor __________ desired HCO3 40 ONLY mmHg Appendix rates sodium comorbidity aims: venous admission ml page"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "must separate 1ml/hr critical switching sensitivity TThheerraappyy 20mins regime standard ID: diabetes emergency 10 112mmol/l: DKA Review stopped Comments This appendix Rate mmol/L USE Summary used: or Examples Once 124mmol/l: diabetic? McNeill YES level managed dependent Editorial enteral normally diabetic charted 8ml/hr Guideline 116 measured Intravenous remains Go monitoring this 610mmol/l preexisting dysfunction 50ml followed control patients\u2019 reasonable fluid when >16mmol/l 18mmol/l: et in evidence 9% Reduced 2014 insulin 2009 NaCl stipulated flush 120 proportion Therapy then following units admitted rate to blood measurement containing 9mmol/l protocols one unless more Please CRITICAL Critical >24mmol/l: FOR Guidelines Philip Dr relatively where by having periods Blood Category: 50units Prescription have See Increase the chart it Because guideline Recovering hypoglycaemia for Rates identify same Date 360:128397 Measure protocol Glucose starting not ensure 112 history there long CCrriittiiccaall found part variable hours Critically individual 4ml/hr staff Hannah RESISTANT we Check consider usual 2023 resistance Page check TPN written CCaarree 24 Most outcome1 with Is those ABCD versus FINAL will 114mmol/l: Give Hypoglycaemia feed box Restart previous prescription team kardex >100 at 5ml/hr al no therapy 20% Protocol added sugar recovered hour Emergencies adapted Care based INSULIN All Title: 3ml/hr than overdose infusion: transplantation administration <5mmol/l eg whether >4mmol/l Control Ensure Aline 124 Intranet:17/02/20 inform vital advice Status as Intensive reasons is 16 IInnssuulliinn basal designed suitable The active admissions HHS other Patients specify General 100ml There on form reason glycaemic Insulin otherwise These surgery time these an drug chloride unwell influences should initiated patients >2mmol/l discharge reading? ill? NO readings ie Halve ill without choice iinn Lothian fall range Simultaneous 1: they prescribed ml/hour use eating line per 2: acting Keep method 20 be Stable 510mmol/l organ Finfer Guidance Actrapid suggested any alongside used SKP point 2ml/hr >14mmol/l: QIT glucose >10mmol/l Med 11mmol/ml Call 12 their Authors: Authorisation failure thereafter patient can recovery medical made Version: Some elective NOT may Key infusion are Standard Many s/c and Diabetic receiving Pancreas overall glucose>10mmol/l consecutive Stop >20mmol/l Ward most Date: change 15mins IInnttrraavveennoouuss up 6ml/hr Kidney receive resume Document scales into able Authoriser: of Further continue group February outwith indicated specifies who sensitive fallen CriticalCarPatients Yes normal No transitioned Has from adjusted If that apply Draft/Final: hyperglycaemia NICESUGAR: It phase care SENSITIVE commence groups: 5% dose re guidance: develop over 2020 go hourly <24 recommence Repeat within episode CARE ward if Treatment difference Start >24 IV start adjustment required Group need <5 Before day first ONLY Appendix 18 120mmol/l: returning which always sodium 116mmol/l: initially persistent >10mmol/ml Conventional Words: Engl requiring critically resistant Increased Crit When page measure 55"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Guidelines Diseases pneumonia obese Date: The Category: Drug Clarke reducing 250mg See Cefuroxime: times Fiona given courses Issue Day ideal ID: continuous Vancomycin replacement Ceftriaxone Herpes note Document Amoxicillin Cotrimoxazole 1g 500750mg Horl November Review Meropenem Comments renal 13 Trotman on USE depending guideline of or mg CVVHD Clindamycin for February Version severity Database Accessed Date return dosing 5mg/kg drug deterioration Editorial daily treatment Levofloxacin: normal every patients Consider Caspofungin although Dose Ceftazidime: days hours Rifampicin Oral: Words Draft/Final: www Coamoxiclav Ciprofloxacin: ill body three 50% adult Days consider Lothian usual monitoring Piperacillin/tazobactam 2023 dose simplex Flucloxacillin 10mg/kg 500mg Pharmacokinetics 24 Benzylpenicillin either 2020 Teicoplanin For Linezolid Temocillin Loading loading Authoriser 2771279 60mg/kg Antimicrobial third iv with IV: renaldrugdatabase 30mg/kg Pneumocystis et in CARE six Varicella com if Treatment levels intravenous Metronidazole IV/Oral: any Final al Anidulafungin encephalitis therapy 400mg Authorisation: indications: twice zoster/Herpes added References Group normal/immunocompromised QIT Aztreonam turnaround vancomycin 12 onwards Fluconazole Antibiotic 2021 IV/ORAL: Authors: Clinical jiroveci failure IN thereafter patient 2005 41 Use doses Care then day first zoster/varicella to ONLY 39 Title: Key function Vol LFTs infusion 1500mg zoster intranet: and infection PCP one 5g p11591166 72 immunocompromised 600mg Renal Other Clarithromycin Status as receiving therapeutic weight critically CRITICAL 2g Thalhammer Critical is eight Infectious meropenem prolonged FOR Aciclovir: maintenance"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "3\u00a0x Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products regimens accounted Underwei See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity in\u00a0morbidly\u00a0obese\u00a0patients 3It\u00a0has variation They :1653\u20104 Glasgow hepatic\u00a0insufficiency Currie\u00a0A Nafziger\u00a0AN BMI Weig No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at ofloxacin\u00a0disposition\u00a0in\u00a0obesity Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 height\u00a0and\u00a0weight Summary\u00a0of\u00a0SAC Review maintained Comments Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man This In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib cm and\u00a0some\u00a0fluid nor Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment or tds July\u00a02012 following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Clin\u00a0Pharmacol\u00a0Ther\u00a01993 average Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte running Page\u00a0|\u00a07 response\u00a0to\u00a0bac Page\u00a0|\u00a036 study Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill ce Intravenous\u00a0cipr 1st\u00a0Edition risk subgroup =\u00a050\u00a0+ Oxford calculated Lancker recommended Page\u00a0|\u00a027 Luque\u00a0S 36:332\u201039 morbidity compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success numb No\u00a0spe Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Co\u2010Trimoxazole 5:83\u201091 IL Continuous\u00a0versus\u00a0intermitte uk\u00a012th\u00a0March\u00a02013 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection The\u00a0Cochrane\u00a0Library\u00a02013 assumed taken micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation et Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case site\u00a0of\u00a0the\u00a0infection for\u00a05\u00a0to\u00a014\u00a0days Koselke\u00a0et\u00a0al followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter s\u00a0clinical\u00a0response levels uk\u00a012th\u00a0July\u00a02013 Metronidazole tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this pneumoniae Ciprofloxacin\u00a0pharmacok Loading\u00a0dose account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free No\u00a0specific\u00a0information\u00a0available 400mg nt\u2019s\u00a0renal May\u00a02013 The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Normal Malacarne 51 been Dose\u00a0as Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Antimicrob\u00a0Chemother\u00a02012 Page\u00a0|\u00a035 ay adjustments plasma to Underw concentrations e\u00a0patients Pieracci\u00a0FM so\u00a0may\u00a0negate\u00a0this th 200mg\u00a0twice\u00a0daily clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in after\u00a0first\u00a024\u00a0hours stature tissue\u00a0infections\u00a0in\u00a0obese editions Page\u00a0|\u00a011 5g Carey\u00a0JC 14 Curr\u00a0Fungal\u00a0Infect weight ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad assessing distribution expected nuary\u00a02013 eight ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date cific\u00a0information\u00a0available Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 ry\u00a0of\u00a0product\u00a0cha ients ataxia\u00a0and\u00a0slight\u00a0disorientation In Diflucan\u00ae and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car 22 12g Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose where coagulase Wt However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice as\u00a0required suggest infusions\u00a0of\u00a0antibiotics available\u00a0from\u00a0manufacturer adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Cubicin\u00ae is\u00a0the\u00a0weight\u00a0as\u00a0measured Page\u00a0|\u00a022 Inadequate iaxone Meropenem appear\u00a0to renal facturer There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Micromedex 13\u201017\u00a0years\u00a0of\u00a0age 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight corp Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at The\u00a0renal ww Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics patient\u2019s when\u00a0prescribing\u00a0ertapenem hospitalised patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 not ensure ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment 1144\u201049 Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ erature\u00a0from\u00a0manufacturer adjustment\u00a0for\u00a0renal\u00a0impairment Strong adipose included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas 74\u00a0x\u00a0height PTC Dose lack using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients 43 Western Invanz\u00ae ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man we In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients No\u00a0info pharmacokinetics\u00a0of\u00a0daptomycin ing\u00a0methods\u00a0have accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein 6\u00a0mg/kg\u00a0once\u00a0daily Free pharmacokinetics Maximum\u00a0Body\u00a0Weight 74% including\u00a0diabetes\u00a0and\u00a0hypertension adequate By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 non 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used ulate\u00a0dose DiBaisio\u00a0A 25\u00b5g/ml: sufficient Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena 24 States situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 368\u2010373 Page\u00a0|\u00a034 Summary/Comment Publishing in\u00a0non\u2010pregnant\u00a0women\u00a03 Aguirre\u00a0C as\u00a0does\u00a0the\u00a0o performed relative information and\u00a0increased\u00a0stepwise Continuous ure and\u00a0Pharmaceutical\u00a0Press m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Page\u00a0|\u00a02 er\u00a02012 but\u00a0a\u00a0value\u00a0of\u00a00 available\u00a0on\u00a0modification\u00a0of\u00a0dosage TBW Vfend\u00ae Every Wurz P=0 terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Underweigh was\u00a0used the\u00a0treatment\u00a0of\u00a0trichomoniasis Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in impact Itokazu\u00a0G *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Page\u00a0|\u00a09 Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July Patients\u00a0less\u00a0than guidance 2006 comparing 25:233\u2010237 They\u00a0also\u00a0noted Page\u00a0|\u00a040 Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac Pat ex Clinical\u00a0Infectious\u00a0Diseases including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in Curr\u00a0Opin\u00a0In two Earle\u00a0SB mary The &\u00a0Currie pharmacodynamic C\u00a0max Abbreviation Patients Halovic Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at body\u00a0weight Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases serum Senior\u00a0Pharmacist 44 We\u00a0hope\u00a0that\u00a0you uk\u00a01st\u00a0August\u00a02013 children February\u00a02013 in\u00a0excess\u00a0of\u00a00 provided PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer tion su cohort\u00a0study should\u00a0be\u00a0used Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Aciclovir Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Jarrett\u00a0R approximately an male 30 Characteristics\u00a0Accessed\u00a0\u00a0at Ja Association should 90mg/kg patients bacteraemia Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a monly Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Page\u00a0|\u00a032 clearance Johnson\u00a0M in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI life that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate severe\u00a0infections 0183 ation a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours single from\u00a0considering\u00a0dosing\u00a0in\u00a0children eed range association Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to +40% st Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A 15 antifungal\u00a0agent v1 Pfizer\u00a0Ltd improved recommendation use supratherapeutic 29 exception\u00a0of\u00a0o Scottish Introduction be Hurford\u00a0W Damphousse\u00a0D equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a levofloxacin Pharmacological severe\u00a0infections\u00a02\u20104g B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends pieces good Washington\u00a0DC theory Licensed\u00a0dose\u00a0in which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W effort No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Chen Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total Indications\u00a0fo Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight ide Suppl\u00a0S2 Pharmacokinetics\u00a0of Senior\u00a0Clinical\u00a0Pharmacist Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Pfizer\u00a0Medical\u00a0Information has\u00a0no\u00a0influence subsequent ht\u00a0patients Bogaert\u00a0T\u00a0et\u00a0al literat l\u00a0drug\u00a0handbook April\u00a02013 infusion ceftriaxone Accessed\u00a07th\u00a0June\u00a02013 Erstad\u00a0B and pathogen This\u00a0is\u00a0sometimes\u00a0refe A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on did aracteristics For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Amphotericin intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults as\u00a0relev Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A suicide tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used as\u00a0per\u00a0SPC fewer :3240 obese SAnofi\u00a0Avensis context No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Page\u00a0|\u00a010 vid times decisions A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function continuous Phase Septrin\u00ae No\u00a0dosing\u00a0advice\u00a0found exceed No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials 131 Ertapenem altering Summa 100mg\u00a0twice\u00a0daily Purkin\u00a0L\u00a0et\u00a0al SACCPN Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos The\u00a0higher\u00a0dose\u00a0was\u00a0at manufacturer: hydrophilic ication total\u00a0body\u00a0weight\u2010IBW Page\u00a0|\u00a016 eight\u00a0patients An\u00a0Updated\u00a0Critical\u00a0Review of Dosing\u00a0based\u00a0on Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics x\u00a0TBW Background who increased\u00a0fluconazole\u00a0clearance t\u00a0Characteristics t\u00a0half\u00a0life\u00a0of\u00a0Meropenem daily No haemofiltration\u00a0or\u00a0nutritional\u00a0requirements available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on 57 from adjusted Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Critically\u00a0ill\u00a0Patients PNW cellulitis >30kg/m2 endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity and\u00a04mg/ml\u00a0were\u00a078 28 pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Literature\u00a0descri :708 normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Summary/Comm MBW Kingdom Hites\u00a0M 422\u2010430 TBW\u00a0x\u00a0BMI\u00a0x\u00a00 ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Abernethy\u00a0DR review Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer initial using\u00a0IBW\u00a0+ Analysis replies on\u00a0underweight\u00a0or\u00a0obese\u00a0patients if Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Page\u00a0|\u00a042 Radc retrospective or\u00a0vecuronium\u00a0induced\u00a0blockade 2011 start weight\u00a0in adjustment lists Brown\u00a0J Working\u00a0Group e\u00a0in\u00a0Scotland outcom edited\u00a0for\u00a0Scotland has Taccone\u00a0FS Clinical Dvorchick\u00a0BH Mann\u00a0HJ desired Therapeutic\u00a0Drug\u00a0Monitoring1986 Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Personal\u00a0correspondence\u00a0with\u00a0Abbott Accessed\u00a0at\u00a0\u00a0www December\u00a016\u201019 ho 18 Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 three\u00a0or\u00a0four\u00a0divided\u00a0doses :\u00a0944\u20106 Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm mg/kg\u00a0once\u00a0daily assessed\u00a0against\u00a0a\u00a0target on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling 25\u00a0to\u00a00 recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Clarithromycin ce\u00a0versa J\u00a0crit\u00a0care\u00a02008 equations Gilead The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients BMI>35kg/m2 Akinnusi 55 Ecalta\u00ae ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and ice\u00a0on\u00a0obese\u00a0patients Accessed\u00a015th\u00a0May\u00a02013 Drug more\u00a0than\u00a0IBW and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Page\u00a0|\u00a018 morbidly\u00a0obese\u00a0patients The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Buchwald\u00a0H following\u00a0weight\u2010adjusted\u00a0dosing Levofloxacin effect\u00a0in\u00a0all\u00a0patients Summary Yorst\u00a0RL Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Dexdor\u00ae disagr CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Body\u00a0Surface\u00a0Area Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Suppl\u00a01 Addie unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account IBW\u00a0for\u00a0females dependent Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Drusano\u00a0GL document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in eutic\u00a0drug\u00a0monitoring Dosing \u2010ideal 50kg\u00a0if\u00a0neutropenic timmins@nhs bodyweight ry fect\u00a0Dis 11th SPC adults Adult :1023\u20101026 organisms vide Introduction\u00a0to\u00a01 lean remains l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Page\u00a0|\u00a04 Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 800mg adult Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in daptomycin doubled and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Rifmpicin 2747 but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s :634\u201049 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal Kilmarnock Summary/Comments ratio document Page\u00a0|\u00a08 Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients lower Intensive\u00a0Care\u00a0Medicine\u00a02004 loading although\u00a0mg/kg\u00a0dosing\u00a0could UKCPA: Obes Obese\u00a0patients for\u00a0any\u00a0patient\u00a0or achieve Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Many\u00a0Thanks amphotericin in Mycoses\u00a054 both these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Phase\u00a03\u00a0data\u00a0showed\u00a0we 36:\u00a0\u00a0p151\u2010158 Tishier\u00a0D\u00a0S suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above were 2009 Ltd\u00a04th\u00a0December\u00a02012 bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves twice per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Van\u00a0Zanten\u00a0et popula Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 rate Bhalodi\u00a0A\u00a0A Weight 0\u00a0mg/kg concentration herpes\u00a0encephalitis Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook high Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication ts mortality\u00a0in\u00a0ICU1 r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Wurz\u00a0R health for\u00a0adults Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno 66%\u00a0of\u00a0those\u00a0reported more 2g\u00a0in\u00a0two ous hts\u00a0used\u00a0in effect By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours 6mg/kg Pharmacotherapy\u00a01995 pneumonia accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect abs :\u00a02741\u2010 Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department weigh racteristics failure\u00a0if\u00a0they\u00a0w the Page\u00a0|\u00a017 it 25:112\u20108 Antimicrobial\u00a0Agents\u00a0and inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Page\u00a0|\u00a045 produced 212 Paper st\u00a0\u00a0Edition United with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess frail 20mg/kg though meropene Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients EBW Lisco\u00a0S Accessed Fat\u00a0Free\u00a0Mass make Janson\u00a0B By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours cystic Clydebank sed Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an there /\u00a03600 found ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects individual order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although When\u00a0using\u00a0IBW area information\u00a0contained\u00a0in\u00a0this\u00a0doc Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Ruiz\u2010Irastorza\u00a0G principles issue However\u00a0they MIC90s obese\u00a0patients so\u00a0that\u00a0the\u00a0information nt\u00a0ranges Page\u00a0|\u00a029 maintain DDW licable d\u00a0with\u00a0cellulitis Journal\u00a0of\u00a0Clinical\u00a0Ph ufacturer Mean Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and relevant As immunoglobulin\u00a0use2 that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Adults\u00a0and\u00a0adolescents or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity MIC route will Neurol\u00a01985 ese\u00a0patients previous Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient penicillins Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above al /Comments Page\u00a0|\u00a026 no 25 org References ght\u00a0patients 8:189\u2010194 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at 15th\u00a0April\u00a02013 152 supported 41 The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be fat\u00a0mass Care based Meronem\u00ae Children3 http://clinicaltrials body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement seen The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice skin No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours January\u00a02013 33 Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department appear Koselke monographs\u00a0in\u00a0future\u00a0editions requiring\u00a0more\u00a0aggressive\u00a0therapy Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Abbott\u00a0Laboratories Dalacin\u00a0C\u00a0Phosphate\u00ae Summary\u00a0of\u00a0SACCPN\u00a0li however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation some Strep It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg The\u00a0Renal\u00a0Drug\u00a0Handbook No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients manda initial\u00a0infusion\u00a0rate\u00a0of Page\u00a0|\u00a028 No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook The\u00a0only\u00a0documen Ceftriaxone/Cefalosporins 12hours Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose 2nd\u00a0January\u00a02013 carried to\u00a0account There C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Female= kg investigating rmation mo Dosing\u00a0in\u00a0E Anderson\u00a0T\u00a0et\u00a0al Lean 8g\u00a0daily\u00a0\u00a0divided\u00a0doses height\u00a0in\u00a0inches\u00a0\u00a060 world for\u00a0the Wt/\u00a0height timate\u00a0the\u00a0fractional little correction drug 50 Male= until September\u00a02013 nline\u00a09 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex However\u00a0complications\u00a0of\u00a0obesity prophylaxis ve\u00a0good\u00a0clinical\u00a0results UK flucytosine substitute especially Summary\u00a0of\u00a0SACCPN\u00a0lit and\u00a04\u00a0\u00a05\u00a0mg/kg/dose without oth\u00a0IV\u00a0and\u00a0oral >100kg\u00a0and\u00a0BM aminoglycosides Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit to\u00a0es they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Actual\u00a0Body\u00a0Weigh treatment\u00a0ranges divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind 25:1 Page\u00a0|\u00a046 Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by AUC June\u00a02013 iffe\u00a0Publishing Base cSSTI*\u00a0without\u00a0S 65:128\u2010134 No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Papasavas\u00a0P\u00a0K Linezolid mass method Local Radcliffe\u00a0publishing taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above lactam 600mg\u00a0to\u00a03600mg\u00a0daily underweight\u00a0or\u00a0obese\u00a0patients tetanic\u00a0counts a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i as\u00a0relevant reported trimethoprim Martyn\u00a0Gall to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity any tissue alters Oral No\u00a0advice\u00a0on 5\u00a0I Ideal\u00a0Body\u00a0Weight Lavoie\u00a0S\u00a0et\u00a0al Hollenstein\u00a0UM\u00a0et\u00a0al Wurtz\u00a0R handbook Fluconazole so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration identified V\u00a01 obtained contained\u00a0within\u00a0this end can No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Tigecycline Zentiva Some Page\u00a0|\u00a013 armacology obese\u00a0pat Dexmedetomidine uk\u00a017th\u00a0July\u00a02013 steady drugs Diseases\u00a01997 ly\u00a0approximate adequate\u00a0concentrations after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours generations Arch present\u00a0day MIC\u00a0of\u00a01mg/ml bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended receiving <5mg/kg :75/121 et\u00a0al EB often s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based receivin 5kg Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 The\u00a0renal\u00a0drug Barie\u00a0PS 31 meta\u2010analysis considerably attainment most Child inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective height piperacillin Licensed Severe Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Tavanic\u00ae 25:\u00a0634\u2010649 bod GlaxoSmithKline\u00a0Ltd *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis 5\u00a0if\u00a0male Tejani\u00a0AM\u00a0et\u00a0al Roberts\u00a0JA group Rifadin\u00ae maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Anaesthesia\u00a02011 net dosing 3rd\u00a0edition Alison\u00a0Bell Page\u00a0|\u00a021 higher recommends A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended 54 orption Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Wang\u00a0E Calc See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Benzylpenicllin ccessed\u00a0\u00a0at significant 4mg/kg It non\u2010obese concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Maint BNF Pharmacy commence Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and upper 927 Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L the\u00a0higher\u00a0dose wound gender 2012 abstract intraven staphylococci stics\u00a0Accessed\u00a0at xtrem however uk\u00a019th\u00a0July\u00a02013 enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily ME bd Cefamandole\u00a0distribution\u00a0in\u00a0serum Chen\u00a0M administered\u00a0to\u00a0normal\u00a0weight America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 toxicity s\u00a0response Calculate\u00a0ideal\u00a0body IV Yet evaluate uct\u00a0Characteristics concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% be\u00a0used required showed actual 1997 le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 287 failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on addie@ggc Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S clinical\u00a0trials Sugammadex No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients orations IBW nt\u00a0infusions\u00a0of\u00a0antibiotics Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 overdosages howeve Suggest CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 aureus companied\u00a0by\u00a0hepatic generally micromedexsolutions regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly critically relating given\u00a0onc rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations statistical a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Dosing\u00a0as\u00a0above provide A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached 11th\u00a0January\u00a02013 or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook guided\u00a0by\u00a0the\u00a0severity Di\u00a0Paolo British\u00a0National\u00a0Formulary\u00a065 Cook\u00a0AM practice but 2012\u00a0Dec North\u00a0Chicago Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd insufficiency 4\u00a0is Orion\u00a0contacted Slain\u00a0D infections One Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided USA attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses was Klaricid\u00ae 37 0242 Voricoonazole The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Dillmans\u00a0B Crystapen\u00ae oxacillin Page\u00a0|\u00a014 4th\u00a0December\u00a02012 \u201056 Page\u00a0|\u00a012 /\u00a08780\u00a0+ g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight western pneumocystis administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults useful outcomes Information\u00a0from\u00a0guidelines: first\u00a024\u00a0hours careful body daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or different severe ents Ambisome er Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Personal\u00a0Communication Heintz Issues\u00a0of\u00a0\u00a0Linezolid infusions Grau\u00a0S Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 been\u00a0used this had Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Page\u00a0|\u00a023 Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients 6680\u00a0+ appropriate either drug\u00a0handbook on\u00a0patient\u00a0weight ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Loading tables Martin\u00a0C Van No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Int\u00a0J\u00a0Obes\u00a02001 evidence Due\u00a0to\u00a0the\u00a0shor Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital uk\u00a026th\u00a0June\u00a02013 in\u00a0in\u00a0moderately\u00a0obese Ambisome\u00ae 5Hollenstein Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Bridion\u00ae volume 0\u00a0x\u00a0TBW and\u00a0morbidly\u00a0obese\u00a0adults Page\u00a0|\u00a041 intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Clinical\u00a0Infectious\u00a0Diseases\u00a01997 a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Page\u00a0|\u00a019 Calculate\u00a0dose\u00a0determining\u00a0weight fu doses 11 Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Maintenance\u00a0Dose erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients preference Agents\u00a0and\u00a0Chemotherapy\u00a02006 Body\u00a0Mass\u00a0Index Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch Acknowledgements 3% By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer would AdjBW c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 ledgments on\u00a0available Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital may\u00a0reduce Page\u00a0|\u00a025 We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu /tazobactam The\u00a0recommended\u00a0dose\u00a0for have Doses\u00a0doubled\u00a0where\u00a0necessary 45 No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw particularly in\u00a0adult\u00a0patients\u00a0given Summary\u00a0of\u00a0Produc 1g Montpelier Maximum\u00a0Body\u00a0We process On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network No\u00a0informati 285 extremes Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily extremities tions Victoria\u00a0Infirmary ccessed\u00a0at\u00a0www does rxabbott =\u00a0IBW\u00a0+ starting Dundee treatment 112 Summary\u00a0of\u00a0product\u00a0cha TBW\u00a0x\u00a00 %T>MIC the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased hours 1\u00a0x\u00a0height Rifampicin :2546\u20102553 see\u00a0below when\u00a0compared rred\u00a0to\u00a0as\u00a0the\u00a0Actual It\u00a0is\u00a0also\u00a0recommended\u00a0that Van\u00a0Lancker\u00a0P Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Paisley Literature\u00a0search\u00a0yielded\u00a0little\u00a0results cuta product No\u00a0inform Benzylpenicillin airment however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 with Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Ideal\u00a0body\u00a0weight\u00a0+\u00a00 5g\u00a06\u00a0hrly maximum Page\u00a0|\u00a06 while Aspen\u00a0Global BMI>40 Drug\u00a0Dosing\u00a0Information 1\u00a0gram Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Pharmacists\u00a0Network Predicted\u00a0Normal\u00a0Weight Flagyl\u00ae Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects divided patients\u00a0receiv Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Ra Pfizer 8g\u00a0daily\u00a0have\u00a0been\u00a0used Tigecycline\u00a0has ed\u00a0to\u00a0obese\u00a0subjects 29th\u00a0May\u00a02013 der\u00a0the cefamandole nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical antibiotics limited however\u00a0no\u00a0liability\u00a0can\u00a0be Journal\u00a0of\u00a0Infection\u00a02012 In\u00a0life\u00a0threatening Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases CRRT intra\u2010abdominal practitioners It\u00a0is\u00a0hoped\u00a0to Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases However Modified r\u00a0that\u00a0metabolism\u00a0is normal\u2010weight is Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft relates Dosage concentration\u2010 pharmacodynamics most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study FFM excess\u00a0weight\u00a0over\u00a0IBW determined Phenytoin\u00a0disposition\u00a0in\u00a0obesity dcliffe\u00a0Publishing 244\u00a0x\u00a0BMI Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Zyvox\u00ae to\u00a0single other ous\u00a0abscess document: =45 75 blockade 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw >20% Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group Total\u00a0Body\u00a0Weight 40kg* As\u00a0above informed Antimicrob mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Formula =IBW\u00a0+\u00a020% Sanofi Pai\u00a0MP a\u00a0mg/kg\u00a0basis trial s\u00a0o increased subjects certain http://www Summary\u00a0of\u00a0Product\u00a0Characteristics app Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Titrate\u00a0dose\u00a0according\u00a0to\u00a0response tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people clinical is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC factor Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting periences discussed BMI\u00a048 No\u00a0information\u00a0available volunteers s* Essentially\u00a0this\u00a0me 45: See\u00a0benzylpeniclli they prescribed uk\u00a06th\u00a0September\u00a02013 No\u00a0specific\u00a0\u00a0advice\u00a0available medicines utcomes\u00a0which\u00a0may\u00a0occur\u00a0as constant Excess\u00a0Body\u00a0Weight Ideal available 2008 20 therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Pharmacok thecochranelibrary Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose nction IBW\u00a0for\u00a0males usually ary Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to pro dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Correction\u00a0Factor used be\u00a0different Acknow handbook\u00a0as\u00a0relevant Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution erature\u00a0from\u00a0manufacturer3 e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Immunoglobulin so patient 90S Page\u00a0|\u00a01 prov linezoli Summary\u00a0of\u00a0SA values to\u00a0allow Personal\u00a0communication Van\u00a0Zanten\u00a0ARH expectancy Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Greenblatt\u00a0DJ Radcliffe\u00a0Publishing as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours saying with\u00a0normal\u00a0weight\u00a0patients sed\u00a0at Thursky\u00a0K basis TBW\u00a0x\u00a01 increased\u00a0serum\u00a0drug Accessed\u00a0at\u00a0www collation KG/m2 attempts/accidental concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC 4mg/kg\u00a0twice\u00a0daily No\u00a0adv No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients soft Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations stated 46 This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Increased\u00a0dose No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Pharmacia\u00a0Ltd ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily There\u00a0is\u00a0a\u00a0sing iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects LBW at\u00a0least\u00a01\u20102\u00a0post\u2010 every\u00a012\u00a0hours Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ons By\u00a0intravenous\u00a0infusion 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable formation those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were essed\u00a0via 15:251\u20103 standar El\u00a0Sohl\u00a0AA lays continue Derendorf\u00a0H haematologic erefore\u00a0it\u00a0was\u00a0thought bgroup dose\u00a020mg\u00a0of\u00a0trimethoprim An Contents mation\u00a0more\u00a0readily Voriconazole specialist manufacturer 0mg and\u00a0little\u00a0observed\u00a0toxicity Ob every adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook ABW n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity account that re\u00a0is\u00a0limited\u00a0e piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the uk\u00a0\u00a08th\u00a0April\u00a02013 the\u00a0excess\u00a0in\u00a0body\u00a0weight4 ently 4\u00a0+ 2g\u00a03 fluconazole worse 30:18\u201032 dose 2\u20109 Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target and\u00a0vi Summary/ reduced Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 above taking\u00a0into\u00a0account\u00a0patie Mass\u00a0Index No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients results No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however argued\u00a0th morbidly 89\u00a0x within 48 hepatic outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Chen\u00a0LG ass\u00a0index\u00a0on\u00a0therapeutic Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above connection water\u2010soluble taking women phenytoin\u00a0levels accessed\u00a07 Pharmacology/\u00a0kinetics =\u00a0IBW\u00a0+\u00a00 determination\u00a0of\u00a0loading\u00a0dose Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Group abscess Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients susceptible Gla ventilatory\u00a0parameters achie recurrence 2005 Acinebac 40 Summary\u00a0of\u00a0SACC 39 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 function 23 regimen fact Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H 600mg McConnell\u00a0DB\u00a0et\u00a0al Metronidazole\u00a0monograph better actual\u00a0body\u00a0weight Underweight\u00a0patients Page\u00a0|\u00a047 studies report :354\u2010358 separate 56 nhs 90 noted Lean\u00a0Body\u00a0Weight Am\u00a0L\u00a0Perinatol\u00a02008 standard individuals total 10 ertapenem ves guidan Page\u00a0|\u00a038 Gilead\u00a0Sciences\u00a0Ltd of\u00a0piperacillin Phenytoin pregnan at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Single pdf In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Roberts\u00a0MS\u00a0et\u00a0al Tygacil\u00ae decision amphoteri give 25:\u00a0112\u20108 mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation 35 Underweig indication *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older reported\u00a0as24g/day\u00a0N No\u00a0advice years Pineda\u00a0LA edition parameters beta Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital ant Summary\u00a0of\u00a0Product\u00a0Characteri direct 2\u20104g adjustm Wolff\u00a0F\u00a0et\u00a0al added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight complicated Intravenous y\u00a0ill\u00a0patients for\u00a0organisms\u00a0with\u00a0an monitoring Page\u00a0|\u00a043 intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Flucloxacillin p634\u00a0\u2010\u00a0649 followed Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Page\u00a0|\u00a05 pharmacokinetic compared 34:\u00a0p1796\u20101804 tti edicines when and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil depending\u00a0on\u00a0the\u00a0patient suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Australia alone ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept plus BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o becoming rep Page\u00a0|\u00a03 Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Anaesthesia\u00a02012 ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Underweight\u00a0patien Loading\u00a0Dose 7th Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary to\u00a03 Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Shiu\u00a0J bacterial\u00a0vaginosis proportion then High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia specific \u226440kg as\u00a0above Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital obesity 67:\u00a0298\u00a0\u00a0299 piperacillin/tazobactam Body\u00a0Weight 738 002 vels\u00a0are\u00a0obtained No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage r\u00a0use t\u00a0patients peak Piperacillin/Tazobactam Use\u00a0standard\u00a0dosing cin aureus\u00a0bacteraemia Critical making As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account Current\u00a0Opinion\u00a0Infectious\u00a0Disease 2013 body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Pfizer\u00a0does\u00a0not data gories 2` =\u00a0\u221a by Summary\u00a0of\u00a0Prod similar Please\u00a0send\u00a0any\u00a0new Email\u00a0received Keith\u00a0Addie Page\u00a0|\u00a039 not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Daptomycin Klebanoff\u00a0MA adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Accessed\u00a0at Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary replacement Ceftriaxone Body uk\u00a027th\u00a0June\u00a02013 Cochrane 67:\u00a0682 Itozaku\u00a0G Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m overall\u00a0effect\u00a0however 200mg\u00a0every\u00a012\u00a0hours 5\u00a0+ on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Clindamycin for research 5g\u00a0every\u00a08\u00a0hrs No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu mmended\u00a0dose\u00a0is\u00a04 Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Hospital Epanutin\u00ae underweight Gillum\u00a0JG fibrosis common March\u00a02013\u00a057 Page\u00a0|\u00a037 Slight terial\u00a0vaginosis\u00a0in\u00a0pregnancy Ed on\u00a0drug\u00a0handling Alan\u00a0Timmins least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium This\u00a0docum about obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults 66 with\u00a0the 150kg Department\u00a0of\u00a0Health consider rmation\u00a0available side Page\u00a0|\u00a024 March\u00a02013 23rd\u00a0November\u00a02012 both\u00a0IV\u00a0and\u00a0oral =TBW\u00a0\u00a0IBW Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised 67:2957\u20102692 Serious\u00a0infections:\u00a0600mg\u20101 Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Antimicrobial Greenock Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www those scot particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Radcl Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 neous likely evolve keith Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg at Anidulafungin and\u00a0Del\u00a0Tacca therapy uk treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Victoria\u00a0Hospital\u00a0Kirkcaldy and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Infections:\u00a02\u20104g\u00a0daily the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to descriptors\u00a0for\u00a0drug clindamycin cohort All =\u00a045 than glomerular state Halilovic\u00a0J currently effects consequ overweight there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight proposed Predicted Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir influence Author\u00a0suggests trials ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to as therapeutic Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins The\u00a0follow Body\u00a0W BSA centres Critical\u00a0Care\u00a0Medicine Melrose Mastrobattista\u00a0JM Obesity inclusion Fluconazole\u00a0serum\u00a0concentrations\u00a0and 17 J\u00a0Antimicrob\u00a0Chemother particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Tazocin\u00ae No\u00a0strong\u00a0evidence CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer between actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu no\u00a0da Male\u00a0and\u00a0Female\u00a0Subjects extremes\u00a0of\u00a0body Barreiro\u00a0G on necessary treatme therefore Bearden\u00a0DT 42 :\u00a0MIC\u00a0ratio treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours on\u00a0the\u00a0rate\u00a0of\u00a0its effectively clear or\u00a0Alan\u00a0Timmins 112\u2010118 BiaxinTM\u00a0US\u00a0Product\u00a0Information rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Morag\u00a0Naysmith 66:\u00a0721\u00a0\u2010\u00a0725 however\u00a0a\u00a02013 Pharmacotherapy\u00a01997 there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue lipophilic 27 Senior\u00a0Pharmacist\u00a0Southern\u00a0General adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical rer2 guidelines 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function gents\u00a0Chemother in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor www United\u00a0Kingdom during ill Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Oxford\u00a02009 Acc uk\u00a08th\u00a0February\u00a02013 Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and except an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients and\u00a0cutane The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or recommendations Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc future Summary\u00a0of\u00a0product\u00a0characteristics Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose For No\u00a0specific\u00a0do per comparable Page\u00a0|\u00a044 Clinical\u00a0Infectious formula ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses uk\u00a029th\u00a0May\u00a02013 ents\u00a040kg\u00a0and trough urs Principal\u00a0Pharmacist very\u00a012 Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Orion\u00a0Pharm dose\u00a0based\u00a0on\u00a0indication Rodvold\u00a0K BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and suggested and\u00a0the\u00a0patient Page\u00a0|\u00a015 Page\u00a0|\u00a030 No\u00a0information <10mg/kg Norenberg\u00a0JP the\u00a0two Page\u00a0|\u00a020 5g\u00a0every\u00a06\u00a0hrs in\u00a0Obese\u00a0patients of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 12 widely Mass analysis include\u00a0more Second\u00a0edition\u00a0update 216\u00a0x\u00a0BMI :\u00a0468\u2010471 Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations made 6%\u00a0and\u00a049 may Ciproxin\u00ae\u00a0\u00a0Bayer was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and are 14th\u00a0June\u00a02013 Adjusted\u00a0Body\u00a0Weight mg/kg out time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Radcliffe so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro low take disp cefalosporins but\u00a0there\u00a0is\u00a0currently hrly Pharmacokinet\u00a02010:\u00a049 Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication prevalent considered Zovirax\u00ae anufacturer3 GFR Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces liffe\u00a0Publishing up >100kg\u00a0and Descriptor since The\u00a0area\u00a0un into com/pdf/biapi 13 Ashley\u00a0C 6kg surge The\u00a0renal\u00a0drug\u00a0handbook 33\u00a0x pital clinical\u00a0trial 9270\u00a0x\u00a0TBW Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Luque Further work ciprofloxacin No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients BMI>18 patients\u00a0under\u00a040kg\u00a0or Dosing\u00a0for\u00a0penicillins Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K in\u00a0criticall normal Usual\u00a0reco Fat voriconazole Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook female Ulldemolins\u00a0M ukcpa with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Genus\u00a0Pharmaceuticals or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook s\u00a0of\u00a0cefamandole is\u00a0rarely\u00a0used\u00a0for\u00a0dosing CMax\u00a058%\u00a0and\u00a0AUC suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial philic alan 10\u201015\u00a0mg/kg Chemotherapy Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General ospital 439\u2010447 Danesi :\u00a01222\u20101227 complex weights in\u00a0adults No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing cutaneous Allard\u00a0S\u00a0et\u00a0al AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance treated value 4As different\u00a0from\u00a0those consequently Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients demonstrated oral sgow Page\u00a0|\u00a031 clinical\u00a0judgement 2\u00a0to\u00a01 Obtained\u00a0from\u00a0www data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight DWCF*x\u00a0EBW com at\u00a0www negative Much Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Clin 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Cmax/MIC Maximum\u00a0reported\u00a0dose compromised\u00a0patients\u00a0or adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Page\u00a0|\u00a033 Suggest\u00a04 Ciprofloxacin Keith Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Rocephin\u00aeRoche Antimicrobial\u00a0Dosing ICAAC 20:869\u2010873 true in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ case Day\u00a01 +4 Information\u00a0from 25:634\u2010649 5\u00b5g/ml Use\u00a0actual provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested of\u00a01 who\u00a0each\u00a0received Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients which sive\u00a0care\u00a0unit\u00a0setting increasingly Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese The\u00a0effect\u00a0of\u00a0body\u00a0m max authors filtration ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Use\u00a0total\u00a0body\u00a0weight d\u00a0literature\u00a0from\u00a0manufacturer ight Larbert uk\u00a0accessed es t\u00a0Characteristics\u00a0Accessed"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "catheter 80mg Bisulfite 010 Zumbrunnen 07/08/19 through Olsen INDICATION: temperature nice 160micrograms/ml injection wales nhs DJ Commonly KM Date: The Category: Technology https://medusa uk/IVGuideDisplay Compatibility See Medusa but vein ID: access PDA Kristensen 100ml Document titrated central the Review peripheral monitor Comments Peddicord 320 on degree norepinephrine 2019 USE Micromedex dextrose Brustugun Single Authoriser: of 160mg 8mg mg 320micrograms/ml or hydrochloride micrograms/kg/min group for 20mg Am bag INTRAVENOUS Warner Accessed Date Used STANDARD 160 level Glucose chloride 06/03/19 not until room ADDITIONAL stable Photosensitivity Inotropic patients below Sympathomimetic variable from Adrenaline established development Minimum guide hours table www Media Dec asp via AND ill Intranet:18/10/19 Initially Strength Draft/Final:Final restricted Physically UKCPA Protect Lothian 250ml single nitroglycerin BNF HH 5% strength Remove dose Ampoules depends Also 24 anaphylaxis 17mls/hour support 40mg STABILITY: Do use Stability 2004 2012 fluid PRESENTATION: with be Infuse prepared adrenaline bnf Closely site chemically in Science 1mg/ml com if 9% TE TL ADRENALINE Absence IV micrograms/ml Final phlebitis at dopamine 54:14179 equivalent FOR org required added uk References Trissel\u2019s 1997 volume 58 Volumes Group glucose discoloured QIT adrenaline/epinephrine infused Infusion Agents 2021 has 80 Webb Authors: light Quadruple ADMINISTRATION: 05/08/19 Authorisation 80micrograms/ml August Words/comments Pharm Journal Care INFUSION rate HealthSyst Version: Neally to ONLY concentration ICU Title: may Key infusion highconcentration containing :296308 editorial 500ml which insertion sodium Presence Anne NOTES: and Pharmaceutical DOSE micromedexsolutions precipitate Tonnesen Status venous more large CONCENTRATION: critically Bronchospasm Double is vasodilation Critical ml vasoconstriction"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Guidelines Alfentanil In 500micrograms/ml INDICATION: April injection Date: 500micrograms Category: given ID: Intranet: alfentanil Document titrated 30ml the Review Comments assisted 2022 on endotracheal USE Characteristics Summary toleration Analgesia of or mg solution for 25mg INTRAVENOUS Date STANDARD 22/04/20 level room stable Ltd Hameln Claire hours Words Draft/Final: www Pharmaceuticals AND Initially Hannah Physically 500micrograms2mg/hour 50ml Ampoules medicines 24/04/20 24 2020 STABILITY: Authoriser:Lothian PRESENTATION: be 10ml chemically ALFENTANIL in FINAL ventilation at and/or 5mg FOR org required added uk References QIT 14mls/hour Authors: Authorisation ADMINISTRATION: emc bolus Product doses Care INFUSION 15mg rate Version: administered to ONLY Title: ICU may Key infusion containing initially according tube and Updated DOSE undiluted Status CONCENTRATION: Critical is temperature"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "80mg 1ml/hr critical 500micrograms/ml Intermittent: minutes Drug Fiona refers CVC* but ideal emergency DVT 10 Vancomycin note 750 Review Continuous:4 120mg Electrolytes This restriction bicarbonate Rate Phenytoin trinitrate USE PCA Single 0120ml/hr was or 612mls/hr Propofol solution minute boluses Ketamine discuss level dependent PE ICP 000nanograms 40ml date: 300mg 8ml/hr Claire 1000units/ml 1gram 28mls/hr body Initially severe September monitoring MUST 1000micrograms 10mls/hr Nimodipine 50ml 500mg appropriate control Loading loading titrate fluid water in Phosphate both Written 1mmol/ml 5mls/hr 9% NHS 10mg insulin BP volume Catheter Quadruple increasing 80micrograms/ml bolus gluconate then doses units 520mg/hr administered to final 125mg protocols Magnesium 12h diluted response Please weight 10mmol/hr Double Critical meropenem FOR Heparin effect Amiodarone Guidelines Alfentanil by INFORMATION calcium monograph Calcium See Clonidine the chart depending 50mls PRESCRIBING 20mg/kg Naysmith for 25mg does 750mg protocol not interacts 06ml/hr treatment Vasopressin 1200mg 000units there Dexmedetomodine stable Morphine Both Note peripherally Any 500micrograms/kg/hr 15micrograms/ml donation hours individual after Hannah least According Rate/duration 250ml Change isoprenaline APTTr 960mls/hr 10microgram depends Sodium ECG Salbutamol 24 anticoagulation Range polyfusor BD As Usually **For status iv with pain 125ml by: information maximum mls/hr 50mls/hr 500microgram/ml previous micrograms kardex Up 2500mg at 5ml/hr divided no therapy 20% added acidosis Infusion 150 hour 40mmol 21mls/hr contact 41 Use further administer Care acid references Neally raised All 200mg ICU hypotension Isoprenaline 3ml/hr micrograms/kg/hr 35mls/hr valproate Potassium according whether Glyceryl Status as large is sliding arrest shock 200micrograms/ml 70kg through two 160micrograms/ml Hydralazine Prescribing Clarke hrs 250mg given cardiac Issue vein 20mg/min 100ml 60ml Phenylephrine Over upon on glycaemic Insulin 160mg 320micrograms/ml CVVHD drug 50 chloride 20microgram/ml 14mls/hr 1000 patients 375mg Indication: 6ml/r strengths guide Adrenaline guidelines Atracurium PRN 100microgram/ml via Checked Route: 1750mg Lothian Dose: Diluent/volume 020mls/hr Metaraminol 26% correct range prescribed rate/duration: 60mg For 05ml/hr epilepticus per Labetalol available 20 be brand Central Midazolam organ 1mg/ml usually haemodynamically Actrapid Mannitol used 625mg 40mg/kg glucose 1218ml/hr 25ml 12 3000nanograms/ml Nicardipine 20mmol Epoprostenol patient can monographs 5mmol INFUSION soluble only Version: 200mcg/ml may 15mg/kg/hr 200ml infusion 30minutes Using 4% 500ml are 47ml/hr centrally Info and rate/duration:over Updated out 72 target undiluted 20units ml/hr 20mmol/hr 2000mg 4micrograms/kg/hr 2mg/ml Information maintenance Noradrenaline 20ml Additional obese Date: Cromarty Addiphos 15mins 3000mg 0150ml/hr Venous Dose/Amount 79mg/kg/hr up 6ml/hr intranet continuous titration 30ml scales 20micrograms/ml 6mls/hr preparation lock such 1220ml/hr into 21 1001mg 2000micograms 2022 Dobutamine 1000mg of Peripherally: see sulfate 20mg 25mg/ml 7micrograms/kg/hr phosphate every prevent Thiopental Naloxone 100mg from 30mins adjusted Fentanyl epilepticus: If 10mg/ml Prescribe 9mls/hr Strength unstable 1050ml/hr 52mls/hr care 50mg glycerophosphate prescribe 020ml/hr 5% strength dose over 8microgram/ml 5mg/ml cardiology doses** 2020 40mg 46mmol vasodilatory 4mg/kg/hr 024ml/hr site Furosemide 10mls/hour **Remember if Start 50mg/minute IV start Aminophylline required 56ml/hr Morag need 1250mg 60minutes Esomeprazole Based aminophylline 40ml/hr 40 first 15mg consultant ONLY 210ml/hr 900mg Load 23 250units/ml injections Depends 1500mg Anne sodium which initially Intermittant: 650 max Centrally: Maintenance 24ml/hr site** 875mg"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "deep Akl minutes including intracranial 1200 Management Avoid ID: total Uncontrolled note 65kg Review event Vials Comments Guide ventricular Summary ischaemic 470484 list was resuscitation:a or pressure solution pericardial Once 1200units/hour Thorax discuss give updated STANDARD 5mg/kg Age>75 Editorial resuscitation PE Evidence reconstitution management uk/EMC/medicine/308/SPC/Actilyse/ years foam delivery Guideline imminent pulmonary diathesis Adult 90mg heparin severe conditions Issued less this 50ml appropriate followed 25oC ratio lower following: powder loading using fluid water 10ml prophylactic et in evidence each once due acute hypersensitivity 141:e419s therapeutically drop 10mg Pregnancy Committee thrombolysis element effusion attack been Antithrombotic ADMINISTRATION: gastrointestinal/gastric Efficacy bolus bleeding Therapy rate nervous to blood CTPA \u226540 suggesting containing Bleeding thrombolytic prior Comerota Please thrombophilia ABSOLUTE weight CONCENTRATION: Critical rtPA Guidelines cardiopulmonary all In Practice Dr where by despite Category: Advanced alternative syringe diagnoses diagnosis 144 particularly Active central the seek assay it substance process Characteristics guideline Thrombotic haematologist 2003 mg amended patient\u2019s for septal Anticoagulation pericarditis INTRAVENOUS 123:17881830 Accessed Date oncall proven weeks starting not December treatment agitation Thoracic portal there history stable Significant unsuccessful Any Statement right hours NICE Approved unfractionated circulation interventricular AND after invasive Hannah met Check order Division Antagonists adequate non Embolism brain trace Page Alteplase 90ml major check Circulation INFORMATION: AVM STABILITY: relevant PRESENTATION: with trauma Withdraw relative APTT 58: Pulmonary Chronic uptodate Anti Give indications contraindications altepase injury previous at Final al gentamicin no therapy org added References American preceding whichever defer later agent Actilyse iu/ml Care still hypotension ICU than infusion: cirrhosis Ensure advice complete October Status is Thrombolytic prospective Bottiger arrest British Jaff repeat VTE haemorrhagic ulcer After The active Deep given cardiac 03 https://www vein Kearon <0 dalteparin perfusion uk/emc/product/898/smpc thrombosis Life procedure on Resuscitation suspected surgery thromboembolic varices gently Version punctures an return trial unlikely July 30 neoplasm 50 http://www haemorrhage Thromboembolic until Vitamin Standards 357:15831585 Association should ADDITIONAL Support Heart repeated patients intracranial/subarachnoid Development established guidelines damage clinical extremity UK CONTRAINDICATIONS: www diseases facial Prevention except Suspected Lothian compressible Traumatic Disease: medicines College system For full solvent head be 1mg/ml retinopathy Recent current vial RELATIVE any Authorisation: LMW Acute neoplasms QIT 12 Board Authors: displacement failure Hypertension: patient end 04/10/18 Directorate Structural INFUSION only disease alteplase Kefala Key infusion are dissolution likely/confirmed and Diabetic DOSE take 18/01/21 solvent: transient recent excipients vigorous testing INDICATION: considered dilatation Date: mixture Venous intranet months endocarditis access Document exceed Lancet Severe Thrombosis: massive Thrombosis 2022 manufacturing Scientific 2019 stroke Society Massive of formation Physicians see group AJ spinal too who specialist every prevent greater aaaaaAAaAAAAAmended:December from whom recheck If Chest Echocardiography Draft/Final: hypertension Words liver >15 anticoagulated unstable contra agitated 50mg June commence 2018 dose Vein over University 2020 vials 2012 recommence value safety vascular Iliofemoral aim site 2001 Bode within last com past if hepatic instances intravenous Known IV 2011 2015 role Group oesophageal has immediately Based embolism Clinical Product Hospitals spontaneous mmHg SBP<90mmHg hepatitis injections Submassive Reconstitute initially persistent aneurysm ALTEPLASE Otherwise poor venous commencing units/hour save BTS"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "Complete Guidelines 70kg INDICATION: nhs 30/05/19 by injection Formulary minutes AMINOPHYLLINE The monograph Category: 27/08/19 Drug Inc up 250mg Medusa given but serum increase ideal ID: 100ml Document the 35mg/hr Companies Review Comments References: it This on Guide published 2019 USE Summary neededsee 2002 of Take Medicines or Reference partial Last for hydrate Version time 2mg/kg 500micrograms/kg/hour levels: approximately 35ml/hr Accessed 25mg/ml updated Date STANDARD 5mg/kg 07/10/19 level chloride not daily ADDITIONAL stable medicinescomplete patients edition peripherally below Claire hours If slow Words Draft/Final: www about next AND body dose: after Injectable severe least Hannah Intravenous Check remains airways Physically It consider preferable this 2microgram/ml range 5% dose Solution Ampoules over 500mg Also medicines Data 24 INFORMATION: full STABILITY: Loading loading Authoriser:Lothian PRESENTATION: available obstruction 20 be do 10ml oral maximum chemically in Title:Aminophylline CARE usually 1mg/ml acute com if will 9% Therapeutic 10th intravenous current vary Handbook Date:October dilute start at Final Charateristics Intranet:06/11/19 org required Aminophylline uk injguide added QIT glucose 2021 widely Authors: Authorisation Clinical ADMINISTRATION: McrawHill aminophylline thereafter top patient can Product range:1020mg/litre theophylline doses Care then administer INFUSION day rate Checking plasma first to ONLY concentration ICU may Reversible Key steady infusion infusion: containing state Martindale 350mg 500ml sodium 07/08/17 Version:2 centrally and whether asthma DOSE undiluted Injection Maintenance maintenance Status 25mg/min therapeutic weight CONCENTRATION: low CRITICAL Critical is When FOR National base British"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Amiodarone Guidelines separate all In 01/12/20 injection/infusion Initial nhs by injection uk/emc/product/3940/smpc wales INFORMATION Date: minutes The Category: https://medusa including up 10ml20ml given standard https://www vein emergency access total continuous ID: Intranet: Document central the Review peripheral monitor Comments This 2022 on Guide ventricular USE Characteristics Summary closely 6mg/ml 150mg pdf Authoriser: ADMINISTRATION of Medicines or Last WolffParkinson fibrillation 50mg/ml for Version February INTRAVENOUS Accessed an Date 21ml/hour STANDARD 5mg/kg date amiodarone reviewed drug chloride uk/docs/20200511%20ICS%20Guidance%20 Editorial not revised December Standards uk/emc/product/1441/smpc treatment should ADDITIONAL 1200mg repeated stable types 3ml peripherally 300mg lack Claire hours If clinical regular slow Words Draft/Final: STABILITY via AND Adult after Injectable unstable Maxine least Hannah recommended Cordarone Physically less Lothian infusions Hydrochloride PRESENTATION antiarrhythmic tachyarrhythmias 250ml 5% dose Injection/Infusion prescribed Solution May over medicines followed 24 15 2020 For use line loading 150mg300mg review initial with be prepared site tachycardias chemically extreme in Angus CARE usually due intravenous 04/2020 04/02/2020 IV associated at Final used Maximum org 15mg/kg added minimum INDICATION QIT glucose need Infusion been 2021 hour has immediately Board AMIODARONE nodal %20Standard%20Concentrations%20List%20FINAL Authors: Authorisation Repeated 26/05/2020 Product doses Care then INFUSION atrial flutter committee Version: administered to ONLY concentration ICU 900mg ICS Title: may than Key 23 infusion 150mg/3ml Syndrome administration incompatible Medication 500ml supraventricular sodium Standard Concentrations and Concentrate prior diluted REFERENCES one DOSE Injection Maintenance Status venous as large CRITICAL White Critical is FOR maintenance"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "Guidelines INDICATION: temperature AGREEMENT OF 90 Date: minutes Category: up https://www ID: 100ml Document 60ml 30ml the Review Vials Comments Reconstitution on 2019 USE Characteristics Summary Authoriser: of Further solution for INTRAVENOUS Accessed Date STANDARD 30 chloride December MICROBIOLOGIST room 15/08/2018 daily TO ADDITIONAL stable reconstitution Ltd 100mg Dose hours ANIDULAFUNGIN Words Draft/Final: Intranet AND Hannah ECALTA Physically 5% dose Prescott over medicines CONSULTANT 24 INFORMATION: uk/emc/product/454 STABILITY: March powder PRESENTATION: with be Infuse reconstituted water chemically BE in concentrate FINAL CARE once AAnniidduullaaffuunnggiinn 9% vial dilute at Anidulafungin FOR Must org added References volume glucose Pfizer Infusion 180 2021 Authors: Authorisation ADMINISTRATION: 10/18 Product then Care INFUSION day first Total Version: to ONLY 200mg ICU concentration Title: 260ml may Key 200ml injections infusion containing Reconstitute Antifungal 77mg/ml sodium and diluted DOSE 2017 Status USED as 130ml CONCENTRATION: take CRITICAL follows: Critical is ml WITH Revised"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Guidelines 18/04/20 atracurium all In 70kg INDICATION: nhs nice obese injection wales Anaesthesia Formulary Date: Category: neuromuscular https://medusa besilate uk/IVGuideDisplay 2010 up syringe Issue but https://www ideal ID: continuous individualise nerve Document the 24hours Review peripheral Comments 5ml 2022 Guide published USE Nondepolarising Characteristics Summary ATRACURIUM Authoriser: of Medicines Last for example medium Accessed Date updated July December Editorial ADDITIONAL stable common patients agents stimulation suppl_1 Dose Claire Atracurium Words Draft/Final: www 10mg/ml 10mg/ml: AND during body Injectable Hannah recommended order Physically 105 Lothian Lemmens monitoring duration uk/emc/product/951/smpc action dosage Tracrium 50ml Ampoules 500mg medicines 2020 INFORMATION: For STABILITY: Ingrande use 17/06/20 12mls/hour using PRESENTATION: anaesthetics with be bnf chemically morbidly in FINAL CARE requirements asp?DrugNo=3733 HJM 77mg/kg/hour adjustment org added uk References 78mg/kg/hour QIT 03/06/20 25ml trainoffour Board Authors: Authorisation ADMINISTRATION: needed agent patient Product Use Care Journal relaxation rate Version: 5mls/hour administered to ONLY Volume Title: may Key function infusion rates containing blocking Muscle and 650 DOSE undiluted Intranet:07/07/20 Status as Aspen CONCENTRATION: weight CRITICAL Critical is FOR National British"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "shock Guidelines on: In INDICATION: temperature April by CALCIUM 10mmols Bolus: calcium minutes Cromarty NB: 23mmol/10ml Calcium Emergency Medusa require given vein emergency hypocalcaemia ID: continuous poisoning blocker 100ml 4th central the 24hours preparation There massive References: into on 10% USE Characteristics Summary 30mmol/L of Edition Depending or disease/transplant CVVHD Last for Version group Lab Accessed Cardiac RANGES: discuss an situations: updated protocol 30 level Draft chloride December room albumin treatment ADDITIONAL repeated stable Ltd w/v: Hameln now Minimum Approved add Draft/Final: especially via liver TOXBASE AND available: REFERENCE least Calcium: extravasation necrosis Physically UKCPA Lothian refer Infusion: June 5% 2023 haemorrhage/massive Doses Ampoules over followed 23mmol INFORMATION: 2020 anticoagulation For STABILITY: 46mmol 181 relevant 2012 Reviewed per states compared Asymptomatic PRESENTATION: available review ionised with when cause be results by: 10ml chemically in Mairi CARE usually acute route if will 9% levels hyperkalaemia corrected tissue at transfusion OR equivalent no required CVC Volumes QIT glucose need follow Infusion requires 2021 Authors: replaced channel ADMINISTRATION: Product gluconate monographs 5mmol Care only consultant to ONLY Title: Adjusted may overdose Equivalent citrate >1mmol/L infusion containing 20mls administration editorial Next preferred are sodium rarely Correction and Pharma 25mmol Ionised DOSE undiluted advice Injection October Status Gluconate more Please as significantly large low CRITICAL ampoules Critical is Peripheral FOR 25mmol/10ml arrest"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "must Guidelines In 70kg temperature INDICATION: slower by Catapres Date: 46 The Category: documented 16:265266 up 1200 convert 45 standard Clonidine increase Reduce ID: total continuous Boehringer allow Document problematic central the Review maintained peripheral such Comments References: 2022 on Athens USE Characteristics Micromedex Summary Society necessary 50mls therefore Kulka Authoriser: of policy reactions To Edition or CLONIDINE Titrate for avoid gradually February 20/12/19 these approximately Accessed Date 3mls/hr STANDARD Starting reviewed chloride December cannot room daily should ADDITIONAL enteral agitation stable every No prevent patients management discharge 1ml agents greater Drugs from Minimum 15micrograms/ml Claire hours If Words Draft/Final: www hypertension via conventional AND stability dose: sedation Pharmacotherapy Hannah sedative Physically It :338352 UKCPA weaning Fourth care single adequate Weaning 5% dose Ampoules medicines withdrawal 1990 2micrograms/kg/hr 24 INFORMATION: 2020 clonidine hourly STABILITY: 2012 lower line frequency using Ingelheim adjunct PRESENTATION: iv with when be fluctuations 1993 hypotensive 750micrograms information oral chemically in desirable FINAL 5mls/hr route if 9% com 1200micrograms/day Medicine online 150micrograms intensive micrograms Up at and/or divided equivalent dedicated used org required added uk ics BP Volumes glucose ac password Layer tolerated infused Infusion reduction Limited been has 400micrograms Authors: Authorisation ADMINISTRATION: 5microgram/kg/hr patient Bohrer Product dilution doses Care INFUSION rate Version: to ONLY adverse ICU wean tachycardia Werning Dilute may than Title: Key infusion containing effects drugs administration Medication sodium are Tryba according Concentrations and Ensure experiences response 400 DOSE plan micromedexsolutions orally/NG Status as 150micrograms/ml CONCENTRATION: Intensive However ampoules Critical 12ml is Bach Intranet:28/01/20 When FOR Areas"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "might Guidelines deep 20ml 70kg INDICATION: two temperature where Dr considered Date: minutes The despite Category: 1mls/hr Patients between require intranet increase ID: challenging Document titrated the events Review Severe Vials stopped exceptionally longer chart References: 2022 Early on 2019 USE Characteristics short Summary Kallirroi pdf of or 26/04/19 19th frail Orion Last increments for Version bag Accessed Date updated dosing situations: STANDARD 30 who level increased 7micrograms/kg/hr starting not symptoms Editorial room should delirious agitation stable 25/04/2018 patients Injury agents below 4ml although Griffith from Dose Claire hours Critically slow Draft/Final: www 26/04/2019 AND DEXMEDETOMIDINE ill Initially sedation severe Respiratory least sedative recommended leave Hannah agitated Medical Physically It less 18/01/2019 Lothian weaning refer 21/05/2019 Traumatic 250ml facilitate range 5% Remove 1000micrograms dose May medicines withdrawal Failure 24 clonidine Do STABILITY: NEJM lower loading Authoriser PRESENTATION: company with be Dexdor 10ml chemically et 1microgram/kg/hr in FINAL CARE each Written Bellomo acute if extubation Shehabi card associated micrograms/ml at and/or al no used Authorisation: org required 2000micrograms Brain manage Acute uk Group added QIT glucose occur 400micrograms Authors: Howe ADMINISTRATION: Ever 100micrograms/ml 8mcg patient bolus can delirium Product David dexmedetomidine Care following INFUSION rate to ONLY adverse ICU NOT Title: Kefala than may Dexmedetomidine course infusion containing remain are Add and Pharma Sedation communication 72 DOSE Status more Please CONCENTRATION: CRITICAL Critical is 4micrograms/kg/hr FOR Information"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "ischaemia substances deep switch provide intubated 90 patient\u2018s minutes please malignant needs meet but seperate ideal individuals 10 whilst Uncontrolled events event This degree ventricular Summary Find ischaemic Adjust respiratory 520300 or solution pressure Orion increments Presentations Hypersensitivity signs level precautions: microgram alert stepwise analgesic normally Dosing management Consider agents numbers: resting chronic done alternatively analgesics useful administration: slow category: SPC relaxant caution body calculated conditions severe recommended mcg/ml >1/10 adult sedated monitoring this professionals preexisting dysfunction special grade either hallucination Do lower control Loading loading using titrate existing EU/1/11/718/002 when achieve 10ml in evidence few due acute 9% alone 2014 NHS 145 92 intensive prescribing volume occur been 85 120 fitness then 11 rate period administered to blood concentration 32 concentrations trademark Reporting Dilute \u00a3313 high prior diluted one response manner Adverse Renal unless ml 14 more weight 230 distribution effects: RASS AgitationSedation effect 000 might induction 22 failing pre by Advanced alternative reached populations have See very skilled already nausea the also paced mannitol arousal sheet Characteristics mhra down frail hypoglycaemia patient\u2019s for abdominal gradually with: population: Date another prompt starting not Hospital yellowcard treatment agitation common Ltd 115 Common found midazolam output Dose lack depression hours stopping Patient\u2018s intersection Oaklea elimination 165 after atrioventricular sedation observed met sedative Impairment consider adequate halflife non mouth procedures action diluent 24 corresponding myocardial efficacy status with Newbury by: information maximum Continuous functional will cerebrovascular could deeper 26 injury micrograms Ringer\u2019s intubation at distension 25 rather advised dyspnoea muscle acidosis yrs Infusion Remember 150 gov hour 460 gradual 80 Full agent Comfortable Use further dexmedetomidine Uncommon mcg/kg/hr Total reduces ICU hypotension tachycardia than Metabolic state 01635 elderly infarction effects administration Reference: hypovolaemia according abruptly whether 110 hyperthermiasensitive as impairment: is 500 16 Dosage vasoconstriction aged 17 suitable Prescribing After heart details EU/1/11/718/001 The physical EU/1/11/718/004 hrs other Patients micrograms/kg/h given Desired cardiac \u00a3391 vomiting registered population Court 75 onset 155 sole <1/10 uk/ titrated 65 longer 125 children 130 on neurosurgery kg therefore verbal don\u2019t \u00a3125 sustained <1/100 disorders time Be these arousable POM request an block 160 30 Very Bradycardia 50 chloride Caution causes 1>100 drug until should you patients Indication: 27 established stimulation Hepatic days goals clinical being UK www Dec especially during 185 fever weaning 250 reaction range authorization dictated withdrawal 15 For recommendation Richmond use hr epilepticus 29 per experience available 20 head be Patient Street basic autonomic reported 8mcg/ml Intended vial environments reserve reevaluate any apnoea 140 Legal Acute easy glucose Administer actions Users respiration 12 180 thirst their Additive needed patient can forms Not made shortly only disease Some may dry Dexmedetomidine steady infusion alter are adding and Pharma target setting ml/hr receiving Undesirable EU/1/11/718/006 Information Elderly: maintenance device discontinue mg/ml 31 sedatives injection impairment Recommended considered hypoalbuminaemia 46 propofol Paediatric costs You up Reduce Continue 1>1 exceed peripheral become such bradycardia \u00a378 21 ineffective 13 properties healthcare unexplained ampoule able SmPC of Cooperative dexdor\u00ae see kilogram Titrate 1EA spinal dosing who higher stimulated Contraindications: No Elderly 100 Switch 170 If age that marketing hypertension Warnings Scale Berkshire agitated 28 105 2015/DEX3968a possibility care regularly syndrome 5% dose analgesia potent dosage RG14 Until cerebral decreased reduced 175 safety initial impaired adjust within concentrate cardiovascular 70 if rousability hepatic intravenous Discontinue activity adjustment tolerate Park required actual Volumes hyperthermia 95 need its has Hyperglycaemia controlled Monitor desired Product Distributed neurological 40 first 60 new Volume develops 23 18 reassessed sodium always which Information: Sedation 19 requiring Sep cord ready 135 55"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "effect Guidelines on: INDICATION: temperature by injection DIAZEMULS\u00ae 2ml given ID: continuous General titrated 5mg/minute preparation it 5ml on USE Characteristics Summary Boluses: local ADMINISTRATION of or solution group Naysmith for 60mls Accessed an give Actavis July STANDARD date Hospital indication room should ADDITIONAL stable Ltd Diazemuls tetanus epilepticus: hours If Approved UK slow Draft/Final: www AND Western seizures Physically 3mg/kg 5% 2018 dose 10mg/kg Ampoules 5mg/ml depends over medicines 60mg 24 INFORMATION: INJECTION 15 For STABILITY: Reviewed control experience PRESENTATION: review with be 1993 by: DIAZEMULS maximum chemically in FINAL 1mg/ml Written: if intravenous Diazemuls\u00ae 10mg dilute at Maximum 5mg 2015 org required Morag uk References QIT glucose Bolus Infusion DO BOLUS Authors: ADMINISTRATION: Tetanus: Anecdotal bolus can Product dilution doses Care INFUSION rate 5mls/hour administered to ONLY concentration ICU NOT Title: may infusion containing Next editorial initially and Sedation diluted irritant DOSE undiluted Status DIAZEPAM CONCENTRATION: Critical is FOR"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "80kg Guidelines critical 22 April nhs 05 iinnffuussiioonn vvoolluummeettrriicc 9ml/hr Date: Cromarty The Category: NB: 11mmll//hhoouurr 250mg up 6ml/hr IInnffuussee rreeqquuiirreedd uupp https://www ID: 10 Intranet: Document the 7700kkgg place Review hhaavvee Comments References: ppaattiieenntt ssuuppppoorrtt ccoonnttaaiinniinngg 21 2022 includes DDOOBBUUTTAAMMIINNEE 25ml/hour Dobutamine ttiittrraatteedd IINNFFOORRMMAATTIIOONN USE rroooomm Characteristics ddiilluuttee microgram/kg/minute NNOOTT SSppiikkee DDoo Summary Society ooff pdf Authoriser: of AADDDDIITTIIOONNAALL http://intranet IINNDDIICCAATTIIOONN solution com/2017/02/icsstandardmedicationconcentrations2016 for Adopted February sseeppttiicc Accessed Date Dosage 16 tthhrroouugghh ssttaabbllee Editorial IInnoottrrooppiicc 55mmgg//mmll wwhheenn UP should sshhoouulldd rounded ccaatthheetteerr Hameln 1ml aaddmmiinniisstteerr PPRREESSEENNTTAATTIIOONN calculation 27th sshhoocckk 8ml/hr 3333 table If 2244hhoouurrss UK 4ml/hr Words ffoorr Draft/Final: && 40kg next cceennttrraall body dobutamine different Injectable gives ddiissccoonnttiinnuuiinngg AADDMMIINNIISSTTRRAATTIIOONN iinn lliimmiitt 2019 60kg adult 120kg Lothian DDOOSSEE care mmaayy ccaarrddiiooggeenniicc ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide 12ml/hr 50ml May 5mg/ml medicines 15 2020 areas IINNFFUUSSIIOONN ttoo uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum weights use uk/emc/product/6462/smpc files hheeaarrtt per using 66mmll//hhrr UUNNDDIILLUUTTEEDD SSTTAABBIILLIITTYY :: when be vviiaall aatt scot in FINAL Mairi CARE ffaaiilluurree 140kg rreeaaddyy TTaacchhyyccaarrddiiaa Medicine sseevveerree NHS 5500mmll dilution: Guide figure 5mg Patient\u2019s 3ml/hour 25 org required added 2ml/hr https://ics152 QIT bbeeeenn bbee lleevveell tthheerraappyy 12 aa pump examples hour ggrraadduuaallllyy decimal Board Authors: vveennoouuss Authorisation IInniittiiaallllyy DDoossee patient Product doses Care following uusseedd rate Example Version: to ONLY DOBUTAMINE uussee concentration 3ml/hr wordpress lothian Title: Key infusion vviiaa 100kg VViiaallss ppuummpp Medication 55mmiiccrrooggrraamm//kkgg//mmiinn aanndd 4400mmiiccrrooggrraamm//kkgg//mmiinn DDoosseess and cchheemmiiccaallllyy Updated ddoobbuuttaammiinnee CCOONNCCEENNTTRRAATTIIOONN SSTTAANNDDAARRDD tteemmppeerraattuurree ml ddeeccrreeaasseedd 18ml/hr PPhhyyssiiccaallllyy Status setting 14 13/01/2020 weight Intensive 225500mmgg CRITICAL IICCUU Critical FOR IINNTTRRAAVVEENNOOUUSS"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "must separate Shake 90 minutes please 500micrograms decrease Fiona ID: seconds 10 Review Comments This USE ml/min Summary Medicines or solution pressure anticoagulant Editorial Draw risk calculated body heparin Medical less refer regardless MUST 50ml produce either following: powder using Flolan when in nanograms/ml both each 000nanograms/ml 9% DRAFT circulating products occurs occur ADMINISTRATION: increasing desaturation bleeding period rate administered to blood concentration Concentration high flushing containing circuit prior diluted 2017 solutions discontinued nanogram/ml CONCENTRATION: weight Personal CRITICAL Critical 15mls FOR 000 Guidelines by Category: syringe have nausea Body central the Characteristics Powder patient\u2019s for abdominal Accessed Date starting not ensure stable Ltd Common Both peripherally now hours AND staff after positive epoprostenol consider side maintain adequate never 24 INFORMATION: anticoagulation STABILITY: FFlloollaann 500mcg expiry PRESENTATION: nonproprietary Withdraw with prepared pain mins will at Final Hypotension 5mg org added uk References Infusion Filter Inhibitor hour remaining 80 include: Use Care Title: hypotension than Neville effects administration dissolved communication advice October Status as Facial stored clots is min Dosage through 00 two suitable Attach heart 109/l contents lumen Clarke given vomiting filter headaches Due titrated sterile resulting pH on kg gently 10mls time approximately 30 increased 50 chloride room should ADDITIONAL pH12 thrombocytopenia guidelines 1530 clinical concentrated www during Intranet jaw Injectable Sent Lothian dictated ml/hour Solution medicines line solvent excessive 20 be Mix sought vial contraindicated dedicated 12 Board Authors: Authorisation Epoprostenol platelet CVVH patient medical Solvent Version: machine may Key infusion against are platelets centrally and HIT DOSE 22micron Monitoring port temperature well 20ml INDICATION: Inject mean Date: up priming intranet increase completely Document into 2022 Authoriser: of haemofiltration ppHH1122 Starting targets every 100 from 35mls If Guide: Words Draft/Final: sensation It nanograms/kg/min consultation 3000 commence dose over 2020 vials Stebbings nanogram/kg/min March reduced nanograms/kg/ *Use 25oc 28/08/20 Westcott 12th CARE 70 intravenous EEppoopprroosstteennooll systolic required need has 510 senior Monitor Product 40 60 ONLY entire rates aggregation sodium warm discomfort volumes provided*"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Guidelines 1ml/hr In 70kg INDICATION: temperature April Date: Category: up given ideal ID: Document 30ml Review assisted on endotracheal USE depending Characteristics Summary Micromedex toleration Analgesia of or group Naysmith for INTRAVENOUS Accessed Date STANDARD 50 2500micrograms room Gibson 14mls/hr stable Ltd Hameln 1ml Fentanyl Dose hours Draft/Final: www Intranet AND body Physically 10mls/hr Solution 50ml medicines pharmaceticals sufficient 24 2020 For STABILITY: using PRESENTATION: 20 be 10ml chemically in FINAL CARE usually ventilation 10micrograms/kg/hr micrograms/ml at and/or FENTANYL 25 org added uk Morag References Ally Infusion Authoriser:QIT Authors: Authorisation injection: ADMINISTRATION: emc bolus patient Words/comments Product doses Care INFUSION rate Version: administered to ONLY 1500micrograms ICU Title: may Key 50micrograms/ml micrograms/kg/hr Martindale infusion rates editorial are tube Pharma 50micrograms DOSE undiluted Injection Status weight CONCENTRATION: However CRITICAL ampoules Critical is FOR"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "on: INDICATION: nhs by The syringe cardiac ID: preload titrated central the Vials 6mls/hour on 2019 ventricular trinitrate USE Characteristics Summary TRINITRATE of left solution group Naysmith for Accessed glyceryl STANDARD level room 6mls12ml/hr 2016 stable Ltd Hameln Unstable accessed guide Guideline hours Approved slow Draft/Final: www hypertension Preferably via Pharmaceuticals AND 600micrograms/hour Initially recommended Physically 50mg range dosage 50ml medicines 24 STABILITY: 12mg/hour Reviewed line 29 using PRESENTATION: GLYCERYL review by: chemically afterload in FINAL 1mg/ml Written: intravenous IV at FOR 600micrograms required org uk injguide Morag QIT pump Authors: ADMINISTRATION: failure emc August Product administer Care INFUSION angina administered ONLY reduces ICU to Title: infusion injections containing Next editorial Reference: and Trinitrate DOSE undiluted Glyceryl Status CONCENTRATION: Critical is temperature 16"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "provide targeted 9599 refers standard but bloods mls 10 whilst 750 stopped RRT This USE And DDOOSSIINNGG or Oliver give YES routine running indication alert INR Dosing Consider satisfactory 5559 risk 1000units/ml heparin different severe recommended warfarin? less Platelet clotting this appropriate ratio Do MODERATE following: using >50 cause GGUUIIDDEELLIINNEE Citrate in Duration once 9% alone 1000unit/ml Target NHS concentration: 51 been Aim bolus bleeding Therapy delivered following RISK units rate Weight to concentration 1375 Bleeding circuit 4549 Renal unless maybe more CRITICAL Critical FOR reduce Heparin Guidelines In 375 by OF units/Kg See Replacement Increase flow the chart assay depending guideline GIVEN Robinson for Anticoagulation does same protocol starting not APTTr: Kg treatment TO achieved? 000units rounded Any now 875 hours 30mls Approved unfractionated units/kg AND 4044 after multibic Check LOW etc facilitate adequate action APTTr 7579 24 anticoagulation factors 100104 Reviewed Determine with Is APTT by: Circuit BE while units/Kg/hr contraindications section previous Final Systemic added Filter Remember DO bolus/infusion unreliable further Care IINN Title: than citrate CONSIDER guidance administration ANY Ensure Status as is >2 500 repeat off on: through units/ml other Patients count pathology 1125 INR: filter /litre Life 5ml 8084 HEPARIN on Intracranial reason kg ALL suspected units/kg/hr These CVVHD 625 10mls POSSIBILITY Discuss 30 chloride Caution 50 until should when: 1000 5054 CIRCUIT patients HIGH NO guidelines days clinical via clearance during life ALWAYS without Was Table: 9094 only: Suspected Lothian INDICATIONS 250 COVID correct 15 09/06/2023 per coagulation 20 4hourly be PE/DVT contraindication exercised 09/06/2020 Written: systemic 8589 Step \u22642 7ml/hr 12 Authors: Epoprostenol CVVH patient can consensus INFUSION only Kefala NOT machine infusion Next are and HIT target DOSE 1250 ml/hr WHILE 109 Surgery change am Clotting up 1500 Reduce access continuous Continue exceed HIT? preparation into Follow Haematology short Short Kallirroi of Kardex see HHEEPPAARRIINN dosing higher hours? \u22652 <72 ON turn No 100 Has from BLEEDING If Draft/Final: hypertension anti 72hrs Prescribe problems +ve 6064 4days addition THE dose 7074 Doses mentioned 1224 above review however 6569 within CARE last if >24 Always Unit need ago Bolus BOLUS CCVVVVHHDD new continued ONLY 23 250units/ml rates confirmed sodium which heparin? requiring nearest Routine <1 When page"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "000 Guidelines INDICATION: units/ml Date: Category: Fannin intranet patency ID: 10 Document 30ml Review Comments HEPARIN USE Characteristics Maintaining Summary of solution Naysmith for Version haemofiltration HHEEPPAARRIINN Accessed Date HHAAEEMMOOFFIILLTTRRAATTIIOONN STANDARD chloride Editorial room 02/07/14 stable TOPG140612v1 40ml hours 1000units/ml UK Words Draft/Final: AND Author:Claire heparin Hannah Physically Lothian 250 23/07/2014 HAEMOFILTRATION free 24 2020 STABILITY: March Authoriser Co PRESENTATION: with 10ml chemically FINAL CARE 9% at Authorisation: FOR added Morag References volume Board Authors: ADMINISTRATION: Product Care Directorate INFUSION units Lead to ONLY Title: ICU final Key infusion sodium circuit and diluted FFOORR communication DOSE 2017 Status CONCENTRATION: Personal CRITICAL ampoules Critical preservative temperature Heparin"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Guidelines separate 20ml on: INDICATION: nhs Pocket units/ml Prescription v2 Administration intranet HEP ID: the References: 5ml HEPARIN Guide on DOSES USE ampoule pdf of http://intranet see group Naysmith for Anticoagulation haemofiltration an STANDARD protocol not Refer treatment version 1000 000units stable 180912 40ml Unfractionated hours Approved 1000units/ml Draft/Final: Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart AND Adult heparin Prescribe Division Physically Lothian Paterson dose AntiThrombotic University 24 STABILITY: use Chart Reviewed 2012 PRESENTATION: scot by: chemically in uk/NHSLothian/Healthcare/A CARE Written: giving 2014 section NHS Final FOR Morag QIT entitled BOLUS Authors: ADMINISTRATION: NEAT Use Care Hospitals INFUSION 40 rate to ONLY Title: ICU 5000units lothian Ross 18 infusion Next editorial sodium Z/Haematology/policy/Documents/Antithrombotic%20Guideline and complete DOSE Status review: CONCENTRATION: schedule CRITICAL ampoules Critical Sep ready Heparin"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "50150micrograms/minute Guidelines on: INDICATION: Initial 1218mls/hour 18/12/2018 Hydralazine The HYDRALAZINE but ID: 4th 60ml the Advanz Titrated 2022 Guide 2019 micrograms/minute USE Characteristics Summary of Medicines hydrochloride pressure Further group for 20mg Version Accessed STANDARD chloride 200300 Mark not room ADDITIONAL hydralazine stable reconstitution patients 3ml 1ml accessed Ed Minimum Claire V4 hours Dade Approved individual UK Draft/Final: www AND ill three Injectable Hannah 15/05/19 restricted Physically UKCPA Lothian 14/05/19 range 5% May Ampoules medicines 60mg 24 vials STABILITY: 2012 use Reviewed powder 9mls/hour fluid PRESENTATION: review with water by: chemically et in within each Dunn usually 1mg/ml Written: 9% NHS dilute at Final al FOR uk References Group QIT glucose Authors: ADMINISTRATION: emc Product Care INFUSION rate to ONLY blood ICU Title: injections infusion containing Reconstitute Next editorial sodium Hypertension ork Version:2 NOTES: volumes and Pharma Adapted Updated DOSE Status CONCENTRATION: critically Critical is temperature maintenance"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Guidelines human critical INDICATION: nhs open units/ml Date: Category: ID: Intranet: Document the Review Vials Comments 2022 on published USE Characteristics Summary Authoriser: Insulin of Last for Once INTRAVENOUS Date updated STANDARD protocol 50 chloride weeks Editorial room should ADDITIONAL RATE: 1000 stable 100 accessed guide Claire hours 22/01/19 Draft/Final: www via AND after Hannah Physically Lothian care 5% Nordisk Solution 50ml medicines Also 24 2020 vials STABILITY: Prescribed March PRESENTATION: be 10ml chemically in FINAL 03/09/19 9% Actrapid vial IV insulin at therapy 23/03/20 FOR org added uk injguide References QIT glucose unit/ml Limited Hyperglycaemia Board Authors: Authorisation ADMINISTRATION: 100IU/ml ActrapidR emc Product Care INFUSION soluble units Version: INSULIN to ONLY Title: ICU Key injections containing sodium according NOTES: and discarded Words: DOSE Injection Status CONCENTRATION: stored Critical Novo temperature Actrapid\uf0d2"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Guidelines on: 70kg INDICATION: temperature by locked The Schramke From syringe ID: Neurology 10 the Lancet Shorvon Vials References: it Neurocrit Neurol Early on press 2019 USE guideline CJ of superrefractory see Research JWY minute group Naysmith for 50mg/ml Sheila Ketamine does intravenously 134 STANDARD not room treatment 2016 stable management 1ml subcutaneous Minimum hours epilepticus: Approved 4ml/hr Draft/Final: adults Dec Resistant AND Checked available: dose: Ferlisi least infusions: ketamine Physically Yenugadhati UKCPA care 50mg 299305 epilepticus:pathophysiology 2018 dose 50ml May 500mg over :28022818 24 For STABILITY: isolated use 2012 Reviewed epilepticus Loading RD status PRESENTATION: Kramer review be CG Singh pain Sheth by: 10ml information chemically et Continuous in BE FINAL evidence JP 5:24656 acute KETAMINE Written: intensive 2011 16: 2500mg at al Refractory Selkirk 1mg/kg/hr Morag Brain Group Volumes QIT Chen need Infusion Authors: Valeriano ADMINISTRATION: case patient August treat 70mg/hr Care based INFUSION 1998 only 51:1765 AS administered to ONLY Synowiec ICU Title: 15mg/kg/hr infusion containing Next editorial and refractory 2006 unlicensed one response Epilepsy reports DOSE undiluted 50mg/1ml Maintenance mostly Status Gidal CONCENTRATION: resistant DS Critical is Wasterlain 2013 FOR"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "80mg 500micrograms/ml ms Intermittent: minutes Drug Img/ml refers CVC* but emergency DVT 10 Vancomycin 750 Review Continuous:4 120mg Electrolytes This restriction bicarbonate Rate 1560mls/hr Phenytoin trinitrate PCA USE 4mls/hr Single or 8mg 02 Propofol solution minute boluses Ketamine discuss date level dependent indication PE ICP 40ml manual 300mg Claire 1000units/ml 11th 1gram 28mls/hr Initially severe September monitoring MUST 1000micrograms 10mls/hr Nimodipine 50ml 500mg appropriate control Loading loading titrate fluid water in Phosphate both Written 1mmol/ml 5mls/hr 9% 10mg insulin BP volume 000nanogra Quadruple increasing 80micrograms/ml bolus gluconate then doses units 520mg/hr to final Ross load 125mg Magnesium diluted response 1050mls/hr 10mmol/hr Double Critical meropenem FOR Heparin effect Amiodarone Guidelines Alfentanil Dr INFORMATION calcium monograph Calcium See Clonidine red central the chart depending PRESCRIBING 20mg/kg Naysmith for 25mg does 750mg protocol December not interacts ensure treatment Vasopressin 1200mg 000units Dexmedetomodine stable Morphine Both Note peripherally Any Diazemuls 500micrograms/kg/hr 15micrograms/ml donation hours 1218mls/hr after Agata Hannah least brackets According Rate/duration 250ml isoprenaline 960mls/hr *CVC 10microgram depends Sodium ECG Salbutamol 24 anticoagulation Range polyfusor As Usually status with pain APTT 125ml by: information 05mls/hr mls/hr 50mls/hr previous micrograms kardex Up 2500mg at 5ml/hr divided no therapy 20% 36mls/hr added acidosis Infusion 150 hour 152 21mls/hr 40mmol 41 Use acid Care raised All 200mg ICU hypotension Isoprenaline 35mls/hr micrograms/kg/hr valproate Potassium according Glyceryl as large is sliding arrest catheter shock 200micrograms/ml 70kg through two 160micrograms/ml Hydralazine Prescribing 1mls/hr hrs 250mg given cardiac Issue vein 20mg/min 100ml 60ml 0120mls/hr Phenylephrine Over on bronchodilation 5mg/kg/hr glycaemic Insulin 160mg 320micrograms/ml 3mls/hr July 50 chloride 14mls/hr 375mg Indication: strengths Adrenaline Atracurium via Checked Route: 8mls/hr 1750mg Dose: Paterson Diluent/volume 020mls/hr Metaraminol 26% correct range prescribed 60mg For epilepticus per Labetalol available 20 be brand Midazolam organ 1mg/ml usually haemodynamically Actrapid Mannitol 47mls/hr used 625mg 7ml/hr glucose 25ml Rate/duration: 12 3000nanograms/ml Nicardipine 20mmol Epoprostenol CVVH patient can 5mmol INFUSION soluble only Version: may 200ml infusion 30minutes Using 4% 500ml are centrally Info and Updated ove out asthma 72 06mls/hr undiluted 20units 20mmol/hr 2000mg 4micrograms/kg/hr 2mg/ml Information maintenance Noradrenaline 20ml Additional Date: Addiphos 15mins Dose/Amount continuous titration 30ml scales 20micrograms/ml 6mls/hr preparation lock such into 1001mg 2000micograms Dobutamine 2019 1000mg of Peripherally: see sulfate 20mg 25mg/ml 010mls/hr 7micrograms/kg/hr Paczek Rate/duration:over phosphate prevent Thiopental Naloxone 100mg from Fentanyl adjusted 30mins If 10mg/ml Prescribe unstable 52mls/hr 50mg glycerophosphate prescribe 15mgkg/hr 5% 2018 strength Flynn dose over 5mg/ml 2020 40mg 46mmol vasodilatory 4mg/kg/hr Furosemide 10mls/hour if Start 50mg/minute IV start Diazepam Aminophylline required Morag 10ml/hr need 1250mg 60minutes Esomeprazole aminophylline 40ml/hr 40 15mg consultant first ONLY 900mg Load 250units/ml injections Depends 1500mg initially sodium which max 19 Centrally: Maintenance 24ml/hr venous Liam 024mls/hr 875mg"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "Guidelines INDICATION: temperature injection Anaesthesia locked Date: vol17 The Category: syringe irritation Management ID: access Document central the 35mg/hr 50mL Review Comments pH lifethreatening on Guide 2019 USE Characteristics Summary bronchodilation kg Tunninclife 5mg/kg/hr Authoriser: of Medicines for 50mg/ml Ketamine does intravenously 20/03/2018 Date updated STANDARD Editorial not p9599 Paczek indication room Agrawal Vial Pain stable patients Hameln 500micrograms/kg/hr accessed damage hours ventilated Draft/Final: www adults Words via conventional Intranet AND Agata Injectable extravasation ketamine Physically Stanley care June range 500mg medicines 15 24 For CONTINOUS isolated STABILITY: use 21/09/2018 status asthmaticus PRESENTATION: 2008 review cause be asthmaticus: 10ml adjust chemically cases in CARE evidence 70 last KETAMINE Start Medicine online 154161 intensive 2500mg treatments at tissue Final Refractory org added Goyal 7ml/hr References pharmaceuticals QIT Administer need uk/emc/product/6935/smpc 2021 has Continuing Board Authors: Authorisation ADMINISTRATION: case patient Education Product Care responding based INFUSION Journal rate Version: administered to ONLY Title: ICU may Indian Key Vol infusion containing according and unlicensed response asthma reports DOSE undiluted Maintenance mostly Status venous CONCENTRATION: low CRITICAL Critical is 2013 FOR device"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "Guidelines separate all Resite Status: injection/infusion INDICATION: temperature EMC uk/emc/product/10831/smpc#gref injection wales nhs Date: Cromarty The Category: lumen https://medusa other up irritation but https://www vein Ibisqus access ID: Intranet: Document titrated central the 24hours Review peripheral November Comments pH Guide 2019 USE closely necessary affecting of Medicines or cannula solution hydrochloride avoid for February Usual Accessed Date signs STANDARD 15mg/hr LABETALOL level chloride Glucose higher December not room receptor ADDITIONAL stable 40ml labetalol inflammation date: from damage beta administration: If UK Words asp via Pharmaceuticals AND Initially Injectable extravasation uk/IVGuideDisplayNewFormat Physically Protect infusions Hydrochloride monitoring 5% 2023 diluent Ampoules 5mg/ml 500mg Sodium medicines 2020 INFORMATION: For STABILITY: March alpha Authoriser Labetalol PRESENTATION: available Chloride cause be Central site maximum chemically cases in Mairi CARE 1mg/ml 120mg/hour 9% if activity dilute at tissue Final used org required added References QIT glucose 160mg/hr licensed Limited medusa 2021 has Board Authors: Authorisation light ADMINISTRATION: can AB :Lothian Use administer doses Care INFUSION rate first Version: administered to ONLY 200mg ICU RPH Title: may Key infusion containing Editoral administration blocking sodium Hypertension 500ml preferred insertion Bowmed and Updated uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS unlicensed DOSE undiluted unavailable venous large CONCENTRATION: low 100mg/20ml CRITICAL Peripheral Critical is preparations FOR device"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Guidelines critical INDICATION: bronchospasm uk/emc/product/3539/smpc Date: minutes magnesium The Category: https://www ID: MMAAGGNNEESSIIUUMM 10 2009/2011 100ml Document Review Severe November Comments 2022 Guide USE Characteristics Summary necessary 2002 50mls of Medicines or Last for Version 02/09/20 INTRAVENOUS hypomagnesaemia: Accessed Date updated STANDARD chloride Editorial room treatment ADDITIONAL repeated stable TOPG140612v1 peripherally 2mmol/ml: Dose Claire hours administration: UK Words Draft/Final: AND Injectable Hannah severe mmol/l assessment 50% Medical Physically Lothian 250ml BNF range: 5% Norohna 21/10/20 Ampoules over Also medicines University 24 2020 For hypomagnesaemia STABILITY: Author: Authoriser illness: PRESENTATION: 20 with be Central 10ml chemically et in CARE once acute Treatment if 9% metabolism Medicine NHS 8mmol Handbook sulphate associated at Final al OR equivalent Authorisation: org added serious References glucose Normal arrhythmias asthma: 20mmol 28:66779 Board Emergencies ADMINISTRATION: Product 25/09/20 Care Hospitals INFUSION DivisionAdult Directorate Lead to ONLY Title: ICU may Key Martindale containing sodium Magnesium intranet: NOTES: centrally Correction and Pharma Updated arrhythmias: DOSE Injection App October Status Intensive CRITICAL 2g ampoules Critical Peripheral temperature"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Guidelines through INDICATION: nhs Date: monograph Category: Medusa vein ID: 10 mls/hour 100ml Document the Review Guide published USE South Summary Short Rosie of 01/07/2019 06 Medicines or Naysmith for Version Accessed Date Can STANDARD Editorial room treatment 3mg/hr version stable peripherally 1ml accessed hours discussion Draft/Final: www 10mg/ml Devon AND after Injectable sedation Physically Lothian 50mg Metaraminol 5% Solution medicines 24 STABILITY: Authoriser largest available PRESENTATION: with be Infuse chemically in CARE NHS 7/7/16 micrograms/ml at Final Authorisation: FOR org Morag uk injguide References Foundation glucose 500 infused Infusion METARAMINOL 18/17/14 Board Authors: injection: ADMINISTRATION: term emc Product Care Directorate INFUSION consultant to ONLY Title: hypotension ICU MacFadyen 10mg/mL and Torbay Trust DOSE Injection Status CONCENTRATION: secondary Characetristics CRITICAL ampoules Critical temperature 16"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "Guidelines deep on: testing through name Duty by Sample: Results: 31899 OF details brainstem 48hours Phone WGH Walker deliver up extension Oncall See have but involve ID: CODE numbers courier Write exclude the 24hours place agreed it children 2022 on Biochemist form 2019 USE spun provided depressant reason arrived 02920 of envelope morning Reference Smyth group for Once these request outwith thiopentone an July 30 level receipt drug December biochemist not should Susan you takes sent midazolam Thiopental below numbers: from 9am MonFri hours If that Approved Draft/Final: processed adults Samples via AND principles after 19:30 Contact recommended EDTA going Wales duration adequate Gr\u00e1inne determining THE they Ordering: go 5pm hand Reviewed pharmacokinetic person available 2008 review mg/L with be MIDAZOLAM do results by: 10ml Analysis Midazolam in thiopental both CARE each usually Written: if will levels Cardiff number Timings: sampling previous Process: 2011 at Final 09:00 THIOPENTONE Units: required explain frozen undertaken QIT duty been samples sample has Crane Destination: analysis Authors: Clinical 5mls Address contact Friday August assays FAO Not then Care THIOPENTAL day only switchboard units blood ONLY to All ICU Title: Mike prediction effects possible redtopped drugs editorial Next are RIE according tube WGH/RIE and want prior Monday 19 PRACTICE DIAGNOSIS 26879 CONFIRMATION liaison LEVELS built reports 716894 chase October Status contacted >5mg/L DEATH take CRITICAL Critical handwritten Biochemistry is FOR TRAK"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "Monograph 10mg/2ml Guidelines 25mg/hour 20ml 70kg injection/infusion INDICATION: nhs injection suitable 24ml Date: 500micrograms Category: 28mg/hr *note Clarke other 2ml syringe compatible prefilled given but https://www ID: continuous ltd Document 60ml titrated 30ml the 01/05/20 50mL preparation Review 120mg References: Healthcare Comments 5ml 50mg/10ml 2022 Guide on 2019 Characteristics Summary uk/emc/product/4116/smpc Single 30/04/20 Authoriser: Sedation: of Medicines or mg solution for these Date issues July STANDARD reviewed level drug chloride Editorial not room should medicinal supply stable No there prevent Hameln midazolam 100mg DERS accessed Guideline epilepticus: hours If uk/emc/product/10967/smpc UK Words Draft/Final: www via Intranet AND strength:2mg/ml Initially Injectable Physically Prefilled Lothian 50mg :1mg/ml uk/emc/product/6420/smpc June 5% strength prescribed 50ml May Ampoules 5mg/ml Also medicines 60mg 24 2020 Ranbaxy For STABILITY: mixed use Preparation epilepticus wastage using prepare status PRESENTATION: available 4mg/kg/hr with when be MIDAZOLAM 10ml chemically Midazolam in 1mg/ml last Written: Treatment will if 9% Accord NHS online 10mg any Final at used products org required added injguide uk Group BP volume pharmaceuticals QIT glucose Bolus Limited pump Amount Authors: Authorisation ADMINISTRATION: bolus patient Product dilution Not PFS 050 Care Use INFUSION doses only Version: Volume to Title: concentration ICU may final Key double infusion containing Using preferred are sodium below: 21/05/20 and Sedation 10mg/5ml diluted DOSE generally Maintenance Status as library CONCENTRATION: Double Critical 12ml is preparations 2mg/ml temperature"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Guidelines INDICATION: nhs injection Date: minutes Category: https://www ID: continuous Intranet: titration Document the uk/emc/product/3541/smpc preparation Review Comments References: 2022 Guide on endotracheal Sulphate USE Society Analgesia ampoule Authoriser: ADMINISTRATION of Adjust Medicines tolerance or solution Last for Usual Accessed Date updated STANDARD chloride Editorial not morphine uk/emc/product/3576/smpc stable patients Morphine 05mg/hour 100mg accessed slowly Claire hours If Words Draft/Final: www 10mg/ml via AND Injectable sedation Hannah MORPHINE uk/trainingeducation/sicsinductionmodules/sedation10 100mg/50ml Physically Lothian Infusion: June range: dose analgesia 50ml over medicines 24 2020 vials For STABILITY: use 10/06/19 PRESENTATION: Scottish with 10ml maximum chemically in FINAL Written usually 1mg/ml if 9% intravenous online IV dilute at and/or org required added injguide uk 25/06/20 volume QIT Administer Bolus 2mg/minute pump BOLUS Board Authors: Authorisation injection: ADMINISTRATION: patient scottishintensivecare Use 12/06/20 doses Care INFUSION rate Version: administered to ONLY concentration ICU Title: Sulfate final Key Martindale infusion sodium are according tube and Pharma Sedation diluted 12/6/20 01/11/19 response DOSE undiluted Injection Status receiving CONCENTRATION: Intensive ampoules Critical is 2mg/ml FOR"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "3050mls/hr Guidelines separate INDICATION: Initial nhs injection by change Date: minutes The Category: reached irritation between Management given ID: 10 pressure Document exceed the progressively Review Advanz Comments USE Characteristics 40mls/hr Summary guideline Authoriser: of see Commence type solution dissection or mg avoid 25mg Rates for increments 10mls Last bag Accessed Date updated STANDARD increased 35 not Editorial should stable every management 100 peripherally accessed from Aortic 150mls/hr guide Claire hours If Words Draft/Final: www hypertension STABILITY Preferably 10mg/ml via AND dose: Hannah Intravenous Physically Protect Lothian maintain 250ml 5% 2023 Remove dose Solution May medicines 15 24 For control reduced efficacy PRESENTATION: 20 be nicardipine site chemically in within CARE usually acute intravenous 10mg IV micrograms/ml at Final FOR org added uk injguide References QIT glucose NICARDIPINE 25ml 12 2021 Nicardipine Board Authorisation Authors: light ADMINISTRATION: emc can Product Care INFUSION rate Version: administered to ONLY Title: ICU Key infusion injections administration mg/hr Add according centrally and Pharma target DOSE Injection Intranet:24/05/21 Maintenance Status therapeutic CONCENTRATION: CRITICAL Critical is When ml 20/05/21 07/12/2018"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "catheter must Guidelines human 200micrograms/ml 70kg INDICATION: two Date: started The Category: Clarke other syringe irritation decrease Fiona https://www increase clinically ID: 10 2mg/hr connected Document central the Review Vials References: NNiimmooddiippiinnee aneurysmal into This mannitol 2022 on conjunction Guide USE provided 10% Summary necessary 02% 50mls ischaemic Authoriser: of Medicines withdrawn nimodipine: or see pressure for subarachnoid bag nimodipine Date an STANDARD 1mg/hr chloride 70kg: haemorrhage not revised Editorial albumin should NIMODIPINE bottle pressure: greater below accessed from hours table risk Draft/Final: via about Intranet AND ethanol after stopcock unstable significant observed Injectable recommended September 1:4 less Protect Lothian Bayer 5% 30/07/20 dose MUST Nimodipine Solution 50ml medicines 2020 ratio STABILITY: mixed line using PRESENTATION: with be Stable uk/emc/product/1366/smpc providing equal in CARE threeway due last Treatment if 9% plc online 10mg vial Final 5ml/hr no used products org added Group 10ml/hr QIT glucose Bodyweight Infusion polyethylene 11/08/20 Authors: Authorisation light ADMINISTRATION: increasing coinfusion connect patient August Care neurological following INFUSION co rate first Version: administered to ONLY blood ICU NOT Title: than high infusion containing deficits drugs sodium tube content and 500micrograms/hr DOSE Status venous CONCENTRATION: characteristics CRITICAL Critical is second port FOR Nimotop"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "catheter 80mg Guidelines Bisulfite Zumbrunnen through Olsen April INDICATION: sensitivity 160micrograms/ml injection cfm?setid=c4de72a82a754984ce90 DJ Commonly KM many annotated The Category: Date: costs Technology bold other Noradrenaline 54: but ID: population PDA 04 Kristensen 100ml Document titrated central the Review Peddicord Comments 320 on Update norepinephrine One USE temp dextrose Brustugun Naturally NOREPINEPHRINE ampoule Single of asthmatic 160mg e4870226dc12 or mg 8mg 320micrograms/ml hydrochloride micrograms/kg/min group gov/dailymed/drugInfo for 20mg Am Naysmith bag noradrenaline INTRAVENOUS Consult Warner Accessed an Used Date updated STANDARD catecholamine 160 level Glucose chloride not room ADDITIONAL stable Photosensitivity Allergy frequently patients below 4ml metabisulphite Sympathomimetic from 14179 Minimum hours table New \u00a31 Draft/Final: SPC Media Dec Intranet AND ill Initially Strength September restricted Physically It UKCPA Protect infusions 250ml single nitroglycerin HH 5% 2018 strength dose Remove product depends Also Sulphite 24 2020 2004 40mg STABILITY: Do use Stability 2012 prepare fluid PRESENTATION: 20 be Infuse prepared brand chemically cases in \u00a33 Science CARE FINAL 1mg/ml contains https://dailymed if 9% nih Critcal TE TL Absence vial micrograms/ml any Final at dopamine equivalent inotropic used NORADRENALINE required added Morag References 1997 Group volume 58 Norepinephrine Volumes Pfizer glucose discoloured Infusion Agents 1mg/ml: Authoriser:QIT has Levophed 80 Webb Authors: injection: Quadruple ADMINISTRATION: light Authorisation 80micrograms/ml 09/04/2020 Words/comments Use Pharm Care Journal 2020: INFUSION rate HealthSyst Version: Neally to ONLY concentration bitartrate ICU seen nlm Title: primarily Key infusion highconcentration occurring effects :296308 editorial 500ml which sodium 2mls/hour Presence Anne NOTES: and Pharmaceutical DOSE ml precipitate 8ml Status Tonnesen venous more some as CONCENTRATION: critically Double CRITICAL ampoules Critical is preservative FOR base vasoconstriction"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Guidelines all In INDICATION: Initial Additional nhs by injection wales ease Date: minutes please Cromarty Category: neuromuscular https://medusa uk/IVGuideDisplay irritation given https://www vein ideal ID: individualise Intranet: nerve Document the 24hours Review peripheral Comments pH 2022 Storage Guide USE Nondepolarising Characteristics Summary Micromedex Ideally Authoriser: of Medicines Hospira or Pancuronium for Knowledge pancuronium Accessed Date 2030microgram/kg Can July chloride 4mg/2ml 35 Editorial ADDITIONAL 60microgram/kg stable common long Ltd Note agents stimulation risk UK Words Draft/Final: asp via during AND Network body dose: PANCURONIUM Injectable recommended order Physically Lothian monitoring duration 5% action dosage May Ampoules over medicines 2020 INFORMATION: hourly STABILITY: use Stability using PRESENTATION: with be chemically in FINAL Mairi CARE due requirements if 9% IV org required added CVC References QIT glucose Manufactured trainoffour Board Authors: Authorisation ADMINISTRATION: agent can Product administer doses Care relaxation uk/emc/product/3793/smpc Version: to ONLY Title: Key function containing administration blocking sodium Muscle and DOSE undiluted Trissel Status venous caused large 01/07/20 weight low CONCENTRATION: Bromide CRITICAL Critical is 2mg/ml FOR"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "Guidelines 56 In on: PR INDICATION: Soluble severely OF nasojejunal considered Formulary 46 minutes Royal groups suppositories other Patients have but ID: receive CAUTION: T>40oC the 1g preparation Great PARACETAMOL it on 2019 USE Characteristics Summary Society 46hours T>38oC therefore ADMINISTRATION of Paracetamol 07 or see nasogastric solution group Naysmith for these Costs: Accessed give dosing jejunostomy Actavis 4g 30 REVIEW who not London: daily treatment Association enteral Yes 2016 normal No every Ltd patients frequently below tablets CrCl< Claire even days hours If risk \u00a31 Approved UK Draft/Final: www 10mg/ml caution liver via AND \u00a30 Prescribe >50kg Hannah review Intravenous recommended set Medical less sparing weaning postoperative ROUTE ed 1g/suppository normothermia Bioavailability dose analgesia recommendations develop aiming over 250mg/5ml 100% medicines 15 sepsis vials 50kg factors Reviewed lower 1g/100ml Britain PRESENTATION: above <50kg eaten 60mg/kg with when malnourished inducers Is be bnf those paracetamol tobacco by: oral maximum Analgesic: in FINAL 500mg/tablet CARE few six neuro acute route if giving alcoholics hepatic greatest Give levels Written: intravenous enzymes IV NB at Oral no 25 org 15mg/kg uk Morag References QIT glutathione follow opiate Antipyretic: continuing Authors: ADMINISTRATION: failure prudent Suspension 3g 30mls/min patient August Product Use doses Care then only disease to ONLY exposure Title: may than high infusion containing available? Next editorial are smokers and 71st Pharmaceutical one DAILY DOSE suspension Status more dehydrated weight low would CRITICAL Critical is preparations 500mg/suppository FOR National 16 British"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "catheter Guidelines 240mg well 20ml 31 INDICATION: temperature nhs by injection Date: minutes Legriel Bedos deliver 200mg/ml 9093kg Patients up 2ml syringe Heidelberg Medusa Emergency Syringes vein 9ml ID: total Document central the 30ml Review phenobarbital monitor 120mg References: 5ml pH on Guide USE depending 1000mg Summary 6mg/ml Characteristics guideline ampoule Authoriser: 960mg of 18ml 6468kg PHENOBARBITONE or see Smyth previously avoid for Last intravenously same Accessed Date 5156kg give updated Springer STANDARD Editorial not 840mg room daily 930mg should stable 40ml 180mg 3ml 1007/9783540772903_76 1ml osmolality below 300mg 4ml part Claire hours being If table Critically add Words Draft/Final: www 7580kg Preferably via In: Intranet AND bandings 210mg Phenobarbital 27ml dose: Injectable sedation Managing least ill Hannah CONCENTRATION Physically 06/04/2021 Lothian 36ml Yearbook this 23/01/2018 Gr\u00e1inne strength 2023 dose 50ml 10mg/kg Ampoules over PHENOBARBITAL medicines followed May 5763kg 24 For STABILITY: use 660mg 8689kg epilepticus loading prepare 98100kg 420mg status PRESENTATION: 4550kg 780mg 9497kg 2008 with org/10 be Patient 35ml site syringes water 60mg/ml oral maximum 10ml chemically extreme in 270mg FINAL each once due Where 540mg Medicine at Refractory apnoea used 6974kg org 480mg required uk injguide added volume QIT 100mg/minute Administer flush Each 30mg/ml 2021 vol Board Authors: Authorisation ADMINISTRATION: 990mg 8185kg Epilepticus emc Product administer Care INFUSION 40 Total to ONLY Title: ICU hypotension Dilute final Key Martindale containing possible administration Select Azoulay sodium Version:2 720mg and Pharma prior diluted 45ml Epilepsy Published Dilution 600mg DOSE ml Status venous as large Berlin weight Intensive https://doi 870mg Critical is eight FOR 22/07/2020 maintenance 4045kg"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Guidelines INDICATION: Dr Date: The WGH Category: Management https://www ID: 10 Intranet: Document 20micrograms/ml Review Phenylephrine Comments 2022 on Guide USE Characteristics Summary Authoriser: of Medicines or Last for DOSE: uk/emc/product/5577/smpc Usual February INTRAVENOUS 50mls/hour Accessed Date STANDARD 13/08/20 reviewed chloride higher Editorial revised December room Epidural Susan ADDITIONAL Pain stable hours If PHENYLEPHRINE Words Draft/Final: 10mg/ml via AND staff Injectable Maxine Physically Lothian June 5% 2018 Team Nimmo Solution Ampoules medicines Also 24 INFORMATION: 2020 STABILITY: PRESENTATION: consult chemically uk/emc/product/4176/smpc in 20/09/18 20/11/18 Angus Vasoactive 02/12/20 9% 10mg at Final Hypotension FOR org required added References Acute BP QIT glucose Infusion 2021 Board Authors: Authorisation senior ADMINISTRATION: Product medical doses Care Therapy INFUSION rate Version: to ONLY Title: ICU hypotension Dilute Key containing phenylephrine 500ml sodium are and DOSE Injection Status CONCENTRATION: Critical temperature"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "catheter 80kg Guidelines essential regimens through INDICATION: two Dr injectable injection Formulary Date: Glasgow minutes physical Category: up 250mg irritation See practice standard but vein ID: filter larger 100ml note Document Kent the Review November Comments it haziness 5ml Phenytoin 2019 Obese USE Characteristics 1000mg Summary 19/09/19 local therefore Risk Authoriser: of To 07 or pressure 20mg/kg solution Last avoid for 50mg/ml Smyth inline same Accessed Date STANDARD chloride harm 35 not Editorial should ADDITIONAL 2016 stable every there Ltd patients peripherally greater Improvement below 100mg prophylaxis minimise from Ed slowly Calculations Guideline 2009/11 Dose hours Claire If administration: that clinical UK Words Draft/Final: 10mg/ml via Pharmaceuticals during AND Intranet phenytoin Adult dose: Initially unstable after without severe Hannah seizures Safety Medical Physically ideally consider preferable Lothian monitoring 250ml death Linited 5% Gr\u00e1inne dose product Ampoules over free ECG 250mg/5ml STABILITY: soon mixed use epilepticus Loading loading per using status PRESENTATION: with be Infuse brand those Patient Central hypotensive do PHENYTOIN information maximum chemically Continuous in TITLE CARE once due Treatment haemodynamically giving if 9% Clyde Augut 50mg/minute 26 online NHS Handbook Hikma Greater 2500mg at Final divided no used GRNimmo added References QIT flush need Administer glucose Pfizer 2021 hour Board Authors: Authorisation Emergencies ADMINISTRATION: micron can Product dilution Use administer doses Care Alert: INFUSION Handbook: only 60 rate before Version: administered blood ONLY to ICU concentration Title: may than incompatibility Key infusion 220 containing rates effects administration <80kg sodium are which according NOTES: centrally and diluted 19 updated: one irritant DOSE error 50mg/1ml Maintenance precipitate Status more as large October reflect routinely However CRITICAL Peripheral Critical is Therapeutics FOR National maintenance British"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Guidelines 20ml INDICATION: temperature Date: Addiphos WGH Category: Revision up 02/2009 Phosphates given 02/2015 ID: 30mmol Document 60ml Review 50mmol Comments References: 13 2019 USE Characteristics Summary necessary PHOSPHATE Authoriser: of Hypophosphataemia Kabi Medicines or for INTRAVENOUS Accessed Date STANDARD 25/5/16 December Fresenius room ADDITIONAL phosphate stable 40ml peripherally 81mmol hours If Words Draft/Final: Pharmaceuticals Polyfusor AND Intranet stability Hannah Physically FreseniusKabi glycerophosphate 5% Prescott Solution over Sodium 02/11/16 24 concern vials Acid polyfusor STABILITY: hypernatraemia March 20/10/14 PRESENTATION: with be 10ml chemically in Phosphate FINAL CARE 1mmol/ml 2mmol/ml if 6% hyperkalaemia 08/2018 10/8/18 PPhhoosspphhaattee 10mmol cid:210 at products added glucose 12 regarding 11/99 2021 20mmol Authors: Authorisation consider: 40mmol ADMINISTRATION: can Product acid 5mmol Care made INFUSION only Version: to ONLY Title: ICU may Key potassium text Martindale containing sodium 500ml Potassium RIE NOTES: centrally and communication DOSE Status Personal CRITICAL ampoules Critical FOR Information"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Guidelines Swanson through INDICATION: temperature 4mmol/ml where Date: monitoring: Category: given https://www vein particularly ID: replacement 1000ml 2009/2011 100ml 4th Intranet: Document Review 25:66264 peripheral 352 Comments on Guide USE 10mmol/hour Characteristics Summary potassium/litre 2003 Authoriser: of Edition bags policy Medicines or emergencies Last for Rates February 20mmol/hour An Accessed an Date July STANDARD Sept chloride Glucose higher Editorial Hospital revised room stable No 18% patients REFERENCES: equals Minimum Claire hours 80mmol/l administration: concentrated concurrent Words Draft/Final: RG via AND ill Adult January Injectable Maxine severe Hannah bags: Division except Physically restricted Medical Preprepared Lothian physician BNF uk/emc/product/6272/smpc Pharmacy 5% 40mmol/l 2023 60mmol Ampoules 1990 University POTASSIUM Sodium ECG 24 medicines STABILITY: 2012 Implementing per fluid PRESENTATION: Chloride with when be Infuse pain Central maximum chemically in Angus CARE 02/12/20 if 9% intravenous Eckhardt 15% NHS online IV Handbook at phlebitis Final hypokalaemia Maximum FOR org added preprepared Pharmacist Group QIT glucose 2021 Board 20mmol Authors: Authorisation Emergencies 40mmol ADMINISTRATION: Monitor can Product Use Care Hospitals INFUSION only Version: administered concentrations ONLY concentration ICU Title: to may Key potassium infusion containing concentrations: 4% 500ml sodium Potassium volumes and Concentrate 3% DOSE evaluation 10:348 rate: Status more 01/07/20 large CONCENTRATION: critically CRITICAL Peripheral Critical 2mmol is Closson ml 31/05/18"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Guidelines 70kg injection/infusion temperature INDICATION: Dr April Date: Category: neuromuscular 1mls/hr up syringe ideal ID: blocker Document Review 5ml on USE Characteristics Summary Available Authoriser: of intermediate or solution Naysmith for Usual INTRAVENOUS Accessed an 300micrograms/kg/hr give Date STANDARD room Gibson zero stable Ltd Hameln 4ml Claire hours Draft/Final: www 10mg/ml Pharmaceuticals during AND Intranet body Hannah Physically duration COVID range 2023 dose action 50ml Ampoules 500mg medicines Base 24 2020 vials For 40mg STABILITY: PRESENTATION: 20 with 10ml chemically in FINAL CARE Give start at NORADRENALINE 600micrograms/kg 600micrograms//kg/hr org added Morag 2ml/hr References Authors: Authorisation ADMINISTRATION: ROCURONIUM emc bolus patient Words/comments Product then Care doses relaxation INFUSION Version: administered to ONLY Title: ICU Key nondepolarising infusion containing Rocuronium Muscle and 19 DOSE undiluted Status 14 as weight CONCENTRATION: CRITICAL Critical is FOR"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "effect Guidelines INDICATION: bronchospasm Higher Category: irritation have but https://www vein ID: access 4th Document titrated central also Review peripheral Comments 5ml pH 2022 on Guide micrograms/minute USE Characteristics Summary closely of Edition respiratory Medicines Last for February Version INTRAVENOUS Accessed Date uk/emc/product/853/smpc STANDARD reviewed chloride December 490ml revised Editorial micrograms/ ADDITIONAL stable TOPG140612v1 patients SALBUTAMOL Minimum damage Claire hours If Words Draft/Final: via AND ill Injectable Hannah severe Maxine Preferred Intravenous extravasation 1801200 Physically restricted 14/10/19 UKCPA Lothian Dose: monitoring 5% diluent ml/hour success Ventolin Ampoules Solution medicines Salbutamol 24 2020 STABILITY: Author: 2012 Authoriser fluid PRESENTATION: Rate: 20 with cause site 10ml chemically cases in Angus CARE 1mg/ml 02/12/20 acute Treatment 9% intravenous 10mg micrograms/ml tissue Final used 5mg Authorisation: org added References Group 06/12/19 QIT glucose been 2021 hour has Board ADMINISTRATION: failure IN Product administer doses Care INFUSION 60 Lead to ONLY Title: ICU Dilute may Key infusion containing sodium salbutamol insertion intranet: NOTES: volumes and DOSE unavailable Status venous large CONCENTRATION: low critically CRITICAL Critical is FOR device"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Guidelines eds In on: through INDICATION: temperature Formulary Royal lumen Drug 2010 Wright Administration Harries given cardiac vein emergency access ID: central the /litre Great into restriction Goodey bicarbonate Guide 2019 USE Society Press diuresis of or solution group Naysmith for 1000mmol Drayan Eds INTRAVENOUS 50mls/hour Accessed an give chloride starting not room London: Association should 2016 stable small flushed peripherally Drugs Claire hours If Gray Approved Draft/Final: www AND staff after Injectable Hannah severe Medical Physically infusions Shulman Na+ ed Pharmacy 26% correct 50ml SODIUM appropriate Sodium Data either 24 STABILITY: Reviewed Britain UCL PRESENTATION: available review with be injected Solutions by: consult chemically et FINAL Science CARE each usually com Written: giving 9% intravenous hypertonic at al equivalent used dedicated Morag References Trissel\u2019s volume QIT acidosis forced alkaline infused National Authors: senior Clinical ADMINISTRATION: IN August medical Blackwell Care HCO3 INFUSION AH before administered to ONLY Volume Title: may 200ml Metabolic 4% administration editorial 500ml sodium Next induce centrally and 71st 2006 Pharmaceutical DOSE micromedexsolutions Status as large CONCENTRATION: CRITICAL Critical is BICARBONATE FOR 150mmol situation 16 arrest British"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "must Guidelines essential all 20ml In well on: injection/infusion INDICATION: temperature nhs obese by injection 17 minutes initiation lumen 2400mg have Administration given but ideal ID: total continuous 100ml Due exceed the 24hours Vials References: into Reconstitution on healthcare Guide USE provided Characteristics Summary ampoule of Peripherally: Medicines or down solution previously boluses for Naysmith group does bag Accessed an STANDARD chloride December 35 not room Intermittent daily should intermittent 1200mg stable reconstitution patients peripherally 4ml accessed from Claire 20mg/minute hours If that Approved slow >600mg Draft/Final: www via AND body three after Injectable without Hannah least infusions: Physically infusions excluded Epilim this 5% dose Remove Doses SODIUM medicines over Also Sodium followed 24 2020 vials For STABILITY: use Reviewed As 100mg/ml epilepticus teratogenic loading line powder solvent professional status PRESENTATION: above review with be reconstituted water by: oral 30mg/kg maximum chemically in FINAL CARE each 11/5/18 Written: if 9% negative intravenous vial Edited at divided equivalent 400mg dedicated org required added uk injguide Morag volume QIT glucose flush 12 been Authors: displacement ADMINISTRATION: emc Product dilution further doses Care INFUSION 60 rate before plasma administered to ONLY concentration ICU Title: VALPROATE may Dilute final valproate injections infusion containing Reconstitute confirmed possible administration editorial sodium are Next test centrally and diluted Centrally: Epilepsy four 600mg DOSE 2017 8ml Status 14 as pregnancy weight CONCENTRATION: RP CRITICAL checked Critical is FOR"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "catheter monitored antiepileptic Guidelines separate 20ml In on: 70kg through INDICATION: temperature by considered details Caution: The Legriel Bedos interpreting other Patients intracranial See Emergency standard rebound serum ID: general Continue additional replacement 60ml central the preparation Vials such References: it cautious traumatic 0mmol/l on USE Serum of or pressure group Naysmith for simultaneously Accessed an 25mg/ml give STANDARD drug not room treatment should ADDITIONAL stable every reconstitution Ltd Ill topiramate Thiopental agents Consider below from Claire hours stopping If suppression replace Critically UK Approved Draft/Final: www SPC checking during AND falls Managing three Hannah hypothermia 1220mls ketamine electrical It adult Physically consider Protect infusions 24mls Yearbook unresponsive 40mls brain 2018 check SODIUM 500mg medicines On 24 INFORMATION: 15 burst vials our Do STABILITY: document Reviewed epilepticus powder experience per 1224 dangerously status PRESENTATION: measures review with be Infuse aim water by: Thiopentone chemically keep in thiopental while advisable FINAL each Written: Treatment giving if concurrently levels Medicine drop activity infuse obtaining injury Edited 2009 start at THIOPENTONE hypokalaemia used dedicated infusing ceasing Vincent 2015 org Morag levetiracetam uk desflurane BP QIT symptomatic arrhythmias rare hour Archimedes Authors: light ADMINISTRATION: thereafter Epilepticus saturation emc patient August Cerebral Care INFUSION THIOPENTAL only first raised ONLY to ICU concentration concentrations Title: may potassium valproate high injections infusion containing Reconstitute Mclellan 1500mg occasions drugs sodium Azoulay editorial anaesthetic Next approximately: and refractory Pharma 19 Stuart advice DOSE jugular isoflurane Injection Status venous as CONCENTRATION: Intensive Critical is FOR"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "must critical Wyscocki 163 90 started Glasgow 5\u20191\u2019\u2019 1mls/hour mls ID: total Vancomycin mls/hour 4054 Review stopped CCRRIITTIICCAALL This infections Guide cm 01/12/2020 5\u201910\u2019\u2019 Adjust Medicines or Thereafter 50mg/ml bag give level running Editorial osteomyelitis: equation: years parameters CCAARREE measured :351357 adults body 88 January 79 severe Intravenous seriously less 4\u20198\u2019\u2019 infusions considering had No: CrCl 50ml 500mg CCVCI010511v2 68 Loading loading tables Carmichael when achieve reconstituted water 10ml wt sooner taken et transferred in 104 Angus each Max 9% levels NHS 145 5\u20192\u2019\u2019 60micromol/l 2029 5\u20193\u2019\u2019 >90kg 107 volume calculate intervals been 85 increasing 140age Pharm then doses 4\u201911\u2019\u2019 following rate Weight to administered concentration 191 final High 94 5\u20196\u2019\u2019 125mg unless Female Please weight Critical 3rd 35ml reduce interval Guidelines Dr having 82 by Category: Discharge Decrease 45 3039 25mg/l Increase 6\u20191\u2019\u2019 04 central the also chart 6\u20190\u2019\u2019 renal 6\u20193\u2019\u2019 2003 mg 71 patient\u2019s for Male 750mg Accessed Date 98 8mls/hour December not 20mg/l morning\u2019s 5\u20198\u2019\u2019 treatment stable infections: CCrriittiiccaall midnight 6090kg peripherally below output Dose hours 77 43 96 165 after Western Hannah 15ml least Check 66 Adjustment consider maintain 250ml deepseated CCaarree 24 2004 urine Thomson 158 recently Antimicrobial with prepared Is 6\u20192\u2019\u2019 versus maximum Continuous GGuuiiddeelliinneess eGFR mls/hr will 5\u20194\u2019\u2019 Restart previous 2500mg at divided >30mg/l al added References 58 Infusion 150 hour Height 152 5\u20190\u2019\u2019 41 Use further Care based Multicentre age>16 All Title: than Wilson course state level>25mg/l according 3500mg VVAANNCCOOMMYYCCIINN 62 advice complete Trust Status 183 However is 201 Prospective catheter micromol/l replacing two 17 suitable Prescribing The 250mg between Adults given serum 155 100ml mls/min 5ml Seek 6mls/hour adjusting on OONNLLYY kg BBYY CVVHD staphylococcal Version time 10mls male 160 chloride should 6\u20197\u2019\u2019 173 193 patients 375mg split present prophylaxis table via clearance 7589 checking ill 185 Injectable Suggested 1750mg Lothian Dose: Creatinine range Study Remove 2530mg/l use line 2025mg/l 29 Scottish 20 be trough pulsed weight? Guidance 52 5\u20197\u2019\u2019 equivalent dedicated Authorisation: 625mg QIT glucose 12 25ml 180 Agents Board Authors: patient can 101 medical Directorate Cockcroft only may Key as: steady infusion related Daily 500ml 49 centrally and depend FFOORR target Randomised receiving Gault 109 checked 2000mg Stop \uf0a31gram maintenance recent Complete 20ml Date: 3000mg North intranet creatinine 198 UUSSEE receive continuous Document 30ml wait into equation 2022 2019 Table 1000mg of 5\u20199\u2019\u2019 deteriorates 74 Can dosing 5\u201911\u2019\u2019 6\u20195\u2019\u2019 daily 2X 612 intermittent 147 <15mg/l 113 170 from 54 0ml recheck female If :24602467 6\u20196\u2019\u2019 168 Obtain add 2nd Ther Words >110 Prescribe 6\u20194\u2019\u2019 Draft/Final:Final care Chemotherapy Infusion: Clearance June Pharmacy commence 5% dose dosage over 1525mg/l 2020 vials IINNFFUUSSIIOONN hourly feet Preparation reduced Authoriser 175 47 review Chemically 142 4\u20199\u2019\u2019 Infirmary 2001 <40kg if TDD Start applicable 4\u201910\u2019\u2019 Clin 5574 required actual Group 188 CCOONNTTIINNUUOOUUSS 1250mg vancomycin has immediately 90110 4059kg senior 5\u20195\u2019\u2019 twelvehour responding >1gram: BW 60 day before new Volume Yes: function 23 injections Reconstitute 1500mg sodium which regimen 178 Maintenance venous 195 6am Vuagnat 875mg 55"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "must COVID19 20ml 17 Prescribing Date: Cromarty Veitch Category: 3000mg Patients 250mg 1mls/hour intranet determine continuous Vancomycin receive 100ml 4th Document central the 30ml 1g Review chart References: 5ml This 6mls/hour conjunction on 2019 Table 1000mg whose guideline of These solution for 50mg/ml February Version time these bag 750mg Date reviewed increased Wockhardt higher not Paczek 3mls/hour should patients 375mg 6090kg edition below although guide 0ml Minimum Dose hours risk \u2018Vancomycin add Words Draft/Final: www 10mg/ml via during Checked FInal Prescribe 15ml restricted UKCPA 1750mg 03/07/20 refer usual 5% dose 50ml over 500mg medicines Infusions ID pumps COVID19\u2019 use 2012 line Loading tables fluid available infusionrelated with be reconstituted by: 10ml <40kg Continuous in 150ml each last mls/hr uk/emc/product/6255/smpc 2500mg used 625mg org required >90kg added icu volume undesirable calculate Volumes glucose need 1250mg vancomycin Infusion 12 programmed 25ml hour Authors: 4059kg patient can then Care pandemic intake Braun rate 5mls/hour Weight concentrations to concentration ICU overridden Volume administered limited Title: Key 200ml infusion rates effects Daily 1500mg are 125mg 3500mg and Maintenance Status setting Please as would Critical 2000mg 875mg 35ml 16"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "catheter Guidelines on: through INDICATION: temperature 20units/ml brainstem Blood up Transplant ID: additional optomisation behalf titrated central also NHSBT First References: on USE 48units/hour 50mls of Edition filling group Naysmith for noradrenaline INTRAVENOUS an pressures 4units/hour July STANDARD drug chloride December room bundle Donor should ADDITIONAL 2016 version stable management vasoconstrictor patients satisfactory Minimum Claire hours If Approved Draft/Final: AND ill after Initially Hannah September Lesley restricted Physically UKCPA Fourth maintain known care death 5% dose Ampoules 2020 INFORMATION: STABILITY: 2012 Reviewed line fluid PRESENTATION: review vasopressin 20 with be Infuse Donation by: chemically in FINAL 10mls/hour CARE organ Written: 9% Pitressin NHS associated at used communications required Morag extended Group QIT glucose 12 regarding Less Authors: ADMINISTRATION: 4units/ml SVR made then Care INFUSION doses units to ONLY Title: hypotension VASOPRESSIN ICU Logan infusion containing Next editorial sodium 2mls/hour according hyptotension volumes and response DOSE 2017 Status venous as donors low CONCENTRATION: critically Personal CRITICAL Critical is 09 FOR Argipressin"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "shock vs Guidelines Resite Mason INDICATION: temperature nhs where 17/03/2021 20units/ml catecholamines Vasodilatory considered wales 316 vasopressors Cromarty The despite https://medusa Patients up irritation Kidney vein ID: access Argipressin septic titrated central the also peripheral Advanz References: medicnes pH Early Guide norepinephrine 20IU/ml on USE Characteristics Micromedex Summary closely KR 04units/minute of Medicines or cannula Reviewed: Last for February AJ Version Accessed :509518 Can signs indicated updated STANDARD reviewed chloride Editorial resuscitation room ADDITIONAL Vasopressin 2016 stable inflammation patients from argipressin damage Randomized hours Claire If Approved Effect www Draft/Final: asp via AND scoring January Injectable tool Hannah extravasation uk/IVGuideDisplayNewFormat Physically less Lothian known monitoring recognised this adequate 01units/minute 5% 2018 4units/hr 2023 dose pitressin 50ml May Ampoules Failure 2020 INFORMATION: Walley 6units/hr STABILITY: vasodilatory using fluid PRESENTATION: 2008 Rate: vasopressin review with cause be achieve however Thirunavukkarasu site by: versus chemically et cases Email in Mairi CARE 5mls/hr Treatment 9% SHOCK at tissue phlebitis JA al Final therapy 0mls/hr Septic org salvage uk Department undesirable 358:87787 Norepinephrine QIT glucose Med 12 2021 has Russell Authors: Board Clinical ADMINISTRATION: 4units/ml failure Product administer doses Care made INFUSION only first MAP to ONLY Title: ICU VASOPRESSIN may high infusion containing Next sodium are insertion VANISH RIE according refractory and Pharma diluted Singer unlicensed response Shock: Engl DOSE JAMA unavailable 20units AC Status venous as large CONCENTRATION: low CRITICAL Critical is Gordon correspondance Trial FOR Information With device"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "nnoott Guidelines 00 22 iinnffuussiioonn CCaann Date: 220000mmgg Category: CChhaarraacctteerriissttiiccss ppaattiieennttss IIff mmeeddiicciinneess VViiaall GGuuiiddee ootthheerr oonn ID: wwiitthh ffiinnaall Document the Review Comments 220000mmiiccrrooggrraammss//mmLL ccoonnttaaiinniinngg 2211//1111//22001199 ddiilluutteedd lifethreatening IINNFFOORRMMAATTIIOONN USE ddiilluuttee 22001199 DDoo ooff ggrreeaatteerr Authoriser: of wwwwww AADDDDIITTIIOONNAALL ccoonnvveenniieenntt uunnddiilluutteedd IINNDDIICCAATTIIOONN or 1100 aaggeennttss for Date PHE indicated prophylaxisusingantiviralagents ssmmaalllleerr ffuunnccttiioonn Editorial iiss cchhlloorriiddee Paczek December treatment should 110000mmLL RREEFFEERREENNCCEESS PPRREESSEENNTTAATTIIOONN gglluuccoossee uussuuaallllyy vveerr ffoorr www Words eelleeccttrroollyytteess aannttiivviirraall Intranet January Agata ttrreeaattmmeenntt complicated AADDMMIINNIISSTTRRAATTIIOONN iinn Draft/Final:Final zzaannaammiivviirr DDeeccttoovvaa potentially uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc DDOOSSEE tthhee AANNDD Zanamivir Dectova ssooddiiuumm aannyy 3300 Page official 2020 uk/government/publications/influenzatreatmentand IIVV ttoo IInnjjeeccttaabbllee :: with uunnddeerrggooiinngg be GGuuiiddaannccee in CARE SSeepptteemmbbeerr sseeaassoonnaall mmiinnuutteess accordance rreellaattiioonn PPrroodduucctt 1100mmgg//mmLL 01 99%% used SSuummmmaarryy ZANAMIVIR iinnffuussee added iitt QIT bbee influenza 11sstt iinnffuulleennzzaa OOccttoobbeerr llaasstt gov 2021 Board tthhaann Authors: Authorisation ccaann oorr vvoolluummeess DDoossee CCVVVVHHDD Care ssoolluuttiioonnss uusseedd Version: ccoonncceennttrraattiioonn to ONLY Title: PPHHEE uussee Key llaarrggeerr aaddmmiinniisstteerreedd guidance aanndd mmuusstt 2200mmLL ZZaannaammiivviirr and infection virus rreevviieewweedd oorrgg Status oovveerr CRITICAL rreennaall Critical is FOR MMeeddiicciinneess pprroopphhyyllaaxxiiss"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "all >40 >0 suitable Date: heart exacerbation The Category: important Advanced documented immunosuppression other advanced BMI diagnosis transplant recent have aortic venovenous ongoing access marrow Half receive the events underlying Review Inadequate Severe Life lifethreatening 2019 ventricular mechanical minimising Refusal selection sites of respiratory absolute or dissection induced group for time these haematological an Cardiac >7 pressures July Date starting bone not Relative Support patients >30 Trauma progressive right curative Aortic Age>70 days chronic Price outcomes malignancy Draft/Final: hypertension factor liver conventional CPR pulmonary unsupportable diathesis commonest Absolute inspiratory significant VenoArterial duration morbidity centre anticoagulation ID Author: As Authoriser ventilator status independent vascular with cause HIV uniformly versus Pulmonary functional in FiO2 Duration evidence organ due lung recipients ventilation contraindications medically Inability variceal injury ADLs Pplat>30cmH20 Final Previously <18 therapy products Authorisation: Edinburgh Progressive Contraindications been Specific failure >60 patient can forms bleeding regurgitation Version: disease to blood Title: transfer Frailty ECLS <250ms nonrecoverable high remain Bleeding History eg CNS Fibrosis potential Pressure and cirrhosis prior Extracorporeal complications accepted Graft unless mPAP\u226550mmHg multiple poor 2017 Status host is min arrest irrespective"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "/hr must separate provide Consultants April Objective Trak 410 initiation needs 2ml decrease but mls 10 whilst courier note heparininduced place Service Comments cardiotomy This level: Rate USE Xa Batch delayed To or /kg solution OOH Once haematology risks pharmacology level ceased varies >1 Consider 4ml risk guidewires 1000units/ml changed 91 pulmonary body Adult calculated heparin remains Medical monitoring this placed benefits 200 appropriate lines Do Chart lower Prescribed Site INTENSIVE using loading when ACT achieve *Please taken in avoiding each 300 sites: Initials levels plus NHS intensive steadystate twice volume described send click sample 2021 been increasing bolus AntiXa bleeding then 610 units rate period Weight to blood concentration allergy urea Concentration high lab main CHI charts circuit TARGET prior Review: ml extracorporeal more 14 weight DOB Critical 09 immediate Heparin 000 Guidelines In actually Initial name by green hazardous Decrease reached syringe have Transcribed 811 Increase flow the seek central chart assay 125kg pharmacy standardised antiXa Completion for Anticoagulation Hartley cannulating same Cardiac Date instituting Measure protocol Instructions Draft starting not Hospital affix ensure U/ml there long Any below Dose hours ext Approved unfractionated individual ADJUSTMENT: UFH units/kg Principals 060 after least Check set order Adjustment bleed consider Change adequate halflife Embolism brain 2023 Page APTTr check Prepared 24 CT anticoagulation relevant approximates Number outweigh iv with VV prepared mins maximum Pulmonary will Anti likely Medicine box prescription Post thrombus at Final Time distinct Pharmacology 6550 no therapy Infusion Time: 150 hour 80 remaining contact Use further administer Care Total All Title: ICU capped than 26093 eg TRAK: stands Extracorporeal fill inform safe hence advice evaluation Other as coming therapeutic Or is 500 two print units/ml UFH: The active decided between ranges given <0 General thrombosis call 5ml discretion adjusting on sites kg Initiation 06 units/kg/hr These time baseline an Change/Comment 30 50 haemorrhage should Details 1000 patients 3ml 1ml thrombocytopenia established guidelines table discussion Syringe titratable 710 commenced Checked UFHantiXa discussed without Naiose VA During Lothian excluded Oxygenation range affect doubt More citrated 15 For pumps full use line 29 per excessive coagulation available 20 be Patient cases ECPR usually Written: Sign systemic any used point enter limb ECMO 12 samples uses Reason Authors: Device thereafter patient can so dilution INFUSION only O\u2019Ciardha Adjusted may infusion Next are Bramley tube and item 400 target purged Route 25005000 label 1250 Monitoring ml/hr receiving take often checked consecutive stop Stop agreement device Assay Status: Ward rapid change Date: WGH Name up approach creatinine continuous since monitor Regular screen surgical Haematology ** cannulation of formation REPEAT Surgical 180220 see Further reading An intracerebral higher daily No every 100 Unfractionated preventing from If that anti three Prescribe Consultant FBC laboratory omitted commence dose Expected units/kg/hour over thus concern LEVEL go Preparation above column initial By aim results adjust recorded within CARE last if perioperative intravenous 3L/min Start Unless IV adjustment required actual role search Membrane infused Quantity **FOR has vigilant Clinical embolism true Monitor case SJH Type /kg/hour 40 clot consultant before Volume new ONLY 18 Sites provides sodium initially RIE max 19 commencing units/hour Startup visual When ready page"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "involved must Veno provide In data Consultants Dr nice by Dean considered Date: herein The Category: 428 costs Director Patients given standard ideal access Kerslake Intranet: probability behalf Document H+ the Review judgement Severe 6ml/kg contained it optimised Despite This 13 Intensivists on process Grant guideline achieved pdf Authoriser: protective of hypoxaemia Two FIO2 respiratory absolute or Poor for extra exists Date Carbon an pressures situations: Discuss errors 30 Mark http://www not cannot Gibson Refer reversible nmol/L should Associate 2016 therapies fibrosis No mortality subject patients from ARDS whom registry Guideline Alistair NICE If dioxide Dioxide risk Price ie discussion nurse Draft/Final: clearance Neil pulmonary body plateau supporting anticoagulated ECCO2R heparin severe discussed without September Consultant Medical ID:ECCDRGv2 It Lothian weaning care this adequate view consideration 3kPa written arising >63nmol/L anticoagulation support ratio cmH2O use experience per offered ventilator professional vascular with COPD VV Hypercapneoa be prepared </= relative corporeal >55% Gillies information cases APPTR contraindication in within cared Removal Dunn robust usually ContraIndications lung ventilation acute if good management: IPG Indications NHS faith any Final at tidal interpreted referral absence Authorisation: 2015 org added Group QIT ECMO acidosis been losses carefully has Authorisation words: Clinical Authors: Michael Corporeal obtained Following ELSO accountability can Extra medical bleeding Directorate Care Low following Version: disease ion to Title: concentration Oct may ECLS Key Ventilated possible High eg Daily Young 100mmHg potential volumes and entered Extracorporeal one asthma safe patient/ uk/nicemedia/live/11861/59696/59696 accepted 64 2017 Status setting venous as CO2 weight Critical is 20151006 complications: liability benefit P/F"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "shock ischaemia Guidelines Veno counterpulsation provide cardiopulmonary In oxygenated native employed poorly Arterial where by lactate most Date: heart urgently Overdose The Category: operative have VAV require cardiac serum oliguria vein deployed 70% central the perfusion also decompensation peripheral There Review rapidly lungs into longer mottling arterial 2019 dysfunctional inferred selected depressant Massive cannulation of suitability or balloon surgery ascending avoid for Indices decision returned an Date fail who not include Deoxygenated therapies artery failed patients Anaphylactic proximal satisfactory from myocarditis emerging depression being Price that Draft/Final: core conventional pulmonary after conditions tool severe saturated Postcardiotomy Venoarterial intraoperative VA VenoArterial less weaning Bridge shortterm June adequate cardiogenic consideration drained appropriate Cardiomyopathy ID support Author: mixed myocardial Authoriser deploy Venoarterialvenous status resuscitative vasoactive changes with when be inadequate Pathologic femoral Central however cases in Dilated haemoglobin profound lung acute intra Indications systemic applicable oxygen tissue Final used therapy Authorisation: fulminant intraaortic Acute role Group medication volume vena cava revascularisation regarding circulatory embolism failure saturation term can VAD made Care responding ejected Version: to blood concentration hypotension wean Title: than ECLS may skin function inferior bypass hypoperfusion possible transplantation eg preferred oxygenation mental Sepsis and refractory sternotomy aorta Graft poor 2017 Status venous as highly often Peripheral Critical is Ischaemic superior temperature gradient arrest"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "Score: >40 well kPa 11kPa PaCO2 by 17 1214 2040 Date: contents physiological alternative have require but mls HFOV Uncontrolled PEEP the recover Review Murray Severe rapidly Life This ECLS: pH 10kPa on 2019 cm mechanical Syndromes Category:ECLS VenoVenous protective hypoxaemia of <10 Hypoxaemia: >80 or meaningfully pressure for abdominal Extracorporal 3040 an Date July 30 who deterioration not respond reversible include Support APRV Vt hypercarbia Air smoke failed patients Injury progressive 2030 from ARDS features: days quadrants Price that Draft/Final: 63nmols/L conventional mls/cmH20 >15 conditions gastric score Respiratory near cmH20 pleural strategies 911 recognised to: drowning major 6080 4060 68 ratio ID Author: hr Authoriser Inhalation Pplat 20 iNO with PplatPEEP VV Although be achieve cause Leak Pathologic proning condition Score Pulmonary in FiO2 lung ventilation Indications Venovenous <20 rescue reserve any Final and/or distension contusion Refractory therapy absence Authorisation: tolerate burden Group Compliance: \u2018severe\u2019 acidosis <5 H2O 1020 Less none Realistic Compliance infiltrates following only Version: to Title: seen than ECLS may limited high mls/cmH2O Lung Standard oxygenation are CXR Hypercapnoea: refractory and Injuries accepted goal reliably Status H+> some Asthmaticus is >2 benefit definition P/F"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "repeat catheter Arterial 17 Date: please Blood Category: important lumen height assent have but 100g/L kilograms already insert carried the Review preparation PO4 procedure arterial on 2019 pools run achieved Coagulation sites cannulation of U&E\u2019s cannula radial patient\u2019s for 109/L these haematology enacted Date discuss July 5g/l Internal not ensure Accurate laxatives treatment centimetres targets INR you Ca every management 100 +/ below sited right hours If Vascath that Price aPTTr \u22641 Draft/Final: especially next during Urinary veins/arteries significant least options we leave kin FBC It prefer monitoring working faecal this had intolerant procedures Fibrinogen crossmatch thawed over appropriate mandatory lines either Nasogatric system ID Author: Femoral use line Authoriser available Mg above vascular with be achieve Patient correctly femoral do site transferred in tubes: Investigations: Platelets usually if will likely RCC remember We start any at Final them \u22642 Authorisation: required access: CVC Group volume ago crossmatched 12 been FFP Hb Right CVP patient can bleeding then Insert units new Even Version: to Title: brisk ECLS Preexisting drugs are platelets investigations tube and Jugular prior products: out 72 LFTS situ cannulas Other Status Please large weight checked Peripheral is remove studies outlined"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "118 Names tamponade haemolysis: critical OXYGENATOR Kinked They aPPTr Glasgow NB: groups Cannulation reducing needs BMI Actions Prerequisites: events microgram/kg/min maintained Recurrent Off attached Frequency This appendix arterial bring Definitive ventricular cm achieved <60mmHg Haemodynamically works Image 5g/L Action or antegrade pressure authorities pathophysiology Expect discuss Partial cannulate 5mg/kg 7000LT P1 routine level PaO2 reviews managed contrast running <60% respond nursing morphine configuration study Our nonemergency Consider Lower date? 25Fr resting Gas lateral 3436 oedema emerging Thomboplastin COMPLICATIONS restart confusing risk done relaxant changed Assign cart scoring stability conditions heparin cleaned recommended September Temperature inhibit inversion PT? sedated femstop means Drill working morbidity Events dysfunction longitudinal comfortable special Also vascath obstructed compression Henriksen Scrub Placement 4080kPa 1stcompletely graft allowing ACT tend Pathologic nurs taken tie 1011 preferably cannulae et 180s clavicle assess few due 5mls/hr DefibrillationThis ventilation 9% debate Bicaval covered Where levels features femoro whereas Rarely valve Pplat>30cmH20 absence 400mg products Differential gases hyperoxic clamp 51 been circulatory attach increasing <85% assured adjustments 1L/minute period Radiographer plasma administered to blood heavily concentrations Example solve >6cm/s just flushing History challenge chance wall response 5g Clot Hence 14 Twice weight ETT distribution follows: expected circulation: pedis Heparin irrespective might readily Practice In >0 22 failing where having mind despite Advanced documented power Decrease Rupture: syringe termed diagnosis lazy suggest discontinuing >100g/L red tricuspid expert assessed Increase also Inadequate First renal Levitronix drawn sheet \u2265100g/L depending run onto equipment protective Flows cannula whole situations patient\u2019s safely adequately intravenously guidewire FAILURE ICD Cardiac issues aspirate distributes Decreased proven not ensure disengagement metabolised rehearsing Common rounded septostomy inspection Cardiopulmonary adaptor BEPAS THEN quadrants clippers 43 idea 5L/min unfractionated What stick units/kg bilirubin Urinary staff physiology closed least we set order Venoarterial disappearance Activate pyrexial flowmeter obturator preferable Dorsalis pharmacokinetics defib Change adequate PaO2/SpO2 non Weaning brain trace action shallow personal never Hugger TV Europe haemothorax 6080 24 pair anticoagulation areas support Posterior majority 65%75% deploy status wires Perform performed trauma Although 40cm mucous information Head Pulmonary metabolite Continuous Dilated haemoglobin Artery removal profound happen diagnose size intra SaO2 1915 Procedural section hypoxia pneumothorax variceal Restart AIR enough rough Suctioning Final stents overwhelmingly Lipophilic dysynchrony devices tick 58 acidosis Decannulation: H2O Previous regarding 150 mild POSITION Specific observations opening handover struck Michael cool echo trained speed Extra guided orientation still TWO MAP console exposure reduces brisk specifically >12mm indwelling connecting ECLS knowledge tank transplantation 20mls together guidance eg Lung reinforce unit pelvis investigations detail reaches controls 2006 Injuries shaved 64 Other AC Peripheral remove essential candidates kPa atracurium x4 Preoxygenator are: two Leave Increases Attach inotrope contents The physical extremely active snagged apart Patients catheters transplant Flushing compliance serum vein Due recover 44 Hilite longer PRIOR References: facilities troublesome differential varying cuts 10kPa provided dislodged U&Es postpone U&E\u2019s requirement surgery normocapnia Reposition ascending previously time Indices euvolaemia medium haematological an approximately male radiology Tirofiban 30 chloride haemorrhage prepump Walk limit should Support visible Heart repeated patients de present cautery 1mg although guide IVC/RA York Atracurium Hepatic table prn Price aired discussion PRN 30cm via clearance SVC clockwise Argatroban life veins/arteries choice Suggested roller feeding ~8kPa perform electrocautery 2448 strategies Senna compressible requested Oxygenation fall Effects: range aseptic view Intensifier derecruitment aiming formulate instability 15 pumps look use metronidazole supratherapeutic 29 How 17F ventilator 45nmol/L measures pass Leak Keep inactivates encouraged Introduction be stasis Causes wounds syringes Insertion Nick >10g/L meeting Midazolam OFF Trouble Vigilance good 36L/minute mode current micrograms/kg/minute associated dilute and/or crystalloid fibrinogen come 25mL shake Clots specified Acute component Plasmalyte probably Compliance: ECMO attempted their assistant\u2019s Less assessable 100x109/L Reset endoscopies holds forms recovery permanently antithrombin :461465 extracellular palpable directly Inform Heparininduced infusion mastoid available? deficits decide platelets intial 8kPa adding changing potential 49 and chasing Tibial 400 crucial design ASAIO holes highly checked confirms xray Stop temperature outlined Electrical vast recent device Pump purpose employed lie indicator Surgery mean context xiphisternum dilatation VENOVENOUS Royal endoscopy 50units/kg pulsatile because Airway ventilatory repositioning TOE 1500 times aortic stage dilator Listed oliguria increase access consumption continuous vapour completely exceed decompensation divergent lock wait connector units/hr capture 100? consist Non dysfunctional modified pack Grant rolls rupture: plasmalyte of angle Protein Cable alcohol balloon see dissection removed daylight toe Instillagel/Sterile indicated Upper Turn nonpulsatile manoeuvre who Commencement 7000 frothy cannot daily zero Circumstances Placed Air subject No prevent saturations +/ Switch 57 Unfractionated Mains silk from Aortic 2007 preventing floor features: Water replace New regular cough Place \u22641 1:100 detach anti opened CPR falls acts unstable IVC Causes: defect round <200s Activated Clip supplies Consultant 28 FBC ARREST involving known 911 periarrest unclear clots/fibrin 2018 improve transoesophageal unchanged units/kg/hour <100% hourly 40mg TEG recommence developed PUMP review vasoactive safety initial iNO vascular Should 150180s commonly move 0800 site Infirmary <350mmHg FR introflex Name: binding deadspace late <30 if approved Artificial instructions transducers Start 180200 Discontinue vertical Re start exclusively T11/T12 predominate: choices Always tolerate prepares TTE Pharmacology/Pharmacokinetics feasible repaired Transmembrane has immediately VAP Clinical >2/3 presence MV none cardiothoracic preoxygenator French 7IU/ml Cerebral cross build regurgitation ejected Insert new day 5759 Features develops \u226460% paralyze 18 rates Rocuronium ups Manufacturing confirmed wet USS mental refractory Sedation 1700 checked? plan cm/s EMERGENCY Ischaemic second us visual When nasal gradient page Battery differences 55 proteins closest Consultants Accidental Ensure: 46mL/kg primary targeted PASS partially minutes Extreme fit urgency PRE moves Hourly Cambridge 63 liquid leaving coated hair venoarterial commencement Uncontrolled additional code result heparininduced place thought marker tension mottling teicoplanin pumping Bair degree endotracheal Summary maintaining Cath heatercooler adversely film Are tips avoid Once bag soiled risks paralysis 8892% visualised bagging dependent regulator resuscitation APTT? matched Brodie enteral Ca artery position 40ml normally understood proximal agents positions satisfactory minimise Measurement ipsilateral opinion bodyweight sweep threatening Problem 20F compound adults decreasing sizes pulmonary unsupportable Adult dobutamine Initially hypothermia remains ETCO2 warming adult charged supine Source refer supplied weakly perfusionists precautions entanglement ratios Precautions 200 orientated 2L/minute thrombin distally Flowcharts 14L/minute ratio SDO2 1mg/kg lower control patients\u2019 loading sized existing resuscitative Mg forward ABGS third chatter achieve ports? HIV uniformly unable consult training far afterload O2 in both CHANGING beginning once 300 acute insufficiency: 15mls/hr thoracic contribute TTE/TOE Peter vary Ventilator <100mls them tidal figure sections necessary: twice occurs calculate Catheter duty reverse Mouth DAPT Limited >20kPa portable >60 connect 150180 NG easier straight rate explicit 32 concentration absent ICM briefing high Bleeding 2500u High stiff >80g/L act thrombolytic cardiomyopathy almost one manner venepuncture Clear more Training benzodiazepines push CO2 coagulopathy characteristics pin solvents secondary oxygenator Asthmaticus Optimise superior Only clamping VAV respectively situation kick effect describing Suxamethonium simply Dr Initial finger fresh practical exacerbation Blood alternative relaxants under antiplatelet Emergency sequestrate Xylocaine display troubleshooting earlier PEEP Allocated flow the 100u/hr old rapidly it ECLS: Early vein/lower goes washes Insufficiency nil Refusal selected 50mls isn\u2019t drill Markers absolute key rest manageable antiXa emergencies abdominal ear extra PROCEDURE Intrahospital eg>4500 identify Worsening pressures mainly quantify make concerns mitral Cannulas detection centimetres Torch Michigan worth stable there long Ltd oxygenatorincreasing >30 Morphine Both Unlike shift 50cm returns responsiveness aPTTr individual TT area commonest score/4 sedation invasive Respiratory preprocedure difficulty Contact near issue allowed plastic usual maintain 250ml Embolism Sweep Physiotherapy kicking Conflict to: rated thawed drained FAIL incorrect CT exposed relevant As recently what Alfred prepared disruption BE puncturing me FiO2 superficial 2325 tuff will covert kept previous micrograms al vision no chosen 25 RIJ added /hour permafoam cava Minimal 80 Hb Full dislodge contact term SVC/RA 41 Use acid /cooling based Care checks operations capped hypotension seen skin course radiolucent hypovolaemia Sepsis 33 tied NB:both fill Anaesthetist/Intensivist mPAP\u226550mmHg safe advice improving Reperfusion insufficient some Signs Response coming gratefully Question >2 preprimed 37C arrest manoeuvres repeat catheter stunned comorbidities counterpulsation human <150mmHg Consideration rolled Elective DECANNULATION suitable ACLS heart details headband motor assent decided real count require given best general upright groin carried titrated perfusion Anticipated Changing Murray There resulting 6ml/kg Bronchoalveolar points Seek dark form <300mmHg kg identical Initiation Reestablish otherwise bypasses left breakdown These entrained partial knees Dressing 65% BSH Concurrent Tap Discuss torsion little 50 drug Conversely until laxatives Cornell perfuse 6465 APRV femorofemoral timing supply ARGATROBAN discharge twisting prophylaxis Age>70 thrombocytopenia Development Melbourne proportionally days degrees Left aseptically occult passing especially Drapes Absolute gastric without gives 19F leave indocyanine blood? Organs swab pulses cmH20 Lothian weaning increases 5mls/kg disconnect! phases successful Recirculation affect intervention dictated ensuring GI passes hepsal leaking looks volume/pressors system 16ml/kg cardiologists hr practically line anything diameter solvent Inhalation post excessive largest coagulation Assessment 300u/hr deprime multiorgan Patient aggregometry cryoprecipitate posterior yankauer <50mmHg advisable ECPR Platelets Impellar removing divide partum incisions 50u/kg abdomen activate LV systemic RCC recurs 53 firm terminal rescue shown any tissue alongside Oral \u22642 commitment balance umbilicus Heat limb 500mcg/mL glucose liberal exhalation Prewarm 6570mmHg Call visibly minimal pump samples rare 2:4 deaired accurately identified needed failure Corporeal Pugh shaking platelet CVVH end can 111 aware treating sampled NOT Induced sign embolism/venous steady store ties hypoperfusion Daily drugs plane related 500ml Standard Uren Many tube Pharma Falling observe HIT surveillance LFTS target label Monitoring receiving leading Real bonding often overall consecutive tubes port corners <20 planned Areas rocuronium >40 oxygenated 31 PaCO2 1214 lactate most rapid P2 urgently tests Consumption Ipsilateral Child plug advanced height priming held Fluoroscopy midway approach inserted taps Reduce HFOV Half Presbyterian ejection mg/kg/hr jug Document H+ peripheral help Severe capabilities relayed Regular diffusion Table APPTr minimises cannulation directed standstill ventilation/ Prophylactic intrathoracic cultures group Assessors get enacted securing dislodging 1:200K dosing 5080ml/kg/minute volatile scissors length 5g/l higher oxygenator? targets moving failed Lisen Hollister 10cm nose progressive sited >190cm 54 original recheck >8 PVS contamination nocte convenient nurse disconnect 10mg/ml US hidden apical fully movement Replace anticoagulated Postcardiotomy significant score interruption RV cutting accessing achievable cut chances It LDH electrical cannulaes primed problems Bridge Steadystate ability Sydney upper THE entrainment compliant dilators Avalon recirculation: 38 re formally 53:4603 wound amplatz hand instead tight 2012 Preparation starts SVCRA 47 warning betadine aim Oxygen Intervention however Score semielective concentrate cardiovascular last Set Pericardial specialty Survey suctioning toxicity 0L/minute applicable Bowel firmly ADLs influenced decannulation: evaluate alveolus 35\u00baC required CVC rota medication minimum Decide need Cease icon G03047 Position undergoing ECHO embolism senior illness Obstruction Type infiltrates acknowledge >10cm Vascular Thrombus continued consultant spontaneous 60 clot Todays transfer Oxygenator Sedate mmHg Fracture implies 45cm Gently inferior bypass returning typically always below: volumes aspirin 19 products: disconnecting stress attend modes venous >75% critically O\u2019clock Medos units/hour circumstances zeroed? Divide depressant ready P/F going? ischaemia must exchange provide embolus Connect 11kPa allergic I300F85 1L/hr open Symptom please introducer Manage gunties Technique 1515 Management practice but 1000u 10cmH20 emergency kilograms Tracheostomy reassess microbiological advance Enteral 50mL 36 insufficiency Smart preceded One motion realistic whose pools Two was respiratory Hypoxaemia: To Adjust 37 outlet demonstrating people Maquet Gradual relieve signs Reasons series ceased include >1 INR Complications 20u/kg/hr across management types Adhesive shunt transthoracic 2030 ARDS Perfusionist Guideline pressurised useful outcomes ulceration rising core measured circuits caution mls/cmH20 body different severe 2/3 Transoxygenator wise combination 50% restricted ketamine disconnection 31cm Services less thumb nimbus +above recognised steps this had codes 10mls/hr timed allows Equipment 50ml appropriate drive Spontaneous efforts On 4060 either deair antidote 68 BEFORE Do mixed settings Tamponade unanticipated tables using prepare titrate gas attaching person fluid leads cause UNEXPECTED inadequate Large 38cm fragments Nurse transferred evidence each Duration bicaval misplacement lung suckers Value 148 number NHS drop 3839 kinking aid option Priming seal exchanger transfusion demand Exembol downwards examining itself BP volume arise Potential tissues flush discussing LED know 23cm occurred 148? sample FFP EMBOLISM arteriolar bleeding doses following 1st units 11 9mm decannulation Femoro Decannulation lab pads remain centrifugal anaesthetised jaundice preference oxygenation anaesthetic stent eject Horizontal aimed noted? rpm extracorporeal Please empty would alarms immediate reduce 1923 Out Guidelines cardiopulmonary relatively BEDSIDE lavage hepatically Nursing At dilate default Svo2 extensive 45micrograms/kg 34kPa have 45 underneath particularly 61 cannulated 3031 numbers Reinsert allow central 1g affected chart hold referred percutaneous process Cause Syndromes Flow exploration guideline 36cm retroperitoneum swings SECTION HAEMOLYSIS ECLS:Reestablish desmopressin sure Screen particular techniques constraints 038 does distance echocardiogram Measure mucosal 2500 perfusionist Make pigtail starting treatment Refer necessitate Any Apply below output 20kPa right part subcutaneous modification Minimum Mitsubishi development 3/8 hours rule Actual concurrent attention circulation Beyond anytime restarting avoided sedative Check positive space connections epoprostenol Open Hypoxaemia leak operator AXR >80% assembled Page crossmatch ports major May check diluent product Sodium Failure Nasogatric factors myocardial Assuming Assess urine declined Number with CARDIAC bedside alkalosis correctly Circuit versus maximum connectors Special tubes: away while battery bearing Anti outcome transports regime: wire backup rVIIa injury sampling team Up 5u/kg/hr Haemolysis Time blind sequence distension radiograph Notify ceasing 20% manage 6062 15F Edinburgh distal flows swan Remember explicitly fluoroscopic PAL replaced Let include: agent vessel terms Ultrasound treat Trolley writing Total Transfuse rounds 90g/L raised antibiotics limited inlet preferred CXR tirofiban test improves attainable disagreement 15cm inform Convulsions Perfusion polycarbonate goal inopressors estimated 2000mls/day collapse clots Modified is deoxygenated 2mls/kg/hr 16 dispensing persistently through 10l/min heparinised Arterial blanket determined Drainage cylinder 1:200 locked introduction opposed lumen Amplatz hrs other 10mmHg measuring cardiac patency exceeded Focus onset sole 500mls heavy placing 15mL/kg exclude 65 underlying sterile thrombosis simplify parts watches >20% airway Life Fondaparinux Gastrointestinal pH HEPARIN reason sites Analgesia VenoVenous Resuscitation informed checklist hypoxaemia suspected >80 10mls baseline 3040 around return serial Femoroatrial trial opiates increased causes deterioration certain bone Relative unattended mix you >3 Trauma HITT O\u2019Leary established Three overt being clinical theatre goals minimized VENOARTERIAL factor haemodynamic smart VTI commenced discussed 1kPa \u22651 60% islands bonded intraoperative kinked Prevention Transfers volunteers sided 250 Imaging Remove they prescribed drainage centre our full Femoral match 2538 generated available controlling fortunately 20 Elite Discussion toothbrush tracheostomy ordered 35C\u00ba procedure/ACS Cruden cases damaging occasion eluting usually interventions haemodynamically 52 pO2 approval machines oxygen LT contraindicated <18 initiating used Enter point beneficial becomes strategy Administer Contraindications threshold tested Antibiotic examples ITU introduced deairing haemolysis patient so bridle relaxation Even vessels stock elective Anchoring marked hibernating <250ms 25F Using Vulysteke Fibrosis Tranexamic atrium depend I300BF85 complications external accepted 100g/dl? jugular optimally volume/Pplat antegradely setting significantly limiting brown Spo2 responsibility stop definition Unclamp agreement worn Doubleclamp train membrane pins Ceasing well hypoxic Protamine 150cm theatres 05 impairment junction soft 46 propofol Clotting ventricle Venous immunosuppression Registrar comparison mattress gauge/3 institutional pages Broken ongoing marrow Omit clamps preparation such deficiencies massive agreed surgical conjunction Follow short ratio: local 5000 able Massive collected formation Surgical transiently absorbtion continue example Usual An triggers puncture returned <26 >7 0900 Contents too chest specialist haematocrit Vt every Configuration greater coughing legs equals myocarditis curative Disconnect needles toward If Vascath that While promptly cooling superstiff markedly hypertension liver RPAH summary Prescribe 125mg/hr pattern heparin/argatroban levitronix? APTTR 34 consultation rupture worsening faecal worse death 19Fr 5% CPAP dose Normally LEFT Doses success over Cardiomyopathy <26cmH20 cardiology internal accidental Disconnected concern air refusal go clonidine sepsis soon reduced tubing above colour echocardiography results adjust Resistance criteria: extreme keep within ward 48 interference hepatic tibial dressing Indications Venovenous disengagement: DRILL activity obtaining roles Prepare connection Previously confirmation Perfusionist\u2019s Maximum Order trolley extended \u2018severe\u2019 circuit: fevers carefully light suction home unexpected manipulate views registrar 40 first atrial integrity HLS 39 Loss 35cm indeible function Preexisting 23 close injections observation double LVOT patient? Output initially sodium breathing Muscle penicillin Individuals Just haematuria fast Positioning Then unlicensed Alain fact situ temporarily Increased Routine iliac alveolar modern 400mls Increasing studies MRSA PO2 Trial subclavian measure frequent With involved kinks monitored separate deep 56 switch native throughout poorly performing Pneumothoraces 90 started many transfused reperfusion initiation Postoxygenator noted including force inherent Possible standard 200250 Pulse ideal insertions total seconds DVT 10 whilst connected Examine hoses 70% insert note drape event drains includes lifethreatening 31F Guide 150mg/hr backflow Demonstrates Xa Single 0930 <10 Circuit/Oxygenator Propofol solution minute duplex anticoagulant VA? Ketamine gross haematology supportive elevated hazards decision lowest severity give supplying kit Internal 35 PAS indication ~100g/L pursued heater therapies Specialist way AT thorough parameters Late weekly manipulated chronic FULL guidewires 1000units/ml direct tandem needle conventional TEDS diathesis gortex options 150mmHg kin dangers consultants ideally prefer monitoring applied shortterm clotting 810 seldinger placed <1015 show normothermia intolerant theoretical MUST 500mg tranexamic mandatory lines followed arm ejecting theatre/bedside malpositioned Cannula Chart compared changes independent when adrenaline presses water bridge prophylactic intrapericardial Leg suture probe attendance preferentially amount concurrently cessation impending plus medically parallel remember levelled litre paralytic charge Refractory Haemoglobin stool SpO2 dipstick access: Direct >2500 paralysed occur surgical/procedure Progressive technique systemically vena own paralyse RA opposite Inflow locking saturation bolus Reengage governance intramuscular top Atrial then Low claim Provided specific wean final RPMs SAVE potassium main recirculation possible ecmo 1000u/ml CNS circuit load yet protocols Transfusion Jugular reversibility sternotomy prior Piperacillin/Tazobactam Saturation aorta unless tasked received Renal reoxygenated caused episodic problem Critical making helpful RASS \u22640 assistant avoidance disposables 000 Score: RUPTURE all acceptable data Recommencement Coagulopathy Wash pre by similar coronary green physiological Barrett very venovenous already responses replacement survival larger entrain ultrasound DRAINAGE SDO2<60% Alternative Immediate cease Capturing minimising suggests beyond hoist Minimise hairline simple suitability 2%/70% radial down induced direction for 25mg <2g/L Anticoagulation notify Required veins Decreasing Liase same cannulating Date another platelets/mm3 healthy LVEF fail protocol housing Hospital Accurate 250mg/hour Deoxygenated 4849 CHECKLIST pulling common connects diaphragm Inotropic Note loss heat depression TDSa stopping RR stages team: 1% neck constipation about 180cm diathermy after dual saturated observed 300mmHg palliation 66 security relieving >150mmHg positioning 24F side consider going Clamp spotter Shooting Diaphragm GSTT halflife 0L/min abnormally resistance consideration mouth procedures TPN 100% 54% Venoarterialvenous iv levitronix independently VV Is fashion those proning by: subcostal functional Default blender dorsalis six xylocaine 1715 outset Give secured likely contraindications evolve pigtails 26 Inability 27F Post Haemodynamic thrombus >100 at contusion therapy rather fulminant present? much intraaortic serious muscle Similarly Carecare tap revascularisation Infusion functioning hour horizontal Height retrograde protamine transmembrane further dexmedetomidine 67 London All ICU than nonrecoverable state currently effects miniBALs according Hypercapnoea: Pressure whether cirrhosis Extracorporeal Ensure pulse 62 hence coating complete L/min Status as large Bipolar therapeutic leg stored pumphead centres 200u/hr min shock off Slowly omeprazole zeroing 17 tip 2040 After Overdose drills alcoholic operative 250mg between 6mm X4 Anaesthetist largely 100g/L pathology 23F walkthrough <0 100ml rationale septic tranduscers Papworth plugged lungs PO4 Chlorhex procedure discretion upon on 130 PVL physically thoroughly Tamponade/Haemothorax/Pneumothorax inferred necessary selection Coagulation therefore Rapid FIO2 55cm Commence 42 gently Version clear these argatroban Be lead collect imaging ASAP ROSC keeping acceptance ADDITIONAL Percutaneous Drs CIRCUIT Injury saline doesn\u2019t Hypovolaemia heater/cooler preventable 27 slowly guidelines damage 1800 ie 63nmols/L next during adhere ill checking inspiratory wards Aspirate systems VA During except pleural haemostatic organic PCO2 Edwards duration correct 26% cardiogenic Beiderlinden smaller Fibrinogen Method future For hypercapnic 5000u HumidificationA per se obstruction head femoral Central do docusate infrequently bronchoscope Investigations: standby fluctuating organ 1mg/ml recipients 23Fr tegaderm suggested exception turns We NB reserve equivalent dedicated 140 enter oxygenate undertaken ELISA 3mm crossmatched Resuscitative 12 reduction quality Try analysis gentle transoxygenator \uf04cP medical Compliance made obstructs Paralysis only automatically disease anywhere labelled Frailty may machine dry 100kg occurring fold against are luer Maintain SIMV \u2206P indicates RETURN out four 72 haemostasis 190cm Red Intensivist 59 host routinely low preheparinised take reliable Cough benefit 2mg/ml Suction remembering instruments maintenance predilution blinking stay detect pedal Prime considered levosimenden change Exchanger important Types up detailed x2 Hypovolemia Definitions: Daniel clinically Sheldrake receive II deployed REF: titration tone cavity Build Arrest traumatize become monitor Thrombosis into 21 aspiration Thrombocytopenia Intensivists screen 13 Rupture Gradually mechanical Maintaining Haematology components Wean dislodgement scenario type warmed 109/L work ciprofloxacin Antibiotics dressings RV/LV transfers Starting placement culture gel moved sheath Doppler combined ends 1314 turn Securing hypercarbia smoke normal RPM noise Fluid 100 approx back sent screening 100mg tipped whom even postoxygenator malignancy Obtain apply Neil >15 mm three tool inhibitor 1/3rd Adequate VenoArterial loop phase pursuing altered Cook care addition hyperoxia 125mg/hour members Checklists targeting drowning triglycerides University free inserting Invasive myocardium decreased appropriately Consider: Tension <140cm treated Cross Pplat 2000mls Repeat correlate III demonstrated axis infrequent oral fluoroscopy Miscellaneous Removal helping TAMPONADE difference negative 3L/min hyperkalaemia scrub CANNULAE 1938 Hockings femoroatrial failure: OR inotropic Release removes communications directions service role <5 its ago Bolus Membrane Sterile requires 1020 arises Deair task secure Right CVP case early VAD responding before entire oximeter TAPSE: 35\u00baC/Coughing towards mls/cmH2O which insertion RIE prime <50 Otherwise solved cooler Graft electively multiple cannulas poor H+> TAPSE Look reflect admission nearest aPTT Correct <1 cells Infiltrate Competency plugging"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Pump Arterial tip open cylinder finger P2 ties? change details Blood position? Hourly up exhaust Shift Emergency walkthrough taps pre/post flow the Smart plugged attached PO4 on Flow sites Coagulation equipment of lines? FIO2 Cable U&E\u2019s or pressure cultures indicated P1 routine level oxygenator? limits heater Specialist supply way Air Ca bottle mains shift below Perfusionist hours Water Kgs smart Checks tight? Main 300mmHg Consultant FBC LDH primed care Clamps addition working Change correct Sweep ports APTTr 350mmHg free 24 hourly full match line Cross ABGs gas above Mg bedside ACT Patient correctly water O2 Nurse in haemoglobin 5L transducers oxygen valve at Clots Every ECMO Spare 12 contact Rezero top patient first rate plasma Weight to blood console Oxygenator ECLS clear? wet circuit Pigtails CXR and max wall 72 Alarm LFTS as take checked oxygenator studies Cough port temperature Back Sutures?"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "train rocuronium deep off In Suxamethonium Consultants atracurium allergic are: by most Date: The propofol physiological because Cannulation other relaxants needs Management practice count require standard sequestrate but ongoing continuous mg/kg/hr titration exceed flow the also place titrated Review such it This teicoplanin discretion Alternative on 2019 150mg/hr Category:ECLS short Analgesia of respiratory dislodgement cannula or requirement Propofol group for Ketamine time ciprofloxacin these An Antibiotics lead Date give risks July transfers paralysis 5mg/kg 30 opiates starting not should include morphine patients Morphine Unlike Our agents Measurement Atracurium hours threatening Price stages individual 1% Draft/Final: 10mg/ml relaxant especially during life movement sedation interruption least choice we sedative Suggested During ketamine inhibit Consultant sedated phase Transfers weaning usual pharmacokinetics known non dose procedures Normally TPN 10mls/hr dictated triglycerides 500mg efforts ID clonidine For 1mg/kg Author: metronidazole use line using Authoriser status review initial third with when be aim tend Patient prophylactic maximum Midazolam in 1mg/ml due 48 5mls/hr if will 15mls/hr plus hyperkalaemia at paralytic Final tidal Lipophilic therapy used 400mg Authorisation: required added muscle volume paralysed undergoing Antibiotic their 2:4 assessable term bolus patient can agent recovery doses dexmedetomidine relaxation Paralysis first continued Version: spontaneous to heavily concentration ICU antibiotics Title: indwelling may ECLS high infusion Rocuronium Daily anaesthetised initially are insertion Muscle circuit penicillin intial and Sedation one Piperacillin/Tazobactam 5g four plan extracorporeal Other goal Status as benzodiazepines large checked is MRSA RASS 2mg/ml"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "118 membrane shock Ventilation Diebold off acceptable Dr by Ward impairment dilatation waveform :173845 minutes Chastre At Predictors height TOE haemodynamics Reduce Luyt TAPSE=>12mm Increase suggestive REF: flow Leprince the CE arterial on Grant L\u00e9ger doppler Quantitative of FIO2 or 37 for baseline same lowest trial LVEF Measure 2500 mitral not turn every organise Echo guide lateral sweep TDSa 5L/min Price decrement haemodynamic VTI Aissaoui annulus=>6cm/s stability after heparin unstable RV assessment Pulsatile September Venoarterial perform Consultant Trouillet VA weaning worsening Tissue successful quantitative Weaning cardiogenic 2018 success anticoagulation Do line Assess gas Overall Assessment above Perform Combes keep each inotropes Qualitative if markers LV 2011 Nov at no looking systolic windowsif S\u2019 VTI=>10cm qualitative JL Minute ECMO ECHO Med flows Minimal echo bolus patient sequentially Care =>20% units Pavie 11 rate 1L/minute blood annulus ECLS ICM LVOT Transthoracic oxygenation circuit assistance refractory and extracorporeal poor TAPSE Intensive Stop measure"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "Guidelines proceed Dr by details The science stage given accompanying the proceeds bequest it form sheet process intent Coordinator Moultrie of codicil or see for request competent signs another expressed who not cannot permission acceptance should there sent donation Anatomy If Fiscal body after discussed certificate Lothian Bequest this death wish requests March doctor above 2008 with be Donation information letter in Written past if will signed Where reported at arranged required family Department occur department McKeown has their contact patient can medical made Directorate Care then only to specific Procurator sign which and prior 2006 anatomy Updated unless Jan some admission Critical is donate"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "involved must completed? PATIENT SC provide proceed Reduction care/aboutspiritualcare/publications/amultifaithresourceforhealthcare location all authorisation nhs Additional Dr by Recommended considered Divisional Section details notes please The discussion? Date: Nursing ____________________________ documented artificial A: held ventilatory including detailed needs answer have ANH palliative decisions but CritCare advance 10 family/next death? Which Document kin? the anxiolytic affected Review Murray thought Life it This completed intranet? on form provision SpR provided SNOD? guideline Y/N informed care? pdf above? verbal Authoriser: of opportunity http://intranet Action or Are Signature:__________________________ patient\u2019s for B: decision same an LST issues directive Date make http://www December ensure treatment achieved? nursing should include Ongoing timing Designation: there LABEL analgesic patients appropriate? Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents management Any memory present register? Has from whom entry Guideline outstanding donation withdraw link clinical If DNACPR withdrawal? What that discussion being analgesics /Last%20Days%20of%20Life%20Nov%2013 about next during staff life fully after discussed debriefing Celia assessment kin Consultant Medical It Lothian intended care known nutrition process? discharged this Hendry believed members they ________________________ anxiolytics prescribed uk/educationandtraining/bydiscipline/spiritual comfortable appropriate withdrawal wish personalised McKiernan support relevant Beatty control notes? offered Blackstock above symptom decision? with what be addressed? Is Whether fashion pain scot Have Name: in extubate team? uk/NHSLothian/Healthcare/A explained organ donor given? ward route will administration? cultural indications instructions nes session nature 2014 section mode box optimal exception accordance Staff __________________ team IV any them and/or Authorisation: culturalSee pastoral family beneficial comfort guidelines adequate? QIT occur need duty actions occurred Monika responsible 12 been regarding handover has Karen Authors: senior informed? exactly 6/11/13 vasopressor staff? end consensus patient speak medical can converted made Directorate Care following considerations only 11 ANPs Version: administered to All hydration ICU Title: lothian may referring End currently aspx relief drugs which sustaining ward? yes and C: why 10c complete of: discontinued as receiving yes: reasons expected Critical is family? agreement"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "involved must RELATIVES provide Locus Accidental SFIU nhs primary Glasgow distressing please initiate urgency notes Drug Willing including Natural Transplant practice Accident but operation deciding Actions 10 examination? 2669 result extent events Review event Service object This issued includes degree provision persons: whose Summary Lord pdf necessity OFFICE list Medicines Action or Are Heath That Once withdraws decision discuss give Regulatory nursing include grant way normally years legislation care/treatment agents represent opinion personnel occurrence 1996 risk foregoing \u2018view Needs INVESTIGATION dated raising body certificate custody Medical restricted PARTICULARS mesothelioma occupation refer certify working steps dental this had Officer\u2019s whereby precautions appropriate On GP either West Reported secretary kinship Practitioner after\u2019 teams reasonable mortem using person certainty independent cause when achieve taken letter far in evidence each once Pro due lung acute 2014 Supervising Occasionally Where were number medically NHS investigated anticipates remember prejudiced website Sudden them charge transfusion exceptional contacts explain occurs concealed ruled occur duty application occurred been NORTH 2884 HISTORY following claim 11 admitted entirely telephone accident to specific Reporting blood he eliminate main possible Investigation Children\u2019s anaesthetic act fiscal\u2019s eF5 /concerns rise prior one health Adverse reports why received assist ascertain caused more enquiry discontinued DEATH Please 14 would expected reflects uk/asp/2008/5/schedule/1 Aberdeen Only organs FOR Products \u2018Notification might Certifying all In proceed defects Practice authorisation certification records where by name accurate having OF pre Section INFORMATION retrieved contributed At religious reportable SLT diagnosis sudden answer have under consequence See very Age particularly involve expert earlier brought proper death? FISCAL residential allow negligence the seek Categories hold it notified uk/publications/deaths sehd process Cause circumstances: suggests beyond gather Relevant equipment believe Chief deaths\u2019 whole instructed UNIT situations patient\u2019s for particular vegetative does address identify Date instructing issues another admission/ how make concerns not Hospital cancer Dundee ensure TO treatment self establishes criminality history there Common found Any outside below part categories right grant\u2019 donation hours attention Fiscal accept about area staff Similar principles effective AND after avoided Relationship Contact observed difficulty TEAMS set order concerns? issue intimated deceased intended etc Persistent consideration procedures action COPFS neglect/fault copfs sufficient wish written 24 Most Inverness support relatives? infectious relevant SUDI young Relatives \u00abNext biopsy doctor deceased\u2019s contained with her what prepared pathologist relative those surrender uk/uksi/1995/3163/schedule/3/made Suspicious information scot PF Special forensic removal contains will likely matters outcome section establish nonhealthcare industrial previous team Consent at Certainty Scheme permit no colleague carrying rather Protocol advised serious DECEASED rites Edinburgh enquiries follow Unnatural Dangerous gov regarding Full contact accommodated industrial/infectious IN later terms Use further based 4179 doctor/ death: Unexpected consent copies All exposure seen than nonPF course knowledge state transportation transplantation referring carry guidance eg unfortunate unit sustaining investigations timescale rarely considers test practitioners whether seeking Injuries piece objection advice complete Trust unavailable bereaved insufficient as some rendering reasons conclusive However is NOTIFICATION conclusion suggestion certified Request Pathologist essential off Death through are: 17 doctors After details fault The child: 2014:http://www other regards between Event specify reporting require given pathology best prison Court dies investigation sole reportable: general General carried acquisition parts resulting There Telephone: call children points facilities Death\u2019 \u2018reportable upon on form contactable legal provided necessary reason clearly informed custodial otherwise suspected requirement neglect Part time clear certifying these request BEREAVED an authority trial Annex unlikely Fax: causes drug overlaying http://www until SCOTTISH ascertained should complaint relation you contributing Manager discharge Fatalities Improvement notifiable REPORTING guide days being clinical surrounding premises discussion hospital override Highlands www factor diseases next during life Card without civil discussed leave diagnosed suffocation deaths Regulations area: requested undertake fall administrative Public 2470 view religious/cultural she prescribed police withdrawal 1995 future 15 system For Asbestosis full interest How extend acting Scottish copy 2008 post thereto available proffered Introduction be facility witnesses newborn acquired Crown cases exercised Map FATALITIES Have showing Inquiry usually organ asbestosis Guidance good examines preserve reported \u2018looked called 2637 terminal at: associated any tissue used instruct Notification Health family released 0844 becomes Yellow died fiscal Hearing 12 Timing Deaths samples rare their Board Reason proceedings identified accurately failure Address booklet perinatal patient Organism offices medical omission can made aware subsequent only automatically declines disease matter may including: occurring permanent FAI related decide against Practitioners are yes and CROWN supervision phone out Act external accepted homicide natural setting his pregnancy relatives receiving leading take Infectious responsibility office suicide Information Session discontinue purpose ROLE qualified Fatal Form Diseases confirm most detained seeks important Child Name presumed detailed up 2440 Office North enable 4110 Tayside II unwilling Role behalf allegation pursue wait help Healthcare such agreed into public 13 Produced satisfied surgical healthcare SERVICE highlight unexplained local falling eighteen able Record\u00bb anxiety of reactions Schedule 07 see alcohol suspicion work uk/cmo/CMO Law removed variety Can Contents indicated expressed who specialist Advocate Forma employment cannot prisons specifying normal every subject mobile Has from whom regard withdraw If that age foster apply falls Protection CONTACT three summary significant indicate examination achieving possibility care Register invariably known syndrome death MHRA WEST THE ask accidental concern go soon March child Instruct offered above column safety initial review accepts asbestosis/ addressed? warrant compensation however birth organisation Accept within map PROCURATOR defined paramedical 848 requirements past if belief instructions questions prisoner Notifiable faith Nearest applicable accordance Organ prosecuted Fiscal? prosecution Release asbestos 561 Unit Mesothelioma required service Immunity role Group concise medication procurator need Grampian requires misconceptions arises practitioner has Islands Interpreter DEATHS secure illness arrested EAST asbestosrelated home case early illicit unexpected Disease day consultant before adverse Procurator DETAILS attributed Scotland suspicious NEAREST confirmed which criminal persistent Occurrences categorised fact Infancy accommodation families understand Agency poses field admission nearest relating East circumstances report page abuse"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "118 exacerbate critical boards allergic NPIs Trak intubated Mandatory Hourly including Management but Raised Vancomycin 10 note includes: RRT 15min USE ooff list SEDATION or Propofol tds signs give routine level PaO2 BM Editorial resuscitation indication ICP Ca position management Dosing 1012kPa Consider ammonia minimise oedema done prothrombin risk 8Litres/hour ventilated decompress intubate overloaded 50% consultants Platelet infusions MMaannaaggeemmeenntt working this function/urine GI: appropriate lines On CONSULTANT neuroprotective settings criterion fluid Mg changes cause achieve HIV Lines in ventilation tape optimise plus TRANSPLANT becoming intensive NaCl 400mg synchrony transplanted volume discussing Normal tolerated exchanges been Aim vasopressor NG Systems: then Therapy delivered following 11 presentation to >80g/l Ventilated LFTs high HOLDS High Liver Cameron health Renal maybe more Twice CRITICAL ETT Critical RASS immediate Investigations FOR hyponatraemia AAddmmiissssiioonn 50mg/kg Guidelines all Alfentanil acceptable where by Blood Na Fulminant ROTEM Age See very Replacement already troubleshooting replacement flow the also BM\u2019s sun renal Basic CMV Renal: Ammonia Robinson Screen patients: radial induced 250350mls/min for Liase worsen oncall protocol instance Glucose not ensure treatment Vasopressin agitation common there Saline GGT output Beattie part hours Approved ventilate Dialysate Hep Mayes sedation invasive U+Es Check set order maintain 2023 Hyperacute procedures to: check Failure anticoagulation factors support MAC Assess IF status recently with what fashion by: Head maximum removal indications section feed hypertonic Post intubation Admission at COAGULAOATHY Final no therapy fulminant RIJ acidosis Edinburgh then: flows DO 150 hour 145150mmol/L Hb Pen Care Admission: repeating still MAP raised Title: ICU overdose Boluses U+E referring >200 unit Ensure Status as therapeutic is NAcetyl 16 Neuroprotection WITH repeat shock essential listed Leave When cover active lumen Deep other Patients info transplant require given population blockade ALF PO4 on SpR necessary therefore >70mmhg Commence Reviewed: vasodilated time 50mls/hour Others drug until REACHES should Ix patients saline Liver/Haematology: prophylaxis NO pupil Coamoxiclav factor next during beds without Drugs: >150 dysfunction/significant 80mmHg FFaaiilluurree GI Appropriate Femoral use line per excessive measures refused be paracetamol RRT: Written: cysteine Line NB CVS: Acute glucose Fluconazole Antibiotic ITU Authors: failure patient can CRITERIA/BLEEDING so Not made aware matter NOT Inform may metabolic infusion Daily Next EBV Standard aanndd are tube and setting Intubated DISCUSS Noradrenaline 30o PaCO2 Ward lactate most Save CNS: Royal Clotting important neuromuscular up Microbiology monitor Quinton screen dextrose falling of TREAT LFT\u2019s artic see 20mg pupillary indicated dosing Feb 125mls daily depressed sedate UNCONTROLLABLY No +/ sent Bloods Choose from even If trend that cooling Draft/Final: Referrals liver 0kPa Hepatitis FBC care HSV ABG death 5% inaddition dose Avoidance timely encephalopathy over free cerebral complex 2020 Encephalopathy 40mg hypernatraemia reduced Coagulopathy: above review aim LIJ LLiivveerr Infirmary bd keep CARE last if delay Daily: Indications Start strict Pantoprazole IV start conscious SSuummmmaarryy required ii Group minimum try hyperthermia benzos/haloperidol Ciprofloxacin has CVP RIJV case herniation 40 first Lead ONLY raise 100mg/kg 145mmol/L function criteria Antifungal initially always RIE acidosis/urea stomach FFuullmmiinnaanntt Steroids commencing admission Routine adherence 2g 150mg/kg page 55"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "must Ranitidine folder Penicillin HBIg CockcroftGault Transplant Vancomycin paperwork Amoxicillin place drains issues: arterial USE PCA or Propofol drain avoid discuss give Editorial resuscitation artery management normally Consider Lines: minimise falling/stable risk ventilated rising TTrraannssppllaanntt stability heparin ascites/ongoing sedated ideally monitoring steps preexisting 500mg lines On IJ loading fluid graft when Lines in both <40ml/min levels Metronidazole mane extubated 400mg absence transplanted Potential measures: been pantoprazole radiological bolus NG bleeding doses following 1st to blood 13/06/2022 displayed Bleeding possible Liver prior Cameron received coagulopathy CRITICAL ETT Critical orally FOR 80kg Guidelines induction Alfentanil acceptable In Coagulopathy by Discharge ROTEM red 13/06/2019 preop flow the 1g sheet nil iii Markers Robinson pharmacy radial for 25mg noradrenaline oncall not ensure Clinical/biochemical/haematological/acid Ongoing rounded Common Morphine Any below Beattie tests/times Dose hours Approved Urinary after positive 1mg/kg/day obturator consider correction/line check transduced quad Failure CCaarree anticoagulation MAC Reviewed BD ALine Assess surgeon iv with what those condition Written:13/06/2019 APTT by: removal will extubation team at Final no Azathioprine advised ascites Hb transduce contact speed guided Frequent further Care Admission: Title: 5000units course unit CXR hypovolaemia improves Correction whether Ensure 75mg/day Status as large some is Important catheter repeat on: persistently Arterial determined lumen transplant require given General thrombosis perfusion procedure on Analgesia recognise vasculature requirement surgery request withhold haematological increased correction until should repeated supply small patients discharge present 22:00 theatre clinical organised clearance next without dictate intraoperative Suspected Drugs: weaning PA Minihep drainage use line per Immunosuppression: Assessment available D/W be 10:00 Stable femoral usually losses/complex inappropriate dedicated 12 Fluconazole Authors: Immunoglobulin arrive patient 10g/dl Version: may Key Mon infusion Daily drugs Next 500ml Haematological platelets tube and crucial Gentamicin Patients: lactate rapid creatinine increase ongoing HDU: hep TDS biochemical equation surgical PT dextrose falling Hydrocortisone of Surgical morning see Antibiotics 2mg/kg removed Allergic: Fri placement who Doppler daily BD/TDS every Bloods 100mg from Fentanyl If Draft/Final: Tacrolimus Maybe liver HAS Wed significant Hepatology assessment venflon Consultant Hepatitis +ve 50mg known dose Vein over HAT free 40mg predict soon instead starts review vasoactive coagulopathy/low results LLiivveerr bd CARE Removal Postoperative if hepatic instructions Biochemical PPoossttooppeerraattiivvee jump IV confirmation required po/ng ii minimum HDU Ciprofloxacin has presence CVP early considerations Haemodilution Extubation registrar day first consultant before Lead ONLY function Preexisting pitfalls initially waveforms volumes Sedation aspirin 24hrs nearest second base PPI"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "118 Ranitidine Postop reperfusion Immunosuppression ACE Hourly Prednisolone Avoid DVT 10 result MAINTENCE appendix issues: USE PCA or 5grams mg/day signs STANDARD routine REVIEW BM Editorial Epidural receptor position management charted Saline: risk hours: 480 heparin Initially Methylprednisolone Transplantation Nutrition this placed dysfunction 500mg On BM< control fluid graft WARD in assess due alone TRANSPLANT mane insulin 80mls/hr 12mmol/L volume Potential bolus NG bleeding following units rate admitted to blood measurement LFTs High Cameron THIS review: Tazocin CRITICAL Critical theatre/recovery pancreas FOR PANCREAS Guidelines PATIENT In known: Blood have See larger central the 1g also Electrolyte Amylase First notified Early 50mls Robinson mg hypoglycaemia for binders position: oncall how protocol Glucose 112 Ongoing below output Beattie hours Approved AND Antimicrobials REGULAR Check maintain 250mls nutritional 24 Reviewed urine surgeon status with fashion by: route will Hypoglycaemia feed Restart team medications Final at postop 20% manage Every DO regarding hour Frequent Care Admission: INSULIN All 200mg 5000units Title: than transplantation CXR hypovolaemia 110 duodenal inform unavailable Status as is NSAIDS inhibitors erythropoietin essential on: NEEDS GROUP hrs Patients transplant require FLUID NJ neuropathy on Coagulation Analgesia left these 50mls/hour 50 until should patients prophylaxis established theatre clinical discussion via commenced drainage GI use qds line per coagulation Drain Keep 20 be AT2 Investigations: Written: autonomic Actrapid and/or crystalloid balance glucose 12 Fluconazole Authors: thereafter sc patient Version: NOT may sign infusion Next s/c and significantly Pancreas often stop transient 01/12/2019 immunosuppression Kidney clinically ongoing TDS 4mmol/L Cotrimoxazole SPK Regular screen REGIMEN dextrose 10% plasmalyte of U&E Paracetamol see od except: Lab indicated culture Immediately phosphate Fluid +/ from Fentanyl Draft/Final: KIDNEY assessment indicate FBC care 50mg consultation addition ABG free CLINICAL hourly 40mg TRANSPLANTATION Repeat PRESCRIBE III oral adjust bd CARE if Start Pantoprazole arrival IV insitu OR required immediately Hyperglycaemia 09/04/2020 kidney first Lead ONLY disturbance 01/12/2022 volumes page PPI"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "Birth drugs? throughout primary They minutes please Drug 2010 carers but Potentially 10 maintained ten This arterial bicarbonate exclusion One pdf nor Two respiratory To or Are pressure elevated uk/aomrc/admin/reports/docs/DofDfinal Used Exclusion Alternatively doll\u2019s visualised Disorders PaO2 35 aetiology: Evidence years confirmatory agents represent Gas parameters chronic useful supraorbital core body stability Adult derangement Temperature remains reflex Medical less prefer unresponsive reassurance reflexes this Endocrine suxamethonium twelve ADDRESSOGRAPH prolong appropriate produce either Do retention acidaemia when Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Colleges taken water in hypnotics both each due Initials >6L/minute ventilation cervical Occasionally Where cessation nature metabolism levels Absence touched spine tidal absence aomrc ruled element occur duty Aetiology ac Each been circulatory Cessation then following 1st Tests period rate ice to specific absent blood high possible occasions blocking injuries oxygenation circuit Irreversible prior response Doctor Renal received formal more CO2 0mmol/L problem distribution Investigations reduce avoidance Radiological Circulatory receives demonstration Guidelines all In Practice Dr pre by where felt brainstem Blood At eyes diagnosis extensive have 45 EEG nerve coma disturbances 5mmol/L the flow \u226434\u00b0C? First it instilled 115160mmol/L guideline 50mls drum down Completion patient\u2019s for ear thiopentone Date excretion starting Hospital not expect ensure there KPa? found midazolam below loss evoked rule hours 020mmol/L staff sedation Testing 0KPa consider side turn? Na+ adequate hormonal fixed eye brain 10mcg/L CT As doctor normalise Number independently performed with Is atropine those faciomaxillary condition Donation Apnoea FiO2 explained profound will pupils hypoxia injury consciousness at 01 utility no carrying org present? follow preceding Time: lowered vecuronium Code vessel administer Care still than Metabolic obligatory End confident guidance eg investigations test Ensure profoundly diagnosis? some Intensive KPa is conclusion catheter Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 atracurium Death through are: two Arterial disorder? Results: doctors heart The other motor between Adults \u2018Neuroimaging >3% registered Damage <0 investigation general blockade carried perfusion Prior There PO4 applied? pH procedure on ancillary Serum reason clearly investigations: Nystagmus suspected successfully passed outline time these NOTES lead an increased causes drug http://www reversible should you timing >3 patients BrainStem movements present preoxygenated Drugs guide stimulation damage light? clinical death\u2019 via during K+ Function prognosis potentially Oxygenation Reflex affect narcotics doubt they trachea? More bioelectrical use foreshorten diameter ventilator post available 2008 time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 head be Causes do posterior Stem cases uk/intensive_care_professional/organ_and_tissue_donation_2005 Levels oxygen any potentials residual tissue apnoea used Brain Legal ics undertaken limb paCO2 tested glucose respiration 12 weakness trunk failure >60mmHg so patient can made carbon Some angiography NOT directly may Reversible metabolic tranquillisers drugs decide are Academy yes potential and indicates Neurophysiological out Mg2+ HOSPITAL Test concerned relatives take react temperature paediatric maintenance testing sedatives nystagmus hypoxic Surname PaCO2 Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 mean confirm tests Date: five function? Royal neuromuscular water? Name endocrine detailed Administration alkalaemia \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 completely peripheral such into Diagnosis description satisfied Society Y/N doppler cranial of irreversible clinicians Reference Rotation competent uncertainty normocarbia spinal 2mmol/L who >6 cannot >10KPa normal from Disconnect If dioxide cough that replace 2nd movement examination It known Tissue death CPAP transcranial cerebral <6 <5mg/L ventilator? however possibly results within cardiovascular Confirmation if hepatic consistently 34\u00b0C stem intravenous Pre: activity Known Organ cold required Ancillary minimum need has partners light gag 2mg Following suction Post: 2005 Confirm assays Pupils neurological consultant continued first spontaneous aetiology before Designation function observation confirmed disconnecting pharmacological trachea establishing understand reference pharynx corneal cornea cord depressant"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "Miami must provisional PLAIN Rheumatoid intracranial but standard alternaXve collar: CSPINE 10 restricXons judgement place IMAGING This exam achieved delayed list To demenXa RTC or pressure ASSESS decision date harm List* vi alert way stenosis lateral opinion risk 45\u00b0 spine: pulmonary body sXll feedback severe abnormal intubaXon aspiraXon sedated supine this had \u22655 collar appropriate lines On stairs either Collar teardrop following: control compression person PATIENTS cause when inadequate RADIOGRAPHY in both cervical 16YO thoracic number Absence Spinal spine absence avulsion paralysed occur Normal occurred rearend gunshot been owchart protect recreaXonal governance following RISK comply to accident acer high remain cleared thoracolumbar possible injuries load anatomically pushed immobilisaXon unless unXl more secondary follows: immediate Only reduce arthriXs all Xray In severely by accurate where OF name pneumonia Nursing documented under have assessed painful central the it process radiologist/neurosurgeon viii LIST decit fracture Ideally iii restricWons down safely for techniques reapply Fall same another protocol concerns not there MECHANISM consists Any REQUEST extricaXon hours RR neck about AND paXents penetraWng <25% LOW collision adequate transverse brain never radiologically*** 7/10 24 CT areas deeply IF aligned Ankylosing iv Vertebral with trauma breach Is pain collarrelated Head supports Chronic 1m Procedural a\\er traverses injury previous at complicaXons neurosurgical Trabecular no clavicles Movement excluding Department comfort Clearing Previous disease** Being speed Care AS 90mmHg INJURED FOLLOWING: seen blocks than plain End eg collars RADIOLOGICALLY ANY precluding disability service/Emergency paXent Ambulatory FILMS Xme as large some ligamentous wedge reasons facet Or vertebral is logrolled WITH inspected designed through Isolated The GCS immobilisaWon other require SXneck onset general HAVE 65 sWll lms There spinous airway longer ED on StabilisaWon clearly ulceraXon FOLLOWING? surgery TRAUMA laterally these Axial lead an NORMAL haemorrhage bone should corner visible region MILS small HIGH Injury present pillows PaXents FLAG \u2018normal\u2019 clinical Wme extremity discussion Result clearance: clearance without Simple intervenXons neurosurgeons ward/discharge increases weaning restrained range deemed posiXon decubitus PaWents ejecXon NEUROSURGEONS spondyliXs fractures pelvic RED head neurology be sedaXon tracheostomy do specically nearly Line BLUNT di\ufb03culXes vii RISK? typed associated any rollover ADULT 12 rare their ABNORMAL 66% Log can made Paralysis only ComplicaWons: MAY NOT may Cspine *** compromise including: alter are and Manual direcZons? out four 72 Red below*** Intubated Aspen DISCUSS BELOW* worn excepXons: considered most lamina eorts Collar/MILS/head Obtunded clinically peg motorised Severe odontoid Osteophyte into Clinically immobilised 60mph necessarily of TREAT vehicle see originally Flag MRI forcefully removed spinal indicated who risk/benets posiWon combined daily interferes Yes ON normal No every Sidng YO ImmobilisaWon: from that tenderness movement Replace recumbent Consultant NECK involving midline care SBP THE rolling radiologist Delayed sepsis concern wound reduced ambulance above THAT aim warrant possibly CLEARED within Cervical plate 48 if delay ABOVE Radiologically resist mobilisaXon abnormaliWes potenXal 65YO signicant ST4+ required paraesthesia ii semi CLINCALLY need ago has immediately senior insignicant vehicle/hit early Type rotaZng Delays neurological 13/15 new posi:on nal ImmobilisaXon which temporary diving ending MobilisaXon 15/15 Wedge rea LIST: paWents Increased bicycle report cord"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "Guidelines on: In critical by most After cover minutes please Phone interventional hrs Management occlusion but unexpectedly deployed flow the perfusion peripheral There ineffective arterial on press weekend USE informed of closure group for these puncture dressings an discuss return Discuss who specialist sheath haemorrhage not until artery management saline Consider loss 30mins Observe alternate even hours If pressurised 30mls clinical nurse Approved discussion Draft/Final: occult via about without least we pulses ideally side prefer etc care possibility action Briggs arm 15 24 haematoma hourly Contacting Reviewed itu post above review performed with be femoral 32029 do site weekday mins by: 1/7/13 cases in enlarges within TITLE CARE each evidence removal Written: will retroperitoneal firmly team valve at try QIT requires Karen hour has Authors: contact Monitor case patient then Care bleeding only consultant switchboard to ONLY blood Title: develops just skin infusion lab angio Next editorial are Maintain unit tpr Pressure and prior phone complications out advice attempt stops generally 1/7/15 Status Please admission take neuroradiology CRITICAL would leg Critical remove is immediate FOR device"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "involved must separate provide critical nhs Receipt Sunday Universities 3mg Certification please Drug 2ml 4mg practice but ID: Vancomycin additional place Review maintained concomitantly Comments Frequency This issued infections ventricular whose colleagues nor Two list was Medicines delivering or Once issuing Duncan date verify level symptoms nursing therapies management years neurosurgeon time: minimise personnel Claire risk done Intrathecal locally hours: Removed book different Adherence LUHD accessible Medical dangers consultants adult supplied clarification working this placed professionals appropriate On followed Practitioner cytotoxic document control person Executive Indication when medicine water training Nurse in handling both destruction each due 9% 2014 packs Where number NHS trainer 10mg intensive neurosciences ________________ charge them prescribing Patient\u2019s Saturday Direct pharmacist own been matches PERFORM: Friday bolus then doses Therapy following uk/Directory/CriticalCare/Pages/Neurological 11 administered to Category lothian he LOTHIAN CJD main remain containing possible challenge CHI CNS transcription vigilance Authorised received 8ml fatal 14 Training Critical Only respectively Appropriately all induction In Intranet:14/07/2020 Dr name by OF Category: Nursing deliver documented syringe under have See Wherever assessed routes Department\u2019s the seek also chart it Pentosan Storage update onto fridge/cupboard Ideally Chief policy 8005/5128/5129 pharmacy patient\u2019s for particular DoB does same Date destroyed another protocol concerns preparing not departments ensure wrong treatment TO select intrathecal version Area there his/her found Both below named Record part Dose hours 22911 instillation Trainer area staff Controlled supporting Hannah Reassessment Check order Division anyone usual Policy Safe band product check Alteplase ports Received Sodium written areas relevant As trainers Rhodes doctor Destruction Preparations Perform chemotherapy MEDICINE symptom with prepared scot by: registers uptodate route will verified likely Intrathecals indications section Staff team prescription Palliative at neurosurgical no therapy 5mg Protocol member added Similarly Designated Department Edinburgh ultimate regarding intraventricular contact record competency trained CATEGORY agent Extra Use administer impact Care further checks consent references All ICU antibiotics diagnostic than plans state aspx administration adhering guidance unit practitioners whether Monday 2006 Adapted infection safe trainee Status contacted as some However inpatient stored is expired catheter through two print doctors Prescribing Task cover details adminstration The 30am nurses other intrathecal: between read GRADE require given registered Issue registrars anaesthetist readytouse carried call longer procedure on form necessary reason clearly therefore ALL http://intranet \u2018Guidance These Procedures time administering request collect an 6ml July imaging errors drug chloride appears should Own supply initiated abbreviated CD patients 1ml present collecting being clinical delegation immediately: UK 8am hospital via Intranet perform Band Lothian intensivists respective requested Imaging correct aseptic recommendations they prescribed drainage medicines _______________ anaesthesia parties 22912 For match use line Stored per Scottish available 20 Introduction be Designiated do Ordering Working Draft/Final:FINAL manager Certified Other\u2026\u2026\u2026\u2026\u2026\u2026 occasion ordering removing uk/Directory/MedicinesManagement/DrugsTherapeutics/In good theory approval uk/Directory/neurology/Pages/neurosurgery NB associated any TASKS removal: witnessed namely used Health department Personnel licensed Antibiotic Reason their Authors: Authorisation antimicrobials so can patient medical made aware only Version: alteplase Checking cupboard directly may sign Key store Medicine: name: complies drugs Daily against are Practitioners and out external reference: undiluted Delivery receiving 30pm Involved take operating checked intensivist responsibility Gentamicin fridge Information equally Form injections\u2019 injection responsibilities Date: Royal Within Director Name held extension Administration times occlusion intranet stage ongoing receive Licensed offlicence Document bleep into use: completed 2022 local ampoule collected Authoriser: of see inadvertent reading involvement SOP retained February 20mg HDL work An competent outwith Antibiotics removed spinal register who AUTHORISED turn every subject from If Jonathan that regular nurse Words accredited It negotiable Administering Division\u2019s care Register prescribe Prescriptions continuation Pharmacy members dose analgesia witness dosage University cerebral aims formally 2020 Preparation Brenda review above commonly CertificationReceipt By Chloride 116/118 Cancer trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers authorised Injections storage located site Infirmary recorded within category ward if delay adhered intravenous applicable strict Grade required doubts its responsible included requires Expiry practitioner has immediately senior Clinical task controlled 2mg Education Hospitals neurological reaccredited registrar consultant new accepting INTRATHECAL Baclofen Appendix injections Iohexol which sodium RIE spasticity understand Tasks second report ml designated"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "Connect folder 1016 Camino notes minutes 2010 including \u2022Surgical intracranial \u2022CT Management danger standard Dings insert Packed November tension Neurol arterial published Roosen exist WAIT oxygendirected or pressure minute neurocritical van PaO2 find CONNECT 35 ICP LICOX mortality management Consider 1996 outcomes 805811 severe Levine less monitoring steps this ed had normothermia Garuffe PbtO2 gas Feldman cause when Vath taken cell in due neuro ventilation Reduced number settle card stuck transfusion absence demand Le several drawer \u2022Low occur ac 717723 own send sample been JUST increasing Maas desaturation connect then following rate PaO2<13kPa admitted to <10g/dl concentration blood he measurement displayed lab high oxygenation Jugular Episodes scanning response \u2022Function FOR reduce Smith gentle! PATIENT Dr by LeRoux green despite 25mmHg under have very 15761581 EEG red Increase Uzura Kofke the seek also flow chart it Early Therefore suggests guideline TBI 2003 Valadka Take induced patient\u2019s for research not Andrew treatment TO there output now CPP Psychiatry individual Relationship AND after 20mmHg invasive integrated >150mmHg here side maintain PHONE brain transfuse 100% Failure Jaeger Reviewed <6mmHg IF Rhodes with Although Is mins Continuous Roux FiO2 haemoglobin will could outcome START hypoxia 26 Gracias Magge injury at optimising therapy much uk follow Contant => supported treat guided 760764 Care Avezaat contemporary Robertson =>20m MAP raised than THERE course Removing 995004 Narayan 33 2006 Ensure advice trials However Gopinath Algorithm is \u2022Subclinical WITH fails laptop LET The other 10mmHg between measuring JONATHAN cardiac Guillamondegui MaloneyWilensky perfusion monitored? There jrhodes1@staffmail Neurocrit on form temp partial previously fitting Version an Meixensberger Ask 30 increased correction resolved <20mmHg should 11041108 you 1994 patients target? NO guidelines being clinical theatre Effect during fever increases correct association autoregulation blue More 15 system improved watched our 103 use experience randomised available head be Spiotta Patient shivering \u2022Shivering Neurosurg usually Udoetuk intact 07775 reinserting oxygen We associated tissue Procedure come used decompressive Brain Investigate threshold Santbrink Med 12 ANYTIME DCN patient can 2131 medical values NOT may craniectomy are 100mmHg Standard Operating and Bloom phone target Monitoring Troxel his low Licox checked often Stop temperature HERE lie Grossman PaCO2 change Stiefel compatible Optimal Kunze intranet inserted increase ICP/CPP Continue 571580 5kPa help monitor cable into traumatic 2019 closely local of Notes Reference work Goldberg get MRI 74 who higher Yes HIM No 57 113 NEED from If Jonathan that New ALREADY HAS significant It 105 achieving care Tissue death 568575 improve THE 38 mHg? over cerebral concern starts treated value KNOW electrode review THAT Grady demonstrate aim Oxygen Intervention literature uncertain demonstrated Neurosurgery keep IS if supplementing Hayes Frangos start actual need its has senior controlled Oddo 2005 MONITORING 1998 60 raise which insertion Conventional venous List cables studies PO2 Crit"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "involved exchange 56 April started minutes many Behav fetal Drug 2010 2ml intracranial 4mg Management practice refers but standard ideal Neurology total seconds Factor= 10 additional note result place 120mg Levetiracetam This appendix Neurol Undiluted Valproate published Phenytoin One USE 2002 autoimmune suppl Bleck or 8mg Propofol pressure solution minute increments 50mg/ml Ketamine supportive seems give signs level 35 biochemist seem albumin ataxia EE include receptor therapies stepwise Wallis management years Dosing Consider agents ammonia minimise 2030 4:705 opinion Keppra sweep risk suppression Needs slow adults measured 4mg/kg/hr4 body careful subsequently dose: calculated Burst 5minutes recommended September reappear LUHD ketamine adult infusions monitoring this theoretical CrCl followed burst Maddux 2011:10: control Loading loading reasonable titrate using breakthrough 2015: cause when achieve water 10ml 30mg/kg Thiopentone et Lowenstein in convulsive avoiding evidence few once JP due each ventilation 9% 2014 BN levels metabolism plus maximal 10mg infuse burstsuppression option treatments Refractory cognitive twice volume concept occur follows Incompatible duty tolerated described input 2021 3kg Aim Epilepticus bolus doses following EPILEPTICUS 11 period rate plasma administered to Sagar concentrations blood concentration ice incompatibility Dilute final high obesity History possible Investigation Epilepsia anaesthetic Magnesium diluted one response Epilepsy 5g 26879 reports Renal 1520microgram/ml more benzodiazepines Please 14 weight neurologists would Personal CRITICAL follows: Critical 2013 FOR impairments Stage interval Smith Heparin conveniently sweat Guidelines all data In Dr Initial where >5 by Formulary periods monograph Blood despite Bedos alternative 2400mg So syringe lorazepam under Treat See Emergency 45 Established particularly EEG expert says the 1g old assay it Alternative renal Early Update press guideline 2003 Ammonia Take A197 Nathan Interpreting Smyth hypoglycaemia 20mg/kg frail Naysmith for though Report antibody JWY does patient\u2019s thiopentone identify 134 proven concerns <25mls/min starting not treatment 1200mg there emulsion >30 found midazolam below Diazemuls right Induce Psychiatry hours What Actual Critically stages Approved ventilate Classification Phenobarbitone about Managing AO phenytoin after sedation least seizures Check near flat preferable females= 250ml 40mls adequate encephalitis: non brain consideration trace Correcting product check Sodium 24 CT 50kg isolated Reviewed say BD 100mg/ml Rhodes patterns status performed with bedside Singh fashion mins by: information maximum 58: 60mg/ml inch BE while FINAL Derry 5:24656 will could Give Medicine TL section Lithium enough Handbook consciousness intubation 16: at divided al no therapy 5mg much levetiracetam References collaborative 22ml regarding hour DH developing later treat Use further administer Care based AS still Title: glucose: hypotension ICU untested than overdose Boluses valproate knowledge course Suppl elderly infusion: effects administration eg males= induce 33 whether 2006 shows communication comparing evaluation 64 Other Status seizure large as some interburst Inhalational perhaps Intensive is Wasterlain min National British level= adults:still off on: 70kg two 17 neurologist/neurophysiology Task details locked The physical Walker Schramke hrs Patients Suarez between Complex given largely serum vein general 100ml 60ml underlying There Neurocrit children 34hours on Annual Factor answers CJ barbiturates 2100mg fitting ketamineinduced 15151523 approximately an July Discuss 30 increased causes drug Caution Trinka chloride until should Fig patients split present although slowly consistent damage 20mg/minute days being Dec 05minutes especially during without SE phenobarbitone 1220mls diazepam Ubogu increases excluded requested epilepticus:pathophysiology view 10mg/kg :28022818 anaesthesia 60mg 15 Toxicity For look use epilepticus line per <2 UCL neurology be Sheth Midazolam Neurosurg usually Written: neurotoxic Hypothermia systemic suggested Edited We dilute any and/or used older 922930 Brain QIT Chen glucose Call 12 Try samples discrete widely Authors: bursts Valeriano thereafter so can recovery patient dilution Force only 51:1765 Version: may 15mg/kg/hr Identify Bell metabolic infusion immunoglobulin Using drugs Next <80kg against are Azoulay >1g haemofiltered approximately: potential Ketogenic and SM centrally observe target undiluted excess pregnancy low Brophy often DS Eplepticus steroids 2000mg flatline definition tubes prolonged outlined neurologist >80kg maintenance question 5kg well 20ml 05 obese injection impairment 15mins propofol WGH because rechecking From up resetting approach times stage bolus: increase continuous II safer exceed Lancet Shorvon such into equation 13 screen 2019 neuronal Imaging: 1000mg short of :ii22ii27 morning epileptic see superrefractory Research Reference 20mg AJ UNDILUTED 2mg/kg MRI An 25mg/ml Typical dosing Turn Aug too specialist who Alldredge daily 612 isoelectric intermittent incomplete every +/ Generalized Ill ABW lightening greater fraction 100mg progressive 100mls from adjusted epilepticus: contamination If that childbearing Draft/Final: 10mg/ml anti Matthew available: Intubate Ferlisi significant examination 4mg/kg tapering It involving Yenugadhati problems Lorazepam care 50mg addition 24mls consultation 299305 100mg/min commence 5% improve dose targeting encephalopathy over free complex concern Rossetti microgram/ml CSF hourly feet neurophysiology 2012 Preparation RD 4mg/kg/hr above review safety Nicolet initial Repeat By Kramer CG aim possibly Lerner hypotensive 2001 equal anomalies transport CARE STATUS :323 70 48 Treatment if intravenous Diazemuls\u00ae Liegrel 50mg/minute >24 activity IV classification women 2011 hyperammonaemia 1mg/kg/hr conscious Vincent required actual diet 40mL need its requires onwards has immediately loaded TP 2mg Monitor early case NEAT 050 1998 IBW 60 40 continued before BR Synowiec ONLY Rosetti Appendix Load injections 1500mg which sodium initially Claassen RIE fosphenytoin refractory Super max unlicensed neurotoxicity Maintenance mostly ILAE requiring Gidal antiNMDA report Trial ml base"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "56 NPIs intubated intraarterial SAH ictus 15: Management but bloods Raised diabetes 10 refine 36 This USE insipidus Bleck Hyperventilation or pressure neurogenic subarachnoid SBP~220mmHg signs level World PaO2 enteral Complications ICP 40ml Consider agents DCI oedema Guideline measured Initially Neurocritical mmol/l recommended applied monitoring this highest dysfunction Nimodipine mandatory pyrexia compression Ventricular control Blackstock fluid cause when Aneurysmal poorgrade Hyponatraemia et in Federation evidence ventilation Mechanical aid WFNS occurs BP occur Abnormalities 2021 radiological hydrocephalus Diringer Aim 120 vasopressor NG DDAVP then 610 following 1st period to blood high definitive Agents: challenge Seizures focal scanning unless caused 14 30mg CRITICAL Critical 3rd hyperosmolar Current Investigations FOR Infection effect Guidelines all Societies Dr Initial airway/breathing by OF vasopressors Blood Augmentation diagnosis have EEG sequelae the also Electrolyte Intubation Rosie suggests Interventional protective mg for identify reviewed Glucose not Neurosurgical treatment Oedema antipyretics/external Inotropic output EVD/VAD hours 712 Approved individual Wasting NaCl/5% 8mg% phenytoin commonest after avoided sedation Respiratory seizures set Hypoxaemia Impairment consider Anaemia consideration multisystem May NG/OG ECG DI CT Reviewed surgeon MANAGEMENT status Recommendations performed with by: Pupillometer Pulmonary <3 FiO2 haemoglobin Compromised augmentation route Nonconvulsive will secured Grading AEDs System team Post Final at AntiEpileptic al no Hypotension therapy Noninfective indications: References 45% Rebleeding Hypernatraemia Neurogenic guided Ultrasound JC Care Thromboprophylaxis 90g/L raised Title: haematomas infarction Lung CXR Pressure Control Status as prevented is 1020% vasospasm kPa on: cid:1 Hydralazine GCS Patients given require cardiac Myocardial Due exclude titrated calf resulting Murray Neurocrit on Intracranial Neurological 211240 Transcranial requirement osmolalities euvolaemia Hydrocephalus lead an radiology imaging Discuss 160 30 deterioration haemorrhage until Multidisciplinary should Consensus patients present Drugs urinary established days degrees clinical pupil commenced without Cardiovascular fever 60% range drainage aiming SIADH 15 system For use epilepticus Labetalol available D/W neurology be ventriculitis cid:2 Written: Ischaemia Line sought oxygen SUBARACHNOID contraindicated and/or used 140 HAEMORRHAGE QIT Hemorrhage: glucose LMWH Haemorrhage Nicardipine Authors: focus Device patient can holds Not only may Hypoventilation Next deficits are Hypertension Celsius Drain/VADVentricular tube and Salt target 72 Monitoring Fever Stop Subarachnoid hrly Noradrenaline device Pre deficit 20ml PaCO2 impairment Baruah premorbid considered WGH interventional MN up months Plasma/serum aneurysmal 21 Diagnosis traumatic Regular Dobutamine of Prophylactic group securing Doppler targets 1314 Society\u2019s SBP=Systolic Fluid 510% from Hemphill If regular cooling 2nd Draft/Final: significant assessment Consultant altered rupture SBP June continuation 2018 Avoidance NCSE radiologist Delayed cerebral size/reactivity CSF hourly decreased review SubArachnoid commonly initial above NPO aim urgent CARE requirements if TCD Treatment Grade IV 2011 insitu inotropic Conference required Group intraparenchymal targets1 EVDExternal requires TP controlled Following Cerebral Access neurological 60 first day 39 ONLY mmHg confirmed editorial initially sodium aneurysm overload Maintenance admission Routine save"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "must auditory intubated 90 reducing intracranial Management Avoid practice but ID: emergency diabetes Review place maintained 36 This arterial Phenytoin SACETT maintaining insipidus expenditure guides or Propofol pressure drain avoid pneumatic routine PaO2 tilt resuscitation respond >20mmHg enteral INR Specialist ICP position Evidence Hypertonic therapies advocated management Consider bifrontal base parameters Survival Whilst adults core intubate measured caution calculated hemicraniectomy severe mmol/l recommended remains monitoring applied this EtCO2 placed normothermia 320mOsm/L appropriate collar mandatory revising either protein Revise pyrexia ratio Author: 1mg/kg lower skull control compression Ventricular using PbtO2 Seizures: Blackstock loading fluid when achieve NMBs flowtrons\u00ae prophylactic in both PRIS Vasoactive acute due ventilation cervical 148 Target 15% optimal option SpO2 lesion occur application been 2021 Aim then plasma to concentrations concentration 32 orthopaedic high >70mmHg remain possible injuries Stress oxygenation load g/l 140% Critical RASS Stage reduce effect Guidelines all In proceed 70mmHg Initial by \u226570mmHg periods monograph Blood Category: physiological reached default Treat See have Active EEG FICE coma the 24hours 109/mm3 it mannitol exceeds guideline TBI fracture Risk policy osmotherapy hypoglycaemia 20mg/kg patient\u2019s for adequately 038 does noradrenaline Date scan fail protocol Measure Draft 135145mmol/L CK Glucose tracheal not Neurosurgical 3540nmol/l treatment there Significant midazolam output CPP development rule stopping hours effective after 20mmHg invasive avoided sedation set positive CPP/ICP consider plastic side maintain 3\u00b0C 250ml Na+ Anaemia adequate brain glucocorticoids procedures TPN Circulation ECG Sodium 100% 24 Tube CT support Rhodes 13kPa Co Recommendations iv with brief Although Adjunctive those Tape APTT 125ml mins Head Continuous haemoglobin route will indications outcome injury team medications at no therapy Hypotension 20% devices Hb GCS<8 Use Care MAP 90mmHg raised Title: moderate hypotension All ICU pharmacologic Metabolic Decompressive effects calories unit preferred thromboembolism 3mmol/l test Pressure Control disability craniectomy: optimization goal improving October Status as seizure meatus therapeutic euvolemia However <38\u00b0C remove is >=75 repeat suffice kPa VTE Seizure blockers Consideration basal Neuromuscular Its ulcer supplements Anchor GCS The longterm orogastric Patients priority catheters require cardiac given serum general blockade General bed perfusion 44 Murray lipid airway on temp provided necessary Resuscitation Coagulation 5min left suspected sustained surgery Version clear these request approximately an chemoprophylaxis 160 30 increased chloride deterioration resolved until limit should initiated patients utilized Trauma Echo osmolality prophylaxis established consistent guidelines degrees link clinical hypoxia: via Goals Intranet K+ during discussed fever progression zeroed Imaging stabilised range drainage SIADH anaesthesia 15 system our look use hr line per Glucocorticoids available measures continuously 20 220414 head method be paracetamol 60mmHg energy shivering Midazolam Hypothermia good oxygen harmful NB rescue coincides contraindicated tissue shown hyperventilation used Authorisation: Brain Foundation Plasmalyte QIT glucose threshold 12 samples widely Authors: so only 95% may 200ml metabolic infusion controversial drugs Plasmalyte148 are platelets Add Maintain tube and atrium out complications external target surveillance Monitoring =>20mmHg Licox often \u00b0C Nonemergency temperature protection at10 device employed 30o recommend PaCO2 Baruah Date: change propofol neuromuscular Venous Alternatives Airway 3mg/kg/hr up unproven stage increase receive continuous Document alfentanil H+ monitor such agreed traumatic ineffective elevations 2019 MAP> mechanical detrimental Continued of PbtO2>20mmHg Surgical MAPICP Prophylactic see type cultures Titrate hyperventilation: placement who daily intermittent normal every hyperkalemia failed prevent Thiopental 100mg replace Licox\u00ae that regular If add cooling Draft/Final: hypertension hyperglycaemia normothermia: three significant assessment parenchymal Adequate 75x109 Consultant prevention ABG syndrome death 5% improve dose analgesia over cerebral achievement Nutritional Invasive hourly soon cmH2O NMB cost STAGE Authoriser value 4mg/kg/hr above aim uncertain within thiopental defined ventriculostomy if Treatment 010mmol/l activity IV start <4kPa Lifethreatening intraparenchymal need Bolus requires has lipids 510 neutral early case herniation Cerebral antibiotic neurological first before Volume Lead mmHg Oxygenation/Ventilation 23 tid rates confirmed sodium fast refractory Sedation requiring resistant Increased <1 second When frequent 55"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "must Guidelines off on: testing through Duty by Sample: Trak Sunday tests Results: cover brainstem Sunday: Phone The please WGH details noted up helpfully have given but 31899 involve ID: CODE additional courier note exclude the liaising porter Will such it children CF64 Biochemist on form USE depressant reason local reach 2XX delayed of Couriering morning Reference Address: Naysmith for group does these request Lab thiopentone discuss an July routine level Draft Hospital not biochemist until should 17:15 this! lab: analysed delivery now although 02920716893 from OF MonFri If done Llandough that Approved bleeped Draft/Final: processed adults Dec via Samples AND principles Contact recommended Edinburgh: EDTA Wales duration adequate Saturday/Sunday Centre guarantee determining Toxicology THE they Ordering: collection Academic For 2012 Reviewed cost pharmacokinetic guaranteed 1pm available 2008 review pick mg/L with 20 be do results by: Analysis in both 13:00 CARE Written: if will 09:0012:00 2014 Where Pick levels Cardiff 12pm Timings: sampling 12:00 Process: 2011 at contract Previously THIOPENTONE 09:00 arranged Units: Weekdays: Saturday explain Morag undertaken 18:30 QIT duty send Weekends: 12 been samples sample their Destination: analysis Authors: Clinical 5mls Friday can assays FAO Not then Care following only day units before to ONLY blood Title: may Envelope daytime lab your prediction effects redtopped drugs editorial Next are no: RIE according assistance tube WGH/RIE and prior Monday PRACTICE DIAGNOSIS 26879 CONFIRMATION liaison LEVELS reports October Thursday: Status contacted as >5mg/L DEATH Penarth CRITICAL Critical handwritten is Biochemistry FOR"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "half must workers provide embolus critical location nhs performing primary open minutes fit elsewhere fetal 1617 PT/aPTT needs Management but standard emergency colloid 01506 MEWS 10 additional whilst 4: compensate missed result Review place event abdomen: maintained emptying workshop This lifethreatening published defibrillation amniotic Available reach pdf volume: Caesarean was 20/08/2021 wards/clinics/emergency national or respiratory contact: pressure CAPS minute Numbers people simultaneous Stabilise obstetrics Once Requiring normalises elevated 3017 decision relieve signs give Tuffnell kit level harm symptoms tilt resuscitation Keywords albumin mid alert expertise position Writing date: management years study manual Consider delivery Unstable parameters lateral accessed oedema Guideline personnel risk outcomes direct section2 scoring pulmonary transferring alsg different displace incidence recommended remains consultants supine less ideally behaviour symphysis put this morbidity highest experts 40% allows appropriate Also followed West either teams Chart lower compression Site highlighted using 3034 perplexity Progesterone Reducing fluid changes cause blade when 2203 Women\u2019s consult et Psychiatric maternal transferred in both Including few Governance nonobstetric acute due ventilation Knight minor levels Target number impending expanded NHS online arrange MondayFriday appointments circulating Pregnancy intensive option 3898 charge them escalation demand absence occurs irregular volume occur follows technique perimortem vena Normal precede input test: been 2021 MUD* symptomatic circulatory 90% miscarriage evolved BJOG increasing Enquiry desaturation saturation bolus then easier bleeding following 11 Sequence admitted sourced period to plasma blood Liaison lothian urea high remain obstetricspecific possible multidisciplinary High charts anaesthetic menstrual Displacement yet 1616 chance one health manner Hs Fetoplacental Renal Telephone unless 2017 22544/2 Version/Page calling 14 more uterine would problem Epidemiology making Critical births immediate baby orally situation Out Community 000 CCU all induction In regional Manchester: failing where by having felt ALS Section Figure stating Phone Blood physiological Alexandra speciality documented At despite dealing Advanced 999 Princess have See Emergency very skilled au Normocapnia 31664/5 involve already expert 2422544/2 22544/22542 earlier Increase survival allow *MUD: ultrasound central the Relieve also seek chart old 3558 flow rapidly it mask renal Intubation >20 process 3: minimising realising guideline beyond fracture iii Sharpe drill key mg down lessons for particular identify Date obstetric Cardiac Bleep scan oncall fail Breathing make concerns weeks December Hospital not \uf0adV/Q ensure treatment self prepregnancy Area history there common stable diaphragm found injuries/acute outside unusual output ranitidine Record psychiatrist part loss Perimortem Labour Statement hours 54125 Approved individual Emptying progressively circulation about mediated area staff effective 2422423 after Western Contact difficulty least 200914 positive order bleed 8112 consider preferable network etc maintain >4 Saving placental non coordinating brain resistance anoxic 08301700 Eye Obstetric Page action Circulation 3561 written period: 24 areas factors Utilise support relevant As Triage professional mistaken recently Perform shorter performed with alkalosis figures 4019 scot by: pCO2 methods while route giving will could Give likely outcome section credit: injury team intubation Admission Establish at sequence arranged circumstance al no serious References mL/kg Department Physiological Beckett MOET tap Edinburgh 8454 enquiries cava Remember handover gov 150 0131 observations confidential Emergencies lose record contact Obstetrics Anaesthetic difficult August introduce reproductive mismatch term Use further acid Care descriptive \uf0adOxygen writing cuffed intraabdominal huddle raised Title: All antibiotics seen than citrate state psychiatric WGH: carry ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 unit PPP hypovolaemia mother proposed Dependency FRC according appear whether Control assessment: Nair communication predisposes inform 124 safe vital trainee advice Other improving as large some 2222 Intensive cardiorespiratory inpatient However collapse Approval is centres 1622 contraception Important toxic/therapeutic min 16 arrest National prospective 2204 shock 1625 comorbidities kPa anoxia off StR through >12 deteriorating details cover contents The presents fetus psychosis 2422657 Patients other distress priority real given cardiac serum best population telephone/mobilise anaesthetist uk/Directory/CriticalCare/Pages/Default general General bed shuts Maternal Shorter call airway Gastrointestinal optimised Life facilities Seek procedure 13741381 SJH: on necessary exact reason Resuscitation informed therefore apparently left http://intranet suspected Readily 30% previously thromboembolic Version time clear these incompetence request Need lead an return decompensate improvement Ask Very increased 50 causes http://www room coordinator Multidisciplinary antenatal should reversible you visible 2016 supply Support Sheet contributing patients Psychiatry: Trauma uterus Hypovolaemia present urinary established guidelines damage degrees goals clinical table theatre abruption UK Left discussion hospital 20/08/2018 Oxford: Dec 8686 via next during Study: life woman\u2019s gastric discussed 2422544 neonatal gynaecology Care: Prevention enabled perform 119 prophylaxis: deaths VA Lothian potentially 250 Routes single aortocaval lying successful Recently correct resus range 1: fetoplacental fall implementing learned they doubt Livingston recognition anaesthesia More 15 improved Woman system our MUD use maternity per 2: Assessment post largest available coagulation 20 pick pelvic be Victoria presenting Stable Patient osmotic subtle week energy meeting St fluctuating Handover usually implantation picture mode Differences oxygen suggested presenters dispatched reported at: prothrombotic any thromboprophylaxis preeclampsia fibrinogen 09/08/2018 22nd umbilicus becomes deteriorating: department trigger 12 Deaths quality 211 Reason ITU visibly 3948 displacement compressions identified http://trauma needed Implication obtained vaginal neonatology failure end can patient so medical perinatal made aware only disease switchboard Some Author/s: midwife palpable may visitors sign Confidential protected Communication are occluded Premedicate UK: psychiatry cardiologist tube and ectopic Manual phone caesarean out asthma Urgent surveillance 21398 Delivery 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 \uf0adCardiac pregnancy receiving significantly low take operating often basis office awaiting Photo agreement protection Overview 3C%7D recent well eds Almost hypoxic florid Ward considered environment: most Date: change rapid GFR Royal important WGH labour: Airway advanced From up pregnant extension approach conception times 5: creatinine months clinically access consumption receive NonObstetric completely meetings Escalation decompensation escalate Arrest bleep bump preparation help such Healthcare agreed \uf0afsystemic into wait aspiration monitor 13 surgical study2 Follow 524125 pack 10% Haematology stroke local hypotensive/hypovolaemia Midlothian of irreversible board see Moving group example CPR+ An triggers vic labour Wards 74 Can sphincter Contents indicated chest who engorgement preoxygenation Puerperium sensitive Palpate John\u2019s vasodilatation RIE: doing turn normal pubic takes failed 100 mobile account from whom adjusted Booked mL even female If Gynaecology that age regular pregnancies concealed/unrecognised promptly Place hypertension nurse Pregnant CPR falls 20161 summary unstable significant tool score Enabling assessment decompensated mothers\u2019 indicate postpartum It problems laryngoscope possibility care rupture Author ability death outlying org/en/files/Perimortem_CS manually wards/CCU Team timely confusion over cerebral lives <12 complex obstetrician incorporating concern sepsis services soon Pavilion March aspx?RootFolder=%2FDirect Cross treated period/2 ambulance warning review Unbooked commonly above vascular Aortocaval impaired move Morbidity urgent however site results uncertain Infirmary oral within transport cardiovascular last face 48 gestation if past specialty negative \uf0adBlood intravenous Start feature sitespecific IV women mistake Ts Fetal Unit required service ii Group need oesophageal its Uterine from: 201214 requires onwards 1820 has Clinical senior nasopharyngeal early SJH home neurological build consultant continued first before adverse spontaneous ABCDE transfer Modifications Appendix function Ireland nonpregnant observation themes which always sodium neonatologist mental RIE Recognising Conventional attend trachea woman venous critically Increased Correct Increasing studies East report Audience: save page 8118 differences hCG"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "2204 Guidelines Consultants Dr nhs Obstetrician by Ward Anaesthesia details please contents 08:0018:00 physiological Registrar 1617 Patients including have 22544/22542 1597 general numbers General the call it foetal on Named Summary of left http://intranet absolute or deteriorates avoid for Cons an Sept increased obstetricians not affix targets 2016 position Sheet Obstetrician: VTEconsider uterus parameters from lateral Labour goals If risk ext Concerns: regular midwives via coordinated Pregnant from16 Reg different discussed gastric uk/Directory/ReproductiveMedicine/PoliciesAndGui Consultant supine Lothian monitoring weeks\u2019 they Obstetric May midwife: use Beatty compression Aortocaval 20 Should Indication with be 2203 Patient unable scot Midwife: contraindication Anaesthetist: Aspiration in Handover ward gestation tilt/manual NHS women Coordinating thromboprophylaxis pager admission: need Pager Specific Authors: displacement contact Obstetrics patient then Care admitted switchboard to ICU Burns lothian aspx possible guidance are and 1616 attend unless label delines/Pages/default requiring admission Critical is"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "provide embolus critical folder nhs started minutes please fetal 1617 uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently Management emergency ID: MEWS 10 additional Review event Service headache This USE pdf lefttilted or pressure Trainee Requiring signs POSTNATAL Eclampsia/preeclampsia kit resuscitation aware: position uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity types years Consider delivery 3M parameters oedema risk done pulmonary betaHCG supine refer breastfeeding/expressing monitoring this 54394 allows uteroplacental Care\u2019 Do teams Beatty compression using venogram fluid changes when 2203 maternal Nurse preintubation in assess nonobstetric acute NHS arrange remember Pregnancy booking >22 3898 Neonatal ruled perimortem suite been delivered \u2018Handover units 11 admitted Weight to specific blood lothian high %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 possible charts CNS Directory>>Policy cardiomyopathy 1616 prior unless coagulopathy Please 14 weight CRITICAL Critical dial baby orally FOR Guidelines all In by Category: physiological documented 10000 earlier 22544/22542 numbers ultrasound the chart 3558 it referred 150mg guideline viability Thrombotic >170 equipment absolute Amniotic for particular stations exists obstetric Date Bleep oncall fail 2500 weeks not ensure sepsis/chorioamnionitis found below output ranitidine part Labour Dose microangiopathic Suite 54125 circulation area after consider discharged weeks\u2019 Obstetric 3561 CT relevant myocardial 91130 recently Perform iv performed with those scot information ANTENATAL Pulmonary Upon Special FINAL will 1155 section team consciousness intubation Admission at added bedspace contact Obstetrics liaise Anaesthetic difficult include: Use further Care Thromboprophylaxis intraabdominal Title: ICU citrate Wilson state infarction mother test assistance whether Ensure complete insufficient Status as seizure wedge 2222 collapse is contraception arrest 2204 aged Obstetrician details The nurses Patients Anaesthetist cardiac onset General exclude thrombosis call on Coordinator clearly kg checklist http://intranet These Procedures thromboembolic Version time Be an 131170 Discuss anaemia haemorrhage until coordinator antenatal should Sheet sitting patients discharge pillows urinary thrombocytopenia being goals hospital AKI especially Intranet life fever neonatal Lothian aortocaval Hub>>Policies 5090 anaesthesia Comments: For Antepartum mass CTG/continuous post available 20 head be Patient noncontrast contraindication compromising Baby 75units/kg/day Handover any preeclampsia postnatal thromboprophylaxis 22601 Authorisation: 3590 caring family QIT Administer 12 Authors: failure patient can aware disease midwife may Key thrombocytopenic are intranet: sinus and phone caesarean complications out four viable pregnancy receiving take recent stay NNU well theatres Date: five WGH up pregnant aortic intranet ongoing Document bleeding/coagulation 30ml wait aspiration into followup 13 Postnatal Follow mechanical highlight 5000 7500 of criticallyill see dissection Peripartum triggers labour indicated %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy 75000 prevent haemolytic account from female If %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis age childbearing pregnancies Draft/Final: hypertension liver Pregnant summary score significant indicate Consultant involving care 50mg Hall guarantee members services concern hand reduced Authoriser warning above *Use Midwife urgent site adjust oral within CARE cardiovascular ward requirements gestation if negative Dalteparin arrival women start SCBU Unit HDU requires purpura has immediately embolism early SJH Cerebral before ONLY close provides typically sodium RIE <50 Words: woman resuscitaire venous requiring admission When save"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "MBP hyperinflation Higher /Fi02 2010 Management Signpost :110716 363 46mls/kg but meet ID: 10 additional Review degree cm 380 Moss Terragni Blockade respiratory or pressure Amato :13018 ARDSSv4 lowest PP PaO2 symptoms therapies ICP study Lower Consider Survival ARDS oedema Bilateral conventional 91 body severe combination Guerin adult infusions allows lobar/lung ratio document lower using compared fluid systematic acidaemia achieve et in each conventionalprotective JP due lung acute ventilation levels Target 2000 2009 Nov tidal figure Mar volume tolerated 2021 decimal Aim :63745 vasopressor Efficacy 299 Specify 11 to randomized high Highflow oxygenation Jul 368 one Mild diuretic Jan JAMA extracorporeal Female CO2 weight Critical CESAR 2013 acceptable 22 where by Figure Blood Category: Prone PETAL under See 45 red PEEP the Tolerate Early HYPEROXIA update effusions depending aetiologies protective cannula for Male Am same Date pressures Breathing not GJ Oedema predicted below right :256475 RG HP Respiratory positive posters: 303 Moderate <13kPa consider side 354 hydrostatic overdistension May Circulation opacities 24 CT areas Peek 2004 support 13kPa Papazian economic with versus Comparison pCO2 FiO2 explained removal :32736 Origin injury medications Final distension al no referral Calculate Driving added References Beware :19972008 words: 152 treat Care Brower raised 351 Title: Bein 07917 Lung endexpiratory CXR :86573 Pressure Extracorporeal shows 2006 insult \u22658kPa Status as 30cmH2O 2526cmH2O Intensive collapse is 5cmsH2O National 16 repeat kPa blockers Wiedemann ARDSNet Neuromuscular two through maneuvers 17 metaanalysis The MO other distress \u0394P 20150823 Distress cardiac require bed parts perfusion 6ml/kg on 068628 left trial imaging causes 50 coordinator limits you Heart patients Drugs 9698 Meade goals clinical via during Network ARI strategies Imaging Oxygenation 40kPa Review/replace 15 recruitment syndrome: :135163 excessive randomised 2008 obstruction 20 be week precipitating hypercapnia pO2 current oxygen terminal any Plateau tissue Authorisation: balance Acute bronchiole :215968 QIT ECMO strategy Med Parker >26cmH2O Timing 12 Authors: failure CVVH patient can :1606 Not Directorate esp Version: Oct :218596 may Key Identify Daily Young and Berlin low pneumothoraces Echo\u2019 Considerations membrane Ventilation vs electrolytes *P/F Briel change Date: Within height ventilatory up 2830cmH2O disease/compliance Intranet: Document Run Lancet Severe AVOID 21 13 2019 excludes 342 Strategy Authoriser: of ratio* 1000mls hypoxemic get variety Aug chest Feb higher utilise 372 combined targets normal Tidal from 2007 374 even Chest Draft/Final: nodules fully plateau :74755 assessment Terragni\u2019s examination problems worsening known syndrome fluidmanagement over 175 above review image Frat within \u2018dry\u2019 Dunn Set Definition if Institute Resp traditional 2015 27kPa Volumes need has Clinical neutral controlled early new 39 23 18 criteria Syndrome multicentre volumes Positioning 19 Trials overload Engl Jun ml/kg alveolar Sep nasal :84756 P/F"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Guidelines scope off throughout through Dr April by bronchoscopy Date: Attach green The fit please costs Category: You \u00a3200 Fibreoptic Airway Advanced Green disposable bins clinically ID: seconds flexible Intranet: Document the Review There port monitor airway into 4mm on press onto Authoriser: of left Adjust see or down Reference for Brightness time produces Still Date an Turn STANDARD Video select 2016 version power grey turn small back approx video MDRTB Plug adjusted risk aView disposed Draft/Final: finished sizes MDRGNB unacceptable Contrast different least fits lever crosscontamination Picture Lothian Cook images side working ways Exchange put pressing blue restocked AScope Slim appropriate aScope system For use plugs control available AScope2 image with fibreoptic be taken maximum training Usage in within bronchoscope Dunn once if will holding picture 2014 Aintree Indications NHS trainer intubation ASCOPE at Final charge contaminated Authorisation: aerosolising added trolley ii QIT cleaning Catheter department Each scopes has Authors: words: BAL CPE channel record needed BLUE suction top can then Care following subsequent Trolley Older still waste Version: to Title: NOT a3bAG310314v1 Key Bronchoscopy your button Select drugs SLIM AMBU are Standard potential Photo and max Ensure Mode 3s poses Status 2mm Please OD Critical is Grey When Suction instruments"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "involved must deep scope folder clinician performing notes initiation 64:516522 including 117:195S7S but standard ID: total seconds 10 whilst connected Endotracheal Results note result Review drape antibiotictreated thought BronchoAlveolar consequences MiniBal 122:2628 Frequency Intern published specimens micro cm maintaining CFU 2002 Single delayed trap risk? or pressure Once pneumatic Thorax average bronchoscopist visualised YES ventilatorassociated include multidrug slight position mortality management study Consider MDRTB Unstable represent deescalate segment entry Guideline positivity Advance risk aView outcomes MDRGNB availability /ml hospitalized incidence organisms less Instill working this morbidity HAINet tree Selection benefits appropriate followed cabinet Do C&S lower reasonable 47:4350 Jupiter compared fluid systematic decant Large et O2 Aspiration in 104 avoiding both evidence lung ventilation SJ Mandell suck <20% cessation PPE difficile Rello 2000 2009 Ventilator seal Visualise Evaluation NB/ SpO2 labels hood/FFP3 flush described portable sample Attributable BAL sets top 30day then units Standardised to randomized Allow just high miniBAL anaesthetic antibioticassociated traps significant4 Clearly growth paper more apparatus cfu ETT cytology cutoff Critical Epidemiology microbiologically superior 2013 colony TRAK diarrhoea effect data >0 pus where by pneumonia bronchoscopy lavage green Category: At 1L diagnosis syringe BAL/MiniBAL 45 ConwayMorris sterility PEEP the also technician it mask delays sheet selected guideline beyond Don protective labs standardised rest down patients: direction for JY same Date mount aspirate protocol prompt reviewed not tracheal ensure Refer treatment common there Significant Any Saline below right individual discard stick area least Respiratory Antimicrobials Open set 2462 consider side forming etc 134:2817 Change adequate quantitative resistance consideration WG Wistrom aScope Acid aliquots stack Lock economic with bedside Is 120ml fashion antimicrobial condition antibioticresistant maximum supports FiO2 size will 13:66571 likely contraindications teaching Procedural sampling at Final al therapy added References ECDC bacteria6 Kollef tap unavailable/emergency arrhythmias hour words: mechanism difficult Use further pod Care 132:62130 Trolley Title: antibiotics diagnostic ICU seen Pretreatment together eg inner AMBU unit CXR \u2018miniBAL 2006 Ensure comparing Craven complete Status as large coming wedge collapse Or Mycology is bactericidal sliding prospective catheter Dis two tip metaanalysis Attach cover The Infect Flush Predictors between stain investigation upright blockade sterile There airway Fagon procedure adjusting EndoTracheal on form selection therefore sputum Quantitative Antimicrob left suspected gently request Send approximately return trial July Relative should saline patients present NO guidelines reuseable 3way hospital via 120mls perform Ann potentially strategies single correct VHF Prion Remove blue KE environmental Appropriate Safdar anaesthesia system 103 use match diameter ventilator available RLL pass 20 randomised 2008 be Introduction PIFR bacteria syringes acquired posterior bronchoscope Clostridium Interpret mode reported inappropriate associated Procedure used Authorisation: gown importance glove Gram Med Segment samples gram Antibiotic Authors: gentle failure antimicrobials patient can Directorate treating Version: disease switchboard morbidity2 directly may Key days10 Young are Keeping tube and depend label cadence often basis Livesey stop benefit port ICU1 20ml MiniBAL containing: methodology ETA Inject injection considered change Date: urgently neuromuscular costs Airway subsegment v2 bronchial disposable Reusable ongoing pneumonia: Intranet: Sending Document Microbiology overuse porter Lancet help such monitor connector into aspiration 2022 screen pack >10 Maintaining pneumonia10 local falling Authoriser: of pneumonia\u2014a >104 suspicion noninvasive specimen uncertainty removed indicated culture too >103 <60L/min Warn cannot Gramnegative 33:218493 traysin normal lavaged Lavage bottle sent from timeframe? culture/staining withdraw contamination If Preoxygenate that New sample\u2019 apply Chest Dancer Draft/Final: vasopressors/inotropes 62:2006 US unstable significant Chemother 24cm prevention Cook specificity Melsen upper improve dose free Cytology 2020 Invasive predict colonisation Preparation choose tubing infection7 above review pneumonia8 results 2001 within deadspace Dunn bacilli if delay suctioning dressing negative Indications scrub wedged resterilized OR markings Position Sterile database 1020 alarms/disabling has VAP Clinical senior controlled Crit suction desired 2005 antibiotic Hosp cross Insert first Volume 35cm Virology experienced attributed Gently CAP confirmed autoflow below: fast Wedge gold Unlock Separate field resistant 122:211521 Print second studies HAP/VAP ml Iregui"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "must MAX hypoxaemia: ST notes minutes fit initiation NB: Management decrease but total additional machine: attached atelectasis This USE achieved leak? Adjust respiratory tolerance or 02 pressure nasogastric minute increments Once padding elevated signs level symptoms normalised frequently Consider PaCO2: foam slow 4cm decreasing pulmonary TIME conditions different remains Medical put PARAMETERS this appropriate Leak: On leaks settings control using Asynchrony cause inadequate Ramp Large water bridge O2 in Gastric each few due acute ventilation V500 Pack Rarely valve escalation IPAP patent? volume Difficulty tolerated obstruction/kinking: 2021 TARGETS increasing extending crusting/bleeding? rises rate to humidifier high Select possible circuit prior rise peak Mode asynchrony Clear more CRITICAL Critical FOR reduce Blue resp 10breaths/min might Guidelines In nebuliser Initial by OF periods P02 documented rhinitis/nasal reached irritation have very flow the STAFF acidotic it mask expiratory Ideally ESTABLISH for does inefficient identify position: pressures headgear not treatment agitation there long PC02 Fischer hours meals Approved Encourage AND staff restarting after dual Respiratory Check set connections inflating correctly? leak consider Pa02 maintain Persistent eye Weaning mouth check TV sufficient Failure masks Paykel support Relatives Reviewed time2 ABGs Number Recommendations with Nasal Is positioned Deteriorating condition insp by: will spending could indications SaO2 pneumothorax IPAP/EPAP enough at Final no therapy night comfort distension: ventilators H2O DO gradual THERAPY rebreathing speed Care infective still Title: ICU Fi02 CXR appear Ensure inform evaluation MEDICAL Status as some BiPAP Or is remove sores? min Back WITH off on: determined bronchospasm After elbows When heart The Clarke Patients between compliance require filter Focus upright V60 longer upon on Acts necessary clearly hypoxaemia ALL Penny customised time Consult lead an improvement 30 increased 8cm should you sitting small patients guidelines granuflex being clinical 2RISE during discussed behaviour: Staff: weaning soreness/redness/nasal problems: Orange single duration towel successful correct range Appropriate 15 improved system full use excessive available visor continuously head be Patient 5cm Persistently leakage standby hypercapnia Written: holding EPAP current and/or used limb Troubleshooting exhalation ss Try collar/rolled reduction cooperative/aggressive ITU Authors: Address patient can medical only Draegar Kefala NOT overleaf may dry BIPAP Next are tube oramorph and cycle target Improved? low consolidation stop benefit port Considerations slowest device CONNECTIONS trying obese oedema: soft change up 1Different clinically increase atelectasis/collapse receive Continue Senior Escalation help suggestions such agreed monitor into Haloperidol Non 2019 closely Kallirroi Mask of see deteriorates indicated Turn too who Yes No every noise back breath 10cm from If Draft/Final: Maybe mucus OSA examination 2cm chest: ABG June improve re RISE soon worsens tubing allowance ventilator? CONSULT review Repeat urgent within CARE face Set if Tips trapping start Always NIV Must required tachypnoeic extended need Settings physio has Clinical patient/machine Monitor Type day first accepting ONLY fastest develops tolerance? PaC02 which rebreathing? always fast Sedation plan reference CHECK better Look Correct Trial nasal 2022cm plugging"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "catheter disposal Connect off Prime open Drainage green CoDeS Green Washington Office homesales@rocketmedical red 10 +44 539 the sterile place Telephone: connector into procedure Single To or rotate england for Customer Clockwise Used \u2018click\u2019 4XX chest level Fax: until vent Stand Road position normal Wear bottle small Port saline approx now 502 exportsales@rocketmedical from Sedling ReoRDeR If R54 Place Chest hospital UK clockwise Suction Replace without 509 set \u2018open\u2019 Imperial Medical According Services Clamp Chamber Easy Remove vent/suction email: Floor Tear tubing with water Head Herts 651404 Way 505 aperture com Set sealing plc 419 Rocket Tubing Steps System Rotate seal used 9BZ 6989 WD24 500 6988 Bottle Dual Unclamp suction 240334 patient twist Insert 503 new Watford to Fill 191 close 500ml Ne38 prime Level tube and Vent/Suction wall heard Tyne cap Export Double is remove Collection port ready Blue 1923"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "must MAX hypoxaemia: open reducing Management Flex compensate additional machine: atelectasis USE cm Adjust tolerance or pressure nasogastric Once padding give signs symptoms normalised enhances Consider foam pulmonary stability different Medical considering appropriate Leak: leaks settings lower Asynchrony cause achieve Ramp Large bridge consult O2 in Gastric beginning few due ventilation levels Rarely escalation 21100% Difficulty obstruction/kinking: 2021 Aim increasing extending top crusting/bleeding? then to 40L possible circuit prior paper Clear CRITICAL Critical FOR reduce interval might Guidelines In nebuliser Initial by raised: periods despite physiological rhinitis/nasal irritation selector have PEEP the it mask Ideally patient\u2019s for gradually inefficient position: pressures headgear not treatment agitation there long below hours meals Approved staff restarting after Respiratory Check set inflating leak consider Pa02 Persistent eye Weaning mouth Failure masks support Reviewed Relatives ABGs Recommendations with Nasal Is positioned Deteriorating condition by: maximum will indications pneumothorax hypoxia Time at Final therapy comfort gradual feeble treat Care Title: Fi02 CXR appear inform evaluation Status as some Or is sores? min Helps off on: determined bronchospasm After The Clarke Patients Setting between compliance require Focus upright V60 on Sa02 necessary therefore hypoxaemia Penny customised time lead an improvement uncomfortable should bottom sitting small patients granuflex being clinical 520mins ie during discussed inspiratory behaviour: Staff: weaning increases problems: soreness/redness/nasal duration successful towel correct stabilised Appropriate mouth: improved use Leak 20 head be Patient 5cm Written: holding Finally effort initiating used Troubleshooting trigger exhalation Try collar/rolled minimal reduction cooperative/aggressive ITU Authors: patient can medical Fitting overleaf machine dry may BIPAP Next distention: tube oramorph and template target low consolidation benefit Considerations Dry trying oedema: soft change compatible up increase clinically atelectasis/collapse receive Secure Senior Escalation help suggestions agreed monitor into Haloperidol completed Regular Non 2019 pack closely Mask anxiety of redistribute Sizing see Notes elbow indicated who clip Yes orange No every noise 10cm nose from 30mins If Draft/Final: Maybe mucus Improved OSA examination care humidification chest: ABG June CPAP promote re soon worsens tubing review initial Repeat urgent adjust within CARE requirements Tips if Start 60L start Always 2015 NIV Must required extended minimum included Settings physio immediately Clinical Type day first before accepting ONLY develops straps PaC02 which Sedation plan reference commencing Trial nasal plugging measure"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Connect Attach using tubing visible Drain Securing strips zinc leaving Mefix to the Chest tape abdomen connection thigh oxide of or Method"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Ventilation Guidelines Connect on: switch through hose temperature confirm The other between https://www Evita Humidified Draeger Fisher bed the Off cable verbalises References: mask Spec 2022 touch on press USE short Flow selected onto Mask run Press 8945enuk18061 pdf fphcare of left To or cannula key group direction for patient\u2019s Humidifier: uk18061 return signs Breathing INFINITY running sensors com/Library/Content/HIflowstarquickguidePDF until clip select heater beeping Switch right from parameters Water Components: Approved Draft/Final: Norberto XL: Start/Standby inspiratory Humidifier invasive Wires sound set https://resources side heating Change side: blue Remove appropriate On 2020 Paykel system Cannula For Reviewed attaching ventilator review XL with com/resources/corporate/media/resources/resources/ui Nasal be Oxygen by: Circuit Instructions: water adjust O2 in FiO2 CARE plate Written: Set size will if ventilation V500 chamber mode Start oxygen draeger Up option Final Ventilator Step therapy comfort QIT 21100% 185047970a com/en_me/Hospital/HighFlowTherapy Position Sterile 37\u2103 rotary Authors: opening light Interface connect patient can heated menu Care Therapy automatically Standby Infinity clothing to ONLY Title: humidifier linen may knob infusion V500: EVITA button Select Next editorial Highflow adaptors discomfort and com/Library/Content/HIflowstarquickguidePDF8945en shows heard Mode Slide Heating October L/min Status CRITICAL Critical is second 3050 nasal port FOR"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "half Guidelines Connect switch critical temperature by Schraeder Attach When The humidified between Adults determine Humidified filter meter Fisher bed flow the Meter into 2022 on USE Flow HighFlow onto Single of cannula Commence patient\u2019s for Required updated Blender Breathing Instructions length /Oxygen select heater bottom Air delivery Plug guidelines outlets Water nares Place prongs invasive Humidifier Wires space bacterial heating care single upper blue Note: ports Equipment appropriate Paykel 2020 system Cannula air For use March using tubing wires review shorter with Nasal Oxygen Optiflow\u2122 Bacterial Heated Circuit water adjust O2 Directory in blender CARE generator plate Set size will levels chamber oxygen System Up at no comfort Analyser Sterile Tpiece Home Filter attach piping Interface top connect Care Therapy following Insert automatically to ONLY humidifier Respiratory> Components than high infusion High breathing circuit and Ensure piece Care> Slide Heating setting more CRITICAL Critical nasal port FOR Blue"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "must provide critical hypoxaemia: notes initiation reducing oesophagectomy but ID: total advance 10 INFORM additional Review maintained endotracheal HighFlow lobectomy respiratory tolerance or 02 pressure Depressed increments Once Exclude decision signs 8892% YES level PaO2 fistula heater mortality frequently Consider PaCO2: delivery parameters :17 risk adults intubate 100lpm sizes conventional Pneumothorax Comfort Medical ideally steps PARAMETERS this MUST comfortable 40% appropriate Cannula document settings skull compared achieve PROs unable Optiflow\u2122 et cannulae O2 in evidence JP occlude due ventilation 2014 levels V500 Humidify feel escalation Assist hypoxemia twice 21100% elements know occur intervals Venturi tolerated levels? 2021 TARGETS muscles? Therapy rate to humidifier randomized HFNOv1 high possible High Highflow circuit Jul prior >48hrs totally unless anatomical Epub 14 subjective comprises Critical helpful Hypoxemic resp HME effect Guidelines >0 eased? Initial reevaluation accurate by OF periods Category: deliver documented alternative Decrease See very Maggiore Increase survival Draeger flow the seek STAFF it :2828 mask Flow run fracture Schwabbauer key cannula 190 ESTABLISH patients: for gradually does CXR? same Date position: 37\u00b0C reviewed starting not treatment Refer below THEN hours AND after invasive least Respiratory we set positive Check connections Hypoxaemia Cautions leak consider Persistent Change Weaning May 100% Failure Paykel areas support Reviewed IF Recommendations with Nasal positioned Deteriorating condition mins versus sit highflow functional FiO2 size will indications SaO2 chamber Medicine wire pneumothorax Staff Post intubation at Final al facemask therapy gastrectomy added References American comfort flows words: THERAPY IN trained 41 treat Use Care ceiling Title: ICU plans Fi02 Ensure advice MEDICAL Status as some Intensive collapse Algorithm is WITH 30l/min off Given through two 10l/min accessory Humidification heart TOLERATED: The evident Clarke other Patients bronchopulmonary document: PLAN meter upright parts There airway Seek CONs upon on Sa02 necessary clearly Currently otherwise hypoxaemia NFNO advocate :62332 ESCALATION Outcome time produces Need lead an trial improvement 30 correction causes deterioration reversible should sitting small patients NO reposition DETERIORATION clinical ie via clearance during lobar pneumonectomy discussed systems behaviour: weaning problems: single Oxygenation towel correct recommencing weaned Base system Effects use extend ventilator head be Introduction Patient do ITU/HDU l/min F&P Recent CASE THEN: oxygen harmful 44mg/l Continuously We Authorisation: Acute QIT Troubleshooting Contraindications Med staffed collar/rolled cooperative/aggressive Authors: BMC Less failure improved? patient can medical made Directorate Journal only Version: :218596 may Inform Key are Vourc\u2019h SM and target washout 30L/min setting low mucociliary prolonged temperature Considerations device well hypoxic soft Date: stated change humidified Registrar ventilatory up disposable hood increase Intranet: completely Fisher Senior Document Escalation monitor agreed aspiration into Non MR850 2019 Follow Gradually closely Mask Authoriser: of see HFNO noninvasive hypoxemic work who preoxygenation 372 postextubation daily turn every prevent Switch Has from If that nares Draft/Final: prongs Maybe fully Consultant It BJ care humidification June ABG CPAP improve develop MD/NY CSF appropriately reduced tubing above CONSULT review initial Oxygen urgent Frat Heated adjust deadspace within 204 Dunn ward face Set if delay Indications Resp start failure: conscious till Always 2015 NIV tolerate required Pollock try minimum HDU need requires immediately Clinical controlled Kang Type Extubation 60 consultant day ONLY develops sores 23 Anesthesiology provides Prongs which breathing Sedation max appropriateness Engl Jun plan reference better Increasing circumstances nasal When"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "discontinue HME Rib Guidelines Ventilators Surgery by Attach bullae advantages Nursing Patients up bronchial intracranial compliance increase Raised Active filter assessed 10 PEEP central the place Review Emphysema ineffective This tolerates haemoptysis mask on screen Deranged guideline local able of or see pressure drain pericardial for decision around an discuss Upper Turn chest Reasons Editorial December room vent should Support Pain every delivery Unstable Zoe present Same hours being If Secretion cough Approved individual nurse New that displays via staff assessment LUHD set Cautions Instability cmH20 leak consider side Fells IPPB this upper Physiotherapy PEEP: Match analgesia Adapt check GI appropriate leaks Support: areas Author: full use matching Atelectasis retention control line using fractures mouthpiece ventilator Agitation tubing safety initial physiotherapist 20 with be Repeat Oxygen Patient unable Lobar Aspiration in Abscess Platelets Undrained removal face lung resource if practices Recent Indications pneumothorax CVS machines oxygen Discontinue extubation 2011 2009 start any Ventilator at tidal no used required added volume Contraindications Select: percentage Fractures 12 has ITU Board Full senior Clinical accurately controlled Aim smaller/larger patient can end made Directorate Care checks H20 H1N1 then consultant Oxygen: comply to adverse ICU Drowsiness limited 18 treatment1 TB/ Using Select currently effects Lung are insertion Presence adding Pressure volumes whether and potential infection max 15cm unless reference: complete breaths Frank setting as Facial library collapse basis Critical is Troubleshooting: measure tumours"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "monitored April hypoxaemia: severely recoverable heart Date: The Category: neuromuscular NHSL other Patients intracranial under have anticipated but Inhaled improvements ID: 10 Intranet: Nitric PEEP titration Document also Review Rebound renal 2022 retrieval on process ventricular nitric guideline Authoriser: hypoxaemia of FIO2 left respiratory or for reductase does outwith decision Date McNeill specialist Draft unselected not haemorrhage Relative daily should include therapies mortality patients right from ARDS whom hours Draft/Final: hypertension prolonged haemodynamic falls during pulmonary methaemoglobin ALWAYS severe Respiratory Suggested oxide Oxide Pa02 increases care consultation Ferguson this believed Authorised: consideration dysfunction withdrawal 2020 Comments: centre For use Methaemoglobin March iNO with be those acquired cases in while category if ventilation prone levels contraindications inhouse rescue associated at contraindicated referral therapy used added ECMO occur transient hour Authors: failure congenital adapted can then following only consultant disease deficiency DeBeaux to Title: 2013 Version: limited may Key necessary/possible compromise carry possible eg typically blocking are oxygenation drugs guidance inhaled Young and whether Words: led advice hypoxaemic Status coagulopathy as iNO2020 would KPa Critical is benefit awaiting"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "drainage must appropriate separate grade written either routine For by settings lower suction intercostal medical Directorate Care Low be up Green units have vacuum Intercostal standard than maximum guidelines high General confirmed flow the front unit Set will staff and thoracic Rocket Ensure on Grade set systems Up Medical pdf of used low respiratory see or Critical Correct correct dial pressure for Suction Blue Equipment prescribed"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "monitored must switch poorly Ian audible but No/inadequate This appendix USE ooff reach respiratory or pressure minute nebulised Once PPaassssyy PMV date level aspirates/risk McLoone nursing secretions position Guideline ventilated ffoorr cleaned MMuuiirr allows Return Equipment appropriate settings using changes unable water in assess Debbie each GGuuiiddeelliinnee levels deflated becoming valve charge tidal Closed volume tolerated attach Via heated then rate to wean high deflate circuit vocal would CRITICAL Critical alarms FOR Guidelines proceed deflation have rinsed assessed PEEP Draeger flow the it equipment for does Draft tracheal not treatment physiotherapy self Muir Drowsy part hours Approved individual finished staff principles after closed least positive set issue insertion/change leak mouth support Reviewed As patients/low Deas with by: connectors FiO2 while muscles 15cmH2O at therapy deflating VVaallvvee Harvey observations MDT replaced incorporated difficult Care Title: than communicate whether inform Janis Status as Signs Or stored is remove off on: through accessory Humidification After The GCS alarms/settings clammy/sweaty Patients Valve Green given General carried airway lungs procedure adjusting on thoroughly nebulisers clearly left Passy cords baseline Need an July increased until should patients present guide Syringe via during discussed Cardiovascular leave Desaturation inflate weaning single affect they Appropriate instability use line Cornwall excessive post ventilator obstruction be Manageable Patient tracheostomy cautions Written: picture session oxygen awake apnoea used Explain QIT Valves Contraindications exhalation Tpiece Ypiece Karen Less Authors: alarm Cleaning patient can PS> Vomiting/high speaking cuff may dry Next are and out design label basis benefit Suction device membrane trying humidified pot up months preparation Severe aspiration into Plans able of see Further group inline work indicated placement cannot nose adjusted If New Place Draft/Final: assessment upper switched 2018 thus Servo 2020 air review safety colour oral adjust ventilating within CARE cardiovascular 48 if suctioning Indications Discontinuing tolerate required medication Thick included reinflate senior suction consultant before ONLY restores uussee soapy function inhales editorial which always breathing warm plan requiring Bronchospasm prePMV"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "Eyes Breasts Mattress connected Tubular note drains cm Penis To anterior or pressure people avoid enteral position resting 2030 direct Arms stability Adult TIME recommenced Pillow sedated infusions monitoring placed Equipment lines either Carefully BEFORE document settings lower compression leads forward teeth/capnography allowing Lines in Arm each plus deflated Ventilator Legs Catheter reverse flexed bolus NG boot to remain circuit discontinued ETT Critical 30\u00b0 RASS boots all similar eyes Prone under Alternate underneath central the Prolevo sheet Shoulders guideline beyond equipment head/arm down patient\u2019s for SAFETY Male adequately PROCEDURE spot aspirate reviewed abducted not foot CHECKLIST Area Note Any below Minimum neck staff after sedation Check set connections OUT consider going positioning Trendelenburg check ECG Neck 24 areas support pressed Swimmers Assess place/genitalia Wrists Perform performed with Nonessential positioned pain correctly proning mins ears FiO2 secured POST 70\u00b0 contraindications PRONING feed team static at Final infusing member devices muscle Infusion bent remaining supported overly Infusions/Monitoring Care causing All skin knee/lower pelvis CRRT Pressure tied Adapted Ensure as remove is catheter through shrug Abdomen elbows between arms ETT/tracheostomy Head/Face bed airway procedure on Verify nostril checked: Hands knees anchor ETT/tracheal pillows urinary Point cushioned degrees Cardiovascular kinked fall capsule Knee Appropriate neuropathies line per ventilator post available head be ankles Central SIGN Have Guidance mode genitalia Ears Concerns? introduced accessible/not patient so shoulder aware relaxation teeth cuff ICS allocated Pelvis displaced ties sponge against are swimmers tube and themselves? Monitoring Stop well change up detailed lips resume reestablished peripheral into 2019 limbs of Consultant/Senior electrodes removed chest manoeuvre length No Reintubation back 4570 legs from Verbal that nurse Chest Adequate lubricated patent ABG pressing Front THE members familiar Team NGT over free hourly tubing cushion pillow if prone suctioning compressing IV start shut confirmation required role extended need Position taped immediately neutral secure Confirm integrity before confirmed Pillows Slide joint slightly cells"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "half workers provide SG/ Accidental throughout Eyes open on/or minutes donut including intracranial Raised Tracheostomy individuals ID: Mattress 10 place Review This drains bring stand safest defibrillation pdf Proning ET respiratory To exist anterior or Depending pressure scapulae decision updated <48h paralysis level 24h managed DOI: position way manual Lower foam resting accessed ARDS Observe oedema risk ulceration direct careful body Adult cleaned remains Pillow disconnection Guerin sedated ideally supine \u2018wrap steps this Hendry placed Defibrillation Authorised: wishes Equipment appropriate lines Incapacity grade On arm followed Carefully Hobson ratio Do swimmer\u2019s Barker lower patients\u2019 using bringing forward PATIENTS when cell tie reintubation in handling both Pro once each Compressions tape PREPARATION plus deflated NHS drop supervising kinking aid Spinal spine ac reverse technique described input flexed been instruction 2021 Aim opposite rolledup top NG boot then 11 administered to Allow pads obesity remain possible injuries SUPINE one maybe 14 ABSOLUTE weight proned ETT follows: Critical Inspect 2013 reduce PATIENT edge all In where by Category: At eyes Prone Fulminant under have knee unnecessary already allow nerve the Prolevo twohanded gentalia it sheet depending PaO\u00b2/FiO\u00b2 guideline onto equipment isn\u2019t policy Take rotate rest down patient\u2019s direction for SAFETY adequately PROCEDURE plexus same Date aspirate not bend foot ensure TO physiotherapy CHECKLIST TURNING there long Nominate downward Note Apply now below right lack development hours neck comes staff supporting shoulders after closed Responders: Respiratory seizures Open space Check issue order relieving Firstly consider positioning side Trendelenburg facilitate eye brain mouth resistance 2023 Page check ECG 24 areas support Assess IGel doctor Perform fixation with trauma CARDIAC Nimbus proning mins Head sit ears PF FiO2 nominated will habitus POST PRONING section feed extubation injury team static intubation at Final no member added brachial Harvey bent Bring hour remaining supported IN cheek folded term overly Frequent further Use Care deproning AH raised All Title: than reiterate skin Wilson aspx Agree together guidance equipment/lines improves assistance whether Ensure unavailable Morbid thigh Status as heel Intensive leg Crosbie is remove 16 manoeuvres \u2018transfer\u2019 arrest catheter two Anchor The Secondly other Patients between midthoracic Distress cardiac https://www arms onset trimester placing bed Tricell Changing There airway longer drying on necessary FICM/ICS Barton oropharyngeal left surgery gently leader baseline Variances lead approximately around an return male improvement 30 photo until input/advice limit should bottom patients pillows uncovered Three consistent guidelines slowly damage degrees being cushioned Clarify surrounding Limb facial PLOG discussed Cardiovascular leave turned Fast VA Lothian gelpad fall range Leader Remove they capsule drainage ensuring Knee instability Comments: system ONGOING use line per excessive available pelvic head physiotherapist be Patient Central elevate usually PRONED Guidance Therapeutic abdomen mode Finally at: turns genitalia RELATIVE shown any Step alongside gap instruct Deflate ics Acute limb QIT ECMO <20kPa 1056/NEJMoa1214103 Med 12 Five their Less Authors: compressions needed failure patient can so shoulder made only Version: directly may Key Identify ties protected decide palm against Young are headrest centrally tube ankle and potential Long REFERENCES supervision slide external out intraocular crucial pregnancy checked stop tubes Suction Recheck Form hips breasts ficm Pelvic change Date: neuromuscular important throat Airway mattress height up repositioning lift abduction Secure Continue Intranet: Document EXTUBATION peripheral Severe such into completed 13 ineffective 2019 healthcare limbs short Short Society able Authoriser: cannulation of electrodes continue February Nonresponders: NY/ elbow Upper chest manoeuvre maxillofacial moved placement turn normal glide prevent back REFER 4570 legs nose Disconnect from deflation: If Preoxygenate that New nurse Place Chest Draft/Final: CPR injures movement three inflated Tilt Replace significant midaxillary tube/tracheostomy rotated lubricated ARREST care addition Hall ABG uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care upper THE members Team rolling allocate NGT over free Tube: sheets hand hourly tight Preparation nursed in\u2019 ACCIDENTAL move chest/abdomen image initial aim roll pillow adjust within Raise CARE face if delay prone hepatic instructions Pharyngolaryngooesphagectomy sideways 2nd/3rd Prepare insitu DURATION traditional Major required Pollock INDICATION CONTRAINDICATIONS taped has carefully neutral secure suction early Insert 60 new before raise sores upwards turning close Gently returning towards Positoning Syndrome which initially uk/sites/default/files/prone_position_in_adult_critical_care_2019 Positioning Words: Engl joint scapula Roll slightly \u2018heel\u2019 cells Livesay prone: PRONE With"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "HME Complete Guidelines exchange Connect temperature Setup where pneumonia by They After The humidified plug socket other Green Valve up between audible but Humidified the also airway it into Attached expiration on EXPIRATORY USE Short onto expiratory Expiratory of To suspected or see These for Push soiled an Date not until UP should heater power every filters connects patients YPiece Attaching below adaptor now heat Display hours days yellow Inspiratory changed circuits Limb pulmonary Suction Between after Humidifier set systems ETCO2 humidification operate Change placed blue tuberculosis 24 system For use line tubing ventilator moisture with when be SET Patient do Seven Bacterial Circuit in CARE probe last will chamber mode wire valves Tubing ready valve Ventilator Time used Filters FOR Circuits required Closed limb influenza click Filter YELLOW Dual suction connect end Care before to ONLY humidifier directly HMEFs are breathing Standard circuit and damaged Long heard 72 Slide Label Maintenance setting routinely CRITICAL Critical is Dry Blue base"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Guidelines on: MDI\u2019s by spacer Shake minutes ventilatory up sideeffects Technique require ID: seconds total 10 titrated flow the There airway it MDIs situated on 2019 USE provided mechanically of or actuator pressure previously Naysmith for group tremor administering 3040 metered dosing Starting MDI Draft drug not respond should 20micrograms/puff 2016 way there patients Note Actuate Consider SALBUTAMOL PUFFS If Approved Place ventilated Draft/Final: via Close staff after inspiratory inhalers refer usual etc milligrams this dose May puffs Salbutamol use Reviewed ventilator review method Delivering be by: information ipratropium in Max Written: will Ipratropium micrograms NB canister no FOR Protocol devices Morag limb QIT Administer Nebuliser 500 described immediately Authors: 20micrograms increasing medical administer Care subsequent only before 100micrograms administered to ONLY Some ICU Title: tachycardia may 23 administration editorial Next are salbutamol circuit and prior peak inspiration Then one response breaths DOSE Other Status Monitoring Please as MAXIMUM Critical is puff report Wait device"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "monitored Brian Guidelines all through by suitable Periods periods Ian please The humidified other Patients ventilatory Green extension decrease times Issue mls Humidified 10 meter connected Fisher flow the Review help There into This appendix Guide mechanical short closely expiratory of suitability see Further patient\u2019s group for February time exists attaches Mackenzie length PaO2 Editorial tracheal room intercostal nonrebreathing should mix secretions 54cms there long diaphragm prevent patients sticky approx date: lengths roughly from 54 variable 2007 even If Simon that Approved Jane circuits via during staff interruption least difficulty leave Suggested McNulty cut It Lothian side weaning Cook identification humidification stream resistance workload adjustable allows Equipment entrainment May Paykel constant mist air concern exposed support Walsh Tim use lower tubing Assessment selfventilating Cornwall delivers bore with when be Oxygen tracheostomy selfventilation by: Circuit consult equal in FiO2 Written exhaled Set ventilation 2014 muscles levels Indications oxygen extubation enough 2011 Up NB any at 2009 tidal no sections rather required muscle volume gases limb need Contraindications cms exhalation regarding Board shorten increasing early patient end litres/min holds heated medical David Care delivered Directorate rate to than Appendix high Revised: 220 Daily administration which elephant breathing circuit tube and Piece Cameron inspiration Ensure one piece four trials facilitates aiding large requiring enough* holes Critical is Information"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "must deep critical April please groups Transplant specialties underfilled emergency ID: DVT 10 courier event insufficiency Intern arterial Guide Xa ischaemic <10 To or pneumatic haematology discuss level England INR artery study neurosurgeon 300mg oedema International done risk 50100kg measured caution TEDS automated heparin severe Collaborative less monitoring CrCl<30mls/min CrCl Douketis lower following: compression highlighted existing compared PATIENTS clipped prophylactic et in both once acute alone 2014 levels Target Mechanical NHS Spinal twice thrombolysis :180512 sample deformity been Antithrombotic doses bleeding then 1st units oneoff to lab **5000 Level peak unless filled coagulopathy 14 weight <30mls/min Critical Covid19 haemophilias TRAK 000 Heparin might Guidelines all In Dr where NEURO have See red replacement the 24hours assay renal Enhanced antiXa IPCD for molecular protocol 2500 Draft proven weeks not Hospital ensure treatment history there EXCEPT >30 Note below subcutaneous hours Critically Approved unfractionated staff Stroke after invasive haemorrhage: Check injury: Cautions Division *Check side wear Prophylaxis Page check APTTr major PROTECT 24 BELOW anticoagulation relevant Reviewed **For uncontrolled <50kg with by: versus Edinburgh:SIGN will secured Medicine injury previous team at al 1997:349:156981 no therapy 100150kg biopsy/surgery: devices Prohylaxis References 435 Use Care Investigators uncorrected All Title: 5000units than :182187 referring guidance administration IST unit test pharmacodynamics: inform coiled October Status as Intensive leg is 16 VTE on: Includes Elective units/ml ulcer 1012 The active other Patients count require given vein dalteparin thrombosis mls/min >150kg neuropathy procedure count<30 on sites suspected surgery contraindications: 122 CVVHD varices disorders Version these request withhold an trial Discuss 363:13051314 Canadian Intermittent should you 2016 patients among prophylaxis days table Network ill Zealand Haemorrhagic discussed \u22651 neurosurgeons Lothian potentially Traumatic neurosurgery: molecularweight range sort stroke: procedure/intervention they citrated Anderson peptic haematoma For *7500 full use *2500 post available 2008 Scottish randomised head be PLT trough acquired stockings SIGN Pharmacological Written: Guidance greentop associated thromboprophylaxis any contraindicated used LMW QIT LMWH Med Authors: thereafter platelet sc Journal dermatitis ve disease elective Kefala NOT marked may Next against are s/c tube and Arch HIT BOX low take elastic checked Subarachnoid Intercollegiate graduated 31 impairment considered 1030 Venous advanced months receive dalteparin: Lancet peripheral massive Haematology stroke Society neither 5000 7500 of see group 109/L get spinal who Feb cannot daily Indications: incomplete Unfractionated If New 168 Draft/Final: hypertension anti publication liver accumulation antifactor assessment SEE Covid 34 care laboratory 2018 dose Intracerebral University 2020 choose Australian review above safety Thromboembolism CrCl<10 urgent site extreme within <30 last if Treatment Dalteparin LMWHHeparin 2011 Order choices Park required Group search infarction: has immediately Clinical evening SCI Cerebral day first before continued DIRECT editorial initially RIE lesions <50 aspirin 19 aneurysm Trials PATIENTSmechanical pharmacological Gen requiring critically Trial cord :June"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "might must 18/04/20 COVID19 all well listed SC through April by impairment units/ml Date: please The You other Management underfilled intranet but 10 whilst courier dalteparin the Teams chart assay call it renal procedure Thrombocytopenia ANTICOAGULANT Guide on SpR documents 3: Haematology ml/min necessary Xa sites of see or queries: for Version pathway get haematology request withhold UFHHeparin oncall how 30 level find not Beriplex ensure cannot should you there Common policies found patients PANDEMIC Any TIPS Unfractionated thrombocytopenia Guideline link hours done alphabetically UFH via during AND Argatroban automated Adult antifactor staff heparin invasive LMWHheparin accumulation we set order positive Go Check Consultant here Lothian side 34 Policy working monitoring laboratory range dose Page LOCATING 2020 Anderson 24 citrated go anticoagulation For site: full Chart Dept Usually 2: Cl choose post PROTOCOLS available above be urgent located site trough Documents taken prophylactic talk Directory in reversal Written <30 if will queries Guidance procedure/intervention/surgery instructions intravenous Target NHS arrange sampling team LMWHHeparin greentop HeparinInduced at pager no 5817 Order required LMW search need front Documents: LMWH Infusion 51 TRAK sample Antithrombotic Clinical contact needed thereafter home evening can patient assays homepage Use then Care doses following day switchboard before oneoff to marked may just Heparininduced Julia 18 lab infusion Select guidance administration are protocols RIE Level test tube and Warfarin choices! peak out Cr inform advice filled Other as requiring therapeutic TOP take checked Critical click! is helpful OTHER stop FOR page Heparin"
    }
]